,trial_id,trial_status,pcd,scd,reg_results_status,other_results_1,other_results_2,secondary_ids,countries,web_address,relevent_comp_date,tabular_results,potential_other_results
0,NCT04246242,,,,,,,,,https://clinicaltrials.gov/show/NCT04246242,,0,0
1,NCT04252885,Completed,2020-04-30,2020-05-31,No Results Posted,,,['GZ8H-V1.0 20200122'],,https://clinicaltrials.gov/show/NCT04252885,2020-04-30,0,0
2,NCT04260594,Not yet recruiting,2020-07-01,2020-12-30,No Results Posted,,,['Abdrcspc202001'],,https://clinicaltrials.gov/show/NCT04260594,2020-07-01,0,0
3,NCT04261426,Not yet recruiting,2020-04-30,2020-06-30,No Results Posted,,,['IVIG-001'],,https://clinicaltrials.gov/show/NCT04261426,2020-04-30,0,0
4,NCT04261907,Not yet recruiting,2020-05-31,2020-06-30,No Results Posted,,,['ASC09F-CTP-ZY-01'],,https://clinicaltrials.gov/show/NCT04261907,2020-05-31,0,0
5,NCT04268537,Not yet recruiting,2020-04-30,2020-10-31,No Results Posted,,,['2020YFC0841300-03'],,https://clinicaltrials.gov/show/NCT04268537,2020-04-30,0,0
6,NCT04273529,Not yet recruiting,2020-05-30,2020-06-30,No Results Posted,,"['Bartlett JB, Dredge K, Dalgleish AG. The evolution of thalidomide and its IMiD derivatives as anticancer agents. Nat Rev Cancer. 2004 Apr;4(4):314-22. doi: 10.1038/nrc1323. Review.']",['20200214-COVID-19-M-T'],,https://clinicaltrials.gov/show/NCT04273529,2020-05-30,0,1
7,NCT04273581,Not yet recruiting,2020-04-30,2020-05-30,No Results Posted,,,['20200214-COVID-19-S-T'],,https://clinicaltrials.gov/show/NCT04273581,2020-04-30,0,0
8,NCT04275245,Recruiting,2020-12-31,2020-12-31,No Results Posted,,,['20200101'],,https://clinicaltrials.gov/show/NCT04275245,2020-12-31,0,0
9,NCT04279197,Recruiting,2022-12-01,2022-12-01,No Results Posted,,,['Fzhy-ncp-2'],,https://clinicaltrials.gov/show/NCT04279197,2022-12-01,0,0
10,NCT04280588,Recruiting,2020-07-01,2020-07-01,No Results Posted,,,"['MRCTA, ECFAH of FMU [2020]027']",,https://clinicaltrials.gov/show/NCT04280588,2020-07-01,0,0
11,NCT04276987,Not yet recruiting,2020-05-31,2020-07-31,No Results Posted,,,['MEXCOVID'],,https://clinicaltrials.gov/show/NCT04276987,2020-05-31,0,0
12,NCT04281693,Not yet recruiting,2020-03-01,2020-03-01,No Results Posted,,,['307-nCoV'],,https://clinicaltrials.gov/show/NCT04281693,2020-03-01,0,0
13,NCT04282902,Recruiting,2020-04-30,2020-06-01,No Results Posted,,"['Dewage SNV, Organ L, Koumoundouros E, Derseh HB, Perera KUE, Samuel CS, Stent AW, Snibson KJ. The efficacy of pirfenidone in a sheep model of pulmonary fibrosis. Exp Lung Res. 2019 Nov - Dec;45(9-10):310-322. doi: 10.1080/01902148.2019.1695019. Epub 2019 Nov 25.', 'Lehmann M, Buhl L, Alsafadi HN, Klee S, Hermann S, Mutze K, Ota C, Lindner M, Behr J, Hilgendorff A, Wagner DE, K√∂nigshoff M. Differential effects of Nintedanib and Pirfenidone on lung alveolar epithelial cell function in ex vivo murine and human lung tissue cultures of pulmonary fibrosis. Respir Res. 2018 Sep 15;19(1):175. doi: 10.1186/s12931-018-0876-y.', 'Ikeda S, Sekine A, Baba T, Katano T, Tabata E, Shintani R, Sadoyama S, Yamakawa H, Oda T, Okuda R, Kitamura H, Iwasawa T, Takemura T, Ogura T. Negative impact of anorexia and weight loss during prior pirfenidone administration on subsequent nintedanib treatment in patients with idiopathic pulmonary fibrosis. BMC Pulm Med. 2019 Apr 11;19(1):78. doi: 10.1186/s12890-019-0841-7.', 'Epstein Shochet G, Wollin L, Shitrit D. Fibroblast-matrix interplay: Nintedanib and pirfenidone modulate the effect of IPF fibroblast-conditioned matrix on normal fibroblast phenotype. Respirology. 2018 Aug;23(8):756-763. doi: 10.1111/resp.13287. Epub 2018 Mar 12.']",['huilanz_76'],,https://clinicaltrials.gov/show/NCT04282902,2020-04-30,0,1
14,NCT04286503,Not yet recruiting,2021-02-28,2021-02-28,No Results Posted,,,['BeijingYouan Hospital'],,https://clinicaltrials.gov/show/NCT04286503,2021-02-28,0,0
15,NCT04293887,Not yet recruiting,2020-05-30,2020-06-30,No Results Posted,,"['Falzarano D, de Wit E, Rasmussen AL, Feldmann F, Okumura A, Scott DP, Brining D, Bushmaker T, Martellaro C, Baseler L, Benecke AG, Katze MG, Munster VJ, Feldmann H. Treatment with interferon-Œ±2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques. Nat Med. 2013 Oct;19(10):1313-7. doi: 10.1038/nm.3362. Epub 2013 Sep 8.', 'Kim UJ, Won EJ, Kee SJ, Jung SI, Jang HC. Combination therapy with lopinavir/ritonavir, ribavirin and interferon-Œ± for Middle East respiratory syndrome. Antivir Ther. 2016;21(5):455-9. doi: 10.3851/IMP3002. Epub 2015 Oct 22.', 'Shalhoub S, Farahat F, Al-Jiffri A, Simhairi R, Shamma O, Siddiqi N, Mushtaq A. IFN-Œ±2a or IFN-Œ≤1a in combination with ribavirin to treat Middle East respiratory syndrome coronavirus pneumonia: a retrospective study. J Antimicrob Chemother. 2015 Jul;70(7):2129-32. doi: 10.1093/jac/dkv085. Epub 2015 Apr 21.', 'Min CK, Cheon S, Ha NY, Sohn KM, Kim Y, Aigerim A, Shin HM, Choi JY, Inn KS, Kim JH, Moon JY, Choi MS, Cho NH, Kim YS. Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity. Sci Rep. 2016 May 5;6:25359. doi: 10.1038/srep25359.']",['Zhaojp'],,https://clinicaltrials.gov/show/NCT04293887,2020-05-30,0,1
16,NCT04295551,Not yet recruiting,2020-07-14,2021-04-14,No Results Posted,,,['QF-XYP1990-1'],,https://clinicaltrials.gov/show/NCT04295551,2020-07-14,0,0
17,NCT04296643,Not yet recruiting,2020-12-01,2021-01-01,No Results Posted,,,['20006014'],,https://clinicaltrials.gov/show/NCT04296643,2020-12-01,0,0
18,NCT04264533,Recruiting,2020-09-30,2020-09-30,No Results Posted,,,['2020001'],,https://clinicaltrials.gov/show/NCT04264533,2020-09-30,0,0
19,NCT04299724,Recruiting,2023-07-31,2024-12-31,No Results Posted,,,['GIMI-IRB-20002'],,https://clinicaltrials.gov/show/NCT04299724,2023-07-31,0,0
20,NCT04302519,Not yet recruiting,2021-06-30,2021-07-30,No Results Posted,,,['KT005HB001'],,https://clinicaltrials.gov/show/NCT04302519,2021-06-30,0,0
21,NCT04251767,Withdrawn,2020-04-30,2020-04-30,No Results Posted,,,['WMT-YJ-202001'],,https://clinicaltrials.gov/show/NCT04251767,2020-04-30,0,0
22,NCT04254874,Recruiting,2020-06-01,2020-07-01,No Results Posted,,,['TJ20200131'],,https://clinicaltrials.gov/show/NCT04254874,2020-06-01,0,0
23,NCT04255017,Recruiting,2020-06-01,2020-07-01,No Results Posted,,,['TJ20200128'],,https://clinicaltrials.gov/show/NCT04255017,2020-06-01,0,0
24,NCT04261270,Recruiting,2020-05-01,2020-07-01,No Results Posted,,,['ASC09F-CTP-TJ-01'],,https://clinicaltrials.gov/show/NCT04261270,2020-05-01,0,0
25,NCT04263402,Recruiting,2020-06-01,2020-07-01,No Results Posted,,,['TJ20200201'],,https://clinicaltrials.gov/show/NCT04263402,2020-06-01,0,0
26,NCT04264858,Not yet recruiting,2020-04-30,2020-05-31,No Results Posted,,,['WuhanUH-2019 nCoV-Ig'],,https://clinicaltrials.gov/show/NCT04264858,2020-04-30,0,0
27,NCT04276896,Recruiting,2023-07-31,2024-12-31,No Results Posted,,,['GIMI-IRB-20001'],,https://clinicaltrials.gov/show/NCT04276896,2023-07-31,0,0
28,NCT04287686,Withdrawn,2020-04-01,2020-04-01,No Results Posted,"['Zhang X, Li S, Niu S. ACE2 and COVID-19 and the resulting ARDS. Postgrad Med J. 2020 Jun 10. pii: postgradmedj-2020-137935. doi: 10.1136/postgradmedj-2020-137935. [Epub ahead of print] Review.']",,['GIRH-APN01'],,https://clinicaltrials.gov/show/NCT04287686,2020-04-01,0,1
29,NCT04291053,Not yet recruiting,2020-08-01,2020-09-01,No Results Posted,,,['TJ-IRB20200205'],,https://clinicaltrials.gov/show/NCT04291053,2020-08-01,0,0
30,NCT04293692,Withdrawn,2020-02-25,2020-02-25,No Results Posted,,,['Pr20200225'],,https://clinicaltrials.gov/show/NCT04293692,2020-02-25,0,0
31,NCT04304313,Recruiting,2020-03-01,2020-11-09,No Results Posted,,,['GST-G1'],,https://clinicaltrials.gov/show/NCT04304313,2020-03-01,0,0
32,NCT04308317,Enrolling by invitation,2021-03-01,2021-05-01,No Results Posted,,,['TT-NPC'],,https://clinicaltrials.gov/show/NCT04308317,2021-03-01,0,0
33,NCT04313322,Recruiting,2020-06-30,2020-09-30,No Results Posted,,,['COVID-19'],,https://clinicaltrials.gov/show/NCT04313322,2020-06-30,0,0
34,NCT04316728,Not yet recruiting,2020-09-01,2020-11-01,No Results Posted,,,['VivaDiag-2020'],,https://clinicaltrials.gov/show/NCT04316728,2020-09-01,0,0
35,NCT04290871,Withdrawn,2021-03-01,2022-03-01,No Results Posted,,,['NO-SARS-COVID-19'],,https://clinicaltrials.gov/show/NCT04290871,2021-03-01,0,0
36,NCT04305106,Recruiting,2020-06-30,2020-07-31,No Results Posted,,,['QLEmer'],,https://clinicaltrials.gov/show/NCT04305106,2020-06-30,0,0
37,NCT04319900,Recruiting,2020-04-30,2020-06-25,No Results Posted,,,['2020-K-24-2'],,https://clinicaltrials.gov/show/NCT04319900,2020-04-30,0,0
38,NCT04322344,Recruiting,2020-06-30,2020-08-30,No Results Posted,,,['covid-19 add-on therapy'],,https://clinicaltrials.gov/show/NCT04322344,2020-06-30,0,0
39,NCT04323332,Not yet recruiting,2020-03-01,2020-04-01,No Results Posted,,,['2020XLA015-1'],,https://clinicaltrials.gov/show/NCT04323332,2020-03-01,0,0
40,NCT04323514,Recruiting,2021-03-13,2021-03-13,No Results Posted,,,['3143'],,https://clinicaltrials.gov/show/NCT04323514,2021-03-13,0,0
41,NCT04323631,Withdrawn,2020-04-30,2020-04-30,No Results Posted,,,['0154-20-RMB'],,https://clinicaltrials.gov/show/NCT04323631,2020-04-30,0,0
42,NCT04324996,Recruiting,2020-05-31,2020-09-30,No Results Posted,,,['ChongqingPublicHMC'],,https://clinicaltrials.gov/show/NCT04324996,2020-05-31,0,0
43,NCT04275414,Recruiting,2020-04-01,2020-05-01,No Results Posted,,,['QLEmer20200214'],,https://clinicaltrials.gov/show/NCT04275414,2020-04-01,0,0
44,NCT04298060,Not yet recruiting,2021-03-01,2022-09-01,No Results Posted,,,['DAS181-2-07'],,https://clinicaltrials.gov/show/NCT04298060,2021-03-01,0,0
45,NCT04320238,Recruiting,2020-05-01,2020-06-01,No Results Posted,,,['Interferon_prophylaxis'],,https://clinicaltrials.gov/show/NCT04320238,2020-05-01,0,0
46,NCT04324528,Recruiting,2020-09-26,2020-11-26,No Results Posted,,,['CYCOV'],,https://clinicaltrials.gov/show/NCT04324528,2020-09-26,0,0
47,NCT04325867,Recruiting,2020-10-01,2020-10-01,No Results Posted,,,['GTP0032'],,https://clinicaltrials.gov/show/NCT04325867,2020-10-01,0,0
48,NCT04326036,Enrolling by invitation,2021-11-01,2021-12-31,No Results Posted,,,['GARM COVID19'],,https://clinicaltrials.gov/show/NCT04326036,2021-11-01,0,0
49,NCT04326075,Not yet recruiting,2020-10-05,2020-11-09,No Results Posted,,,['EC-COVID-RCT-Fenice'],,https://clinicaltrials.gov/show/NCT04326075,2020-10-05,0,0
50,NCT04326452,Recruiting,2020-05-01,2020-06-01,No Results Posted,,,"['COVID19PEEP2020', 'GO2 PEEP Study ( Other Identifier: GO2 Devices )']",,https://clinicaltrials.gov/show/NCT04326452,2020-05-01,0,0
51,NCT04327349,Enrolling by invitation,2020-05-20,2020-09-30,No Results Posted,,,"['IR.MAZUMS.REC.1399.7330', 'IRCT20181104041551N1 ( Registry Identifier: Iranian Registry of Clinical Trials (IRCT) )']",,https://clinicaltrials.gov/show/NCT04327349,2020-05-20,0,0
52,NCT04328272,Not yet recruiting,2020-05-28,2020-06-28,No Results Posted,,,['Ath/ct101/22/3'],,https://clinicaltrials.gov/show/NCT04328272,2020-05-28,0,0
53,NCT04330144,Not yet recruiting,2021-03-30,2022-03-30,No Results Posted,,,['3-2020-0036'],,https://clinicaltrials.gov/show/NCT04330144,2021-03-30,0,0
54,NCT04330586,Not yet recruiting,2020-06-30,2020-09-30,No Results Posted,,,['KUMC-COVID-19'],,https://clinicaltrials.gov/show/NCT04330586,2020-06-30,0,0
55,NCT04331613,Recruiting,2020-12-01,2020-12-01,No Results Posted,,,['ChineseASZQ-006'],,https://clinicaltrials.gov/show/NCT04331613,2020-12-01,0,0
56,NCT04332666,Not yet recruiting,2020-05-30,2020-06-15,No Results Posted,,,['P2020/201'],,https://clinicaltrials.gov/show/NCT04332666,2020-05-30,0,0
57,NCT04333251,Not yet recruiting,2022-12-31,2022-12-31,No Results Posted,,,['020-123'],,https://clinicaltrials.gov/show/NCT04333251,2022-12-31,0,0
58,NCT04333472,Not yet recruiting,2020-06-06,2020-07-06,No Results Posted,,,['CAN-COR-1'],,https://clinicaltrials.gov/show/NCT04333472,2020-06-06,0,0
59,NCT04335201,Not yet recruiting,2020-09-30,2020-12-31,No Results Posted,,,['DEFI-VID19'],,https://clinicaltrials.gov/show/NCT04335201,2020-09-30,0,0
60,NCT04252274,Recruiting,2020-08-31,2020-12-31,No Results Posted,,,['DC-COVID-19'],,https://clinicaltrials.gov/show/NCT04252274,2020-08-31,0,0
61,NCT04261517,Completed,2020-02-25,2020-02-25,No Results Posted,"['Chen J, Liu D, Liu L, Liu P, Xu Q, Xia L, Ling Y, Huang D, Song S, Zhang D, Qian Z, Li T, Shen Y, Lu H. [A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 May 25;49(2):215-219. Chinese.']",,['HC-COVID-19'],,https://clinicaltrials.gov/show/NCT04261517,2020-02-25,0,1
62,NCT04291729,Completed,2020-03-19,2020-03-19,No Results Posted,,,['ASC-CTP-NC-01'],,https://clinicaltrials.gov/show/NCT04291729,2020-03-19,0,0
63,NCT04306055,Completed,2020-03-13,2020-04-03,No Results Posted,,,['Blood donor recruitment'],,https://clinicaltrials.gov/show/NCT04306055,2020-03-13,0,0
64,NCT04310228,Recruiting,2020-05-01,2020-05-01,No Results Posted,,,['2020YFC0844100'],,https://clinicaltrials.gov/show/NCT04310228,2020-05-01,0,0
65,NCT04315480,"Active, not recruiting",2020-04-09,2020-05-01,No Results Posted,,,['TOCICOV-1'],,https://clinicaltrials.gov/show/NCT04315480,2020-04-09,0,0
66,NCT04317092,Recruiting,2020-12-19,2022-12-19,No Results Posted,,,"['TOCIVID-19', '2020-001110-38 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04317092,2020-12-19,0,0
67,NCT04322773,Recruiting,2021-06-01,2021-06-01,No Results Posted,,,['APPI2-CV-2020-01'],,https://clinicaltrials.gov/show/NCT04322773,2021-06-01,0,0
68,NCT04324021,Recruiting,2020-07-01,2020-09-01,No Results Posted,,,"['Sobi.IMMUNO-101', '2020-001167-93 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04324021,2020-07-01,0,0
69,NCT04325672,Withdrawn,2022-12-31,2022-12-31,No Results Posted,,,['20-002864'],,https://clinicaltrials.gov/show/NCT04325672,2022-12-31,0,0
70,NCT04328012,Recruiting,2021-01-01,2021-04-01,No Results Posted,,,['1581969'],,https://clinicaltrials.gov/show/NCT04328012,2021-01-01,0,0
71,NCT04330300,Suspended,2021-07-31,2021-12-01,No Results Posted,,,['C.A. 2348'],,https://clinicaltrials.gov/show/NCT04330300,2021-07-31,0,0
72,NCT04330495,Not yet recruiting,2020-11-06,2020-11-06,No Results Posted,,,['EnCOVID-HidroxiCLOROQUINA'],,https://clinicaltrials.gov/show/NCT04330495,2020-11-06,0,0
73,NCT04331470,Recruiting,2020-04-20,2020-05-20,No Results Posted,,,['97548'],,https://clinicaltrials.gov/show/NCT04331470,2020-04-20,0,0
74,NCT04331665,Not yet recruiting,2020-10-30,2021-01-31,No Results Posted,,,"['U-DEPLOY: RUX-COVID', '20-5315 ( Other Identifier: University Health Network )']",,https://clinicaltrials.gov/show/NCT04331665,2020-10-30,0,0
75,NCT04331834,Recruiting,2020-10-03,2020-10-30,No Results Posted,,,['PrEP_COVID'],,https://clinicaltrials.gov/show/NCT04331834,2020-10-03,0,0
76,NCT04332094,Recruiting,2020-09-01,2020-10-01,No Results Posted,,,['IIBSP-COV-2020-23'],,https://clinicaltrials.gov/show/NCT04332094,2020-09-01,0,0
77,NCT04333407,Recruiting,2021-03-30,2021-03-30,No Results Posted,,,['20HH5868'],,https://clinicaltrials.gov/show/NCT04333407,2021-03-30,0,0
78,NCT04334005,Not yet recruiting,2020-06-30,2020-06-30,No Results Posted,,,['COVITD-19'],,https://clinicaltrials.gov/show/NCT04334005,2020-06-30,0,0
79,NCT04334382,Recruiting,2020-12-31,2021-12-31,No Results Posted,,,['1051360'],,https://clinicaltrials.gov/show/NCT04334382,2020-12-31,0,0
80,NCT04336254,Recruiting,2020-12-31,2021-03-31,No Results Posted,"['Ye Q, Wang H, Xia X, Zhou C, Liu Z, Xia ZE, Zhang Z, Zhao Y, Yehenala J, Wang S, Zhou G, Hu K, Wu B, Wu CT, Wang S, He Y. Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II). Trials. 2020 Jun 12;21(1):520. doi: 10.1186/s13063-020-04380-5.']",,"['2020K-G005', 'hDPSC-CoVID-2019-02-2020 ( Other Identifier: Renmin Hospital of Wuhan University )']",,https://clinicaltrials.gov/show/NCT04336254,2020-12-31,0,1
81,NCT04336462,Recruiting,2020-02-21,2020-08-01,No Results Posted,,,['JT202002LZ'],,https://clinicaltrials.gov/show/NCT04336462,2020-02-21,0,0
82,NCT04336904,"Active, not recruiting",2020-07-01,2020-07-01,No Results Posted,,,['HS216C17-PHASE III'],,https://clinicaltrials.gov/show/NCT04336904,2020-07-01,0,0
83,NCT04337216,,,,,,,,,https://clinicaltrials.gov/show/NCT04337216,,0,0
84,NCT04337541,Recruiting,2020-07-01,2020-07-01,No Results Posted,,,['2020-04-02'],,https://clinicaltrials.gov/show/NCT04337541,2020-07-01,0,0
85,NCT04338698,Not yet recruiting,2020-09-01,2020-11-30,No Results Posted,,,['12(06)/2016-Coord'],,https://clinicaltrials.gov/show/NCT04338698,2020-09-01,0,0
86,NCT04338802,Not yet recruiting,2020-05-04,2020-08-01,No Results Posted,,,['huilanz Zhang'],,https://clinicaltrials.gov/show/NCT04338802,2020-05-04,0,0
87,NCT04338906,Not yet recruiting,2021-06-01,2021-12-31,No Results Posted,,,['CLOCC-2020'],,https://clinicaltrials.gov/show/NCT04338906,2021-06-01,0,0
88,NCT04339660,Recruiting,2020-06-30,2020-06-30,No Results Posted,,,['Pr20200402'],,https://clinicaltrials.gov/show/NCT04339660,2020-06-30,0,0
89,NCT04341038,Recruiting,2020-06-01,2020-07-01,No Results Posted,,,"['TACRO-BELL-COVID', '2020-001445-39 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04341038,2020-06-01,0,0
90,NCT04341207,Recruiting,2022-04-01,2022-04-01,No Results Posted,,,"['2020-001250-21', '2020/3078 ( Other Identifier: CSET number )']",,https://clinicaltrials.gov/show/NCT04341207,2022-04-01,0,0
91,NCT04342221,Recruiting,2021-03-01,2022-02-01,No Results Posted,,,"['COV-HCQ', '2020-001224-33 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04342221,2021-03-01,0,0
92,NCT04343677,,,,,,,,,https://clinicaltrials.gov/show/NCT04343677,,0,0
93,NCT04344080,Recruiting,2020-12-01,2021-02-01,No Results Posted,,,"['CYTOCOV-19', 'U1111-1250-2078 ( Registry Identifier: UTN )', 'DRKS00021199 ( Registry Identifier: DRKS )']",,https://clinicaltrials.gov/show/NCT04344080,2020-12-01,0,0
94,NCT04252118,Recruiting,2020-12-01,2021-12-01,No Results Posted,,,['2020003D'],,https://clinicaltrials.gov/show/NCT04252118,2020-12-01,0,0
95,NCT04252664,Suspended,2020-04-10,2020-04-27,No Results Posted,,,['CAP-China remdesivir 1'],,https://clinicaltrials.gov/show/NCT04252664,2020-04-10,0,0
96,NCT04257656,Terminated,2020-03-30,2020-04-10,No Results Posted,"['Wang Y, Zhou F, Zhang D, Zhao J, Du R, Hu Y, Cheng Z, Gao L, Jin Y, Luo G, Fu S, Lu Q, Du G, Wang K, Lu Y, Fan G, Zhang Y, Liu Y, Ruan S, Liu W, Jaki T, Hayden FG, Horby PW, Cao B, Wang C. Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial. Trials. 2020 May 24;21(1):422. doi: 10.1186/s13063-020-04352-9.', 'Wang Y, Zhang D, Du G, Du R, Zhao J, Jin Y, Fu S, Gao L, Cheng Z, Lu Q, Hu Y, Luo G, Wang K, Lu Y, Li H, Wang S, Ruan S, Yang C, Mei C, Wang Y, Ding D, Wu F, Tang X, Ye X, Ye Y, Liu B, Yang J, Yin W, Wang A, Fan G, Zhou F, Liu Z, Gu X, Xu J, Shang L, Zhang Y, Cao L, Guo T, Wan Y, Qin H, Jiang Y, Jaki T, Hayden FG, Horby PW, Cao B, Wang C. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2020 May 16;395(10236):1569-1578. doi: 10.1016/S0140-6736(20)31022-9. Epub 2020 Apr 29. Erratum in: Lancet. 2020 May 30;395(10238):1694.']",,['CAP-China remdesivir 2'],,https://clinicaltrials.gov/show/NCT04257656,2020-03-30,0,1
97,NCT04273646,Not yet recruiting,2020-06-30,2022-02-15,No Results Posted,,,['202001'],,https://clinicaltrials.gov/show/NCT04273646,2020-06-30,0,0
98,NCT04276688,Completed,2020-03-30,2020-03-31,No Results Posted,"['Hung IF, Lung KC, Tso EY, Liu R, Chung TW, Chu MY, Ng YY, Lo J, Chan J, Tam AR, Shum HP, Chan V, Wu AK, Sin KM, Leung WS, Law WL, Lung DC, Sin S, Yeung P, Yip CC, Zhang RR, Fung AY, Yan EY, Leung KH, Ip JD, Chu AW, Chan WM, Ng AC, Lee R, Fung K, Yeung A, Wu TC, Chan JW, Yan WW, Chan WM, Chan JF, Lie AK, Tsang OT, Cheng VC, Que TL, Lau CS, Chan KH, To KK, Yuen KY. Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial. Lancet. 2020 May 30;395(10238):1695-1704. doi: 10.1016/S0140-6736(20)31042-4. Epub 2020 May 10.']",,['UW-20-074'],,https://clinicaltrials.gov/show/NCT04276688,2020-03-30,0,1
99,NCT04280224,Recruiting,2020-09-30,2020-12-30,No Results Posted,,,['xinxiangM'],,https://clinicaltrials.gov/show/NCT04280224,2020-09-30,0,0
100,NCT04299152,Not yet recruiting,2020-10-09,2020-11-10,No Results Posted,,,['2020-TH-001'],,https://clinicaltrials.gov/show/NCT04299152,2020-10-09,0,0
101,NCT04304690,Recruiting,2020-07-16,2020-10-16,No Results Posted,,,['APHP200310'],,https://clinicaltrials.gov/show/NCT04304690,2020-07-16,0,0
102,NCT04315896,Recruiting,2020-10-31,2021-03-22,No Results Posted,,,['HidroxycloroquinaCOVID19'],,https://clinicaltrials.gov/show/NCT04315896,2020-10-31,0,0
103,NCT04318015,Recruiting,2020-12-31,2021-03-31,No Results Posted,,,['ProfilaxisCOVID'],,https://clinicaltrials.gov/show/NCT04318015,2020-12-31,0,0
104,NCT04320277,Not yet recruiting,2020-06-30,2020-07-30,No Results Posted,"['Benucci M, Damiani A, Infantino M, Manfredi M, Quartuccio L. Old and new antirheumatic drugs for the treatment of COVID-19. Joint Bone Spine. 2020 May;87(3):195-197. doi: 10.1016/j.jbspin.2020.03.013.']",,['HPrato-3'],,https://clinicaltrials.gov/show/NCT04320277,2020-06-30,0,1
105,NCT04320953,Completed,2020-03-26,2020-04-09,No Results Posted,,,['ncMCE1'],,https://clinicaltrials.gov/show/NCT04320953,2020-03-26,0,0
106,NCT04321174,Recruiting,2021-03-31,2022-03-31,No Results Posted,,,['CORIPREV-1'],,https://clinicaltrials.gov/show/NCT04321174,2021-03-31,0,0
107,NCT04323345,Recruiting,2020-12-15,2021-01-15,No Results Posted,,,['MUST23032020'],,https://clinicaltrials.gov/show/NCT04323345,2020-12-15,0,0
108,NCT04324073,"Active, not recruiting",2021-03-27,2021-12-31,No Results Posted,,,['APHP200375-2'],,https://clinicaltrials.gov/show/NCT04324073,2021-03-27,0,0
109,NCT04324190,Recruiting,2020-06-01,2021-12-01,No Results Posted,,,['IPUB_2020_01'],,https://clinicaltrials.gov/show/NCT04324190,2020-06-01,0,0
110,NCT04325061,Recruiting,2020-10-30,2020-10-30,No Results Posted,,"['Villar J, Belda J, A√±√≥n JM, Blanco J, P√©rez-M√©ndez L, Ferrando C, Mart√≠nez D, Soler JA, Ambr√≥s A, Mu√±oz T, Rivas R, Corpas R, D√≠az-Dominguez FJ, Soro M, Garc√≠a-Bello MA, Fern√°ndez RL, Kacmarek RM; DEXA-ARDS Network. Evaluating the efficacy of dexamethasone in the treatment of patients with persistent acute respiratory distress syndrome: study protocol for a randomized controlled trial. Trials. 2016 Jul 22;17:342. doi: 10.1186/s13063-016-1456-4.', 'Villar J, Ferrando C, Mart√≠nez D, Ambr√≥s A, Mu√±oz T, Soler JA, Aguilar G, Alba F, Gonz√°lez-Higueras E, Conesa LA, Mart√≠n-Rodr√≠guez C, D√≠az-Dom√≠nguez FJ, Serna-Grande P, Rivas R, Ferreres J, Belda J, Capilla L, Tallet A, A√±√≥n JM, Fern√°ndez RL, Gonz√°lez-Mart√≠n JM; dexamethasone in ARDS network. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. Lancet Respir Med. 2020 Mar;8(3):267-276. doi: 10.1016/S2213-2600(19)30417-5. Epub 2020 Feb 7.']",['2020-001278-31'],,https://clinicaltrials.gov/show/NCT04325061,2020-10-30,0,1
111,NCT04325633,Not yet recruiting,2021-05-13,2021-07-13,No Results Posted,,,['APHP200387'],,https://clinicaltrials.gov/show/NCT04325633,2021-05-13,0,0
112,NCT04326426,Enrolling by invitation,2020-08-01,2020-08-31,No Results Posted,,,['VLY-686-3501'],,https://clinicaltrials.gov/show/NCT04326426,2020-08-01,0,0
113,NCT04329650,Recruiting,2020-05-20,2020-05-20,No Results Posted,,,['SILCOR-COVID-19'],,https://clinicaltrials.gov/show/NCT04329650,2020-05-20,0,0
114,NCT04331054,Recruiting,2020-07-13,2020-07-13,No Results Posted,,,"['P 200394', '2020-001306-35 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04331054,2020-07-13,0,0
115,NCT04333420,Recruiting,2020-10-31,2020-12-31,No Results Posted,,,['IFX-1-P2.9'],,https://clinicaltrials.gov/show/NCT04333420,2020-10-31,0,0
116,NCT04333628,Not yet recruiting,2021-04-01,2021-12-01,No Results Posted,,,['EMC 0045-20'],,https://clinicaltrials.gov/show/NCT04333628,2021-04-01,0,0
117,NCT04334044,Recruiting,2020-06-01,2020-06-01,No Results Posted,,,['HAL 345/2020'],,https://clinicaltrials.gov/show/NCT04334044,2020-06-01,0,0
118,NCT04334434,Not yet recruiting,2020-06-01,2020-07-31,No Results Posted,,,['002'],,https://clinicaltrials.gov/show/NCT04334434,2020-06-01,0,0
119,NCT04338568,Recruiting,2020-04-30,2020-04-30,No Results Posted,,"['Pisani L, Vercesi V, van Tongeren PSI, Lagrand WK, Leopold SJ, Huson MAM, Henwood PC, Walden A, Smit MR, Riviello ED, Pelosi P, Dondorp AM, Schultz MJ; Lung Ultrasound Consortium. The diagnostic accuracy for ARDS of global versus regional lung ultrasound scores - a post hoc analysis of an observational study in invasively ventilated ICU patients. Intensive Care Med Exp. 2019 Jul 25;7(Suppl 1):44. doi: 10.1186/s40635-019-0241-6.', 'Li K, Fang Y, Li W, Pan C, Qin P, Zhong Y, Liu X, Huang M, Liao Y, Li S. CT image visual quantitative evaluation and clinical classification of coronavirus disease (COVID-19). Eur Radiol. 2020 Mar 25. doi: 10.1007/s00330-020-06817-6. [Epub ahead of print]']",['CTU2020032'],,https://clinicaltrials.gov/show/NCT04338568,2020-04-30,0,1
120,NCT04341584,Not yet recruiting,2020-05-01,2020-12-31,No Results Posted,,,['APHP200375-5'],,https://clinicaltrials.gov/show/NCT04341584,2020-05-01,0,0
121,NCT04342156,Not yet recruiting,2020-08-01,2020-10-01,No Results Posted,,,['2020/00402'],,https://clinicaltrials.gov/show/NCT04342156,2020-08-01,0,0
122,NCT04342169,Recruiting,2022-04-01,2023-04-01,No Results Posted,,,['IRB_00131893'],,https://clinicaltrials.gov/show/NCT04342169,2022-04-01,0,0
123,NCT04342650,Recruiting,2020-09-01,2020-09-01,No Results Posted,,,['CAAE: 30504220.5.0000.0005'],,https://clinicaltrials.gov/show/NCT04342650,2020-09-01,0,0
124,NCT04343001,Not yet recruiting,2021-04-01,2021-08-01,No Results Posted,,,['2020-KEP-420'],,https://clinicaltrials.gov/show/NCT04343001,2021-04-01,0,0
125,NCT04343144,Not yet recruiting,2020-07-31,2020-09-30,No Results Posted,,,['APHP200389-5'],,https://clinicaltrials.gov/show/NCT04343144,2020-07-31,0,0
126,NCT04343183,Not yet recruiting,2020-06-01,2020-06-01,No Results Posted,,,['STUDY00001051'],,https://clinicaltrials.gov/show/NCT04343183,2020-06-01,0,0
127,NCT04343690,Not yet recruiting,2020-06-30,2020-06-30,No Results Posted,,,['Pro00105319'],,https://clinicaltrials.gov/show/NCT04343690,2020-06-30,0,0
128,NCT04343755,Recruiting,2021-04-01,2021-04-01,No Results Posted,,,['Pro2020-0375'],,https://clinicaltrials.gov/show/NCT04343755,2021-04-01,0,0
129,NCT04343794,Recruiting,2021-12-31,2022-01-31,No Results Posted,,,['COVID19_Biovitals_Protocol_1'],,https://clinicaltrials.gov/show/NCT04343794,2021-12-31,0,0
130,NCT04343963,Recruiting,2020-09-30,2021-04-30,No Results Posted,,,['Inf-3323'],,https://clinicaltrials.gov/show/NCT04343963,2020-09-30,0,0
131,NCT04344106,Recruiting,2020-04-15,2020-05-01,No Results Posted,,,['20202703-2'],,https://clinicaltrials.gov/show/NCT04344106,2020-04-15,0,0
132,NCT04344210,Enrolling by invitation,2020-08-20,2020-08-30,No Results Posted,,,['2020241093'],,https://clinicaltrials.gov/show/NCT04344210,2020-08-20,0,0
133,NCT04344236,Recruiting,2020-05-01,2020-05-09,No Results Posted,,,['s20-00444'],,https://clinicaltrials.gov/show/NCT04344236,2020-05-01,0,0
134,NCT04344444,Recruiting,2021-04-10,2021-12-10,No Results Posted,,,['COVID 2020-001'],,https://clinicaltrials.gov/show/NCT04344444,2021-04-10,0,0
135,NCT04344535,Enrolling by invitation,2021-04-30,2021-08-31,No Results Posted,,,['SBU-COVID19-ConvalescentPlasma'],,https://clinicaltrials.gov/show/NCT04344535,2021-04-30,0,0
136,NCT04344548,Not yet recruiting,2020-06-10,2020-11-10,No Results Posted,,,['UNAL FSA COVID'],,https://clinicaltrials.gov/show/NCT04344548,2020-06-10,0,0
137,NCT04344730,Recruiting,2020-12-31,2020-12-31,No Results Posted,,,"['APHP200388', '2020-001457-43 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04344730,2020-12-31,0,0
138,NCT04344756,Not yet recruiting,2020-07-31,2020-09-30,No Results Posted,,,['APHP200389-6'],,https://clinicaltrials.gov/show/NCT04344756,2020-07-31,0,0
139,NCT04344782,Not yet recruiting,2020-09-30,2020-11-30,No Results Posted,,,['APHP200389-7'],,https://clinicaltrials.gov/show/NCT04344782,2020-09-30,0,0
140,NCT04345406,Not yet recruiting,2029-12-01,2029-12-01,No Results Posted,,,['ACEIS COVID 19'],,https://clinicaltrials.gov/show/NCT04345406,2029-12-01,0,0
141,NCT04345445,Not yet recruiting,2020-10-31,2020-10-31,No Results Posted,,,['TVCS-COVID19'],,https://clinicaltrials.gov/show/NCT04345445,2020-10-31,0,0
142,NCT04345523,Recruiting,2020-07-01,2020-07-01,No Results Posted,,,['ConPlas-19'],,https://clinicaltrials.gov/show/NCT04345523,2020-07-01,0,0
143,NCT04345549,Completed,2020-03-30,2020-03-30,No Results Posted,,,['AU08'],,https://clinicaltrials.gov/show/NCT04345549,2020-03-30,0,0
144,NCT04345887,Not yet recruiting,2020-07-21,2020-10-21,No Results Posted,,,['10042020'],,https://clinicaltrials.gov/show/NCT04345887,2020-07-21,0,0
145,NCT04346017,Recruiting,2020-12-01,2020-12-01,No Results Posted,,,['CHUB-IL6-COVID-19'],,https://clinicaltrials.gov/show/NCT04346017,2020-12-01,0,0
146,NCT04346329,Not yet recruiting,2020-06-01,2020-10-01,No Results Posted,,,['UNAL-COVID-CP'],,https://clinicaltrials.gov/show/NCT04346329,2020-06-01,0,0
147,NCT04346368,Not yet recruiting,2020-12-01,2020-12-01,No Results Posted,,,['SC-2020-01'],,https://clinicaltrials.gov/show/NCT04346368,2020-12-01,0,0
148,NCT04346927,Not yet recruiting,2020-06-10,2020-07-31,No Results Posted,,,['009'],,https://clinicaltrials.gov/show/NCT04346927,2020-06-10,0,0
149,NCT04346953,Not yet recruiting,2020-06-01,2020-07-31,No Results Posted,,,['002'],,https://clinicaltrials.gov/show/NCT04346953,2020-06-01,0,0
150,NCT04347889,Not yet recruiting,2020-12-30,2020-12-30,No Results Posted,,,['IRB2020-00222'],,https://clinicaltrials.gov/show/NCT04347889,2020-12-30,0,0
151,NCT04347941,Not yet recruiting,2021-03-11,2021-05-11,No Results Posted,,,['APPROVE-CARE-2020'],,https://clinicaltrials.gov/show/NCT04347941,2021-03-11,0,0
152,NCT04347980,Recruiting,2020-06-01,2020-08-01,No Results Posted,,,['2037815010'],,https://clinicaltrials.gov/show/NCT04347980,2020-06-01,0,0
153,NCT04348383,Recruiting,2020-07-08,2020-08-08,No Results Posted,,,['IMIB-DFC-2020-02'],,https://clinicaltrials.gov/show/NCT04348383,2020-07-08,0,0
154,NCT04348461,Not yet recruiting,2020-09-15,2020-09-30,No Results Posted,,,['BALMYS-19'],,https://clinicaltrials.gov/show/NCT04348461,2020-09-15,0,0
155,NCT04348695,Recruiting,2020-05-13,2020-05-13,No Results Posted,,,"['Ruxo-Sim-20', '2020-001405-23 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04348695,2020-05-13,0,0
156,NCT04348864,Recruiting,2021-04-01,2021-04-01,No Results Posted,,,['2020/03/18'],,https://clinicaltrials.gov/show/NCT04348864,2021-04-01,0,0
157,NCT04348877,Not yet recruiting,2020-10-01,2020-12-01,No Results Posted,,,['FMASU P15/ 2020'],,https://clinicaltrials.gov/show/NCT04348877,2020-10-01,0,0
158,NCT04349371,Recruiting,2021-04-01,2021-04-01,No Results Posted,,,['AAAS9992'],,https://clinicaltrials.gov/show/NCT04349371,2021-04-01,0,0
159,NCT04349410,Enrolling by invitation,2020-10-11,2020-11-11,No Results Posted,,,['FMTVDM2020'],,https://clinicaltrials.gov/show/NCT04349410,2020-10-11,0,0
160,NCT04349618,Not yet recruiting,2021-07-14,2022-04-14,No Results Posted,,,['69HCL20_0322'],,https://clinicaltrials.gov/show/NCT04349618,2021-07-14,0,0
161,NCT04350086,Not yet recruiting,2020-11-20,2020-11-20,No Results Posted,,,['87RI20_0011 (PRODEX)'],,https://clinicaltrials.gov/show/NCT04350086,2020-11-20,0,0
162,NCT04350281,Recruiting,2022-03-31,2022-07-31,No Results Posted,,,['UW 20-211'],,https://clinicaltrials.gov/show/NCT04350281,2022-03-31,0,0
163,NCT04350671,Enrolling by invitation,2020-04-20,2020-04-24,No Results Posted,,,['Interferon Beta 1a in COVID-19'],,https://clinicaltrials.gov/show/NCT04350671,2020-04-20,0,0
164,NCT04350684,Enrolling by invitation,2020-04-22,2020-04-24,No Results Posted,,,['Umifenovir in COVID-19'],,https://clinicaltrials.gov/show/NCT04350684,2020-04-22,0,0
165,NCT04350931,Not yet recruiting,2020-10-01,2020-12-01,No Results Posted,,,['FMASU P19a/ 2020'],,https://clinicaltrials.gov/show/NCT04350931,2020-10-01,0,0
166,NCT04351295,Not yet recruiting,2030-12-01,2030-12-01,No Results Posted,,,['faviprevir covid'],,https://clinicaltrials.gov/show/NCT04351295,2030-12-01,0,0
167,NCT04351490,Not yet recruiting,2020-07-01,2020-07-01,No Results Posted,,,"['2020_30', '2020-A00873-36 ( Other Identifier: ID-RCB number,ANSM )']",,https://clinicaltrials.gov/show/NCT04351490,2020-07-01,0,0
168,NCT04351542,Completed,2020-04-06,2020-04-12,No Results Posted,,,['AU09'],,https://clinicaltrials.gov/show/NCT04351542,2020-04-06,0,0
169,NCT04351620,Recruiting,2020-06-01,2020-06-01,No Results Posted,,,['IRB20-0572'],,https://clinicaltrials.gov/show/NCT04351620,2020-06-01,0,0
170,NCT04351763,Recruiting,2021-03-02,2021-04-10,No Results Posted,,,['NCU-COVID19'],,https://clinicaltrials.gov/show/NCT04351763,2021-03-02,0,0
171,NCT04351789,Not yet recruiting,2023-04-01,2023-04-01,No Results Posted,,,['PISCA Study'],,https://clinicaltrials.gov/show/NCT04351789,2023-04-01,0,0
172,NCT04352400,Not yet recruiting,2021-12-01,2021-12-01,No Results Posted,,"['Yamamoto M, Matsuyama S, Li X, Takeda M, Kawaguchi Y, Inoue JI, Matsuda Z. Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay. Antimicrob Agents Chemother. 2016 Oct 21;60(11):6532-6539. doi: 10.1128/AAC.01043-16. Print 2016 Nov.', 'Hoffmann M, Kleine-Weber H, Schroeder S, Kr√ºger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, M√ºller MA, Drosten C, P√∂hlmann S. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.', 'Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11. Erratum in: Lancet. 2020 Mar 28;395(10229):1038. Lancet. 2020 Mar 28;395(10229):1038.', 'Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, Ruan L, Song B, Cai Y, Wei M, Li X, Xia J, Chen N, Xiang J, Yu T, Bai T, Xie X, Zhang L, Li C, Yuan Y, Chen H, Li H, Huang H, Tu S, Gong F, Liu Y, Wei Y, Dong C, Zhou F, Gu X, Xu J, Liu Z, Zhang Y, Li H, Shang L, Wang K, Li K, Zhou X, Dong X, Qu Z, Lu S, Hu X, Ruan S, Luo S, Wu J, Peng L, Cheng F, Pan L, Zou J, Jia C, Wang J, Liu X, Wang S, Wu X, Ge Q, He J, Zhan H, Qiu F, Guo L, Huang C, Jaki T, Hayden FG, Horby PW, Zhang D, Wang C. A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med. 2020 May 7;382(19):1787-1799. doi: 10.1056/NEJMoa2001282. Epub 2020 Mar 18.', 'Minakata D, Fujiwara SI, Ikeda T, Kawaguchi SI, Toda Y, Ito S, Ochi SI, Nagayama T, Mashima K, Umino K, Nakano H, Yamasaki R, Morita K, Kawasaki Y, Sugimoto M, Yamamoto C, Ashizawa M, Hatano K, Sato K, Oh I, Ohmine K, Muroi K, Ohmori T, Kanda Y. Comparison of gabexate mesilate and nafamostat mesilate for disseminated intravascular coagulation associated with hematological malignancies. Int J Hematol. 2019 Feb;109(2):141-146. doi: 10.1007/s12185-018-02567-w. Epub 2018 Dec 8.', 'Yu G, Li S, Wan R, Wang X, Hu G. Nafamostat mesilate for prevention of post-ERCP pancreatitis: a meta-analysis of prospective, randomized, controlled trials. Pancreas. 2015 May;44(4):561-9. doi: 10.1097/MPA.0000000000000310.', 'Ferreira FL, Bota DP, Bross A, M√©lot C, Vincent JL. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA. 2001 Oct 10;286(14):1754-8.']",['RACONA Nafamostat'],,https://clinicaltrials.gov/show/NCT04352400,2021-12-01,0,1
173,NCT04352803,Not yet recruiting,2024-04-01,2026-04-01,No Results Posted,,,['COVID-MSCIV'],,https://clinicaltrials.gov/show/NCT04352803,2024-04-01,0,0
174,NCT04352959,Not yet recruiting,2020-05-20,2020-06-20,No Results Posted,,,['BBCovid'],,https://clinicaltrials.gov/show/NCT04352959,2020-05-20,0,0
175,NCT04354155,Not yet recruiting,2022-09-15,2022-10-15,No Results Posted,,,['COVAC-TP'],,https://clinicaltrials.gov/show/NCT04354155,2022-09-15,0,0
176,NCT04355026,Recruiting,2020-06-30,2020-07-31,No Results Posted,,,['SBCebromhexinCovid-19'],,https://clinicaltrials.gov/show/NCT04355026,2020-06-30,0,0
177,NCT04355247,Recruiting,2020-07-31,2021-04-30,No Results Posted,,,['CCAM 20-01'],,https://clinicaltrials.gov/show/NCT04355247,2020-07-31,0,0
178,NCT04355676,Not yet recruiting,2020-08-30,2020-08-30,No Results Posted,,,['XPORT-CoV-1002'],,https://clinicaltrials.gov/show/NCT04355676,2020-08-30,0,0
179,NCT04356508,Not yet recruiting,2020-06-30,2021-08-31,No Results Posted,,,['UW20213'],,https://clinicaltrials.gov/show/NCT04356508,2020-06-30,0,0
180,NCT04318444,Recruiting,2021-03-01,2022-03-01,No Results Posted,,,['AAAS9676'],,https://clinicaltrials.gov/show/NCT04318444,2021-03-01,0,0
181,NCT04319445,Recruiting,2020-12-01,2020-12-01,No Results Posted,,,['IRB00064587'],,https://clinicaltrials.gov/show/NCT04319445,2020-12-01,0,0
182,NCT04320056,Recruiting,2021-04-30,2021-10-31,No Results Posted,,,['21909'],,https://clinicaltrials.gov/show/NCT04320056,2021-04-30,0,0
183,NCT04326920,Recruiting,2020-10-31,2020-12-31,No Results Posted,"['Bosteels C, Maes B, Van Damme K, De Leeuw E, Declercq J, Delporte A, Demeyere B, Vermeersch S, Vuylsteke M, Willaert J, Boll√© L, Vanbiervliet Y, Decuypere J, Libeer F, Vandecasteele S, Peene I, Lambrecht B. Sargramostim to treat patients with acute hypoxic respiratory failure due to COVID-19 (SARPAC): A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jun 5;21(1):491. doi: 10.1186/s13063-020-04451-7.']",,['SARPAC'],,https://clinicaltrials.gov/show/NCT04326920,2020-10-31,0,1
184,NCT04329572,Suspended,2020-05-31,2020-06-30,No Results Posted,,,['HIAPRE0320OR'],,https://clinicaltrials.gov/show/NCT04329572,2020-05-31,0,0
185,NCT04330638,Recruiting,2020-09-01,2020-12-01,No Results Posted,"['Maes B, Bosteels C, De Leeuw E, Declercq J, Van Damme K, Delporte A, Demeyere B, Vermeersch S, Vuylsteke M, Willaert J, Boll√© L, Vanbiervliet Y, Decuypere J, Libeer F, Vandecasteele S, Peene I, Lambrecht B. Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jun 3;21(1):468. doi: 10.1186/s13063-020-04453-5.']",,['COV-AID'],,https://clinicaltrials.gov/show/NCT04330638,2020-09-01,0,1
186,NCT04331808,"Active, not recruiting",2021-03-31,2021-12-31,No Results Posted,,,['APHP200375-1'],,https://clinicaltrials.gov/show/NCT04331808,2021-03-31,0,0
187,NCT04332380,Not yet recruiting,2020-08-31,2020-12-31,No Results Posted,,,['ABN011-1'],,https://clinicaltrials.gov/show/NCT04332380,2020-08-31,0,0
188,NCT04332835,Not yet recruiting,2020-08-31,2020-12-31,No Results Posted,,,['ABN011-2'],,https://clinicaltrials.gov/show/NCT04332835,2020-08-31,0,0
189,NCT04333589,Recruiting,2020-06-01,2020-09-15,No Results Posted,"['Li J, Zhang C, Wu Z, Wang G, Zhao H. The Mechanism and Clinical Outcome of patients with Corona Virus Disease 2019 Whose Nucleic Acid Test has changed from negative to positive, and the therapeutic efficacy of Favipiravir: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jun 5;21(1):488. doi: 10.1186/s13063-020-04430-y.']",,['2020 research 112'],,https://clinicaltrials.gov/show/NCT04333589,2020-06-01,0,1
190,NCT04334265,Recruiting,2020-06-01,2020-12-01,No Results Posted,"['Zhang C, Li J, Wu Z, Wang H, Que C, Zhao H, Wang G. Efficacy and safety of Anluohuaxian in the treatment of patients with severe Coronavirus disease 2019- a multicenter, open label, randomized controlled study: a structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jun 8;21(1):495. doi: 10.1186/s13063-020-04399-8.']",,['2020 research 110'],,https://clinicaltrials.gov/show/NCT04334265,2020-06-01,0,1
191,NCT04334980,Not yet recruiting,2021-08-31,2021-12-31,No Results Posted,,,['bacTRL-Spike-1'],,https://clinicaltrials.gov/show/NCT04334980,2021-08-31,0,0
192,NCT04335032,Not yet recruiting,2020-07-13,2020-07-31,No Results Posted,,,['EPA-COV-001'],,https://clinicaltrials.gov/show/NCT04335032,2020-07-13,0,0
193,NCT04335123,Recruiting,2020-09-01,2020-10-01,No Results Posted,,,['STUDY00145514'],,https://clinicaltrials.gov/show/NCT04335123,2020-09-01,0,0
194,NCT04337008,Recruiting,2020-06-03,2020-07-31,No Results Posted,,,"['2020-16', '2020-A00795-34 ( Other Identifier: ANSM )']",,https://clinicaltrials.gov/show/NCT04337008,2020-06-03,0,0
195,NCT04338009,Enrolling by invitation,2020-12-31,2020-12-31,No Results Posted,,,['842810'],,https://clinicaltrials.gov/show/NCT04338009,2020-12-31,0,0
196,NCT04339712,Recruiting,2022-04-01,2022-04-01,No Results Posted,,,"['ESCAPE', '2020-001039-29 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04339712,2022-04-01,0,0
197,NCT04341493,Recruiting,2020-08-30,2020-12-30,No Results Posted,"['Calder√≥n JM, Zer√≥n HM, Padmanabhan S. Treatment with Hydroxychloroquine vs Hydroxychloroquine + Nitazoxanide in COVID-19 patients with risk factors for poor prognosis: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jun 8;21(1):504. doi: 10.1186/s13063-020-04448-2.']",,['2020-03-681'],,https://clinicaltrials.gov/show/NCT04341493,2020-08-30,0,1
198,NCT04344184,Not yet recruiting,2021-05-01,2021-05-01,No Results Posted,,,['HM20018977'],,https://clinicaltrials.gov/show/NCT04344184,2021-05-01,0,0
199,NCT04344431,Recruiting,2021-04-01,2021-05-01,No Results Posted,,,['2020PPRC03'],,https://clinicaltrials.gov/show/NCT04344431,2021-04-01,0,0
200,NCT04345601,Not yet recruiting,2022-02-01,2022-02-01,No Results Posted,,,['H-47561 MSC for COVID-19'],,https://clinicaltrials.gov/show/NCT04345601,2022-02-01,0,0
201,NCT04345679,Not yet recruiting,2020-06-01,2021-04-01,No Results Posted,,,['AntiCOVID19ORT'],,https://clinicaltrials.gov/show/NCT04345679,2020-06-01,0,0
202,NCT04346797,Recruiting,2020-09-30,2020-12-31,No Results Posted,,,['APHP200375-4'],,https://clinicaltrials.gov/show/NCT04346797,2020-09-30,0,0
203,NCT04348474,Suspended,2020-06-30,2020-07-31,No Results Posted,,,['HIAPRE0420OR'],,https://clinicaltrials.gov/show/NCT04348474,2020-06-30,0,0
204,NCT04348929,Recruiting,2021-08-16,2021-11-01,No Results Posted,,,['2020-A00881-38'],,https://clinicaltrials.gov/show/NCT04348929,2021-08-16,0,0
205,NCT04350580,Recruiting,2020-06-01,2020-08-01,No Results Posted,,,"['D20-P013', '2020-001570-30 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04350580,2020-06-01,0,0
206,NCT04351724,Recruiting,2020-12-01,2020-12-31,No Results Posted,,,['ACOVACT'],,https://clinicaltrials.gov/show/NCT04351724,2020-12-01,0,0
207,NCT04352608,Recruiting,2020-08-13,2020-12-13,No Results Posted,,,['PRO-nCOV-1001'],,https://clinicaltrials.gov/show/NCT04352608,2020-08-13,0,0
208,NCT04352946,Not yet recruiting,2020-06-24,2020-08-24,No Results Posted,,,['GFICOVID-19-1'],,https://clinicaltrials.gov/show/NCT04352946,2020-06-24,0,0
209,NCT04353037,Recruiting,2021-04-01,2021-06-15,No Results Posted,,,['2020-0003'],,https://clinicaltrials.gov/show/NCT04353037,2021-04-01,0,0
210,NCT04353518,Not yet recruiting,2021-03-30,2021-05-30,No Results Posted,,,['CRSC20005'],,https://clinicaltrials.gov/show/NCT04353518,2021-03-30,0,0
211,NCT04354870,Recruiting,2020-08-01,2020-09-01,No Results Posted,,,['s20-00390'],,https://clinicaltrials.gov/show/NCT04354870,2020-08-01,0,0
212,NCT04355052,Recruiting,2020-10-11,2020-12-11,No Results Posted,,,['7092-20-SMC'],,https://clinicaltrials.gov/show/NCT04355052,2020-10-11,0,0
213,NCT04355234,Not yet recruiting,2021-08-31,2021-08-31,No Results Posted,,,['APHP 200448'],,https://clinicaltrials.gov/show/NCT04355234,2021-08-31,0,0
214,NCT04355429,Not yet recruiting,2020-07-01,2020-08-01,No Results Posted,,"['Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.', 'Li F, Li W, Farzan M, Harrison SC. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science. 2005 Sep 16;309(5742):1864-8.', 'Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan B, Yang P, Sarao R, Wada T, Leong-Poi H, Crackower MA, Fukamizu A, Hui CC, Hein L, Uhlig S, Slutsky AS, Jiang C, Penninger JM. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature. 2005 Jul 7;436(7047):112-6.', 'Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020 Apr;46(4):586-590. doi: 10.1007/s00134-020-05985-9. Epub 2020 Mar 3.']",['APHP200410'],,https://clinicaltrials.gov/show/NCT04355429,2020-07-01,0,1
215,NCT04355754,Recruiting,2020-05-01,2020-12-31,No Results Posted,,,['Ventil-COVID-19'],,https://clinicaltrials.gov/show/NCT04355754,2020-05-01,0,0
216,NCT04355962,Recruiting,2021-03-31,2021-03-31,No Results Posted,,,['2020-00719'],,https://clinicaltrials.gov/show/NCT04355962,2021-03-31,0,0
217,NCT04356677,Not yet recruiting,2021-04-01,2021-04-01,No Results Posted,,,['BHC-RIB-5401-HC'],,https://clinicaltrials.gov/show/NCT04356677,2021-04-01,0,0
218,NCT04357106,Recruiting,2020-07-01,2020-08-01,No Results Posted,,,['CHMI-030420-01'],,https://clinicaltrials.gov/show/NCT04357106,2020-07-01,0,0
219,NCT04357327,Recruiting,2020-05-31,2020-07-31,No Results Posted,,,['68/2020'],,https://clinicaltrials.gov/show/NCT04357327,2020-05-31,0,0
220,NCT04357366,Recruiting,2022-04-15,2022-04-15,No Results Posted,,,"['SAVE', '2020-001466-11 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04357366,2022-04-15,0,0
221,NCT04357613,Not yet recruiting,2020-11-01,2020-12-01,No Results Posted,,,['P20/05_IMAGE19'],,https://clinicaltrials.gov/show/NCT04357613,2020-11-01,0,0
222,NCT04357782,Recruiting,2020-06-01,2020-08-01,No Results Posted,,,['Davis 001'],,https://clinicaltrials.gov/show/NCT04357782,2020-06-01,0,0
223,NCT04357808,Recruiting,2020-06-01,2020-06-01,No Results Posted,,,"['SARCOVID', '2020-001634-36 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04357808,2020-06-01,0,0
224,NCT04357860,Not yet recruiting,2020-07-27,2020-07-27,No Results Posted,,,['SARICOR'],,https://clinicaltrials.gov/show/NCT04357860,2020-07-27,0,0
225,NCT04358406,Not yet recruiting,2020-08-01,2020-09-01,No Results Posted,,,['BTI-202'],,https://clinicaltrials.gov/show/NCT04358406,2020-08-01,0,0
226,NCT04358614,Completed,2020-04-05,2020-04-07,No Results Posted,,,['HPrato-4'],,https://clinicaltrials.gov/show/NCT04358614,2020-04-05,0,0
227,NCT04358809,Not yet recruiting,2021-02-28,2021-04-30,No Results Posted,,,['CRSC20006'],,https://clinicaltrials.gov/show/NCT04358809,2021-02-28,0,0
228,NCT04359095,Not yet recruiting,2020-10-11,2020-10-31,No Results Posted,,"['Hatem A, Mohamed S, Abu Elhassan UE, Ismael EAM, Rizk MS, El-Kholy A, El-Harras M. Clinical characteristics and outcomes of patients with severe acute respiratory infections (SARI): results from the Egyptian surveillance study 2010-2014. Multidiscip Respir Med. 2019 Apr 1;14:11. doi: 10.1186/s40248-019-0174-7. eCollection 2019.', 'Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.', 'Munster VJ, Koopmans M, van Doremalen N, van Riel D, de Wit E. A Novel Coronavirus Emerging in China - Key Questions for Impact Assessment. N Engl J Med. 2020 Feb 20;382(8):692-694. doi: 10.1056/NEJMp2000929. Epub 2020 Jan 24.', 'Zu ZY, Jiang MD, Xu PP, Chen W, Ni QQ, Lu GM, Zhang LJ. Coronavirus Disease 2019 (COVID-19): A Perspective from China. Radiology. 2020 Feb 21:200490. doi: 10.1148/radiol.2020200490. [Epub ahead of print]', 'Asociaci√≥n Colombiana de Infectolog√≠a. Consenso Colombiano de atenci√≥n, diagn√≥stico y manejo de la Infecci√≥n por SARS COV-2 / COVID 19 en establecimientos de atenci√≥n de la salud. 2020.', 'Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, Shi Z, Hu Z, Zhong W, Xiao G. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020 Mar;30(3):269-271. doi: 10.1038/s41422-020-0282-0. Epub 2020 Feb 4.', 'Yao X, Ye F, Zhang M, Cui C, Huang B, Niu P, Liu X, Zhao L, Dong E, Song C, Zhan S, Lu R, Li H, Tan W, Liu D. In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 2020 Mar 9. pii: ciaa237. doi: 10.1093/cid/ciaa237. [Epub ahead of print]', 'Mo Y, Fisher D. A review of treatment modalities for Middle East Respiratory Syndrome. J Antimicrob Chemother. 2016 Dec;71(12):3340-3350. Epub 2016 Sep 1. Review.', 'Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, Ruan L, Song B, Cai Y, Wei M, Li X, Xia J, Chen N, Xiang J, Yu T, Bai T, Xie X, Zhang L, Li C, Yuan Y, Chen H, Li H, Huang H, Tu S, Gong F, Liu Y, Wei Y, Dong C, Zhou F, Gu X, Xu J, Liu Z, Zhang Y, Li H, Shang L, Wang K, Li K, Zhou X, Dong X, Qu Z, Lu S, Hu X, Ruan S, Luo S, Wu J, Peng L, Cheng F, Pan L, Zou J, Jia C, Wang J, Liu X, Wang S, Wu X, Ge Q, He J, Zhan H, Qiu F, Guo L, Huang C, Jaki T, Hayden FG, Horby PW, Zhang D, Wang C. A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med. 2020 May 7;382(19):1787-1799. doi: 10.1056/NEJMoa2001282. Epub 2020 Mar 18.', 'Devaux CA, Rolain JM, Colson P, Raoult D. New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? Int J Antimicrob Agents. 2020 May;55(5):105938. doi: 10.1016/j.ijantimicag.2020.105938. Epub 2020 Mar 12.', 'Romanelli F, Smith KM, Hoven AD. Chloroquine and hydroxychloroquine as inhibitors of human immunodeficiency virus (HIV-1) activity. Curr Pharm Des. 2004;10(21):2643-8. Review.', 'Yan Y, Zou Z, Sun Y, Li X, Xu KF, Wei Y, Jin N, Jiang C. Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model. Cell Res. 2013 Feb;23(2):300-2. doi: 10.1038/cr.2012.165. Epub 2012 Dec 4.', 'Khan M, Santhosh SR, Tiwari M, Lakshmana Rao PV, Parida M. Assessment of in vitro prophylactic and therapeutic efficacy of chloroquine against Chikungunya virus in vero cells. J Med Virol. 2010 May;82(5):817-24. doi: 10.1002/jmv.21663.', 'Farias KJ, Machado PR, de Almeida Junior RF, de Aquino AA, da Fonseca BA. Chloroquine interferes with dengue-2 virus replication in U937 cells. Microbiol Immunol. 2014 Jun;58(6):318-26. doi: 10.1111/1348-0421.12154.', 'Gao J, Tian Z, Yang X. Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends. 2020 Mar 16;14(1):72-73. doi: 10.5582/bst.2020.01047. Epub 2020 Feb 19.', 'Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, Doudier B, Courjon J, Giordanengo V, Vieira VE, Dupont HT, Honor√© S, Colson P, Chabri√®re E, La Scola B, Rolain JM, Brouqui P, Raoult D. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020 Mar 20:105949. doi: 10.1016/j.ijantimicag.2020.105949. [Epub ahead of print]', 'Ruuskanen O, Lahti E, Jennings LC, Murdoch DR. Viral pneumonia. Lancet. 2011 Apr 9;377(9773):1264-75. doi: 10.1016/S0140-6736(10)61459-6. Epub 2011 Mar 22. Review.', 'de Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016 Aug;14(8):523-34. doi: 10.1038/nrmicro.2016.81. Epub 2016 Jun 27. Review.', 'Short KR, Kedzierska K, van de Sandt CE. Back to the Future: Lessons Learned From the 1918 Influenza Pandemic. Front Cell Infect Microbiol. 2018 Oct 8;8:343. doi: 10.3389/fcimb.2018.00343. eCollection 2018. Review.', 'Lipatov AS, Govorkova EA, Webby RJ, Ozaki H, Peiris M, Guan Y, Poon L, Webster RG. Influenza: emergence and control. J Virol. 2004 Sep;78(17):8951-9. Review.', 'Remolina YA, Ulloa MM, Vargas H, D√≠az L, G√≥mez SL, Saavedra A, S√°nchez E, Cort√©s JA. Viral Infection in Adults with Severe Acute Respiratory Infection in Colombia. PLoS One. 2015 Nov 17;10(11):e0143152. doi: 10.1371/journal.pone.0143152. eCollection 2015.', 'Lachin JM. A review of methods for futility stopping based on conditional power. Stat Med. 2005 Sep 30;24(18):2747-64. Review.']",['76968'],,https://clinicaltrials.gov/show/NCT04359095,2020-10-11,0,1
229,NCT04359251,Completed,2020-03-25,2020-03-25,No Results Posted,,,['COVID-19 PEEP titration'],,https://clinicaltrials.gov/show/NCT04359251,2020-03-25,0,0
230,NCT04359290,Not yet recruiting,2020-09-01,2020-11-01,No Results Posted,,,['KKS-278'],,https://clinicaltrials.gov/show/NCT04359290,2020-09-01,0,0
231,NCT04359316,Not yet recruiting,2020-05-03,2020-05-05,No Results Posted,,,['Azithromycin in COVID-19'],,https://clinicaltrials.gov/show/NCT04359316,2020-05-03,0,0
232,NCT04359329,Recruiting,2020-11-15,2020-11-15,No Results Posted,,,['SBU-EstrogenPatch-COVID19'],,https://clinicaltrials.gov/show/NCT04359329,2020-11-15,0,0
233,NCT04359615,Not yet recruiting,2020-05-03,2020-05-05,No Results Posted,,,['Favipiravir in COVID-19'],,https://clinicaltrials.gov/show/NCT04359615,2020-05-03,0,0
234,NCT04359875,Not yet recruiting,2020-06-01,2020-12-01,No Results Posted,,,['2020-CD-COVIQuest (COVID-19)'],,https://clinicaltrials.gov/show/NCT04359875,2020-06-01,0,0
235,NCT04359953,Not yet recruiting,2021-06-01,2021-06-01,No Results Posted,,,['7747'],,https://clinicaltrials.gov/show/NCT04359953,2021-06-01,0,0
236,NCT04360096,Not yet recruiting,2020-10-01,2020-11-30,No Results Posted,,,['RLF-100_002'],,https://clinicaltrials.gov/show/NCT04360096,2020-10-01,0,0
237,NCT04360356,Not yet recruiting,2020-10-01,2020-12-01,No Results Posted,,,['IVR/NTZ'],,https://clinicaltrials.gov/show/NCT04360356,2020-10-01,0,0
238,NCT04360551,Not yet recruiting,2021-06-30,2021-06-30,No Results Posted,,,['H051'],,https://clinicaltrials.gov/show/NCT04360551,2021-06-30,0,0
239,NCT04360759,Not yet recruiting,2021-05-31,2021-07-31,No Results Posted,,,['HIV-COVID-19 CQOTE'],,https://clinicaltrials.gov/show/NCT04360759,2021-05-31,0,0
240,NCT04360811,Recruiting,2021-04-01,2022-04-01,No Results Posted,,,['RC31/20/0123'],,https://clinicaltrials.gov/show/NCT04360811,2021-04-01,0,0
241,NCT04360876,Not yet recruiting,2020-09-30,2020-12-31,No Results Posted,,,['20-0811'],,https://clinicaltrials.gov/show/NCT04360876,2020-09-30,0,0
242,NCT04360980,Recruiting,2020-05-20,2020-05-30,No Results Posted,"['Dalili N, Kashefizadeh A, Nafar M, Poorrezagholi F, Firouzan A, Samadian F, Samavat S, Ziaie S, Fatemizadeh S. Adding Colchicine to the Antiretroviral Medication - Lopinavir/Ritonavir (Kaletra) in Hospitalized Patients with Non-Severe Covid-19 Pneumonia: A Structured Summary of a Study Protocol for a Randomized Controlled Trial. Trials. 2020 Jun 5;21(1):489. doi: 10.1186/s13063-020-04455-3.']",,['SBMU.IR.REC.165423'],,https://clinicaltrials.gov/show/NCT04360980,2020-05-20,0,1
243,NCT04361318,Not yet recruiting,2020-10-01,2020-12-01,No Results Posted,,,['HCQ/NTZ'],,https://clinicaltrials.gov/show/NCT04361318,2020-10-01,0,0
244,NCT04361422,Not yet recruiting,2020-06-01,2020-09-01,No Results Posted,,,['9469305c'],,https://clinicaltrials.gov/show/NCT04361422,2020-06-01,0,0
245,NCT04361435,Not yet recruiting,2020-07-31,2020-12-31,No Results Posted,,"['Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, Cereda D, Coluccello A, Foti G, Fumagalli R, Iotti G, Latronico N, Lorini L, Merler S, Natalini G, Piatti A, Ranieri MV, Scandroglio AM, Storti E, Cecconi M, Pesenti A; COVID-19 Lombardy ICU Network, Nailescu A, Corona A, Zangrillo A, Protti A, Albertin A, Forastieri Molinari A, Lombardo A, Pezzi A, Benini A, Scandroglio AM, Malara A, Castelli A, Coluccello A, Micucci A, Pesenti A, Sala A, Alborghetti A, Antonini B, Capra C, Troiano C, Roscitano C, Radrizzani D, Chiumello D, Coppini D, Guzzon D, Costantini E, Malpetti E, Zoia E, Catena E, Agosteo E, Barbara E, Beretta E, Boselli E, Storti E, Harizay F, Della Mura F, Lorini FL, Donato Sigurt√† F, Marino F, Mojoli F, Rasulo F, Grasselli G, Casella G, De Filippi G, Castelli G, Aldegheri G, Gallioli G, Lotti G, Albano G, Landoni G, Marino G, Vitale G, Battista Perego G, Evasi G, Citerio G, Foti G, Natalini G, Merli G, Sforzini I, Bianciardi L, Carnevale L, Grazioli L, Cabrini L, Guatteri L, Salvi L, Dei Poli M, Galletti M, Gemma M, Ranucci M, Riccio M, Borelli M, Zambon M, Subert M, Cecconi M, Mazzoni MG, Raimondi M, Panigada M, Belliato M, Bronzini N, Latronico N, Petrucci N, Belgiorno N, Tagliabue P, Cortellazzi P, Gnesin P, Grosso P, Gritti P, Perazzo P, Severgnini P, Ruggeri P, Sebastiano P, Covello RD, Fernandez-Olmos R, Fumagalli R, Keim R, Rona R, Valsecchi R, Cattaneo S, Colombo S, Cirri S, Bonazzi S, Greco S, Muttini S, Langer T, Alaimo V, Viola U. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020 Apr 6. doi: 10.1001/jama.2020.5394. [Epub ahead of print]', 'Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30;:.', 'Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Feb 7. doi: 10.1001/jama.2020.1585. [Epub ahead of print]', 'Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 Feb 24. doi: 10.1001/jama.2020.2648. [Epub ahead of print]', 'Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y, Zhang L, Yu Z, Fang M, Yu T, Wang Y, Pan S, Zou X, Yuan S, Shang Y. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24. Erratum in: Lancet Respir Med. 2020 Apr;8(4):e26.', 'Kanne JP, Little BP, Chung JH, Elicker BM, Ketai LH. Essentials for Radiologists on COVID-19: An Update-Radiology Scientific Expert Panel. Radiology. 2020 Feb 27:200527. doi: 10.1148/radiol.2020200527. [Epub ahead of print]', 'Pan F, Ye T, Sun P, Gui S, Liang B, Li L, Zheng D, Wang J, Hesketh RL, Yang L, Zheng C. Time Course of Lung Changes at Chest CT during Recovery from Coronavirus Disease 2019 (COVID-19). Radiology. 2020 Jun;295(3):715-721. doi: 10.1148/radiol.2020200370. Epub 2020 Feb 13.', 'Shi H, Han X, Jiang N, Cao Y, Alwalid O, Gu J, Fan Y, Zheng C. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020 Apr;20(4):425-434. doi: 10.1016/S1473-3099(20)30086-4. Epub 2020 Feb 24.', 'Roqu√© i Figuls M, Gin√©-Garriga M, Granados Rugeles C, Perrotta C, Vilar√≥ J. Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old. Cochrane Database Syst Rev. 2016 Feb 1;2:CD004873. doi: 10.1002/14651858.CD004873.pub5. Review.', 'Chaves GS, Freitas DA, Santino TA, Nogueira PAM, Fregonezi GA, Mendon√ßa KM. Chest physiotherapy for pneumonia in children. Cochrane Database Syst Rev. 2019 Jan 2;1:CD010277. doi: 10.1002/14651858.CD010277.pub3.', 'Hough JL, Flenady V, Johnston L, Woodgate PG. Chest physiotherapy for reducing respiratory morbidity in infants requiring ventilatory support. Cochrane Database Syst Rev. 2008 Jul 16;(3):CD006445. doi: 10.1002/14651858.CD006445.pub2. Review.', 'Lauwers E, Ides K, Van Hoorenbeeck K, Verhulst S. The effect of intrapulmonary percussive ventilation in pediatric patients: A systematic review. Pediatr Pulmonol. 2018 Nov;53(11):1463-1474. doi: 10.1002/ppul.24135. Epub 2018 Jul 18.', 'Ferreira LL, Valenti VE, Vanderlei LC. Chest physiotherapy on intracranial pressure of critically ill patients admitted to the intensive care unit: a systematic review. Rev Bras Ter Intensiva. 2013 Oct-Dec;25(4):327-33. doi: 10.5935/0103-507X.20130055. Review. English, Portuguese.', 'Schieppati D, Germon R, Galli F, Rigamonti MG, Stucchi M, Boffito DC. Influence of frequency and amplitude on the mucus viscoelasticity of the novel mechano-acoustic Frequencer‚Ñ¢. Respir Med. 2019 Jul;153:52-59. doi: 10.1016/j.rmed.2019.04.011. Epub 2019 May 27.', 'Cantin AM, Bacon M, Berthiaume Y. Mechanical airway clearance using the frequencer electro-acoustical transducer in cystic fibrosis. Clin Invest Med. 2006 Jun;29(3):159-65.', 'Adams JY, Rogers AJ, Schuler A, Marelich GP, Fresco JM, Taylor SL, Riedl AW, Baker JM, Escobar GJ, Liu VX. Association Between Peripheral Blood Oxygen Saturation (SpO(2))/Fraction of Inspired Oxygen (FiO(2)) Ratio Time at Risk and Hospital Mortality in Mechanically Ventilated Patients. Perm J. 2020;24. doi: 10.7812/TPP/19.113. Epub 2020 Jan 31.', 'Bilan N, Dastranji A, Ghalehgolab Behbahani A. Comparison of the spo2/fio2 ratio and the pao2/fio2 ratio in patients with acute lung injury or acute respiratory distress syndrome. J Cardiovasc Thorac Res. 2015;7(1):28-31. doi: 10.15171/jcvtr.2014.06. Epub 2015 Mar 29.', 'Ghazal S, Sauthier M, Brossier D, Bouachir W, Jouvet PA, Noumeir R. Using machine learning models to predict oxygen saturation following ventilator support adjustment in critically ill children: A single center pilot study. PLoS One. 2019 Feb 20;14(2):e0198921. doi: 10.1371/journal.pone.0198921. eCollection 2019.', 'Koyauchi T, Yasui H, Enomoto N, Hasegawa H, Hozumi H, Suzuki Y, Karayama M, Furuhashi K, Fujisawa T, Nakamura Y, Inui N, Yokomura K, Suda T. Pulse oximetric saturation to fraction of inspired oxygen (SpO(2)/FIO(2)) ratio 24 hours after high-flow nasal cannula (HFNC) initiation is a good predictor of HFNC therapy in patients with acute exacerbation of interstitial lung disease. Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620906327. doi: 10.1177/1753466620906327.', 'Kwack WG, Lee DS, Min H, Choi YY, Yun M, Kim Y, Lee SH, Song I, Park JS, Cho YJ, Jo YH, Yoon HI, Lee JH, Lee CT, Lee YJ. Evaluation of the SpO2/FiO2 ratio as a predictor of intensive care unit transfers in respiratory ward patients for whom the rapid response system has been activated. PLoS One. 2018 Jul 31;13(7):e0201632. doi: 10.1371/journal.pone.0201632. eCollection 2018.', 'Wiedermann FJ, Stichlberger M, Glodny B. ARDS diagnosed by SpO(2)/FiO(2) ratio compared with PaO(2)/FiO(2) ratio: the role as a diagnostic tool for early enrolment into clinical trials. Open Med (Wars). 2016 Aug 2;11(1):297. doi: 10.1515/med-2016-0056. eCollection 2016.']",['MP-21-2020-2871'],,https://clinicaltrials.gov/show/NCT04361435,2020-07-31,0,1
246,NCT04361448,Not yet recruiting,2020-05-20,2020-05-20,No Results Posted,,,['20.43'],,https://clinicaltrials.gov/show/NCT04361448,2020-05-20,0,0
247,NCT04361461,Withdrawn,2020-11-04,2020-11-04,No Results Posted,,,['APS001/2020'],,https://clinicaltrials.gov/show/NCT04361461,2020-11-04,0,0
248,NCT04361526,Recruiting,2020-07-01,2020-07-01,No Results Posted,,,['HCB/2020/0464'],,https://clinicaltrials.gov/show/NCT04361526,2020-07-01,0,0
249,NCT04361916,Recruiting,2020-10-31,2020-12-31,No Results Posted,,,['Mon-Covid'],,https://clinicaltrials.gov/show/NCT04361916,2020-10-31,0,0
250,NCT04362111,Not yet recruiting,2020-07-01,2020-12-01,No Results Posted,,,['Chatham-Cytokine Covid-19'],,https://clinicaltrials.gov/show/NCT04362111,2020-07-01,0,0
251,NCT04362124,Not yet recruiting,2021-06-01,2021-11-01,No Results Posted,,,['PEC03_2020'],,https://clinicaltrials.gov/show/NCT04362124,2021-06-01,0,0
252,NCT04362358,Not yet recruiting,2021-10-01,2021-10-01,No Results Posted,,,['7799'],,https://clinicaltrials.gov/show/NCT04362358,2021-10-01,0,0
253,NCT04363372,Recruiting,2020-08-01,2020-09-01,No Results Posted,,,['MRx-4DP0004-II-001'],,https://clinicaltrials.gov/show/NCT04363372,2020-08-01,0,0
254,NCT04363528,Not yet recruiting,2020-10-30,2020-10-30,No Results Posted,,,['P20/08'],,https://clinicaltrials.gov/show/NCT04363528,2020-10-30,0,0
255,NCT04363541,Not yet recruiting,2020-09-01,2020-11-01,No Results Posted,,"['Liu J, Zhang X, Zhang F, Hong N, Wang G, Wang A, Wang L. Identification and characterization of microRNAs from in vitro-grown pear shoots infected with Apple stem grooving virus in response to high temperature using small RNA sequencing. BMC Genomics. 2015 Nov 16;16:945. doi: 10.1186/s12864-015-2126-8.', 'Wang MR, Cui ZH, Li JW, Hao XY, Zhao L, Wang QC. In vitro thermotherapy-based methods for plant virus eradication. Plant Methods. 2018 Oct 6;14:87. doi: 10.1186/s13007-018-0355-y. eCollection 2018. Review.']",['U1111-1250-7416'],,https://clinicaltrials.gov/show/NCT04363541,2020-09-01,0,1
256,NCT04363749,Not yet recruiting,2021-04-27,2021-11-27,No Results Posted,,,['APHP200476'],,https://clinicaltrials.gov/show/NCT04363749,2021-04-27,0,0
257,NCT04363840,Not yet recruiting,2020-12-01,2020-12-01,No Results Posted,,,['20-063'],,https://clinicaltrials.gov/show/NCT04363840,2020-12-01,0,0
258,NCT04363866,Not yet recruiting,2020-12-01,2021-06-01,No Results Posted,,,['STUDY00021303'],,https://clinicaltrials.gov/show/NCT04363866,2020-12-01,0,0
259,NCT04364022,Recruiting,2020-10-01,2020-10-01,No Results Posted,,,['CCER 2020-00864'],,https://clinicaltrials.gov/show/NCT04364022,2020-10-01,0,0
260,NCT04365127,Recruiting,2020-09-01,2021-04-17,No Results Posted,,,['STUDY00000611'],,https://clinicaltrials.gov/show/NCT04365127,2020-09-01,0,0
261,NCT04365439,Not yet recruiting,2020-05-30,2020-06-30,No Results Posted,,,['2020-00895'],,https://clinicaltrials.gov/show/NCT04365439,2020-05-30,0,0
262,NCT04365699,Recruiting,2020-12-31,2020-12-31,No Results Posted,,,['20-00416'],,https://clinicaltrials.gov/show/NCT04365699,2020-12-31,0,0
263,NCT04365738,Completed,2020-04-10,2020-04-26,No Results Posted,,,['PR COVID-19'],,https://clinicaltrials.gov/show/NCT04365738,2020-04-10,0,0
264,NCT04366050,Not yet recruiting,2021-04-01,2021-04-01,No Results Posted,,,['RAMIC Trial'],,https://clinicaltrials.gov/show/NCT04366050,2021-04-01,0,0
265,NCT04273763,"Active, not recruiting",2020-05-10,2020-06-01,No Results Posted,,,['2019NCP1.0'],,https://clinicaltrials.gov/show/NCT04273763,2020-05-10,0,0
266,NCT04321096,Recruiting,2020-12-31,2021-05-01,No Results Posted,,,['2020-001200-42'],,https://clinicaltrials.gov/show/NCT04321096,2020-12-31,0,0
267,NCT04328441,Recruiting,2020-10-25,2020-12-25,No Results Posted,"['Ten Doesschate T, Moorlag SJCFM, van der Vaart TW, Taks E, Debisarun P, Ten Oever J, Bleeker-Rovers CP, Verhagen PB, Lalmohamed A, Ter Heine R, van Crevel R, van de Wijgert J, Janssen AB, Bonten MJ, van Werkhoven CH, Netea MG; BCG-CORONA study team#. Two Randomized Controlled Trials of Bacillus Calmette-Gu√©rin Vaccination to reduce absenteeism among health care workers and hospital admission by elderly persons during the COVID-19 pandemic: A structured summary of the study protocols for two randomised controlled trials. Trials. 2020 Jun 5;21(1):481. doi: 10.1186/s13063-020-04389-w.']",,['NL73249.041.20'],,https://clinicaltrials.gov/show/NCT04328441,2020-10-25,0,1
268,NCT04328480,Recruiting,2020-06-30,2020-08-30,No Results Posted,,"['Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ; HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.']",['COLCOVID version1.2'],,https://clinicaltrials.gov/show/NCT04328480,2020-06-30,0,1
269,NCT04329923,Recruiting,2021-04-01,2021-12-01,No Results Posted,,,['842838'],,https://clinicaltrials.gov/show/NCT04329923,2021-04-01,0,0
270,NCT04334928,Recruiting,2020-06-30,2020-07-31,No Results Posted,,,['PrEP COVID-19'],,https://clinicaltrials.gov/show/NCT04334928,2020-06-30,0,0
271,NCT04335071,Recruiting,2020-10-01,2020-10-01,No Results Posted,,,"['2020-00691', '2020DR2044 ( Other Identifier: Swissmedic )']",,https://clinicaltrials.gov/show/NCT04335071,2020-10-01,0,0
272,NCT04338958,Recruiting,2021-01-31,2021-08-31,No Results Posted,"['La Ros√©e F, Bremer HC, Gehrke I, Kehr A, Hochhaus A, Birndt S, Fellhauer M, Henkes M, Kumle B, Russo SG, La Ros√©e P. The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation. Leukemia. 2020 Jun 9. doi: 10.1038/s41375-020-0891-0. [Epub ahead of print]']",,['RuxCoFlam'],,https://clinicaltrials.gov/show/NCT04338958,2021-01-31,0,1
273,NCT04344457,Recruiting,2020-06-20,2020-09-30,No Results Posted,,,['HIZ-PRC-COVID-19'],,https://clinicaltrials.gov/show/NCT04344457,2020-06-20,0,0
274,NCT04345848,Recruiting,2020-11-30,2020-11-30,No Results Posted,"['Levi M, Thachil J, Iba T, Levy JH. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020 Jun;7(6):e438-e440. doi: 10.1016/S2352-3026(20)30145-9. Epub 2020 May 11.']",,['2020-00794'],,https://clinicaltrials.gov/show/NCT04345848,2020-11-30,0,1
275,NCT04347226,Recruiting,2021-09-01,2022-09-01,No Results Posted,,,['AAAS9881'],,https://clinicaltrials.gov/show/NCT04347226,2021-09-01,0,0
276,NCT04348435,Enrolling by invitation,2020-12-31,2021-04-30,No Results Posted,,,['Allogeneic COVID-19 Protection'],,https://clinicaltrials.gov/show/NCT04348435,2020-12-31,0,0
277,NCT04349631,Enrolling by invitation,2020-12-31,2020-12-31,No Results Posted,,,['Protection Against COVID-19'],,https://clinicaltrials.gov/show/NCT04349631,2020-12-31,0,0
278,NCT04351191,Recruiting,2020-05-30,2020-06-30,No Results Posted,,,['NBC-COVID1902'],,https://clinicaltrials.gov/show/NCT04351191,2020-05-30,0,0
279,NCT04352465,Not yet recruiting,2020-06-30,2020-11-30,No Results Posted,,,['LDE-MTX_COVID19'],,https://clinicaltrials.gov/show/NCT04352465,2020-06-30,0,0
280,NCT04353271,"Active, not recruiting",2020-07-01,2020-12-01,No Results Posted,,,['[1582736-1]'],,https://clinicaltrials.gov/show/NCT04353271,2020-07-01,0,0
281,NCT04356833,Recruiting,2021-01-14,2021-01-14,No Results Posted,,,['132151'],,https://clinicaltrials.gov/show/NCT04356833,2021-01-14,0,0
282,NCT04358939,Recruiting,2020-11-10,2020-11-24,No Results Posted,,,"['HIGH-PRONE-COVID-19', '2020-A01121-38 ( Other Identifier: IdRCB )', 'DR200125 ( Other Identifier: University Hospital, Tours )']",,https://clinicaltrials.gov/show/NCT04358939,2020-11-10,0,0
283,NCT04359225,Not yet recruiting,2021-12-31,2021-12-31,No Results Posted,,,['GN20HS182'],,https://clinicaltrials.gov/show/NCT04359225,2021-12-31,0,0
284,NCT04359654,Not yet recruiting,2020-08-01,2020-11-01,No Results Posted,,,['132333'],,https://clinicaltrials.gov/show/NCT04359654,2020-08-01,0,0
285,NCT04359797,Enrolling by invitation,2021-04-01,2021-06-01,No Results Posted,,,['200727'],,https://clinicaltrials.gov/show/NCT04359797,2021-04-01,0,0
286,NCT04359810,Recruiting,2020-12-01,2021-04-01,No Results Posted,"[""Eckhardt CM, Cummings MJ, Rajagopalan KN, Borden S, Bitan ZC, Wolf A, Kantor A, Briese T, Meyer BJ, Jacobson SD, Scotto D, Mishra N, Philip NM, Stotler BA, Schwartz J, Shaz B, Spitalnik SL, Eisenberg A, Hod EA, Justman J, Cheung K, Lipkin WI, O'Donnell MR. Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial. Trials. 2020 Jun 8;21(1):499. doi: 10.1186/s13063-020-04422-y.""]",,['AAAS9924'],,https://clinicaltrials.gov/show/NCT04359810,2020-12-01,0,1
287,NCT04361643,Not yet recruiting,2020-08-31,2020-12-31,No Results Posted,,,['COVID19-EC01'],,https://clinicaltrials.gov/show/NCT04361643,2020-08-31,0,0
288,NCT04361942,Recruiting,2020-11-30,2020-12-31,No Results Posted,,"['Vega A, Mart√≠n-Ferrero MA, Del Canto F, Alberca M, Garc√≠a V, Munar A, Orozco L, Soler R, Fuertes JJ, Huguet M, S√°nchez A, Garc√≠a-Sancho J. Treatment of Knee Osteoarthritis With Allogeneic Bone Marrow Mesenchymal Stem Cells: A Randomized Controlled Trial. Transplantation. 2015 Aug;99(8):1681-90. doi: 10.1097/TP.0000000000000678.', 'Noriega DC, Ardura F, Hern√°ndez-Ramajo R, Mart√≠n-Ferrero M√Å, S√°nchez-Lite I, Toribio B, Alberca M, Garc√≠a V, Moraleda JM, S√°nchez A, Garc√≠a-Sancho J. Intervertebral Disc Repair by Allogeneic Mesenchymal Bone Marrow Cells: A Randomized Controlled Trial. Transplantation. 2017 Aug;101(8):1945-1951. doi: 10.1097/TP.0000000000001484.', 'Barbado J, Tabera S, S√°nchez A, Garc√≠a-Sancho J. Therapeutic potential of allogeneic mesenchymal stromal cells transplantation for lupus nephritis. Lupus. 2018 Nov;27(13):2161-2165. doi: 10.1177/0961203318804922. Epub 2018 Oct 5.', 'Leng Z, Zhu R, Hou W, Feng Y, Yang Y, Han Q, Shan G, Meng F, Du D, Wang S, Fan J, Wang W, Deng L, Shi H, Li H, Hu Z, Zhang F, Gao J, Liu H, Li X, Zhao Y, Yin K, He X, Gao Z, Wang Y, Yang B, Jin R, Stambler I, Lim LW, Su H, Moskalev A, Cano A, Chakrabarti S, Min KJ, Ellison-Hughes G, Caruso C, Jin K, Zhao RC. Transplantation of ACE2(-) Mesenchymal Stem Cells Improves the Outcome of Patients with COVID-19 Pneumonia. Aging Dis. 2020 Mar 9;11(2):216-228. doi: 10.14336/AD.2020.0228. eCollection 2020 Apr.']","['TerCel_007', '2020-001682-36 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04361942,2020-11-30,0,1
289,NCT04362176,Recruiting,2021-04-01,2021-04-01,No Results Posted,,,['200738'],,https://clinicaltrials.gov/show/NCT04362176,2021-04-01,0,0
290,NCT04363060,Not yet recruiting,2020-07-30,2020-07-30,No Results Posted,,,['RC20_0168'],,https://clinicaltrials.gov/show/NCT04363060,2020-07-30,0,0
291,NCT04363450,Recruiting,2020-07-06,2020-08-03,No Results Posted,,,['LSU NO HSC IRB 20-050'],,https://clinicaltrials.gov/show/NCT04363450,2020-07-06,0,0
292,NCT04364828,Not yet recruiting,2021-04-01,2021-08-01,No Results Posted,,,['COVID-19 NGS'],,https://clinicaltrials.gov/show/NCT04364828,2021-04-01,0,0
293,NCT04365231,Not yet recruiting,2020-06-01,2021-01-01,No Results Posted,,,['HASCOPT2020'],,https://clinicaltrials.gov/show/NCT04365231,2020-06-01,0,0
294,NCT04365309,Enrolling by invitation,2020-04-01,2020-06-01,No Results Posted,,,['Xi jingH'],,https://clinicaltrials.gov/show/NCT04365309,2020-04-01,0,0
295,NCT04365608,Recruiting,2020-05-20,2020-05-20,No Results Posted,,,['INT_EMS_PPE_1'],,https://clinicaltrials.gov/show/NCT04365608,2020-05-20,0,0
296,NCT04366063,Recruiting,2020-06-06,2020-12-10,No Results Posted,,,"['991919', 'IRCT20200217046526N2 ( Registry Identifier: Iranian Registry of Clinical Trials (IRCT) )']",,https://clinicaltrials.gov/show/NCT04366063,2020-06-06,0,0
297,NCT04366089,Recruiting,2020-10-30,2020-12-31,No Results Posted,,"['Hern√°ndez A, Papadakos PJ, Torres A, Gonz√°lez DA, Vives M, Ferrando C, Baeza J. Two known therapies could be useful as adjuvant therapy in critical patients infected by COVID-19. Rev Esp Anestesiol Reanim. 2020 May;67(5):245-252. doi: 10.1016/j.redar.2020.03.004. Epub 2020 Apr 14. English, Spanish.', 'Conti P, Gallenga CE, Tet√® G, Caraffa A, Ronconi G, Younes A, Toniato E, Ross R, Kritas SK. How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and lung inflammation mediated by IL-1. J Biol Regul Homeost Agents. 2020 Mar 31;34(2). doi: 10.23812/Editorial-Conti-2. [Epub ahead of print]', 'Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, Evaluation and Treatment Coronavirus (COVID-19). 2020 May 18. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK554776/', 'Xu K, Cai H, Shen Y, Ni Q, Chen Y, Hu S, Li J, Wang H, Yu L, Huang H, Qiu Y, Wei G, Fang Q, Zhou J, Sheng J, Liang T, Li L. [Management of corona virus disease-19 (COVID-19): the Zhejiang experience]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 Feb 21;49(1):0. Chinese.']",['110/2020'],,https://clinicaltrials.gov/show/NCT04366089,2020-10-30,0,1
298,NCT04366180,Recruiting,2020-06-01,2020-10-01,No Results Posted,,,['P054'],,https://clinicaltrials.gov/show/NCT04366180,2020-06-01,0,0
299,NCT04366297,Completed,2020-02-25,2020-02-25,No Results Posted,,,['IO_PPE_MS_1'],,https://clinicaltrials.gov/show/NCT04366297,2020-02-25,0,0
300,NCT04366739,Not yet recruiting,2020-08-30,2020-09-30,No Results Posted,,,['D20-P016'],,https://clinicaltrials.gov/show/NCT04366739,2020-08-30,0,0
301,NCT04366817,Not yet recruiting,2020-04-01,2020-06-01,No Results Posted,,,['APHP200471'],,https://clinicaltrials.gov/show/NCT04366817,2020-04-01,0,0
302,NCT04366856,Not yet recruiting,2020-05-01,2020-07-01,No Results Posted,,,['APHP200504'],,https://clinicaltrials.gov/show/NCT04366856,2020-05-01,0,0
303,NCT04366882,Recruiting,2020-12-01,2020-12-01,No Results Posted,,,['JessaH_COVID-19_MIA'],,https://clinicaltrials.gov/show/NCT04366882,2020-12-01,0,0
304,NCT04366908,Not yet recruiting,2020-07-28,2020-08-28,No Results Posted,,,['COVIDIOL'],,https://clinicaltrials.gov/show/NCT04366908,2020-07-28,0,0
305,NCT04366947,"Active, not recruiting",2020-05-20,2020-05-20,No Results Posted,,,['IO_PPE_1'],,https://clinicaltrials.gov/show/NCT04366947,2020-05-20,0,0
306,NCT04367636,Not yet recruiting,2020-08-01,2020-08-01,No Results Posted,,,['EC/2019/0841'],,https://clinicaltrials.gov/show/NCT04367636,2020-08-01,0,0
307,NCT04368013,Not yet recruiting,2026-04-14,2026-04-14,No Results Posted,,,['CoVUm'],,https://clinicaltrials.gov/show/NCT04368013,2026-04-14,0,0
308,NCT04368156,Recruiting,2020-07-31,2020-07-31,No Results Posted,"['Tornero C, Vallejo R, Cede√±o D, Ordu√±a J, Pastor E, Belaouchi M, Escamilla B, Laredo M, Del Mar Garzando M. A prospective, randomized, controlled study assessing vagus nerve stimulation using the gammaCore¬Æ-Sapphire device for patients with moderate to severe CoViD-19 Respiratory Symptoms (SAVIOR): A structured summary of a study protocol for a randomised controlled trial"". Trials. 2020 Jun 26;21(1):576. doi: 10.1186/s13063-020-04486-w.']",,['SAVIOR'],,https://clinicaltrials.gov/show/NCT04368156,2020-07-31,0,1
309,NCT04368260,Recruiting,2020-07-31,2020-07-31,No Results Posted,,,['HSR200127'],,https://clinicaltrials.gov/show/NCT04368260,2020-07-31,0,0
310,NCT04368299,Not yet recruiting,2021-10-31,2021-12-31,No Results Posted,,,['TeleSLE'],,https://clinicaltrials.gov/show/NCT04368299,2021-10-31,0,0
311,NCT04368377,Completed,2020-04-23,2020-04-23,No Results Posted,,,['18275/2020'],,https://clinicaltrials.gov/show/NCT04368377,2020-04-23,0,0
312,NCT04368676,Not yet recruiting,2021-06-30,2021-06-30,No Results Posted,,,['115855'],,https://clinicaltrials.gov/show/NCT04368676,2021-06-30,0,0
313,NCT04369274,Not yet recruiting,2020-11-01,2020-11-01,No Results Posted,,,['2020P001051'],,https://clinicaltrials.gov/show/NCT04369274,2020-11-01,0,0
314,NCT04369365,Recruiting,2020-08-27,2020-12-27,No Results Posted,,,['OnCoVID-19 Trial'],,https://clinicaltrials.gov/show/NCT04369365,2020-08-27,0,0
315,NCT04369378,Not yet recruiting,2020-09-15,2020-10-31,No Results Posted,,,['27-126'],,https://clinicaltrials.gov/show/NCT04369378,2020-09-15,0,0
316,NCT04369469,Recruiting,2020-11-01,2021-02-01,No Results Posted,,,['ALXN1210-COV-305'],,https://clinicaltrials.gov/show/NCT04369469,2020-11-01,0,0
317,NCT04369794,Not yet recruiting,2021-06-01,2022-05-01,No Results Posted,,,['COVID-19 BATTLE trial'],,https://clinicaltrials.gov/show/NCT04369794,2021-06-01,0,0
318,NCT04370938,Recruiting,2020-10-29,2020-10-29,No Results Posted,,,['STUDY20040051'],,https://clinicaltrials.gov/show/NCT04370938,2020-10-29,0,0
319,NCT04371523,Not yet recruiting,2020-07-31,2020-08-30,No Results Posted,,,['3190'],,https://clinicaltrials.gov/show/NCT04371523,2020-07-31,0,0
320,NCT04324489,Completed,2020-04-16,2020-04-30,No Results Posted,,,['DAS181-SARS-CoV-2'],,https://clinicaltrials.gov/show/NCT04324489,2020-04-16,0,0
321,NCT04333550,Recruiting,2020-09-01,2021-03-01,No Results Posted,,"['Drakesmith H, Prentice A. Viral infection and iron metabolism. Nat Rev Microbiol. 2008 Jul;6(7):541-52. doi: 10.1038/nrmicro1930. Review.', 'Nairz M, Haschka D, Demetz E, Weiss G. Iron at the interface of immunity and infection. Front Pharmacol. 2014 Jul 16;5:152. doi: 10.3389/fphar.2014.00152. eCollection 2014. Review.', 'Georgiou NA, van der Bruggen T, Oudshoorn M, Nottet HS, Marx JJ, van Asbeck BS. Inhibition of human immunodeficiency virus type 1 replication in human mononuclear blood cells by the iron chelators deferoxamine, deferiprone, and bleomycin. J Infect Dis. 2000 Feb;181(2):484-90.', 'Vlahakos D, Arkadopoulos N, Kostopanagiotou G, Siasiakou S, Kaklamanis L, Degiannis D, Demonakou M, Smyrniotis V. Deferoxamine attenuates lipid peroxidation, blocks interleukin-6 production, ameliorates sepsis inflammatory response syndrome, and confers renoprotection after acute hepatic ischemia in pigs. Artif Organs. 2012 Apr;36(4):400-8. doi: 10.1111/j.1525-1594.2011.01385.x. Epub 2011 Dec 21.', 'Wang H, Li Z, Niu J, Xu Y, Ma L, Lu A, Wang X, Qian Z, Huang Z, Jin X, Leng Q, Wang J, Zhong J, Sun B, Meng G. Antiviral effects of ferric ammonium citrate. Cell Discov. 2018 Mar 27;4:14. doi: 10.1038/s41421-018-0013-6. eCollection 2018.', 'Cinatl J Jr, Cinatl J, Rabenau H, G√ºmbel HO, Kornhuber B, Doerr HW. In vitro inhibition of human cytomegalovirus replication by desferrioxamine. Antiviral Res. 1994 Sep;25(1):73-7.', 'Visseren F, Verkerk MS, van der Bruggen T, Marx JJ, van Asbeck BS, Diepersloot RJ. Iron chelation and hydroxyl radical scavenging reduce the inflammatory response of endothelial cells after infection with Chlamydia pneumoniae or influenza A. Eur J Clin Invest. 2002 Mar;32 Suppl 1:84-90.', 'Sappey C, Boelaert JR, Legrand-Poels S, Forceille C, Favier A, Piette J. Iron chelation decreases NF-kappa B and HIV type 1 activation due to oxidative stress. AIDS Res Hum Retroviruses. 1995 Sep;11(9):1049-61.', 'Chang HC, Bayeva M, Taiwo B, Palella FJ Jr, Hope TJ, Ardehali H. Short communication: high cellular iron levels are associated with increased HIV infection and replication. AIDS Res Hum Retroviruses. 2015 Mar;31(3):305-12. doi: 10.1089/aid.2014.0169. Epub 2014 Oct 7.', 'Meyer D. Iron chelation as therapy for HIV and Mycobacterium tuberculosis co-infection under conditions of iron overload. Curr Pharm Des. 2006;12(16):1943-7. Review.', 'Cinatl J, Scholz M, Weber B, Cinatl J, Rabenau H, Markus BH, Encke A, Doerr HW. Effects of desferrioxamine on human cytomegalovirus replication and expression of HLA antigens and adhesion molecules in human vascular endothelial cells. Transpl Immunol. 1995 Dec;3(4):313-20.', 'Mabeza GF, Loyevsky M, Gordeuk VR, Weiss G. Iron chelation therapy for malaria: a review. Pharmacol Ther. 1999 Jan;81(1):53-75. Review.', 'Weinberg GA. Iron chelators as therapeutic agents against Pneumocystis carinii. Antimicrob Agents Chemother. 1994 May;38(5):997-1003.', 'Paradkar PN, De Domenico I, Durchfort N, Zohn I, Kaplan J, Ward DM. Iron depletion limits intracellular bacterial growth in macrophages. Blood. 2008 Aug 1;112(3):866-74. doi: 10.1182/blood-2007-12-126854. Epub 2008 Mar 27.', 'Giannakopoulou E, Pardali V, Zoidis G. Metal-chelating agents against viruses and parasites. Future Med Chem. 2018 Jun 1;10(11):1283-1285. doi: 10.4155/fmc-2018-0100. Epub 2018 May 3. Review.', 'Gordeuk V, Thuma P, Brittenham G, McLaren C, Parry D, Backenstose A, Biemba G, Msiska R, Holmes L, McKinley E, et al. Effect of iron chelation therapy on recovery from deep coma in children with cerebral malaria. N Engl J Med. 1992 Nov 19;327(21):1473-7.', 'Duchemin JB, Paradkar PN. Iron availability affects West Nile virus infection in its mosquito vector. Virol J. 2017 Jun 5;14(1):103. doi: 10.1186/s12985-017-0770-0.']",['1398.1224'],,https://clinicaltrials.gov/show/NCT04333550,2020-09-01,0,1
322,NCT04343768,Completed,2020-04-27,2020-04-27,No Results Posted,"['Irvani SSN, Golmohammadi M, Pourhoseingholi MA, Shokouhi S, Darazam IA. Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial. Trials. 2020 Jun 3;21(1):473. doi: 10.1186/s13063-020-04382-3.']",,['Different Interferons in COVID'],,https://clinicaltrials.gov/show/NCT04343768,2020-04-27,0,1
323,NCT04345614,Recruiting,2020-07-01,2020-09-01,No Results Posted,,,['CM4620-204'],,https://clinicaltrials.gov/show/NCT04345614,2020-07-01,0,0
324,NCT04346667,Recruiting,2020-05-30,2021-06-30,No Results Posted,,,['NBC-COVID19-02'],,https://clinicaltrials.gov/show/NCT04346667,2020-05-30,0,0
325,NCT04350320,Recruiting,2020-10-20,2020-11-20,No Results Posted,,,['IMIB-COLVID-2020-03'],,https://clinicaltrials.gov/show/NCT04350320,2020-10-20,0,0
326,NCT04354597,Not yet recruiting,2020-08-15,2020-10-15,No Results Posted,,,['20 KHCC 67'],,https://clinicaltrials.gov/show/NCT04354597,2020-08-15,0,0
327,NCT04358926,Recruiting,2020-06-30,2020-07-30,No Results Posted,,,['120-20-ASF'],,https://clinicaltrials.gov/show/NCT04358926,2020-06-30,0,0
328,NCT04360122,Not yet recruiting,2020-11-01,2020-12-01,No Results Posted,,,['FMASU P20a/ 2020'],,https://clinicaltrials.gov/show/NCT04360122,2020-11-01,0,0
329,NCT04361032,Not yet recruiting,2020-09-04,2020-10-04,No Results Posted,,,['ECC2020-06'],,https://clinicaltrials.gov/show/NCT04361032,2020-09-04,0,0
330,NCT04364815,Not yet recruiting,2021-05-01,2021-05-01,No Results Posted,,,['RGAO-2020-0339'],,https://clinicaltrials.gov/show/NCT04364815,2021-05-01,0,0
331,NCT04369456,Recruiting,2020-10-22,2020-10-22,No Results Posted,,,['20-PP-09'],,https://clinicaltrials.gov/show/NCT04369456,2020-10-22,0,0
332,NCT04369820,Recruiting,2020-09-01,2020-11-01,No Results Posted,,,"['2020-14', 'IDRCB ( Other Identifier: 2020-A00757-32 )']",,https://clinicaltrials.gov/show/NCT04369820,2020-09-01,0,0
333,NCT04370288,Recruiting,2020-09-20,2020-09-21,No Results Posted,,,['IR.MUMS.REC.1399.122'],,https://clinicaltrials.gov/show/NCT04370288,2020-09-20,0,0
334,NCT04371367,Recruiting,2020-06-27,2020-10-27,No Results Posted,,,['2020-21'],,https://clinicaltrials.gov/show/NCT04371367,2020-06-27,0,0
335,NCT04371406,Not yet recruiting,2020-08-02,2020-09-02,No Results Posted,,,"['APHP200447', '2020-001702-35 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04371406,2020-08-02,0,0
336,NCT04371510,Recruiting,2020-10-22,2021-02-22,No Results Posted,,,['20-PP-08'],,https://clinicaltrials.gov/show/NCT04371510,2020-10-22,0,0
337,NCT04371601,"Active, not recruiting",2021-12-31,2022-12-31,No Results Posted,,,['MSC-CoViD-2020'],,https://clinicaltrials.gov/show/NCT04371601,2021-12-31,0,0
338,NCT04371965,Not yet recruiting,2020-07-01,2020-08-01,No Results Posted,,,['KILLER'],,https://clinicaltrials.gov/show/NCT04371965,2020-07-01,0,0
339,NCT04371978,Not yet recruiting,2021-06-30,2021-09-30,No Results Posted,,,['0303-20-RMC'],,https://clinicaltrials.gov/show/NCT04371978,2021-06-30,0,0
340,NCT04372030,Not yet recruiting,2020-06-30,2021-10-31,No Results Posted,,,['US3R'],,https://clinicaltrials.gov/show/NCT04372030,2020-06-30,0,0
341,NCT04372082,Not yet recruiting,2023-05-01,2023-05-01,No Results Posted,,,"['2020_40', '2020-002188-72 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04372082,2023-05-01,0,0
342,NCT04372602,Not yet recruiting,2021-07-31,2021-12-31,No Results Posted,,,['04-28-20-DiPersio'],,https://clinicaltrials.gov/show/NCT04372602,2021-07-31,0,0
343,NCT04372680,Recruiting,2020-09-22,2020-09-22,No Results Posted,,,"['RC31/20/0138', '2020-A00916-33 ( Other Identifier: ID-RCB )']",,https://clinicaltrials.gov/show/NCT04372680,2020-09-22,0,0
344,NCT04372693,Enrolling by invitation,2020-05-30,2020-06-30,No Results Posted,,,['FON170133'],,https://clinicaltrials.gov/show/NCT04372693,2020-05-30,0,0
345,NCT04373005,Not yet recruiting,2020-12-04,2020-12-04,No Results Posted,,,"['U-DEPLOY: RESPONSE', 'CAPCR 20-5337 ( Other Identifier: University Health Network )']",,https://clinicaltrials.gov/show/NCT04373005,2020-12-04,0,0
346,NCT04373291,Not yet recruiting,2020-12-01,2021-01-01,No Results Posted,,,"['BCG-DENMARK-COVID', '2020-001888-90 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04373291,2020-12-01,0,0
347,NCT04373382,Not yet recruiting,2022-02-01,2022-02-01,No Results Posted,,,['20-0084-E'],,https://clinicaltrials.gov/show/NCT04373382,2022-02-01,0,0
348,NCT04373824,Recruiting,2020-07-25,2020-07-25,No Results Posted,,,['MHC-COVID-19- INV- ACT-BHR'],,https://clinicaltrials.gov/show/NCT04373824,2020-07-25,0,0
349,NCT04374149,Not yet recruiting,2020-09-01,2021-04-30,No Results Posted,,,['PHU COVID-19-001'],,https://clinicaltrials.gov/show/NCT04374149,2020-09-01,0,0
350,NCT04374474,Not yet recruiting,2021-06-01,2021-12-01,No Results Posted,,,['Anosmia_CoVID 19'],,https://clinicaltrials.gov/show/NCT04374474,2021-06-01,0,0
351,NCT04374487,Not yet recruiting,2021-05-09,2021-05-09,No Results Posted,,,['MHC-COVID-19-CP'],,https://clinicaltrials.gov/show/NCT04374487,2021-05-09,0,0
352,NCT04374539,Recruiting,2021-05-05,2021-08-29,No Results Posted,,,['2020-001722-66'],,https://clinicaltrials.gov/show/NCT04374539,2021-05-05,0,0
353,NCT04374552,Not yet recruiting,2020-11-01,2021-04-01,No Results Posted,,,['Pro2020000872'],,https://clinicaltrials.gov/show/NCT04374552,2020-11-01,0,0
354,NCT04374903,Not yet recruiting,2020-08-01,2020-09-01,No Results Posted,,,['20 KHCC 74'],,https://clinicaltrials.gov/show/NCT04374903,2020-08-01,0,0
355,NCT04375202,Recruiting,2020-06-30,2020-10-31,No Results Posted,,,['2020-001475-33'],,https://clinicaltrials.gov/show/NCT04375202,2020-06-30,0,0
356,NCT04251871,Recruiting,2021-01-22,2021-01-22,No Results Posted,,,['2020001D'],,https://clinicaltrials.gov/show/NCT04251871,2021-01-22,0,0
357,NCT04280705,Recruiting,2023-04-01,2023-04-01,No Results Posted,"['Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, Hohmann E, Chu HY, Luetkemeyer A, Kline S, Lopez de Castilla D, Finberg RW, Dierberg K, Tapson V, Hsieh L, Patterson TF, Paredes R, Sweeney DA, Short WR, Touloumi G, Lye DC, Ohmagari N, Oh MD, Ruiz-Palacios GM, Benfield T, F√§tkenheuer G, Kortepeter MG, Atmar RL, Creech CB, Lundgren J, Babiker AG, Pett S, Neaton JD, Burgess TH, Bonnett T, Green M, Makowski M, Osinusi A, Nayak S, Lane HC; ACTT-1 Study Group Members. Remdesivir for the Treatment of Covid-19 - Preliminary Report. N Engl J Med. 2020 May 22. doi: 10.1056/NEJMoa2007764. [Epub ahead of print]']",,['20-0006'],,https://clinicaltrials.gov/show/NCT04280705,2023-04-01,0,1
358,NCT04326790,Recruiting,2020-08-31,2020-09-30,No Results Posted,"['Deftereos SG, Giannopoulos G, Vrachatis DA, Siasos GD, Giotaki SG, Gargalianos P, Metallidis S, Sianos G, Baltagiannis S, Panagopoulos P, Dolianitis K, Randou E, Syrigos K, Kotanidou A, Koulouris NG, Milionis H, Sipsas N, Gogos C, Tsoukalas G, Olympios CD, Tsagalou E, Migdalis I, Gerakari S, Angelidis C, Alexopoulos D, Davlouros P, Hahalis G, Kanonidis I, Katritsis D, Kolettis T, Manolis AS, Michalis L, Naka KK, Pyrgakis VN, Toutouzas KP, Triposkiadis F, Tsioufis K, Vavouranakis E, Martin√®z-Dolz L, Reimers B, Stefanini GG, Cleman M, Goudevenos J, Tsiodras S, Tousoulis D, Iliodromitis E, Mehran R, Dangas G, Stefanadis C; GRECCO-19 investigators. Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019: The GRECCO-19 Randomized Clinical Trial. JAMA Netw Open. 2020 Jun 1;3(6):e2013136. doi: 10.1001/jamanetworkopen.2020.13136.', 'Deftereos SG, Siasos G, Giannopoulos G, Vrachatis DA, Angelidis C, Giotaki SG, Gargalianos P, Giamarellou H, Gogos C, Daikos G, Lazanas M, Lagiou P, Saroglou G, Sipsas N, Tsiodras S, Chatzigeorgiou D, Moussas N, Kotanidou A, Koulouris N, Oikonomou E, Kaoukis A, Kossyvakis C, Raisakis K, Fountoulaki K, Comis M, Tsiachris D, Sarri E, Theodorakis A, Martinez-Dolz L, Sanz-S√°nchez J, Reimers B, Stefanini GG, Cleman M, Filippou D, Olympios CD, Pyrgakis VN, Goudevenos J, Hahalis G, Kolettis TM, Iliodromitis E, Tousoulis D, Stefanadis C. The Greek study in the effects of colchicine in COvid-19 complications prevention (GRECCO-19 study): Rationale and study design. Hellenic J Cardiol. 2020 Apr 3. pii: S1109-9666(20)30061-0. doi: 10.1016/j.hjc.2020.03.002. [Epub ahead of print]']",,['906295542'],,https://clinicaltrials.gov/show/NCT04326790,2020-08-31,0,1
359,NCT04333225,"Active, not recruiting",2020-07-30,2020-07-30,No Results Posted,,,['020-132'],,https://clinicaltrials.gov/show/NCT04333225,2020-07-30,0,0
360,NCT04333355,Recruiting,2020-12-20,2021-04-30,No Results Posted,,,['PC-TecSalud Fase I'],,https://clinicaltrials.gov/show/NCT04333355,2020-12-20,0,0
361,NCT04333732,Not yet recruiting,2021-02-01,2021-02-01,No Results Posted,,,['202004099'],,https://clinicaltrials.gov/show/NCT04333732,2021-02-01,0,0
362,NCT04336332,Recruiting,2021-04-30,2021-04-30,No Results Posted,,,"['002011', 'Pro2020000712 ( Other Identifier: Rutgers Health Sciences IRB )']",,https://clinicaltrials.gov/show/NCT04336332,2021-04-30,0,0
363,NCT04336774,Recruiting,2020-11-01,2020-11-09,No Results Posted,,,['pro00105212'],,https://clinicaltrials.gov/show/NCT04336774,2020-11-01,0,0
364,NCT04340232,Not yet recruiting,2020-08-01,2020-10-01,No Results Posted,,,['20-0738'],,https://clinicaltrials.gov/show/NCT04340232,2020-08-01,0,0
365,NCT04341441,Recruiting,2020-06-30,2021-04-30,No Results Posted,,,['1410401'],,https://clinicaltrials.gov/show/NCT04341441,2020-06-30,0,0
366,NCT04341870,Suspended,2020-05-08,2020-08-01,No Results Posted,,,['APHP200375-3'],,https://clinicaltrials.gov/show/NCT04341870,2020-05-08,0,0
367,NCT04343989,Recruiting,2020-07-01,2020-07-01,No Results Posted,,,['s20-00392'],,https://clinicaltrials.gov/show/NCT04343989,2020-07-01,0,0
368,NCT04344041,Recruiting,2020-07-01,2020-07-01,No Results Posted,,,['2020-001602-34'],,https://clinicaltrials.gov/show/NCT04344041,2020-07-01,0,0
369,NCT04346082,Not yet recruiting,2021-04-30,2021-04-30,No Results Posted,,,['online-mind'],,https://clinicaltrials.gov/show/NCT04346082,2021-04-30,0,0
370,NCT04348071,Not yet recruiting,2020-08-01,2020-10-01,No Results Posted,,,['20-0869'],,https://clinicaltrials.gov/show/NCT04348071,2020-08-01,0,0
371,NCT04349098,Recruiting,2020-08-31,2020-08-31,No Results Posted,,,"['XPORT-CoV-1001', '2020-001411-25 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04349098,2020-08-31,0,0
372,NCT04351906,Recruiting,2020-07-01,2020-09-01,No Results Posted,,"['Schmidt M, Jaber S, Zogheib E, Godet T, Capellier G, Combes A. Feasibility and safety of low-flow extracorporeal CO(2) removal managed with a renal replacement platform to enhance lung-protective ventilation of patients with mild-to-moderate ARDS. Crit Care. 2018 May 10;22(1):122. doi: 10.1186/s13054-018-2038-5.']",['AZ 63/20'],,https://clinicaltrials.gov/show/NCT04351906,2020-07-01,0,1
373,NCT04354610,Recruiting,2020-07-18,2020-10-18,No Results Posted,,,['2020PI072'],,https://clinicaltrials.gov/show/NCT04354610,2020-07-18,0,0
374,NCT04355637,Recruiting,2020-08-31,2020-10-18,No Results Posted,,,"['TACTIC-COVID', '2020-001616-18 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04355637,2020-08-31,0,0
375,NCT04357990,Recruiting,2020-07-01,2020-07-01,No Results Posted,,,['KS-0470'],,https://clinicaltrials.gov/show/NCT04357990,2020-07-01,0,0
376,NCT04363216,Not yet recruiting,2021-05-01,2021-05-01,No Results Posted,,,['JT#15681'],,https://clinicaltrials.gov/show/NCT04363216,2021-05-01,0,0
377,NCT04363437,Recruiting,2020-05-31,2020-06-14,No Results Posted,,,['2020-04-12'],,https://clinicaltrials.gov/show/NCT04363437,2020-05-31,0,0
378,NCT04363593,Recruiting,2020-11-04,2020-11-04,No Results Posted,,,['29BRC20.0122'],,https://clinicaltrials.gov/show/NCT04363593,2020-11-04,0,0
379,NCT04365972,Completed,2020-04-30,2020-04-30,No Results Posted,,,['TAU-COVID-19'],,https://clinicaltrials.gov/show/NCT04365972,2020-04-30,0,0
380,NCT04370015,Not yet recruiting,2020-06-30,2020-10-15,No Results Posted,,,['16082019'],,https://clinicaltrials.gov/show/NCT04370015,2020-06-30,0,0
381,NCT04371640,Recruiting,2020-07-01,2020-08-01,No Results Posted,,,['15680'],,https://clinicaltrials.gov/show/NCT04371640,2020-07-01,0,0
382,NCT04372004,Not yet recruiting,2021-05-01,2021-06-01,No Results Posted,,,['TCAI_CATCH COVID-19'],,https://clinicaltrials.gov/show/NCT04372004,2021-05-01,0,0
383,NCT04373161,Completed,2020-04-22,2020-04-22,No Results Posted,,,['2020032301'],,https://clinicaltrials.gov/show/NCT04373161,2020-04-22,0,0
384,NCT04374019,Recruiting,2021-05-01,2021-05-01,No Results Posted,,,['MCC-20-COVID-01-PMC'],,https://clinicaltrials.gov/show/NCT04374019,2021-05-01,0,0
385,NCT04374032,Recruiting,2020-08-31,2020-10-31,No Results Posted,,,['EN-COVCS-01'],,https://clinicaltrials.gov/show/NCT04374032,2020-08-31,0,0
386,NCT04374279,Not yet recruiting,2021-06-01,2021-06-01,No Results Posted,,,"['COV2003', 'IRB00249425 ( Other Identifier: JHM IRB )']",,https://clinicaltrials.gov/show/NCT04374279,2021-06-01,0,0
387,NCT04374942,Enrolling by invitation,2020-08-27,2022-01-30,No Results Posted,,,"['HEROs Protocol 1.5', 'ISRCTN14326006 ( Registry Identifier: ISRCTN )']",,https://clinicaltrials.gov/show/NCT04374942,2020-08-27,0,0
388,NCT04375774,Recruiting,2020-05-01,2020-05-01,No Results Posted,,,['2020/15AVR/226'],,https://clinicaltrials.gov/show/NCT04375774,2020-05-01,0,0
389,NCT04376515,"Active, not recruiting",2020-06-01,2020-09-01,No Results Posted,,,['UCaliforniaIrvineSYoung'],,https://clinicaltrials.gov/show/NCT04376515,2020-06-01,0,0
390,NCT04376593,Enrolling by invitation,2021-05-01,2022-05-01,No Results Posted,,,['1592298'],,https://clinicaltrials.gov/show/NCT04376593,2021-05-01,0,0
391,NCT04376788,Not yet recruiting,2020-06-01,2020-06-01,No Results Posted,,,['FMASU P22/2020'],,https://clinicaltrials.gov/show/NCT04376788,2020-06-01,0,0
392,NCT04377308,Recruiting,2021-04-20,2021-10-20,No Results Posted,,,['FRIDA COVID19'],,https://clinicaltrials.gov/show/NCT04377308,2021-04-20,0,0
393,NCT04377477,Recruiting,2021-05-10,2022-07-23,No Results Posted,,,['NP 4097'],,https://clinicaltrials.gov/show/NCT04377477,2021-05-10,0,0
394,NCT04377503,Not yet recruiting,2020-08-01,2020-11-01,No Results Posted,,,['covid-19 hsd'],,https://clinicaltrials.gov/show/NCT04377503,2020-08-01,0,0
395,NCT04377646,Not yet recruiting,2020-05-24,2020-07-31,No Results Posted,,,"['UR17DN02-001', 'TN2020-NAT-INS-38 ( Other Identifier: Tunisian Ministry of Health )']",,https://clinicaltrials.gov/show/NCT04377646,2020-05-24,0,0
396,NCT04377750,Recruiting,2020-04-29,2021-05-08,No Results Posted,,,['0224-20-HMO-CTIL'],,https://clinicaltrials.gov/show/NCT04377750,2020-04-29,0,0
397,NCT04377802,Not yet recruiting,2020-11-16,2020-12-30,No Results Posted,,,['KFSH-ONC-02'],,https://clinicaltrials.gov/show/NCT04377802,2020-11-16,0,0
398,NCT04377997,Not yet recruiting,2021-01-01,2022-01-01,No Results Posted,,"['Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo FX, Chong M, Lee M. Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State. JAMA. 2020 Mar 19. doi: 10.1001/jama.2020.4326. [Epub ahead of print]', 'Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30;:.', 'Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Feb 7. doi: 10.1001/jama.2020.1585. [Epub ahead of print]', 'Frencken JF, Donker DW, Spitoni C, Koster-Brouwer ME, Soliman IW, Ong DSY, Horn J, van der Poll T, van Klei WA, Bonten MJM, Cremer OL. Myocardial Injury in Patients With Sepsis and Its Association With Long-Term Outcome. Circ Cardiovasc Qual Outcomes. 2018 Feb;11(2):e004040. doi: 10.1161/CIRCOUTCOMES.117.004040.', 'Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, Gong W, Liu X, Liang J, Zhao Q, Huang H, Yang B, Huang C. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol. 2020 Mar 25. doi: 10.1001/jamacardio.2020.0950. [Epub ahead of print]', 'C. P. COVID-19: Abnormal Clotting Common in More Severe Disease. 2020.', 'Chan MY, Andreotti F, Becker RC. Hypercoagulable states in cardiovascular disease. Circulation. 2008 Nov 25;118(22):2286-97. doi: 10.1161/CIRCULATIONAHA.108.778837. Review.', 'Zarychanski R, Doucette S, Fergusson D, Roberts D, Houston DS, Sharma S, Gulati H, Kumar A. Early intravenous unfractionated heparin and mortality in septic shock. Crit Care Med. 2008 Nov;36(11):2973-9. doi: 10.1097/CCM.0b013e31818b8c6b.', 'Jaimes F, De La Rosa G, Morales C, Fortich F, Arango C, Aguirre D, Mu√±oz A. Unfractioned heparin for treatment of sepsis: A randomized clinical trial (The HETRASE Study). Crit Care Med. 2009 Apr;37(4):1185-96. doi: 10.1097/CCM.0b013e31819c06bc.', 'Safety of Heparin in Patients with Septic Shock.', 'Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020 May;18(5):1094-1099. doi: 10.1111/jth.14817. Epub 2020 Apr 27.', 'Iba T, Levy JH, Warkentin TE, Thachil J, van der Poll T, Levi M; Scientific and Standardization Committee on DIC, and the Scientific and Standardization Committee on Perioperative and Critical Care of the International Society on Thrombosis and Haemostasis. Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation. J Thromb Haemost. 2019 Nov;17(11):1989-1994. doi: 10.1111/jth.14578. Epub 2019 Aug 13.', 'Zarychanski R, Abou-Setta AM, Kanji S, Turgeon AF, Kumar A, Houston DS, Rimmer E, Houston BL, McIntyre L, Fox-Robichaud AE, H√©bert P, Cook DJ, Fergusson DA; Canadian Critical Care Trials Group. The efficacy and safety of heparin in patients with sepsis: a systematic review and metaanalysis. Crit Care Med. 2015 Mar;43(3):511-8. doi: 10.1097/CCM.0000000000000763. Review.', 'Zidane M, Schram MT, Planken EW, Molendijk WH, Rosendaal FR, van der Meer FJ, Huisman MV. Frequency of major hemorrhage in patients treated with unfractionated intravenous heparin for deep venous thrombosis or pulmonary embolism: a study in routine clinical practice. Arch Intern Med. 2000 Aug 14-28;160(15):2369-73.', 'Schulman S, Kearon C; Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost. 2005 Apr;3(4):692-4.', 'Morris TA, Castrejon S, Devendra G, Gamst AC. No difference in risk for thrombocytopenia during treatment of pulmonary embolism and deep venous thrombosis with either low-molecular-weight heparin or unfractionated heparin: a metaanalysis. Chest. 2007 Oct;132(4):1131-9. Epub 2007 Jul 23.', 'Stein PD, Hull RD, Matta F, Yaekoub AY, Liang J. Incidence of thrombocytopenia in hospitalized patients with venous thromboembolism. Am J Med. 2009 Oct;122(10):919-30. doi: 10.1016/j.amjmed.2009.03.026. Epub 2009 Aug 13. Review.']",['2020P001136'],,https://clinicaltrials.gov/show/NCT04377997,2021-01-01,0,1
399,NCT04378244,Not yet recruiting,2021-01-12,2021-03-12,No Results Posted,,,['AF20-203'],,https://clinicaltrials.gov/show/NCT04378244,2021-01-12,0,0
400,NCT04378257,Not yet recruiting,2020-09-30,2020-10-20,No Results Posted,,,['12/2020'],,https://clinicaltrials.gov/show/NCT04378257,2020-09-30,0,0
401,NCT04379037,Not yet recruiting,2020-10-01,2021-01-01,No Results Posted,,,['NCM-001'],,https://clinicaltrials.gov/show/NCT04379037,2020-10-01,0,0
402,NCT04379154,Recruiting,2020-06-28,2020-11-16,No Results Posted,,,['2020_0060'],,https://clinicaltrials.gov/show/NCT04379154,2020-06-28,0,0
403,NCT04379336,Recruiting,2021-04-28,2021-04-28,No Results Posted,,,['TASK-008 BCG-CORONA'],,https://clinicaltrials.gov/show/NCT04379336,2021-04-28,0,0
404,NCT04379479,Not yet recruiting,2020-08-01,2020-12-01,No Results Posted,,,"['IC-20-001', 'SH-001-2020 ( Other Identifier: Instituto Polit√©cnico Nacional )']",,https://clinicaltrials.gov/show/NCT04379479,2020-08-01,0,0
405,NCT04379518,Not yet recruiting,2021-04-06,2021-04-30,No Results Posted,,,"['I 659920', 'NCI-2020-02317 ( Registry Identifier: CTRP (Clinical Trial Reporting Program) )', 'I 659920 ( Other Identifier: Roswell Park Cancer Institute )', 'P30CA016056 ( U.S. NIH Grant/Contract )']",,https://clinicaltrials.gov/show/NCT04379518,2021-04-06,0,0
406,NCT04379661,Recruiting,2021-04-01,2021-04-01,No Results Posted,,,['AAAS9939'],,https://clinicaltrials.gov/show/NCT04379661,2021-04-01,0,0
407,NCT04380519,Recruiting,2020-10-15,2020-11-15,No Results Posted,,,['CL04041078'],,https://clinicaltrials.gov/show/NCT04380519,2020-10-15,0,0
408,NCT04380948,,,,,,,,,https://clinicaltrials.gov/show/NCT04380948,,0,0
409,NCT04273321,Completed,2020-04-15,2020-04-15,No Results Posted,,,['Methylprednisolone in COVID-19'],,https://clinicaltrials.gov/show/NCT04273321,2020-04-15,0,0
410,NCT04278963,Suspended,2021-01-01,2021-01-01,No Results Posted,,,['YHQW-V3.0'],,https://clinicaltrials.gov/show/NCT04278963,2021-01-01,0,0
411,NCT04310865,Suspended,2021-03-30,2021-06-30,No Results Posted,,,['YHQW-Severe-V2.0'],,https://clinicaltrials.gov/show/NCT04310865,2021-03-30,0,0
412,NCT04322396,Recruiting,2020-10-31,2021-03-31,No Results Posted,"['Sivapalan P, Ulrik CS, Bojesen RD, Lapperre TS, Ekl√∂f JV, H√•kansson KEJ, Browatzki A, Tidemansen C, Wilcke JT, Janner J, Gottlieb V, Meteran H, Porsbjerg C, Madsen BL, Moberg M, Pedersen L, Benfield TL, Lundgren JD, Knop FK, Biering-S√∏rensen T, Ghanizada M, Sonne TP, B√∏dtger UCS, Jensen SG, Rasmussen DB, Br√∏ndum E, Tupper OD, S√∏rensen SW, Alstrup G, Laursen CB, M√∏ller UW, Sverrild A, Jensen JS. Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jun 10;21(1):513. doi: 10.1186/s13063-020-04409-9.']",,['KronLungesyg_COVID_19_protokol'],,https://clinicaltrials.gov/show/NCT04322396,2020-10-31,0,1
413,NCT04334512,Recruiting,2021-06-01,2021-09-01,No Results Posted,,,['PRG-044'],,https://clinicaltrials.gov/show/NCT04334512,2021-06-01,0,0
414,NCT04335084,Recruiting,2021-06-01,2021-09-01,No Results Posted,,,['PRG-042'],,https://clinicaltrials.gov/show/NCT04335084,2021-06-01,0,0
415,NCT04340544,Recruiting,2021-11-30,2022-09-30,No Results Posted,,,['COMIHY'],,https://clinicaltrials.gov/show/NCT04340544,2021-11-30,0,0
416,NCT04344015,Recruiting,2021-04-12,2021-04-12,No Results Posted,,,['20D.346'],,https://clinicaltrials.gov/show/NCT04344015,2021-04-12,0,0
417,NCT04346147,Recruiting,2020-08-01,2020-09-01,No Results Posted,,,['24032020'],,https://clinicaltrials.gov/show/NCT04346147,2020-08-01,0,0
418,NCT04346199,Not yet recruiting,2020-11-30,2020-11-30,No Results Posted,,,['D822FC00001'],,https://clinicaltrials.gov/show/NCT04346199,2020-11-30,0,0
419,NCT04347915,Recruiting,2020-09-30,2020-12-31,No Results Posted,,,['BK-CLV-201'],,https://clinicaltrials.gov/show/NCT04347915,2020-09-30,0,0
420,NCT04354389,Not yet recruiting,2020-06-30,2020-10-31,No Results Posted,,,"['DAS181-3-02-EU', '2020-001874-30 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04354389,2020-06-30,0,0
421,NCT04356690,Recruiting,2020-12-01,2021-12-01,No Results Posted,,,['H-40102'],,https://clinicaltrials.gov/show/NCT04356690,2020-12-01,0,0
422,NCT04365985,Recruiting,2020-05-01,2020-08-01,No Results Posted,,,['2020-097'],,https://clinicaltrials.gov/show/NCT04365985,2020-05-01,0,0
423,NCT04366271,Recruiting,2020-07-31,2021-05-31,No Results Posted,,,"['MESCEL-COVID19', '2020-001450-22 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04366271,2020-07-31,0,0
424,NCT04373135,Recruiting,2020-10-01,2020-12-01,No Results Posted,,,['UCLA-20-000683'],,https://clinicaltrials.gov/show/NCT04373135,2020-10-01,0,0
425,NCT04375046,Not yet recruiting,2020-09-01,2020-10-01,No Results Posted,,,['proposed by Mahmoud kazazzaz'],,https://clinicaltrials.gov/show/NCT04375046,2020-09-01,0,0
426,NCT04376476,Recruiting,2021-06-05,2021-06-05,No Results Posted,,,"['69HCL20_0342', '2020-A01102-37 ( Other Identifier: ID-RCB )']",,https://clinicaltrials.gov/show/NCT04376476,2021-06-05,0,0
427,NCT04379271,Recruiting,2020-09-01,2020-10-01,No Results Posted,,,['P2-IMU-838-COV'],,https://clinicaltrials.gov/show/NCT04379271,2020-09-01,0,0
428,NCT04379453,Recruiting,2020-04-27,2020-04-27,No Results Posted,,,['4094-20'],,https://clinicaltrials.gov/show/NCT04379453,2020-04-27,0,0
429,NCT04379492,Recruiting,2021-05-01,2021-05-01,No Results Posted,,,['20-187'],,https://clinicaltrials.gov/show/NCT04379492,2021-05-01,0,0
430,NCT04380376,Recruiting,2020-10-30,2020-10-30,No Results Posted,,,['PSRI05-20'],,https://clinicaltrials.gov/show/NCT04380376,2020-10-30,0,0
431,NCT04380688,Not yet recruiting,2020-09-30,2020-09-30,No Results Posted,,,['D822FC00003'],,https://clinicaltrials.gov/show/NCT04380688,2020-09-30,0,0
432,NCT04380909,Recruiting,2021-04-01,2021-04-01,No Results Posted,,,['2020-00990'],,https://clinicaltrials.gov/show/NCT04380909,2021-04-01,0,0
433,NCT04380935,Not yet recruiting,2020-08-31,2020-08-31,No Results Posted,,,['convalescent plasma RSCM-FKUI'],,https://clinicaltrials.gov/show/NCT04380935,2020-08-31,0,0
434,NCT04381000,Completed,2020-05-29,2020-06-10,No Results Posted,,,['3'],,https://clinicaltrials.gov/show/NCT04381000,2020-05-29,0,0
435,NCT04381052,Not yet recruiting,2020-08-01,2020-08-01,No Results Posted,,,['AAAT0142'],,https://clinicaltrials.gov/show/NCT04381052,2020-08-01,0,0
436,NCT04381338,Not yet recruiting,2020-09-30,2020-09-30,No Results Posted,,,['UPadova_1'],,https://clinicaltrials.gov/show/NCT04381338,2020-09-30,0,0
437,NCT04381364,Not yet recruiting,2020-12-01,2020-12-31,No Results Posted,,,['2020-02183'],,https://clinicaltrials.gov/show/NCT04381364,2020-12-01,0,0
438,NCT04381377,Recruiting,2021-04-01,2021-04-01,No Results Posted,,,['P–û-COV-III-20'],,https://clinicaltrials.gov/show/NCT04381377,2021-04-01,0,0
439,NCT04381858,Recruiting,2020-08-30,2020-09-30,No Results Posted,,,['2020-A-10'],,https://clinicaltrials.gov/show/NCT04381858,2020-08-30,0,0
440,NCT04381871,Not yet recruiting,2020-08-01,2020-09-01,No Results Posted,,,['GA& COVID19'],,https://clinicaltrials.gov/show/NCT04381871,2020-08-01,0,0
441,NCT04382092,Completed,2020-04-24,2020-04-24,No Results Posted,,,['2019/14MAR/124'],,https://clinicaltrials.gov/show/NCT04382092,2020-04-24,0,0
442,NCT04382131,Not yet recruiting,2020-07-31,2020-07-31,No Results Posted,,,['AC20042'],,https://clinicaltrials.gov/show/NCT04382131,2020-07-31,0,0
443,NCT04382560,Recruiting,2020-05-31,2020-05-31,No Results Posted,,,['ESPCOV1'],,https://clinicaltrials.gov/show/NCT04382560,2020-05-31,0,0
444,NCT04382625,Not yet recruiting,2022-01-01,2022-06-01,No Results Posted,,,['18244'],,https://clinicaltrials.gov/show/NCT04382625,2022-01-01,0,0
445,NCT04382729,Recruiting,2020-07-01,2020-07-01,No Results Posted,,,['ESC270320'],,https://clinicaltrials.gov/show/NCT04382729,2020-07-01,0,0
446,NCT04382755,Not yet recruiting,2021-05-01,2021-09-01,No Results Posted,,,['ZILU-COV'],,https://clinicaltrials.gov/show/NCT04382755,2021-05-01,0,0
447,NCT04382846,Not yet recruiting,2030-12-01,2030-12-01,No Results Posted,,,['tanta covid treatment'],,https://clinicaltrials.gov/show/NCT04382846,2030-12-01,0,0
448,NCT04382924,Not yet recruiting,2022-01-01,2022-02-01,No Results Posted,,,['AGN120-3'],,https://clinicaltrials.gov/show/NCT04382924,2022-01-01,0,0
449,NCT04383002,Not yet recruiting,2020-12-01,2020-12-01,No Results Posted,,,['20-5449'],,https://clinicaltrials.gov/show/NCT04383002,2020-12-01,0,0
450,NCT04383574,Not yet recruiting,2020-07-20,2020-07-20,No Results Posted,,,['PRO-nCOV-1002'],,https://clinicaltrials.gov/show/NCT04383574,2020-07-20,0,0
451,NCT04383587,Enrolling by invitation,2020-05-29,2020-06-12,No Results Posted,,,['20-004054'],,https://clinicaltrials.gov/show/NCT04383587,2020-05-29,0,0
452,NCT04384380,Recruiting,2020-06-30,2020-09-30,No Results Posted,,"['Cheng SC, Chang YC, Fan Chiang YL, Chien YC, Cheng M, Yang CH, Huang CH, Hsu YN. First case of Coronavirus Disease 2019 (COVID-19) pneumonia in Taiwan. J Formos Med Assoc. 2020 Mar;119(3):747-751. doi: 10.1016/j.jfma.2020.02.007. Epub 2020 Feb 26.', 'Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30;:.', 'Zhang W, Du RH, Li B, Zheng XS, Yang XL, Hu B, Wang YY, Xiao GF, Yan B, Shi ZL, Zhou P. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect. 2020 Feb 17;9(1):386-389. doi: 10.1080/22221751.2020.1729071. eCollection 2020.', 'Cortegiani A, Ingoglia G, Ippolito M, Giarratano A, Einav S. A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19. J Crit Care. 2020 Jun;57:279-283. doi: 10.1016/j.jcrc.2020.03.005. Epub 2020 Mar 10.', 'Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, Doudier B, Courjon J, Giordanengo V, Vieira VE, Dupont HT, Honor√© S, Colson P, Chabri√®re E, La Scola B, Rolain JM, Brouqui P, Raoult D. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020 Mar 20:105949. doi: 10.1016/j.ijantimicag.2020.105949. [Epub ahead of print]']",['TYGH109014'],,https://clinicaltrials.gov/show/NCT04384380,2020-06-30,0,1
453,NCT04384549,Not yet recruiting,2021-02-11,2021-02-11,No Results Posted,,,"['APHP200462', '2020-001678-31 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04384549,2021-02-11,0,0
454,NCT04384588,Recruiting,2021-04-06,2021-04-06,No Results Posted,,,['FALP 001-2020'],,https://clinicaltrials.gov/show/NCT04384588,2021-04-06,0,0
455,NCT04385576,Recruiting,2020-09-15,2020-12-30,No Results Posted,,"['Canelli R, Connor CW, Gonzalez M, Nozari A, Ortega R. Barrier Enclosure during Endotracheal Intubation. N Engl J Med. 2020 May 14;382(20):1957-1958. doi: 10.1056/NEJMc2007589. Epub 2020 Apr 3.']",['2020410-8498'],,https://clinicaltrials.gov/show/NCT04385576,2020-09-15,0,1
456,NCT04328961,Recruiting,2020-09-30,2020-10-31,No Results Posted,"['Barnabas RV, Brown E, Bershteyn A, Miller RS, Wener M, Celum C, Wald A, Chu H, Wesche D, Baeten JM; Hydroxychloroquine COVID-19 PEP Study Team. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jun 3;21(1):475. doi: 10.1186/s13063-020-04446-4.']",,"['STUDY00009750', 'INV-016204 ( Other Grant/Funding Number: Bill and Melinda Gates Foundation )']",,https://clinicaltrials.gov/show/NCT04328961,2020-09-30,0,1
457,NCT04334148,Recruiting,2020-07-01,2020-07-01,No Results Posted,,,['Pro00105274'],,https://clinicaltrials.gov/show/NCT04334148,2020-07-01,0,0
458,NCT04335097,Recruiting,2021-04-08,2025-12-20,No Results Posted,,"['Samsudin MI, Liu N, Prabhakar SM, Chong SL, Kit Lye W, Koh ZX, Guo D, Rajesh R, Ho AFW, Ong MEH. A novel heart rate variability based risk prediction model for septic patients presenting to the emergency department. Medicine (Baltimore). 2018 Jun;97(23):e10866. doi: 10.1097/MD.0000000000010866.', 'Melillo P, Izzo R, Orrico A, Scala P, Attanasio M, Mirra M, De Luca N, Pecchia L. Automatic prediction of cardiovascular and cerebrovascular events using heart rate variability analysis. PLoS One. 2015 Mar 20;10(3):e0118504. doi: 10.1371/journal.pone.0118504. eCollection 2015.']",['127157'],,https://clinicaltrials.gov/show/NCT04335097,2021-04-08,0,1
459,NCT04340050,"Active, not recruiting",2020-12-31,2021-12-31,No Results Posted,,,['IRB20-0523'],,https://clinicaltrials.gov/show/NCT04340050,2020-12-31,0,0
460,NCT04340349,Enrolling by invitation,2020-07-20,2020-08-20,No Results Posted,,"['Devaux CA, Rolain JM, Colson P, Raoult D. New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? Int J Antimicrob Agents. 2020 May;55(5):105938. doi: 10.1016/j.ijantimicag.2020.105938. Epub 2020 Mar 12.', 'Hoffmann M, Kleine-Weber H, Schroeder S, Kr√ºger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, M√ºller MA, Drosten C, P√∂hlmann S. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.', 'Lucas JM, Heinlein C, Kim T, Hernandez SA, Malik MS, True LD, Morrissey C, Corey E, Montgomery B, Mostaghel E, Clegg N, Coleman I, Brown CM, Schneider EL, Craik C, Simon JA, Bedalov A, Nelson PS. The androgen-regulated protease TMPRSS2 activates a proteolytic cascade involving components of the tumor microenvironment and promotes prostate cancer metastasis. Cancer Discov. 2014 Nov;4(11):1310-25. doi: 10.1158/2159-8290.CD-13-1010. Epub 2014 Aug 13.', 'Shen LW, Mao HJ, Wu YL, Tanaka Y, Zhang W. TMPRSS2: A potential target for treatment of influenza virus and coronavirus infections. Biochimie. 2017 Nov;142:1-10. doi: 10.1016/j.biochi.2017.07.016. Epub 2017 Aug 1. Review.']",['25/20'],,https://clinicaltrials.gov/show/NCT04340349,2020-07-20,0,1
461,NCT04341415,Recruiting,2020-07-01,2020-07-01,No Results Posted,,,['CRN_2020_8'],,https://clinicaltrials.gov/show/NCT04341415,2020-07-01,0,0
462,NCT04342728,Enrolling by invitation,2020-12-30,2021-04-30,No Results Posted,,,['IRB 20-361'],,https://clinicaltrials.gov/show/NCT04342728,2020-12-30,0,0
463,NCT04347538,Recruiting,2021-06-01,2022-06-01,No Results Posted,,,['200693'],,https://clinicaltrials.gov/show/NCT04347538,2021-06-01,0,0
464,NCT04350476,Not yet recruiting,2021-04-01,2021-04-01,No Results Posted,,,['GCO 20-0932'],,https://clinicaltrials.gov/show/NCT04350476,2021-04-01,0,0
465,NCT04352348,Recruiting,2021-05-31,2022-03-31,No Results Posted,,,"['APHP200382', '2020-A00754-35 ( Other Identifier: ANSM )']",,https://clinicaltrials.gov/show/NCT04352348,2021-05-31,0,0
466,NCT04352751,Recruiting,2021-04-01,2021-04-01,No Results Posted,,,['PIPK- 0000 /NIBD-0000/2020'],,https://clinicaltrials.gov/show/NCT04352751,2021-04-01,0,0
467,NCT04352933,Recruiting,2020-10-31,2021-04-01,No Results Posted,,,['PROLIFIC2020 (A095583)'],,https://clinicaltrials.gov/show/NCT04352933,2020-10-31,0,0
468,NCT04353206,Recruiting,2021-05-01,2021-05-01,No Results Posted,,,['Acute Care CP Consortium Trial'],,https://clinicaltrials.gov/show/NCT04353206,2021-05-01,0,0
469,NCT04354259,Recruiting,2020-08-01,2020-11-30,No Results Posted,,,['JF-4-2020'],,https://clinicaltrials.gov/show/NCT04354259,2020-08-01,0,0
470,NCT04354831,Recruiting,2022-05-01,2023-05-01,No Results Posted,,,['PRO00037712'],,https://clinicaltrials.gov/show/NCT04354831,2022-05-01,0,0
471,NCT04357457,Not yet recruiting,2020-07-01,2020-07-01,No Results Posted,,,"['APHP200461', '2020-001909-22 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04357457,2020-07-01,0,0
472,NCT04362085,Recruiting,2020-11-01,2020-12-01,No Results Posted,,,['RAPID COVID-COAG'],,https://clinicaltrials.gov/show/NCT04362085,2020-11-01,0,0
473,NCT04364009,Recruiting,2020-09-10,2020-09-24,No Results Posted,,,"['ANACONDA-COVID-19', '2020-001734-36 ( EudraCT Number )', 'DR200111 ( Other Identifier: University Hospital of Tours )']",,https://clinicaltrials.gov/show/NCT04364009,2020-09-10,0,0
474,NCT04364802,Recruiting,2021-05-01,2021-05-01,No Results Posted,,,['58748'],,https://clinicaltrials.gov/show/NCT04364802,2021-05-01,0,0
475,NCT04365257,Recruiting,2020-12-01,2020-12-01,No Results Posted,,,"['IRB00246659', 'COV2001 ( Other Identifier: Johns Hopkins University )']",,https://clinicaltrials.gov/show/NCT04365257,2020-12-01,0,0
476,NCT04365517,Not yet recruiting,2020-06-30,2020-12-30,No Results Posted,,,['Sacco FBF'],,https://clinicaltrials.gov/show/NCT04365517,2020-06-30,0,0
477,NCT04367077,Recruiting,2021-09-01,2022-08-01,No Results Posted,,,['B04-03'],,https://clinicaltrials.gov/show/NCT04367077,2021-09-01,0,0
478,NCT04378712,Completed,2020-03-23,2020-03-23,No Results Posted,,,['JT202005LZ'],,https://clinicaltrials.gov/show/NCT04378712,2020-03-23,0,0
479,NCT04378920,Recruiting,2020-07-31,2020-10-31,No Results Posted,,,"['2020-003', '2020-001393-30 ( EudraCT Number )', '2020-A00900-39 ( Other Identifier: IDCRB )']",,https://clinicaltrials.gov/show/NCT04378920,2020-07-31,0,0
480,NCT04379076,Recruiting,2020-10-30,2020-12-30,No Results Posted,,,['CLI107 COVID UK (ILIAD-7-UK)'],,https://clinicaltrials.gov/show/NCT04379076,2020-10-30,0,0
481,NCT04381988,Recruiting,2021-05-01,2021-05-01,No Results Posted,,,['20-176'],,https://clinicaltrials.gov/show/NCT04381988,2021-05-01,0,0
482,NCT04382391,Recruiting,2020-09-01,2020-12-30,No Results Posted,,,['2020-132-AGH'],,https://clinicaltrials.gov/show/NCT04382391,2020-09-01,0,0
483,NCT04384731,Not yet recruiting,2020-11-30,2021-01-30,No Results Posted,,,['P20/06'],,https://clinicaltrials.gov/show/NCT04384731,2020-11-30,0,0
484,NCT04384900,Recruiting,2020-11-01,2020-12-01,No Results Posted,,,['H-20027361'],,https://clinicaltrials.gov/show/NCT04384900,2020-11-01,0,0
485,NCT04385017,Recruiting,2021-06-12,2021-06-12,No Results Posted,,,['20-PP-07'],,https://clinicaltrials.gov/show/NCT04385017,2021-06-12,0,0
486,NCT04385043,Recruiting,2020-10-15,2021-05-15,No Results Posted,,"['Mair-Jenkins J, Saavedra-Campos M, Baillie JK, Cleary P, Khaw FM, Lim WS, Makki S, Rooney KD, Nguyen-Van-Tam JS, Beck CR; Convalescent Plasma Study Group. The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis. J Infect Dis. 2015 Jan 1;211(1):80-90. doi: 10.1093/infdis/jiu396. Epub 2014 Jul 16. Review.', 'Linee Guida Cinesi sulla Gestione di COVID-19 Versione 7¬∞ Pubblicate in data 3/3/2020 dalla Commissione della Salute Nazionale della R.P.C..', 'Arabi Y, Balkhy H, Hajeer AH, Bouchama A, Hayden FG, Al-Omari A, Al-Hameed FM, Taha Y, Shindo N, Whitehead J, Merson L, AlJohani S, Al-Khairy K, Carson G, Luke TC, Hensley L, Al-Dawood A, Al-Qahtani S, Modjarrad K, Sadat M, Rohde G, Leport C, Fowler R. Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol. Springerplus. 2015 Nov 19;4:709. doi: 10.1186/s40064-015-1490-9. eCollection 2015.', 'Dean CL, Hooper JW, Dye JM, Zak SE, Koepsell SA, Corash L, Benjamin RJ, Kwilas S, Bonds S, Winkler AM, Kraft CS. Characterization of Ebola convalescent plasma donor immune response and psoralen treated plasma in the United States. Transfusion. 2020 May;60(5):1024-1031. doi: 10.1111/trf.15739. Epub 2020 Mar 4.']",['Covid-19 convalescent plasma'],,https://clinicaltrials.gov/show/NCT04385043,2020-10-15,0,1
487,NCT04385095,Recruiting,2020-08-31,2021-05-31,No Results Posted,,,['SG016'],,https://clinicaltrials.gov/show/NCT04385095,2020-08-31,0,0
488,NCT04385108,Not yet recruiting,2021-12-31,2021-12-31,No Results Posted,,,['RC31/20/0162'],,https://clinicaltrials.gov/show/NCT04385108,2021-12-31,0,0
489,NCT04385199,Recruiting,2020-08-01,2020-08-01,No Results Posted,,,['13807'],,https://clinicaltrials.gov/show/NCT04385199,2020-08-01,0,0
490,NCT04385264,Not yet recruiting,2020-08-01,2020-10-01,No Results Posted,,,['Unisante'],,https://clinicaltrials.gov/show/NCT04385264,2020-08-01,0,0
491,NCT04385771,Not yet recruiting,2021-05-31,2021-10-31,No Results Posted,,,['CYCOV-II'],,https://clinicaltrials.gov/show/NCT04385771,2021-05-31,0,0
492,NCT04386070,Not yet recruiting,2021-05-14,2026-05-14,No Results Posted,,,"['RG_20-029 COVID-19', '2020-001448-24 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04386070,2021-05-14,0,0
493,NCT04386239,Not yet recruiting,2020-12-01,2020-12-01,No Results Posted,,,['COVID-SARI-001'],,https://clinicaltrials.gov/show/NCT04386239,2020-12-01,0,0
494,NCT04387292,Recruiting,2021-02-01,2021-02-01,No Results Posted,,,['MMT_2020_12'],,https://clinicaltrials.gov/show/NCT04387292,2021-02-01,0,0
495,NCT04387955,Not yet recruiting,2021-05-01,2021-06-01,No Results Posted,,,['ACROVID'],,https://clinicaltrials.gov/show/NCT04387955,2021-05-01,0,0
496,NCT04388410,Not yet recruiting,2020-10-31,2020-12-31,No Results Posted,,,['3380'],,https://clinicaltrials.gov/show/NCT04388410,2020-10-31,0,0
497,NCT04389294,Recruiting,2020-09-30,2020-10-30,No Results Posted,,,['2020-0850'],,https://clinicaltrials.gov/show/NCT04389294,2020-09-30,0,0
498,NCT04389359,Not yet recruiting,2021-08-01,2025-08-01,No Results Posted,,,['A095590'],,https://clinicaltrials.gov/show/NCT04389359,2021-08-01,0,0
499,NCT04389671,Not yet recruiting,2020-10-01,2020-11-01,No Results Posted,,,['02-CL-2001a'],,https://clinicaltrials.gov/show/NCT04389671,2020-10-01,0,0
500,NCT04390139,Recruiting,2020-10-01,2020-12-01,No Results Posted,,,['BST-COVID-01'],,https://clinicaltrials.gov/show/NCT04390139,2020-10-01,0,0
501,NCT04390178,"Active, not recruiting",2020-06-01,2020-12-01,No Results Posted,,,['CP1'],,https://clinicaltrials.gov/show/NCT04390178,2020-06-01,0,0
502,NCT04390191,Recruiting,2021-04-01,2021-05-01,No Results Posted,,,['GCO 20-0900'],,https://clinicaltrials.gov/show/NCT04390191,2021-04-01,0,0
503,NCT04394039,Not yet recruiting,2020-08-01,2020-12-31,No Results Posted,,,['NUS-IRB_S-20-12'],,https://clinicaltrials.gov/show/NCT04394039,2020-08-01,0,0
504,NCT04313127,"Active, not recruiting",2020-12-30,2022-12-20,No Results Posted,"['Zhu FC, Li YH, Guan XH, Hou LH, Wang WJ, Li JX, Wu SP, Wang BS, Wang Z, Wang L, Jia SY, Jiang HD, Wang L, Jiang T, Hu Y, Gou JB, Xu SB, Xu JJ, Wang XW, Wang W, Chen W. Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial. Lancet. 2020 Jun 13;395(10240):1845-1854. doi: 10.1016/S0140-6736(20)31208-3. Epub 2020 May 22.']",,['JSVCT088'],,https://clinicaltrials.gov/show/NCT04313127,2020-12-30,0,1
505,NCT04321993,Recruiting,2022-02-01,2022-03-01,No Results Posted,,,['SAIL-004'],,https://clinicaltrials.gov/show/NCT04321993,2022-02-01,0,0
506,NCT04322565,Recruiting,2020-06-20,2020-07-20,No Results Posted,,,['ColCOVID-19'],,https://clinicaltrials.gov/show/NCT04322565,2020-06-20,0,0
507,NCT04325893,Recruiting,2020-09-01,2020-09-01,No Results Posted,,,['49RC20_0071'],,https://clinicaltrials.gov/show/NCT04325893,2020-09-01,0,0
508,NCT04328129,Recruiting,2022-03-23,2022-03-23,No Results Posted,,,['2020-009'],,https://clinicaltrials.gov/show/NCT04328129,2022-03-23,0,0
509,NCT04341389,"Active, not recruiting",2021-01-31,2021-01-31,No Results Posted,,,['JSVCT089'],,https://clinicaltrials.gov/show/NCT04341389,2021-01-31,0,0
510,NCT04341935,Not yet recruiting,2020-10-30,2020-12-30,No Results Posted,,"['Vankadari N, Wilce JA. Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26. Emerg Microbes Infect. 2020 Mar 17;9(1):601-604. doi: 10.1080/22221751.2020.1739565. eCollection 2020.', 'Iacobellis G. COVID-19 and diabetes: Can DPP4 inhibition play a role? Diabetes Res Clin Pract. 2020 Apr;162:108125. doi: 10.1016/j.diabres.2020.108125. Epub 2020 Mar 26.']",['20200384'],,https://clinicaltrials.gov/show/NCT04341935,2020-10-30,0,1
511,NCT04342182,Recruiting,2020-07-01,2020-07-01,No Results Posted,,,['NL73489.078.20'],,https://clinicaltrials.gov/show/NCT04342182,2020-07-01,0,0
512,NCT04358783,Recruiting,2021-02-01,2021-05-30,No Results Posted,,,['IF20-00002'],,https://clinicaltrials.gov/show/NCT04358783,2021-02-01,0,0
513,NCT04359537,Recruiting,2020-08-25,2020-09-25,No Results Posted,,,['F.1-1/2015/ERB/SZABMU/549'],,https://clinicaltrials.gov/show/NCT04359537,2020-08-25,0,0
514,NCT04361253,Recruiting,2021-06-01,2021-12-01,No Results Posted,,,['2020P001215'],,https://clinicaltrials.gov/show/NCT04361253,2021-06-01,0,0
515,NCT04363346,Recruiting,2022-01-01,2022-01-01,No Results Posted,,,"['IDIM-2020-28708', '2020LS083 ( Other Identifier: University of Minnesota Masonic Cancer Center )']",,https://clinicaltrials.gov/show/NCT04363346,2022-01-01,0,0
516,NCT04363502,Recruiting,2020-08-01,2020-08-01,No Results Posted,,,['IRB00247932'],,https://clinicaltrials.gov/show/NCT04363502,2020-08-01,0,0
517,NCT04366960,Recruiting,2020-08-01,2020-11-01,No Results Posted,"['Levi M, Thachil J, Iba T, Levy JH. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020 Jun;7(6):e438-e440. doi: 10.1016/S2352-3026(20)30145-9. Epub 2020 May 11.']",,['2020-001708-41'],,https://clinicaltrials.gov/show/NCT04366960,2020-08-01,0,1
518,NCT04367831,Recruiting,2020-11-01,2021-04-01,No Results Posted,"['Levi M, Thachil J, Iba T, Levy JH. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020 Jun;7(6):e438-e440. doi: 10.1016/S2352-3026(20)30145-9. Epub 2020 May 11.']",,['AAAS8980'],,https://clinicaltrials.gov/show/NCT04367831,2020-11-01,0,1
519,NCT04370782,Recruiting,2020-09-30,2020-12-31,No Results Posted,,,['20-21'],,https://clinicaltrials.gov/show/NCT04370782,2020-09-30,0,0
520,NCT04371952,Not yet recruiting,2020-12-01,2020-12-01,No Results Posted,,,['RC20_0191'],,https://clinicaltrials.gov/show/NCT04371952,2020-12-01,0,0
521,NCT04372979,Not yet recruiting,2020-10-01,2021-05-01,No Results Posted,,,['2020-A01166-33'],,https://clinicaltrials.gov/show/NCT04372979,2020-10-01,0,0
522,NCT04375124,Recruiting,2020-08-31,2020-09-30,No Results Posted,,,['KSSEAH--0059'],,https://clinicaltrials.gov/show/NCT04375124,2020-08-31,0,0
523,NCT04377789,Recruiting,2020-07-31,2020-08-31,No Results Posted,,,['KSSEAH--0058'],,https://clinicaltrials.gov/show/NCT04377789,2020-07-31,0,0
524,NCT04388683,Recruiting,2021-04-30,2021-07-31,No Results Posted,,,['STUDY00000554'],,https://clinicaltrials.gov/show/NCT04388683,2021-04-30,0,0
525,NCT04389333,Recruiting,2020-04-26,2020-05-20,No Results Posted,,,['nc-MCE pilotRCT'],,https://clinicaltrials.gov/show/NCT04389333,2020-04-26,0,0
526,NCT04389372,Recruiting,2021-03-01,2021-12-01,No Results Posted,,,['Chro-Mig-Smart'],,https://clinicaltrials.gov/show/NCT04389372,2021-03-01,0,0
527,NCT04389385,"Active, not recruiting",2020-09-30,2021-05-31,No Results Posted,,,['EruCovid2020'],,https://clinicaltrials.gov/show/NCT04389385,2020-09-30,0,0
528,NCT04389801,Not yet recruiting,2020-09-30,2020-12-31,No Results Posted,,,['0012'],,https://clinicaltrials.gov/show/NCT04389801,2020-09-30,0,0
529,NCT04389944,Recruiting,2020-06-30,2020-06-30,No Results Posted,,,['Req-2020-00508; me20khanna2'],,https://clinicaltrials.gov/show/NCT04389944,2020-06-30,0,0
530,NCT04390061,Not yet recruiting,2020-09-01,2020-10-01,No Results Posted,,,['2020-002035-30'],,https://clinicaltrials.gov/show/NCT04390061,2020-09-01,0,0
531,NCT04390152,Not yet recruiting,2020-11-01,2021-05-01,No Results Posted,,,['BIOXSOMCOV001'],,https://clinicaltrials.gov/show/NCT04390152,2020-11-01,0,0
532,NCT04390217,Not yet recruiting,2020-12-31,2021-03-31,No Results Posted,,,['LBS-COVID19-201'],,https://clinicaltrials.gov/show/NCT04390217,2020-12-31,0,0
533,NCT04390412,Recruiting,2020-08-01,2020-12-01,No Results Posted,,,"['23568', 'IRCT20200509047366N1 ( Registry Identifier: Iranian Registry of Clinical Trials )']",,https://clinicaltrials.gov/show/NCT04390412,2020-08-01,0,0
534,NCT04390464,Recruiting,2021-05-07,2022-05-01,No Results Posted,,,['TACTIC-R'],,https://clinicaltrials.gov/show/NCT04390464,2021-05-07,0,0
535,NCT04390477,Recruiting,2020-07-01,2021-05-01,No Results Posted,,,['COVID.PROB'],,https://clinicaltrials.gov/show/NCT04390477,2020-07-01,0,0
536,NCT04390503,Recruiting,2021-04-01,2021-04-01,No Results Posted,,,['AAAT0052'],,https://clinicaltrials.gov/show/NCT04390503,2021-04-01,0,0
537,NCT04391712,Recruiting,2020-05-30,2020-06-30,No Results Posted,,,['2020.01'],,https://clinicaltrials.gov/show/NCT04391712,2020-05-30,0,0
538,NCT04391829,Not yet recruiting,2020-07-15,2020-08-31,No Results Posted,,"['Li D, Jin M, Bao P, Zhao W, Zhang S. Clinical Characteristics and Results of Semen Tests Among Men With Coronavirus Disease 2019. JAMA Netw Open. 2020 May 1;3(5):e208292. doi: 10.1001/jamanetworkopen.2020.8292.']",['COVIDSPERM'],,https://clinicaltrials.gov/show/NCT04391829,2020-07-15,0,1
539,NCT04392141,Recruiting,2020-06-01,2020-10-01,No Results Posted,,"['Nerlekar N, Beale A, Harper RW. Colchicine--a short history of an ancient drug. Med J Aust. 2014 Dec 11;201(11):687-8.', 'Larsson S, R√∏nsted N. Reviewing Colchicaceae alkaloids - perspectives of evolution on medicinal chemistry. Curr Top Med Chem. 2014;14(2):274-89. Review.', 'Slobodnick A, Shah B, Krasnokutsky S, Pillinger MH. Update on colchicine, 2017. Rheumatology (Oxford). 2018 Jan 1;57(suppl_1):i4-i11. doi: 10.1093/rheumatology/kex453. Review.', 'Cronstein BN, Molad Y, Reibman J, Balakhane E, Levin RI, Weissmann G. Colchicine alters the quantitative and qualitative display of selectins on endothelial cells and neutrophils. J Clin Invest. 1995 Aug;96(2):994-1002.', 'Umar S, Shah MA, Munir MT, Yaqoob M, Fiaz M, Anjum S, Kaboudi K, Bouzouaia M, Younus M, Nisa Q, Iqbal M, Umar W. Synergistic effects of thymoquinone and curcumin on immune response and anti-viral activity against avian influenza virus (H9N2) in turkeys. Poult Sci. 2016 Jul 1;95(7):1513-20. doi: 10.3382/ps/pew069. Epub 2016 Mar 4.', 'Wu QF, Wang W, Dai XY, Wang ZY, Shen ZH, Ying HZ, Yu CH. Chemical compositions and anti-influenza activities of essential oils from Mosla dianthera. J Ethnopharmacol. 2012 Jan 31;139(2):668-71. doi: 10.1016/j.jep.2011.11.056. Epub 2011 Dec 16.']",['1399.062'],,https://clinicaltrials.gov/show/NCT04392141,2020-06-01,0,1
540,NCT04392323,Recruiting,2020-07-01,2020-07-31,No Results Posted,,"['Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30;:.', 'Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.', 'Wu JT, Leung K, Leung GM. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet. 2020 Feb 29;395(10225):689-697. doi: 10.1016/S0140-6736(20)30260-9. Epub 2020 Jan 31. Erratum in: Lancet. 2020 Feb 4;:.', 'Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung KSM, Lau EHY, Wong JY, Xing X, Xiang N, Wu Y, Li C, Chen Q, Li D, Liu T, Zhao J, Liu M, Tu W, Chen C, Jin L, Yang R, Wang Q, Zhou S, Wang R, Liu H, Luo Y, Liu Y, Shao G, Li H, Tao Z, Yang Y, Deng Z, Liu B, Ma Z, Zhang Y, Shi G, Lam TTY, Wu JT, Gao GF, Cowling BJ, Yang B, Leung GM, Feng Z. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020 Mar 26;382(13):1199-1207. doi: 10.1056/NEJMoa2001316. Epub 2020 Jan 29.', 'Hanna TP, Evans GA, Booth CM. Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemic. Nat Rev Clin Oncol. 2020 May;17(5):268-270. doi: 10.1038/s41571-020-0362-6.', 'Elizabeth Brindle M, Gawande A. Managing COVID-19 in Surgical Systems. Ann Surg. 2020 Jul;272(1):e1-e2. doi: 10.1097/SLA.0000000000003923.', 'Lei S, Jiang F, Su W, Chen C, Chen J, Mei W, Zhan LY, Jia Y, Zhang L, Liu D, Xia ZY, Xia Z. Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection. EClinicalMedicine. 2020 Apr 5:100331. doi: 10.1016/j.eclinm.2020.100331. [Epub ahead of print]', 'Aminian A, Kermansaravi M, Azizi S, Alibeigi P, Safamanesh S, Mousavimaleki A, Rezaei MT, Faridi M, Mokhber S, Pazouki A, Safari S. Bariatric Surgical Practice During the Initial Phase of COVID-19 Outbreak. Obes Surg. 2020 Apr 20. doi: 10.1007/s11695-020-04617-x. [Epub ahead of print]', 'Luong-Nguyen M, Hermand H, Abdalla S, Cabrit N, Hobeika C, Brouquet A, Go√©r√© D, Sauvanet A. Nosocomial infection with SARS-Cov-2 within Departments of Digestive Surgery. J Visc Surg. 2020 Apr 27. pii: S1878-7886(20)30122-3. doi: 10.1016/j.jviscsurg.2020.04.016. [Epub ahead of print]', 'Yang S, Zhang Y, Cai J, Wang Z. Clinical Characteristics of COVID-19 After Gynecologic Oncology Surgery in Three Women: A Retrospective Review of Medical Records. Oncologist. 2020 Apr 7. doi: 10.1634/theoncologist.2020-0157. [Epub ahead of print]', 'Wong SC, Kwong RT, Wu TC, Chan JWM, Chu MY, Lee SY, Wong HY, Lung DC. Risk of nosocomial transmission of coronavirus disease 2019: an experience in a general ward setting in Hong Kong. J Hosp Infect. 2020 Apr 4. pii: S0195-6701(20)30174-2. doi: 10.1016/j.jhin.2020.03.036. [Epub ahead of print]', 'Zhong Q, Liu YY, Luo Q, Zou YF, Jiang HX, Li H, Zhang JJ, Li Z, Yang X, Ma M, Tang LJ, Chen YY, Zheng F, Ke JJ, Zhang ZZ. Spinal anaesthesia for patients with coronavirus disease 2019 and possible transmission rates in anaesthetists: retrospective, single-centre, observational cohort study. Br J Anaesth. 2020 Jun;124(6):670-675. doi: 10.1016/j.bja.2020.03.007. Epub 2020 Mar 28.']",['IRB #20-0404'],,https://clinicaltrials.gov/show/NCT04392323,2020-07-01,0,1
541,NCT04392427,Not yet recruiting,2022-05-01,2022-05-01,No Results Posted,,"['Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W; China Novel Coronavirus Investigating and Research Team. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020 Feb 20;382(8):727-733. doi: 10.1056/NEJMoa2001017. Epub 2020 Jan 24.', 'Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019 Mar;17(3):181-192. doi: 10.1038/s41579-018-0118-9. Review.', 'Rossignol JF. Nitazoxanide: a first-in-class broad-spectrum antiviral agent. Antiviral Res. 2014 Oct;110:94-103. doi: 10.1016/j.antiviral.2014.07.014. Epub 2014 Aug 7. Review.', 'Graci JD, Cameron CE. Mechanisms of action of ribavirin against distinct viruses. Rev Med Virol. 2006 Jan-Feb;16(1):37-48. Review.', 'Caly L, Druce JD, Catton MG, Jans DA, Wagstaff KM. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Res. 2020 Apr 3;178:104787. doi: 10.1016/j.antiviral.2020.104787. [Epub ahead of print]']",['20.05.69'],,https://clinicaltrials.gov/show/NCT04392427,2022-05-01,0,1
542,NCT04392453,Not yet recruiting,2020-12-01,2020-12-01,No Results Posted,,,['FDG_Icone'],,https://clinicaltrials.gov/show/NCT04392453,2020-12-01,0,0
543,NCT04392713,Recruiting,2020-07-01,2020-07-01,No Results Posted,,"['≈ûim≈üek Yavuz S, √únal S. Antiviral treatment of COVID-19. Turk J Med Sci. 2020 Apr 21;50(SI-1):611-619. doi: 10.3906/sag-2004-145. Review.']",['IVE-COV'],,https://clinicaltrials.gov/show/NCT04392713,2020-07-01,0,1
544,NCT04392778,Recruiting,2020-07-01,2020-09-01,No Results Posted,,,['Bak. Sadi Konuk-Istinye Uni.'],,https://clinicaltrials.gov/show/NCT04392778,2020-07-01,0,0
545,NCT04393961,Recruiting,2020-07-29,2020-08-29,No Results Posted,,,['2458'],,https://clinicaltrials.gov/show/NCT04393961,2020-07-29,0,0
546,NCT04394169,Not yet recruiting,2020-09-25,2021-03-25,No Results Posted,,,['HCB/2020/0549'],,https://clinicaltrials.gov/show/NCT04394169,2020-09-25,0,0
547,NCT04394182,Recruiting,2020-12-31,2021-04-21,No Results Posted,,"['Kirkby C, Mackenzie M. Is low dose radiation therapy a potential treatment for COVID-19 pneumonia? Radiother Oncol. 2020 Jun;147:221. doi: 10.1016/j.radonc.2020.04.004. Epub 2020 Apr 6.', 'Berk LB, Hodes PJ. Roentgen therapy for infections: an historical review. Yale J Biol Med. 1991 Mar-Apr;64(2):155-65.', 'Calabrese EJ, Dhawan G. How radiotherapy was historically used to treat pneumonia: could it be useful today? Yale J Biol Med. 2013 Dec 13;86(4):555-70.', 'Cuttler JM. Application of Low Doses of Ionizing Radiation in Medical Therapies. Dose Response. 2020 Jan 6;18(1):1559325819895739. doi: 10.1177/1559325819895739. eCollection 2020 Jan-Mar.', 'Arenas M, Sabater S, Hern√°ndez V, Rovirosa A, Lara PC, Biete A, Pan√©s J. Anti-inflammatory effects of low-dose radiotherapy. Indications, dose, and radiobiological mechanisms involved. Strahlenther Onkol. 2012 Nov;188(11):975-81. doi: 10.1007/s00066-012-0170-8. Epub 2012 Aug 22. Review.', 'Calabrese EJ, Dhawan G, Kapoor R, Kozumbo WJ. Radiotherapy treatment of human inflammatory diseases and conditions: Optimal dose. Hum Exp Toxicol. 2019 Aug;38(8):888-898. doi: 10.1177/0960327119846925. Epub 2019 May 6. Review.', 'R√∂del F, Keilholz L, Herrmann M, Sauer R, Hildebrandt G. Radiobiological mechanisms in inflammatory diseases of low-dose radiation therapy. Int J Radiat Biol. 2007 Jun;83(6):357-66. Review.', 'Schaue D, Jahns J, Hildebrandt G, Trott KR. Radiation treatment of acute inflammation in mice. Int J Radiat Biol. 2005 Sep;81(9):657-67.', 'Torres Royo L, Antelo Redondo G, √Årquez Pianetta M, Arenas Prat M. Low-Dose radiation therapy for benign pathologies. Rep Pract Oncol Radiother. 2020 Mar-Apr;25(2):250-254. doi: 10.1016/j.rpor.2020.02.004. Epub 2020 Feb 22. Review.', 'Lara PC, Burgos J, Macias D. Low dose lung radiotherapy for COVID-19 pneumonia. The rationale for a cost-effective anti-inflammatory treatment. Clin Transl Radiat Oncol. 2020 Apr 25;23:27-29. doi: 10.1016/j.ctro.2020.04.006. eCollection 2020 Jul.']",['20.4.1597-GHM'],,https://clinicaltrials.gov/show/NCT04394182,2020-12-31,0,1
548,NCT04394208,Not yet recruiting,2020-08-30,2020-09-30,No Results Posted,,,['CairoU COVID-19 Study Group'],,https://clinicaltrials.gov/show/NCT04394208,2020-08-30,0,0
549,NCT04306393,Recruiting,2021-03-21,2022-03-21,No Results Posted,"['Lei C, Su B, Dong H, Bellavia A, Di Fenza R, Safaee Fakhr B, Gianni S, Grassi LG, Kacmarek R, Araujo Morais CC, Pinciroli R, Vassena E, Berra L. Protocol of a randomized controlled trial testing inhaled Nitric Oxide in mechanically ventilated patients with severe acute respiratory syndrome in COVID-19 (SARS-CoV-2). medRxiv. 2020 Mar 13. pii: 2020.03.09.20033530. doi: 10.1101/2020.03.09.20033530.']",,['NO-SARS-COVID-19'],,https://clinicaltrials.gov/show/NCT04306393,2021-03-21,0,1
550,NCT04338828,Recruiting,2021-04-01,2022-04-01,No Results Posted,,,['2019P00XXXX'],,https://clinicaltrials.gov/show/NCT04338828,2021-04-01,0,0
551,NCT04341675,Recruiting,2020-07-01,2020-09-01,No Results Posted,,,['2020-0337'],,https://clinicaltrials.gov/show/NCT04341675,2020-07-01,0,0
552,NCT04342663,Recruiting,2020-08-01,2020-09-01,No Results Posted,,,['202004023'],,https://clinicaltrials.gov/show/NCT04342663,2020-08-01,0,0
553,NCT04345991,Recruiting,2020-05-15,2020-06-01,No Results Posted,,,"['APHP200375-10', '2020-001246-18 ( EudraCT Number )']",,,2020-05-15,0,0
554,NCT04347681,Recruiting,2020-12-31,2021-04-11,No Results Posted,,,['HAEM0321'],,https://clinicaltrials.gov/show/NCT04347681,2020-12-31,0,0
555,NCT04350736,Recruiting,2020-06-01,2020-06-01,No Results Posted,,,"['0183', '2020-000577-24 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04350736,2020-06-01,0,0
556,NCT04354714,Withdrawn,2021-07-31,2021-12-31,No Results Posted,,,['04-13-20-DiPersio'],,https://clinicaltrials.gov/show/NCT04354714,2021-07-31,0,0
557,NCT04355143,Recruiting,2021-04-25,2021-04-25,No Results Posted,,,['20-000685'],,https://clinicaltrials.gov/show/NCT04355143,2021-04-25,0,0
558,NCT04355533,Not yet recruiting,2020-06-01,2021-09-01,No Results Posted,,,"['APHP200467', '2020-A00999-30 ( Registry Identifier: ID-RCB )']",,https://clinicaltrials.gov/show/NCT04355533,2020-06-01,0,0
559,NCT04355897,Recruiting,2020-07-01,2020-08-01,No Results Posted,,,['20-23'],,https://clinicaltrials.gov/show/NCT04355897,2020-07-01,0,0
560,NCT04358081,Recruiting,2020-06-25,2020-07-24,No Results Posted,,,['CJWT629A12301'],,https://clinicaltrials.gov/show/NCT04358081,2020-06-25,0,0
561,NCT04360837,Recruiting,2021-06-01,2021-06-01,No Results Posted,,"['Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, Cereda D, Coluccello A, Foti G, Fumagalli R, Iotti G, Latronico N, Lorini L, Merler S, Natalini G, Piatti A, Ranieri MV, Scandroglio AM, Storti E, Cecconi M, Pesenti A; COVID-19 Lombardy ICU Network, Nailescu A, Corona A, Zangrillo A, Protti A, Albertin A, Forastieri Molinari A, Lombardo A, Pezzi A, Benini A, Scandroglio AM, Malara A, Castelli A, Coluccello A, Micucci A, Pesenti A, Sala A, Alborghetti A, Antonini B, Capra C, Troiano C, Roscitano C, Radrizzani D, Chiumello D, Coppini D, Guzzon D, Costantini E, Malpetti E, Zoia E, Catena E, Agosteo E, Barbara E, Beretta E, Boselli E, Storti E, Harizay F, Della Mura F, Lorini FL, Donato Sigurt√† F, Marino F, Mojoli F, Rasulo F, Grasselli G, Casella G, De Filippi G, Castelli G, Aldegheri G, Gallioli G, Lotti G, Albano G, Landoni G, Marino G, Vitale G, Battista Perego G, Evasi G, Citerio G, Foti G, Natalini G, Merli G, Sforzini I, Bianciardi L, Carnevale L, Grazioli L, Cabrini L, Guatteri L, Salvi L, Dei Poli M, Galletti M, Gemma M, Ranucci M, Riccio M, Borelli M, Zambon M, Subert M, Cecconi M, Mazzoni MG, Raimondi M, Panigada M, Belliato M, Bronzini N, Latronico N, Petrucci N, Belgiorno N, Tagliabue P, Cortellazzi P, Gnesin P, Grosso P, Gritti P, Perazzo P, Severgnini P, Ruggeri P, Sebastiano P, Covello RD, Fernandez-Olmos R, Fumagalli R, Keim R, Rona R, Valsecchi R, Cattaneo S, Colombo S, Cirri S, Bonazzi S, Greco S, Muttini S, Langer T, Alaimo V, Viola U. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020 Apr 6. doi: 10.1001/jama.2020.5394. [Epub ahead of print]']",['COVID-19EIT'],,https://clinicaltrials.gov/show/NCT04360837,2021-06-01,0,1
562,NCT04361214,Recruiting,2020-07-01,2020-07-01,No Results Posted,,,['IRB20-0622'],,https://clinicaltrials.gov/show/NCT04361214,2020-07-01,0,0
563,NCT04361344,Recruiting,2021-01-19,2021-01-19,No Results Posted,,,['CHPAU2020/02'],,https://clinicaltrials.gov/show/NCT04361344,2021-01-19,0,0
564,NCT04362189,Not yet recruiting,2020-10-31,2020-10-31,No Results Posted,,,['Allogeneic Treatment COVID-19'],,https://clinicaltrials.gov/show/NCT04362189,2020-10-31,0,0
565,NCT04365153,Recruiting,2020-12-31,2020-12-31,No Results Posted,,,['IND 149328'],,https://clinicaltrials.gov/show/NCT04365153,2020-12-31,0,0
566,NCT04368000,Recruiting,2020-12-01,2021-01-01,No Results Posted,,,['IRB_00132123'],,https://clinicaltrials.gov/show/NCT04368000,2020-12-01,0,0
567,NCT04368845,Recruiting,2020-07-31,2021-03-01,No Results Posted,,,['1'],,https://clinicaltrials.gov/show/NCT04368845,2020-07-31,0,0
568,NCT04372628,Not yet recruiting,2020-12-01,2021-05-01,No Results Posted,,,['200827'],,https://clinicaltrials.gov/show/NCT04372628,2020-12-01,0,0
569,NCT04373096,Not yet recruiting,2020-08-31,2020-08-31,No Results Posted,,,['20-5448'],,https://clinicaltrials.gov/show/NCT04373096,2020-08-31,0,0
570,NCT04380402,Not yet recruiting,2021-12-31,2022-05-08,No Results Posted,,,['MountAuburn'],,https://clinicaltrials.gov/show/NCT04380402,2021-12-31,0,0
571,NCT04384445,Not yet recruiting,2020-10-30,2020-12-31,No Results Posted,,,['19881'],,https://clinicaltrials.gov/show/NCT04384445,2020-10-30,0,0
572,NCT04386447,Not yet recruiting,2020-10-31,2020-12-31,No Results Posted,,,['OsCOVID19'],,https://clinicaltrials.gov/show/NCT04386447,2020-10-31,0,0
573,NCT04387240,Not yet recruiting,2020-10-01,2020-12-01,No Results Posted,,,['20-0192'],,https://clinicaltrials.gov/show/NCT04387240,2020-10-01,0,0
574,NCT04390022,Recruiting,2020-08-04,2020-08-30,No Results Posted,,,['SAINT'],,https://clinicaltrials.gov/show/NCT04390022,2020-08-04,0,0
575,NCT04391101,Not yet recruiting,2021-06-01,2021-12-01,No Results Posted,,,['002'],,https://clinicaltrials.gov/show/NCT04391101,2021-06-01,0,0
576,NCT04392128,Not yet recruiting,2020-12-31,2021-01-31,No Results Posted,,,"['2020-005', '2020-002002-45 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04392128,2020-12-31,0,0
577,NCT04392232,Recruiting,2020-12-31,2020-12-31,No Results Posted,,,['20-045'],,https://clinicaltrials.gov/show/NCT04392232,2020-12-31,0,0
578,NCT04392531,Recruiting,2020-07-01,2020-07-01,No Results Posted,,,['FJD-COVID19-20-01'],,,2020-07-01,0,0
579,NCT04393038,Recruiting,2020-12-30,2021-04-30,No Results Posted,,,['ABX464-401'],,https://clinicaltrials.gov/show/NCT04393038,2020-12-30,0,0
580,NCT04393051,Not yet recruiting,2020-06-30,2020-07-30,No Results Posted,,"['Richardson P, Griffin I, Tucker C, Smith D, Oechsle O, Phelan A, Rawling M, Savory E, Stebbing J. Baricitinib as potential treatment for 2019-nCoV acute respiratory disease. Lancet. 2020 Feb 15;395(10223):e30-e31. doi: 10.1016/S0140-6736(20)30304-4. Epub 2020 Feb 4. Erratum in: Lancet. 2020 Jun 20;395(10241):1906.', 'Favalli EG, Biggioggero M, Maioli G, Caporali R. Baricitinib for COVID-19: a suitable treatment? Lancet Infect Dis. 2020 Apr 3. pii: S1473-3099(20)30262-0. doi: 10.1016/S1473-3099(20)30262-0. [Epub ahead of print]']",['BARICIVID-19'],,https://clinicaltrials.gov/show/NCT04393051,2020-06-30,0,1
581,NCT04393727,Recruiting,2020-09-30,2020-10-30,No Results Posted,,"['Shen C, Wang Z, Zhao F, Yang Y, Li J, Yuan J, Wang F, Li D, Yang M, Xing L, Wei J, Xiao H, Yang Y, Qu J, Qing L, Chen L, Xu Z, Peng L, Li Y, Zheng H, Chen F, Huang K, Jiang Y, Liu D, Zhang Z, Liu Y, Liu L. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma. JAMA. 2020 Mar 27. doi: 10.1001/jama.2020.4783. [Epub ahead of print]']",['TSUNAMI'],,https://clinicaltrials.gov/show/NCT04393727,2020-09-30,0,1
582,NCT04393792,Recruiting,2020-08-01,2020-08-01,No Results Posted,,,"['SPON-AK-0420', '2020-001721-31 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04393792,2020-08-01,0,0
583,NCT04393818,Not yet recruiting,2020-07-01,2020-10-01,No Results Posted,,,['COVID-19/06'],,https://clinicaltrials.gov/show/NCT04393818,2020-07-01,0,0
584,NCT04394013,Not yet recruiting,2020-08-01,2020-12-01,No Results Posted,,,['180320201'],,https://clinicaltrials.gov/show/NCT04394013,2020-08-01,0,0
585,NCT04394403,Recruiting,2020-07-15,2021-07-15,No Results Posted,,,['coronastress'],,https://clinicaltrials.gov/show/NCT04394403,2020-07-15,0,0
586,NCT04394442,Recruiting,2020-08-01,2020-08-01,No Results Posted,,,['SNH1352020'],,https://clinicaltrials.gov/show/NCT04394442,2020-08-01,0,0
587,NCT04395144,Recruiting,2020-10-30,2020-12-31,No Results Posted,,,['2021-01'],,https://clinicaltrials.gov/show/NCT04395144,2020-10-30,0,0
588,NCT04395456,Not yet recruiting,2021-01-01,2021-03-01,No Results Posted,,,['AMY-101_SAVE'],,https://clinicaltrials.gov/show/NCT04395456,2021-01-01,0,0
589,NCT04395768,Not yet recruiting,2021-05-31,2021-12-31,No Results Posted,,,['Alliance-COVID19'],,https://clinicaltrials.gov/show/NCT04395768,2021-05-31,0,0
590,NCT04395911,Not yet recruiting,2020-09-01,2020-12-01,No Results Posted,,,['SCD-005'],,https://clinicaltrials.gov/show/NCT04395911,2020-09-01,0,0
591,NCT04395976,Not yet recruiting,2020-09-10,2020-10-01,No Results Posted,,,['BAMC01'],,https://clinicaltrials.gov/show/NCT04395976,2020-09-10,0,0
592,NCT04396106,Not yet recruiting,2020-07-01,2020-08-01,No Results Posted,,,['AT-03A-001'],,https://clinicaltrials.gov/show/NCT04396106,2020-07-01,0,0
593,NCT04396314,Not yet recruiting,2020-12-31,2021-04-30,No Results Posted,,"['Bravo C, Skjaerven LH, Espart A, Guitard Sein-Echaluce L, Catalan-Matamoros D. Basic Body Awareness Therapy in patients suffering from fibromyalgia: A randomized clinical trial. Physiother Theory Pract. 2019 Oct;35(10):919-929. doi: 10.1080/09593985.2018.1467520. Epub 2018 May 3.', 'Madsen TS, Carlsson J, Nordbrandt M, Jensen JA. Refugee experiences of individual basic body awareness therapy and the level of transference into daily life. An interview study. J Bodyw Mov Ther. 2016 Apr;20(2):243-51. doi: 10.1016/j.jbmt.2015.10.007. Epub 2015 Oct 26.']",['UL-002'],,https://clinicaltrials.gov/show/NCT04396314,2020-12-31,0,1
594,NCT04397328,Not yet recruiting,2021-04-30,2021-04-30,No Results Posted,,,['9881'],,https://clinicaltrials.gov/show/NCT04397328,2021-04-30,0,0
595,NCT04397523,Recruiting,2021-04-29,2021-04-29,No Results Posted,,,['ITM05/2020MKD'],,https://clinicaltrials.gov/show/NCT04397523,2021-04-29,0,0
596,NCT04397666,Recruiting,2020-09-15,2020-11-15,No Results Posted,,,['P20/09_COVEYES'],,https://clinicaltrials.gov/show/NCT04397666,2020-09-15,0,0
597,NCT04397705,Not yet recruiting,2020-08-01,2020-10-01,No Results Posted,,,['CFTSp186'],,https://clinicaltrials.gov/show/NCT04397705,2020-08-01,0,0
598,NCT04398277,Recruiting,2021-04-01,2021-04-01,No Results Posted,,,['20-183'],,https://clinicaltrials.gov/show/NCT04398277,2021-04-01,0,0
599,NCT04398290,Not yet recruiting,2021-01-01,2021-01-15,No Results Posted,,,['20200449'],,https://clinicaltrials.gov/show/NCT04398290,2021-01-01,0,0
600,NCT04398303,Not yet recruiting,2020-10-01,2020-10-01,No Results Posted,,,['AHS 20-03'],,https://clinicaltrials.gov/show/NCT04398303,2020-10-01,0,0
601,NCT04399746,Recruiting,2020-05-20,2020-06-10,No Results Posted,,,['IvAzCol'],,https://clinicaltrials.gov/show/NCT04399746,2020-05-20,0,0
602,NCT04400032,Not yet recruiting,2021-01-01,2021-06-01,No Results Posted,,,['20200243-01H'],,https://clinicaltrials.gov/show/NCT04400032,2021-01-01,0,0
603,NCT04404634,,,,,,,,,https://clinicaltrials.gov/show/NCT04404634,,0,0
604,NCT04305457,Recruiting,2021-04-01,2022-04-01,No Results Posted,,,['NOgas mildCOVID-19'],,https://clinicaltrials.gov/show/NCT04305457,2021-04-01,0,0
605,NCT04321278,Recruiting,2020-08-30,2020-08-30,No Results Posted,,,['30155020.5.1001.0071'],,https://clinicaltrials.gov/show/NCT04321278,2020-08-30,0,0
606,NCT04331600,Recruiting,2020-09-30,2020-12-31,No Results Posted,,,['WROCLAW CORONA STUDY 2020'],,https://clinicaltrials.gov/show/NCT04331600,2020-09-30,0,0
607,NCT04332107,Recruiting,2020-09-30,2021-09-30,No Results Posted,,,['20-30504'],,https://clinicaltrials.gov/show/NCT04332107,2020-09-30,0,0
608,NCT04346693,"Active, not recruiting",2020-12-01,2020-12-01,No Results Posted,,,['DAL-05-04-2020'],,https://clinicaltrials.gov/show/NCT04346693,2020-12-01,0,0
609,NCT04348370,Recruiting,2021-05-01,2021-11-01,No Results Posted,,,['2020-0432F'],,https://clinicaltrials.gov/show/NCT04348370,2021-05-01,0,0
610,NCT04350450,Withdrawn,2020-08-01,2020-08-01,No Results Posted,,,['2020-11445'],,https://clinicaltrials.gov/show/NCT04350450,2020-08-01,0,0
611,NCT04363814,Recruiting,2021-07-01,2021-07-31,No Results Posted,,,['MV130-SLG-35'],,https://clinicaltrials.gov/show/NCT04363814,2021-07-01,0,0
612,NCT04374591,"Active, not recruiting",2020-06-01,2020-06-01,No Results Posted,,,['Sodium Bicarbonate COVID-19'],,https://clinicaltrials.gov/show/NCT04374591,2020-06-01,0,0
613,NCT04377737,Withdrawn,2020-08-01,2020-09-01,No Results Posted,,,['20-HPNCL-02'],,https://clinicaltrials.gov/show/NCT04377737,2020-08-01,0,0
614,NCT04379375,Not yet recruiting,2020-10-10,2020-10-10,No Results Posted,,,['PRO00037864'],,https://clinicaltrials.gov/show/NCT04379375,2020-10-10,0,0
615,NCT04380532,"Active, not recruiting",2021-05-15,2021-06-15,No Results Posted,,,['Imm24'],,https://clinicaltrials.gov/show/NCT04380532,2021-05-15,0,0
616,NCT04381884,Recruiting,2020-06-30,2020-06-30,No Results Posted,,,['IVM-AR-1'],,https://clinicaltrials.gov/show/NCT04381884,2020-06-30,0,0
617,NCT04390594,Not yet recruiting,2020-12-01,2021-06-01,No Results Posted,,,['2020-002'],,https://clinicaltrials.gov/show/NCT04390594,2020-12-01,0,0
618,NCT04392869,"Active, not recruiting",2020-07-01,2020-10-01,No Results Posted,,,['PIBPD 431 (PPFID 2018-2020)'],,https://clinicaltrials.gov/show/NCT04392869,2020-07-01,0,0
619,NCT04393415,Not yet recruiting,2020-07-25,2020-08-01,No Results Posted,,,['covid -19'],,https://clinicaltrials.gov/show/NCT04393415,2020-07-25,0,0
620,NCT04395105,Recruiting,2020-12-31,2021-01-31,No Results Posted,,,['1264'],,https://clinicaltrials.gov/show/NCT04395105,2020-12-31,0,0
621,NCT04397497,Not yet recruiting,2020-09-22,2020-11-22,No Results Posted,,,['COMBAT-19'],,https://clinicaltrials.gov/show/NCT04397497,2020-09-22,0,0
622,NCT04398004,Recruiting,2022-05-06,2022-05-06,No Results Posted,,,"['ACHIEVE', '2020-001882-36 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04398004,2022-05-06,0,0
623,NCT04398147,Not yet recruiting,2021-03-01,2021-08-01,No Results Posted,,,['Ad5-nCoV-2020003'],,https://clinicaltrials.gov/show/NCT04398147,2021-03-01,0,0
624,NCT04399109,Recruiting,2021-05-19,2021-05-19,No Results Posted,,,['PID00770'],,https://clinicaltrials.gov/show/NCT04399109,2021-05-19,0,0
625,NCT04399252,Recruiting,2022-05-25,2022-05-25,No Results Posted,,,['Pro00105674'],,https://clinicaltrials.gov/show/NCT04399252,2022-05-25,0,0
626,NCT04399356,Not yet recruiting,2020-10-01,2020-11-30,No Results Posted,,,['STUDY00000605'],,https://clinicaltrials.gov/show/NCT04399356,2020-10-01,0,0
627,NCT04399681,Recruiting,2020-08-10,2020-09-10,No Results Posted,,,['KSSEAH--'],,https://clinicaltrials.gov/show/NCT04399681,2020-08-10,0,0
628,NCT04399798,Not yet recruiting,2020-09-15,2020-11-15,No Results Posted,,,['2020-001185-11'],,https://clinicaltrials.gov/show/NCT04399798,2020-09-15,0,0
629,NCT04400058,Recruiting,2020-12-30,2020-12-30,No Results Posted,,,['GAM10-10'],,https://clinicaltrials.gov/show/NCT04400058,2020-12-30,0,0
630,NCT04400305,Recruiting,2020-09-01,2020-09-01,No Results Posted,,,['05-281983'],,https://clinicaltrials.gov/show/NCT04400305,2020-09-01,0,0
631,NCT04400799,Not yet recruiting,2021-03-14,2021-04-14,No Results Posted,,,['OVID Trial'],,https://clinicaltrials.gov/show/NCT04400799,2021-03-14,0,0
632,NCT04400838,Not yet recruiting,2021-08-01,2021-08-01,No Results Posted,,,['COV002'],,https://clinicaltrials.gov/show/NCT04400838,2021-08-01,0,0
633,NCT04400890,Not yet recruiting,2020-09-01,2020-11-01,No Results Posted,,,['McCreary2020'],,https://clinicaltrials.gov/show/NCT04400890,2020-09-01,0,0
634,NCT04400929,Not yet recruiting,2021-06-01,2022-06-01,No Results Posted,,,['SH-Leuk-01'],,https://clinicaltrials.gov/show/NCT04400929,2021-06-01,0,0
635,NCT04401150,Not yet recruiting,2021-11-01,2022-01-01,No Results Posted,,,['MP-31-2021-3741'],,https://clinicaltrials.gov/show/NCT04401150,2021-11-01,0,0
636,NCT04401202,Recruiting,2020-12-31,2020-12-31,No Results Posted,,,['266-20'],,https://clinicaltrials.gov/show/NCT04401202,2020-12-31,0,0
637,NCT04401410,Not yet recruiting,2021-08-15,2021-08-15,No Results Posted,,,['H-47739 BAT IT'],,https://clinicaltrials.gov/show/NCT04401410,2021-08-15,0,0
638,NCT04401423,Not yet recruiting,2021-06-01,2021-12-01,No Results Posted,,,['AAAT0535'],,https://clinicaltrials.gov/show/NCT04401423,2021-06-01,0,0
639,NCT04401527,Not yet recruiting,2020-10-01,2020-12-01,No Results Posted,,,['SN02-01'],,https://clinicaltrials.gov/show/NCT04401527,2020-10-01,0,0
640,NCT04401644,Not yet recruiting,2021-12-01,2021-12-01,No Results Posted,,,['RBA20203'],,https://clinicaltrials.gov/show/NCT04401644,2021-12-01,0,0
641,NCT04402203,Recruiting,2020-07-01,2020-07-01,No Results Posted,,,['29318042020'],,https://clinicaltrials.gov/show/NCT04402203,2020-07-01,0,0
642,NCT04402840,Recruiting,2020-07-01,2020-12-01,No Results Posted,,,['2004963113'],,https://clinicaltrials.gov/show/NCT04402840,2020-07-01,0,0
643,NCT04402983,Recruiting,2020-12-01,2020-12-01,No Results Posted,,,['Telerehab_Covid19'],,https://clinicaltrials.gov/show/NCT04402983,2020-12-01,0,0
644,NCT04403269,Recruiting,2021-05-05,2021-05-05,No Results Posted,,,['P20/07 GERONIMO 19'],,https://clinicaltrials.gov/show/NCT04403269,2021-05-05,0,0
645,NCT04403477,Recruiting,2020-07-20,2020-10-30,No Results Posted,,,['BSMMU/2020/6104'],,https://clinicaltrials.gov/show/NCT04403477,2020-07-20,0,0
646,NCT04403555,Not yet recruiting,2030-12-01,2030-12-03,No Results Posted,,,['tanta combo covid treatment'],,https://clinicaltrials.gov/show/NCT04403555,2030-12-01,0,0
647,NCT04403906,Not yet recruiting,2021-06-01,2021-08-01,No Results Posted,,,['IRAS283137'],,https://clinicaltrials.gov/show/NCT04403906,2021-06-01,0,0
648,NCT04404192,Not yet recruiting,2021-07-01,2021-09-01,No Results Posted,,,['PH94B-CL-029'],,https://clinicaltrials.gov/show/NCT04404192,2021-07-01,0,0
649,NCT04404218,Not yet recruiting,2020-11-01,2021-05-01,No Results Posted,,,['CTO3176'],,https://clinicaltrials.gov/show/NCT04404218,2020-11-01,0,0
650,NCT04307693,Terminated,2020-04-30,2020-04-30,No Results Posted,,,['S2020-0472-0001'],,https://clinicaltrials.gov/show/NCT04307693,2020-04-30,0,0
651,NCT04317040,Recruiting,2020-09-01,2020-12-01,No Results Posted,,,"['CD24Fc-007', '20200674 ( Other Identifier: WIRB )']",,https://clinicaltrials.gov/show/NCT04317040,2020-09-01,0,0
652,NCT04321421,Completed,2020-04-28,2020-05-07,No Results Posted,"['Perotti C, Del Fante C, Baldanti F, Franchini M, Percivalle E, Vecchio Nepita E, Seminari E, De Silvestri A, Bruno R, Klersy C. Plasma from donors recovered from the new Coronavirus 2019 as therapy for critical patients with COVID-19 (COVID-19 plasma study): a multicentre study protocol. Intern Emerg Med. 2020 May 28. doi: 10.1007/s11739-020-02384-2. [Epub ahead of print]']",,['IRCCSSanMatteoH'],,https://clinicaltrials.gov/show/NCT04321421,2020-04-28,0,1
653,NCT04327206,Recruiting,2020-10-30,2022-03-30,No Results Posted,,,['62586'],,https://clinicaltrials.gov/show/NCT04327206,2020-10-30,0,0
654,NCT04328467,"Active, not recruiting",2020-08-01,2020-08-01,No Results Posted,,,['STUDY00009414'],,https://clinicaltrials.gov/show/NCT04328467,2020-08-01,0,0
655,NCT04328493,Recruiting,2021-04-01,2022-04-01,No Results Posted,,,['COVID'],,https://clinicaltrials.gov/show/NCT04328493,2021-04-01,0,0
656,NCT04334629,Recruiting,2020-09-25,2021-05-25,No Results Posted,,,['282009'],,https://clinicaltrials.gov/show/NCT04334629,2020-09-25,0,0
657,NCT04334850,Recruiting,2020-07-01,2020-08-01,No Results Posted,,,"['APHP200392', '2020-001324-33 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04334850,2020-07-01,0,0
658,NCT04341610,Withdrawn,2021-01-30,2021-04-30,No Results Posted,,,['EudraCT number: 2020-001330-36'],,https://clinicaltrials.gov/show/NCT04341610,2021-01-30,0,0
659,NCT04345289,Recruiting,2021-06-15,2021-06-15,No Results Posted,,,"['25032020', '2020-001367-88 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04345289,2021-06-15,0,0
660,NCT04351516,Recruiting,2020-12-31,2021-05-01,No Results Posted,,,"['COVID65plus', '2020-001482-37 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04351516,2020-12-31,0,0
661,NCT04354428,Recruiting,2020-07-01,2020-10-01,No Results Posted,,,"['STUDY00009878', 'INV-017062 ( Other Grant/Funding Number: Bill and Melinda Gates Foundation )']",,https://clinicaltrials.gov/show/NCT04354428,2020-07-01,0,0
662,NCT04359264,"Active, not recruiting",2020-05-29,2020-06-30,No Results Posted,,,['20-081'],,https://clinicaltrials.gov/show/NCT04359264,2020-05-29,0,0
663,NCT04362059,Not yet recruiting,2020-07-27,2020-11-02,No Results Posted,,"['Anzueto A, Baughman RP, Guntupalli KK, Weg JG, Wiedemann HP, Ravent√≥s AA, Lemaire F, Long W, Zaccardelli DS, Pattishall EN. Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group. N Engl J Med. 1996 May 30;334(22):1417-21.', 'Surfactant replacement therapy for severe neonatal respiratory distress syndrome: an international randomized clinical trial. Collaborative European Multicenter Study Group. Pediatrics. 1988 Nov;82(5):683-91.', 'Dushianthan A, Goss V, Cusack R, Grocott MP, Postle AD. Altered molecular specificity of surfactant phosphatidycholine synthesis in patients with acute respiratory distress syndrome. Respir Res. 2014 Nov 7;15:128. doi: 10.1186/s12931-014-0128-8.', 'Goss V, Hunt AN, Postle AD. Regulation of lung surfactant phospholipid synthesis and metabolism. Biochim Biophys Acta. 2013 Feb;1831(2):448-58. doi: 10.1016/j.bbalip.2012.11.009. Epub 2012 Nov 27. Review.', 'G√ºnther A, Schmidt R, Harodt J, Schmehl T, Walmrath D, Ruppert C, Grimminger F, Seeger W. Bronchoscopic administration of bovine natural surfactant in ARDS and septic shock: impact on biophysical and biochemical surfactant properties. Eur Respir J. 2002 May;19(5):797-804.', 'Hoffmann M, Kleine-Weber H, Schroeder S, Kr√ºger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, M√ºller MA, Drosten C, P√∂hlmann S. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.', 'M√∂ller JC, Schaible T, Roll C, Schiffmann JH, Bindl L, Schrod L, Reiss I, Kohl M, Demirakca S, Hentschel R, Paul T, Vierzig A, Groneck P, von Seefeld H, Schumacher H, Gortner L; Surfactant ARDS Study Group. Treatment with bovine surfactant in severe acute respiratory distress syndrome in children: a randomized multicenter study. Intensive Care Med. 2003 Mar;29(3):437-46. Epub 2003 Feb 15.', 'Postle AD, Mander A, Reid KB, Wang JY, Wright SM, Moustaki M, Warner JO. Deficient hydrophilic lung surfactant proteins A and D with normal surfactant phospholipid molecular species in cystic fibrosis. Am J Respir Cell Mol Biol. 1999 Jan;20(1):90-8.', 'Qi F, Qian S, Zhang S, Zhang Z. Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses. Biochem Biophys Res Commun. 2020 May 21;526(1):135-140. doi: 10.1016/j.bbrc.2020.03.044. Epub 2020 Mar 19.', 'Rebello CM, Jobe AH, Eisele JW, Ikegami M. Alveolar and tissue surfactant pool sizes in humans. Am J Respir Crit Care Med. 1996 Sep;154(3 Pt 1):625-8.', 'Rodr√≠guez-Capote K, Manzanares D, Haines T, Possmayer F. Reactive oxygen species inactivation of surfactant involves structural and functional alterations to surfactant proteins SP-B and SP-C. Biophys J. 2006 Apr 15;90(8):2808-21. Epub 2006 Jan 27.', 'Schmidt R, Markart P, Ruppert C, Wygrecka M, Kuchenbuch T, Walmrath D, Seeger W, Guenther A. Time-dependent changes in pulmonary surfactant function and composition in acute respiratory distress syndrome due to pneumonia or aspiration. Respir Res. 2007 Jul 27;8:55.', 'Schwarz KB. Oxidative stress during viral infection: a review. Free Radic Biol Med. 1996;21(5):641-9. Review.', 'Shi H, Han X, Jiang N, Cao Y, Alwalid O, Gu J, Fan Y, Zheng C. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020 Apr;20(4):425-434. doi: 10.1016/S1473-3099(20)30086-4. Epub 2020 Feb 24.']",['RHM CRI0399'],,https://clinicaltrials.gov/show/NCT04362059,2020-07-27,0,1
664,NCT04364594,"Active, not recruiting",2020-05-24,2020-05-30,No Results Posted,,,['0013008/20'],,https://clinicaltrials.gov/show/NCT04364594,2020-05-24,0,0
665,NCT04366115,Not yet recruiting,2022-06-01,2023-06-01,No Results Posted,,,['AVM0703-101'],,https://clinicaltrials.gov/show/NCT04366115,2022-06-01,0,0
666,NCT04366141,Recruiting,2021-01-01,2021-01-01,No Results Posted,,,['H20-01270'],,https://clinicaltrials.gov/show/NCT04366141,2021-01-01,0,0
667,NCT04368988,Recruiting,2020-12-31,2021-07-31,No Results Posted,,,['2019nCoV-101'],,https://clinicaltrials.gov/show/NCT04368988,2020-12-31,0,0
668,NCT04373200,Recruiting,2020-11-25,2020-11-25,No Results Posted,,,"['35RC20_9795_HARMONICOV', '2020-A01100-39 ( Other Identifier: ANSM (N¬∞ID-RCB) )']",,https://clinicaltrials.gov/show/NCT04373200,2020-11-25,0,0
669,NCT04374526,Recruiting,2020-09-30,2021-06-30,No Results Posted,,,['3205'],,https://clinicaltrials.gov/show/NCT04374526,2020-09-30,0,0
670,NCT04377659,Recruiting,2021-05-01,2021-05-01,No Results Posted,,,['20-185'],,https://clinicaltrials.gov/show/NCT04377659,2021-05-01,0,0
671,NCT04378803,"Active, not recruiting",2020-10-01,2020-10-01,No Results Posted,,,['20200443'],,https://clinicaltrials.gov/show/NCT04378803,2020-10-01,0,0
672,NCT04382547,Enrolling by invitation,2021-06-30,2021-06-30,No Results Posted,,,['IBCE_MSC2(Covid)'],,https://clinicaltrials.gov/show/NCT04382547,2021-06-30,0,0
673,NCT04384497,Recruiting,2020-06-01,2020-12-01,No Results Posted,,,['CP2'],,https://clinicaltrials.gov/show/NCT04384497,2020-06-01,0,0
674,NCT04386291,Recruiting,2021-05-19,2022-01-30,No Results Posted,,,['7987'],,https://clinicaltrials.gov/show/NCT04386291,2021-05-19,0,0
675,NCT04388527,Recruiting,2020-08-30,2020-09-30,No Results Posted,,,['842996 (PennCCP-01)'],,https://clinicaltrials.gov/show/NCT04388527,2020-08-30,0,0
676,NCT04397692,Not yet recruiting,2020-08-24,2020-09-30,No Results Posted,,,['BAI_COV19_01_US'],,https://clinicaltrials.gov/show/NCT04397692,2020-08-24,0,0
677,NCT04401046,Not yet recruiting,2020-11-30,2020-11-30,No Results Posted,,,['COVID-TRAUMA-IPC 2020-026'],,https://clinicaltrials.gov/show/NCT04401046,2020-11-30,0,0
678,NCT04402892,Not yet recruiting,2021-03-01,2021-03-01,No Results Posted,,,['APHP200551'],,https://clinicaltrials.gov/show/NCT04402892,2021-03-01,0,0
679,NCT04402918,Recruiting,2020-05-19,2020-12-31,No Results Posted,,,['2020/500'],,https://clinicaltrials.gov/show/NCT04402918,2020-05-19,0,0
680,NCT04403243,Recruiting,2020-07-22,2020-08-23,No Results Posted,,,['MSU080520'],,https://clinicaltrials.gov/show/NCT04403243,2020-07-22,0,0
681,NCT04403646,Not yet recruiting,2020-09-30,2020-10-31,No Results Posted,,,['HCJSM-20-005'],,https://clinicaltrials.gov/show/NCT04403646,2020-09-30,0,0
682,NCT04403685,Recruiting,2020-07-08,2020-08-31,No Results Posted,,,['TOCIBRAS'],,https://clinicaltrials.gov/show/NCT04403685,2020-07-08,0,0
683,NCT04404426,Not yet recruiting,2021-06-15,2021-07-15,No Results Posted,,,"['35RC20_9815_CACOLAC', 'CPP 1288 HPS1 ( Other Identifier: CPP Ouest 6 (Brest) )', '2020-A01189-30 ( Other Identifier: ID RCB )']",,https://clinicaltrials.gov/show/NCT04404426,2021-06-15,0,0
684,NCT04405102,Not yet recruiting,2022-01-06,2022-07-06,No Results Posted,,,['2021-3474'],,https://clinicaltrials.gov/show/NCT04405102,2022-01-06,0,0
685,NCT04405271,Not yet recruiting,2020-11-15,2020-11-15,No Results Posted,,,['16052020'],,https://clinicaltrials.gov/show/NCT04405271,2020-11-15,0,0
686,NCT04405310,Recruiting,2020-06-20,2020-07-20,No Results Posted,,,['DI/20/201/04/19'],,https://clinicaltrials.gov/show/NCT04405310,2020-06-20,0,0
687,NCT04405492,Not yet recruiting,2021-03-25,2021-03-25,No Results Posted,,,['APHP200556'],,https://clinicaltrials.gov/show/NCT04405492,2021-03-25,0,0
688,NCT04405843,Not yet recruiting,2020-10-01,2020-11-01,No Results Posted,,,['ScDi823'],,https://clinicaltrials.gov/show/NCT04405843,2020-10-01,0,0
689,NCT04405999,Recruiting,2020-06-20,2020-09-30,No Results Posted,,,['05-20-02-–°'],,https://clinicaltrials.gov/show/NCT04405999,2020-06-20,0,0
690,NCT04406064,Not yet recruiting,2024-06-01,2025-06-01,No Results Posted,,,['2020-0353'],,https://clinicaltrials.gov/show/NCT04406064,2024-06-01,0,0
691,NCT04406246,Recruiting,2020-12-31,2020-12-31,No Results Posted,,,['2020-04-682'],,https://clinicaltrials.gov/show/NCT04406246,2020-12-31,0,0
692,NCT04406389,Not yet recruiting,2020-12-01,2021-06-01,No Results Posted,,,['20-04021936'],,https://clinicaltrials.gov/show/NCT04406389,2020-12-01,0,0
693,NCT04406493,Recruiting,2021-04-28,2021-04-28,No Results Posted,,,['0059-20-HYMC'],,https://clinicaltrials.gov/show/NCT04406493,2021-04-28,0,0
694,NCT04406532,Not yet recruiting,2021-01-01,2021-03-01,No Results Posted,,,['2020-11535'],,https://clinicaltrials.gov/show/NCT04406532,2021-01-01,0,0
695,NCT04407286,Recruiting,2020-08-18,2021-05-18,No Results Posted,,,['STUDY00011960'],,https://clinicaltrials.gov/show/NCT04407286,2020-08-18,0,0
696,NCT04407507,Not yet recruiting,2020-08-01,2020-10-01,No Results Posted,,"['Caly L, Druce JD, Catton MG, Jans DA, Wagstaff KM. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Res. 2020 Apr 3;178:104787. doi: 10.1016/j.antiviral.2020.104787. [Epub ahead of print]', 'Chaccour CJ, Kobylinski KC, Bassat Q, Bousema T, Drakeley C, Alonso P, Foy BD. Ivermectin to reduce malaria transmission: a research agenda for a promising new tool for elimination. Malar J. 2013 May 7;12:153. doi: 10.1186/1475-2875-12-153.', ""Smit MR, Ochomo E, Aljayyoussi G, Kwambai T, Abong'o B, Bayoh N, Gimnig J, Samuels A, Desai M, Phillips-Howard PA, Kariuki S, Wang D, Ward S, Ter Kuile FO. Efficacy and Safety of High-Dose Ivermectin for Reducing Malaria Transmission (IVERMAL): Protocol for a Double-Blind, Randomized, Placebo-Controlled, Dose-Finding Trial in Western Kenya. JMIR Res Protoc. 2016 Nov 17;5(4):e213."", 'Xie M, Chen Q. Insight into 2019 novel coronavirus - An updated interim review and lessons from SARS-CoV and MERS-CoV. Int J Infect Dis. 2020 May;94:119-124. doi: 10.1016/j.ijid.2020.03.071. Epub 2020 Apr 1. Review.', 'Yang SNY, Atkinson SC, Wang C, Lee A, Bogoyevitch MA, Borg NA, Jans DA. The broad spectrum antiviral ivermectin targets the host nuclear transport importin Œ±/Œ≤1 heterodimer. Antiviral Res. 2020 May;177:104760. doi: 10.1016/j.antiviral.2020.104760. Epub 2020 Mar 3.']",['SARS-COV-IverMX-01'],,https://clinicaltrials.gov/show/NCT04407507,2020-08-01,0,1
697,NCT04408027,Not yet recruiting,2021-06-01,2021-06-01,No Results Posted,,,['REB1000070362'],,https://clinicaltrials.gov/show/NCT04408027,2021-06-01,0,0
698,NCT04408040,Not yet recruiting,2022-06-01,2022-06-01,No Results Posted,,,['NSH 1281'],,https://clinicaltrials.gov/show/NCT04408040,2022-06-01,0,0
699,NCT04408235,Not yet recruiting,2021-06-01,2021-06-01,No Results Posted,,,['EudraCT N¬∞: 2020-001972-13'],,https://clinicaltrials.gov/show/NCT04408235,2021-06-01,0,0
700,NCT04283461,Recruiting,2021-11-22,2021-11-22,No Results Posted,,,"['20-0003', '1UM1AI148373-01 ( U.S. NIH Grant/Contract )']",,https://clinicaltrials.gov/show/NCT04283461,2021-11-22,0,0
701,NCT04292730,"Active, not recruiting",2020-06-01,2020-06-01,No Results Posted,,,"['GS-US-540-5774', '2020-000842-32 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04292730,2020-06-01,0,0
702,NCT04292899,"Active, not recruiting",2020-06-01,2020-06-01,No Results Posted,"['Goldman JD, Lye DCB, Hui DS, Marks KM, Bruno R, Montejano R, Spinner CD, Galli M, Ahn MY, Nahass RG, Chen YS, SenGupta D, Hyland RH, Osinusi AO, Cao H, Blair C, Wei X, Gaggar A, Brainard DM, Towner WJ, Mu√±oz J, Mullane KM, Marty FM, Tashima KT, Diaz G, Subramanian A; GS-US-540-5773 Investigators. Remdesivir for 5 or 10 Days in Patients with Severe Covid-19. N Engl J Med. 2020 May 27. doi: 10.1056/NEJMoa2015301. [Epub ahead of print]']",,"['GS-US-540-5773', '2020-000841-15 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04292899,2020-06-01,0,1
703,NCT04320615,"Active, not recruiting",2020-08-31,2020-09-30,No Results Posted,,,"['WA42380', '2020-001154-22 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04320615,2020-08-31,0,0
704,NCT04322123,"Active, not recruiting",2020-08-30,2020-08-30,No Results Posted,,,['Brazil COVID Coalition I Trial'],,https://clinicaltrials.gov/show/NCT04322123,2020-08-30,0,0
705,NCT04323228,Not yet recruiting,2020-10-01,2020-10-30,No Results Posted,,,['ONS_COVID-19'],,https://clinicaltrials.gov/show/NCT04323228,2020-10-01,0,0
706,NCT04329832,Recruiting,2020-12-31,2021-12-31,No Results Posted,"['Brown SM, Peltan ID, Webb B, Kumar N, Starr N, Grissom C, Buckel WR, Srivastava R, Harris ES, Leither L, Johnson SA, Paine R 3rd, Greene T. Hydroxychloroquine vs. Azithromycin for Hospitalized Patients with Suspected or Confirmed COVID-19 (HAHPS): Protocol for a Pragmatic, Open Label, Active Comparator Trial. Ann Am Thorac Soc. 2020 May 19. doi: 10.1513/AnnalsATS.202004-309SD. [Epub ahead of print]']",,['1051355'],,https://clinicaltrials.gov/show/NCT04329832,2020-12-31,0,1
707,NCT04334967,Suspended,2020-05-27,2020-05-27,No Results Posted,,,['2020000186'],,https://clinicaltrials.gov/show/NCT04334967,2020-05-27,0,0
708,NCT04337788,Not yet recruiting,2020-07-01,2020-09-01,No Results Posted,,,['87RI20_0013'],,https://clinicaltrials.gov/show/NCT04337788,2020-07-01,0,0
709,NCT04344600,Recruiting,2021-06-01,2021-12-01,No Results Posted,,,['IRB00248163'],,https://clinicaltrials.gov/show/NCT04344600,2021-06-01,0,0
710,NCT04344951,Recruiting,2021-04-01,2021-04-30,No Results Posted,,"['Arabi YM, Murthy S, Webb S. COVID-19: a novel coronavirus and a novel challenge for critical care. Intensive Care Med. 2020 May;46(5):833-836. doi: 10.1007/s00134-020-05955-1. Epub 2020 Mar 3. Erratum in: Intensive Care Med. 2020 Mar 18;:.', 'Devaux CA, Rolain JM, Colson P, Raoult D. New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? Int J Antimicrob Agents. 2020 May;55(5):105938. doi: 10.1016/j.ijantimicag.2020.105938. Epub 2020 Mar 12.', 'Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, Doudier B, Courjon J, Giordanengo V, Vieira VE, Dupont HT, Honor√© S, Colson P, Chabri√®re E, La Scola B, Rolain JM, Brouqui P, Raoult D. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020 Mar 20:105949. doi: 10.1016/j.ijantimicag.2020.105949. [Epub ahead of print]']",['UNIKINON-01/HOPE'],,https://clinicaltrials.gov/show/NCT04344951,2021-04-01,0,1
711,NCT04348513,Recruiting,2021-05-02,2021-05-31,No Results Posted,"['Pantos C, Kostopanagiotou G, Armaganidis A, Trikas A, Tseti I, Mourouzis I. Triiodothyronine for the treatment of critically ill patients with COVID-19 infection: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jun 26;21(1):573. doi: 10.1186/s13063-020-04474-0.']",,['T3inj-02/ThySupport'],,https://clinicaltrials.gov/show/NCT04348513,2021-05-02,0,1
712,NCT04351243,Recruiting,2020-07-01,2020-10-01,No Results Posted,,,['KIN-1901-2001'],,https://clinicaltrials.gov/show/NCT04351243,2020-07-01,0,0
713,NCT04355364,Recruiting,2020-08-21,2020-08-21,No Results Posted,"['Desilles JP, Gregoire C, Le Cossec C, Lambert J, Mophawe O, Losser MR, Lambiotte F, Le Tacon S, Cantier M, Engrand N, Trouiller P, Pottecher J. Efficacy and safety of aerosolized intra-tracheal dornase alfa administration in patients with SARS-CoV-2-induced acute respiratory distress syndrome (ARDS): a structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jun 19;21(1):548. doi: 10.1186/s13063-020-04488-8.']",,['CGE_2020_9'],,https://clinicaltrials.gov/show/NCT04355364,2020-08-21,0,1
714,NCT04357340,Completed,2020-04-30,2020-05-30,No Results Posted,,,['99-1-103-47429'],,https://clinicaltrials.gov/show/NCT04357340,2020-04-30,0,0
715,NCT04363736,"Active, not recruiting",2020-07-03,2020-08-03,No Results Posted,,,['CA42481'],,https://clinicaltrials.gov/show/NCT04363736,2020-07-03,0,0
716,NCT04363827,Recruiting,2020-09-01,2021-03-01,No Results Posted,,,['IRST100.47'],,https://clinicaltrials.gov/show/NCT04363827,2020-09-01,0,0
717,NCT04370236,Not yet recruiting,2021-02-01,2021-02-01,No Results Posted,,,['XPro1595-COVID-19'],,https://clinicaltrials.gov/show/NCT04370236,2021-02-01,0,0
718,NCT04370886,Completed,2020-04-30,2020-05-10,No Results Posted,,,['Recruit Blood Donors via SMS'],,https://clinicaltrials.gov/show/NCT04370886,2020-04-30,0,0
719,NCT04373044,Recruiting,2021-05-01,2022-05-01,No Results Posted,,,"['0S-20-3', 'NCI-2020-02685 ( Registry Identifier: CTRP (Clinical Trial Reporting Program) )', '0S-20-3 ( Other Identifier: USC / Norris Comprehensive Cancer Center )', 'P30CA014089 ( U.S. NIH Grant/Contract )']",,https://clinicaltrials.gov/show/NCT04373044,2021-05-01,0,0
720,NCT04374461,Recruiting,2021-05-01,2021-05-01,No Results Posted,,,['20-168'],,https://clinicaltrials.gov/show/NCT04374461,2021-05-01,0,0
721,NCT04377672,Recruiting,2021-05-28,2022-05-28,No Results Posted,,,['IRB00247557'],,https://clinicaltrials.gov/show/NCT04377672,2021-05-28,0,0
722,NCT04384965,Recruiting,2022-05-01,2022-11-01,No Results Posted,,,['059/2020'],,https://clinicaltrials.gov/show/NCT04384965,2022-05-01,0,0
723,NCT04385186,Not yet recruiting,2020-11-30,2020-12-30,No Results Posted,,,['CT01'],,https://clinicaltrials.gov/show/NCT04385186,2020-11-30,0,0
724,NCT04385849,Not yet recruiting,2020-07-11,2020-07-11,No Results Posted,,,['QUILT-COVID-19'],,https://clinicaltrials.gov/show/NCT04385849,2020-07-11,0,0
725,NCT04391179,Recruiting,2020-12-01,2020-12-01,No Results Posted,,,['HUM00179783'],,https://clinicaltrials.gov/show/NCT04391179,2020-12-01,0,0
726,NCT04396067,Not yet recruiting,2020-09-01,2020-11-01,No Results Posted,,,['COVID-19'],,https://clinicaltrials.gov/show/NCT04396067,2020-09-01,0,0
727,NCT04397757,Recruiting,2020-09-13,2020-11-13,No Results Posted,,,['843003 (PennCCP-02)'],,https://clinicaltrials.gov/show/NCT04397757,2020-09-13,0,0
728,NCT04397796,Not yet recruiting,2021-06-01,2021-06-01,No Results Posted,,,['QUILT-COVID-19-MSC'],,https://clinicaltrials.gov/show/NCT04397796,2021-06-01,0,0
729,NCT04401475,Not yet recruiting,2021-02-01,2021-04-01,No Results Posted,,,['EB05-01-2020'],,https://clinicaltrials.gov/show/NCT04401475,2021-02-01,0,0
730,NCT04402879,Recruiting,2020-12-01,2021-06-01,No Results Posted,,,['REB20-0518'],,https://clinicaltrials.gov/show/NCT04402879,2020-12-01,0,0
731,NCT04405544,Recruiting,2020-07-22,2020-10-22,No Results Posted,,,['NMSC-01-20'],,https://clinicaltrials.gov/show/NCT04405544,2020-07-22,0,0
732,NCT04405986,Recruiting,2020-12-19,2020-12-19,No Results Posted,,,['CHUBX 2020/20'],,https://clinicaltrials.gov/show/NCT04405986,2020-12-19,0,0
733,NCT04406181,Recruiting,2020-12-31,2021-01-01,No Results Posted,,,['COVID-19 Cardiac psy wellbeing'],,https://clinicaltrials.gov/show/NCT04406181,2020-12-31,0,0
734,NCT04407182,Recruiting,2020-06-13,2020-06-15,No Results Posted,,,['IESS-HTMC-JUTD-2020-0305-M'],,https://clinicaltrials.gov/show/NCT04407182,2020-06-13,0,0
735,NCT04407208,Completed,2020-06-22,2020-06-22,No Results Posted,,,['3471041S322342020040800002'],,https://clinicaltrials.gov/show/NCT04407208,2020-06-22,0,0
736,NCT04407390,Recruiting,2021-05-01,2022-05-01,No Results Posted,,,['H-20026601'],,https://clinicaltrials.gov/show/NCT04407390,2021-05-01,0,0
737,NCT04408131,Recruiting,2021-01-27,2021-01-27,No Results Posted,,,"['2020-32', '2020-A01398-31 ( Other Identifier: ID RCB )']",,https://clinicaltrials.gov/show/NCT04408131,2021-01-27,0,0
738,NCT04408157,Not yet recruiting,2021-05-22,2021-06-22,No Results Posted,,,['v1.1 06.05.2020'],,https://clinicaltrials.gov/show/NCT04408157,2021-05-22,0,0
739,NCT04408209,Recruiting,2020-06-30,2021-09-15,No Results Posted,,,['245-14-4-20'],,https://clinicaltrials.gov/show/NCT04408209,2020-06-30,0,0
740,NCT04408287,Not yet recruiting,2020-12-31,2021-08-31,No Results Posted,,,['115929'],,https://clinicaltrials.gov/show/NCT04408287,2020-12-31,0,0
741,NCT04408456,Recruiting,2020-06-30,2020-06-30,No Results Posted,,,['IEC-04/2020-1624'],,https://clinicaltrials.gov/show/NCT04408456,2020-06-30,0,0
742,NCT04409327,Recruiting,2020-09-01,2020-10-01,No Results Posted,,,['RTB101-210'],,https://clinicaltrials.gov/show/NCT04409327,2020-09-01,0,0
743,NCT04409483,Withdrawn,2020-12-31,2021-12-31,No Results Posted,,,['Trascov'],,https://clinicaltrials.gov/show/NCT04409483,2020-12-31,0,0
744,NCT04409509,Not yet recruiting,2020-12-01,2020-12-01,No Results Posted,,,['CSL312_COVID-19'],,https://clinicaltrials.gov/show/NCT04409509,2020-12-01,0,0
745,NCT04409522,Recruiting,2020-06-05,2020-09-25,No Results Posted,,,['IR.BMSU.REC.1399.039'],,https://clinicaltrials.gov/show/NCT04409522,2020-06-05,0,0
746,NCT04409743,Recruiting,2021-05-01,2021-11-01,No Results Posted,,,['IRB-55940'],,https://clinicaltrials.gov/show/NCT04409743,2021-05-01,0,0
747,NCT04409821,Not yet recruiting,2022-02-01,2022-02-01,No Results Posted,,,"['P-2020-544', '0216-00030B ( Other Grant/Funding Number: Independent Research Fund Denmark )']",,https://clinicaltrials.gov/show/NCT04409821,2022-02-01,0,0
748,NCT04409873,Not yet recruiting,2020-10-31,2021-08-31,No Results Posted,,,"['20-30874', 'R00RG2901 ( Other Grant/Funding Number: UCOP Emergency COVID19 Rsrch Fd: Cal Breast Cancer Rsrch Pgm )']",,https://clinicaltrials.gov/show/NCT04409873,2020-10-31,0,0
749,NCT04410328,Not yet recruiting,2020-12-15,2021-12-15,No Results Posted,,"['Macatangay BJC, Jackson EK, Abebe KZ, Comer D, Cyktor J, Klamar-Blain C, Borowski L, Gillespie DG, Mellors JW, Rinaldo CR, Riddler SA. A Randomized, Placebo-Controlled, Pilot Clinical Trial of Dipyridamole to Decrease Human Immunodeficiency Virus-Associated Chronic Inflammation. J Infect Dis. 2020 Apr 27;221(10):1598-1606. doi: 10.1093/infdis/jiz344.', 'Li Z LX, Huang Yi-Y et al. FEP-based screening prompts drug repositioning against COVID-19. 2020.', 'Liu X LZ, Liu S et al. . Therapeutic effects of dipyridamole on COVID-19 patients with coagulation dysfunction. 2020.', 'K√∂hler D, Streienberger A, Morote-Garc√≠a JC, Granja TF, Schneider M, Straub A, Boison D, Rosenberger P. Inhibition of Adenosine Kinase Attenuates Acute Lung Injury. Crit Care Med. 2016 Apr;44(4):e181-9. doi: 10.1097/CCM.0000000000001370.', 'Fata-Hartley CL, Palmenberg AC. Dipyridamole reversibly inhibits mengovirus RNA replication. J Virol. 2005 Sep;79(17):11062-70.', 'Weyrich AS, Skalabrin EJ, Kraiss LW. Targeting the inflammatory response in secondary stroke prevention: a role for combining aspirin and extended-release dipyridamole. Am J Ther. 2009 Mar-Apr;16(2):164-70. doi: 10.1097/MJT.0b013e31814b17bf. Review.', 'Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, Ruan L, Song B, Cai Y, Wei M, Li X, Xia J, Chen N, Xiang J, Yu T, Bai T, Xie X, Zhang L, Li C, Yuan Y, Chen H, Li H, Huang H, Tu S, Gong F, Liu Y, Wei Y, Dong C, Zhou F, Gu X, Xu J, Liu Z, Zhang Y, Li H, Shang L, Wang K, Li K, Zhou X, Dong X, Qu Z, Lu S, Hu X, Ruan S, Luo S, Wu J, Peng L, Cheng F, Pan L, Zou J, Jia C, Wang J, Liu X, Wang S, Wu X, Ge Q, He J, Zhan H, Qiu F, Guo L, Huang C, Jaki T, Hayden FG, Horby PW, Zhang D, Wang C. A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med. 2020 May 7;382(19):1787-1799. doi: 10.1056/NEJMoa2001282. Epub 2020 Mar 18.']",['Pro2020001399'],,https://clinicaltrials.gov/show/NCT04410328,2020-12-15,0,1
750,NCT04410458,Enrolling by invitation,2020-05-31,2020-06-12,No Results Posted,,,['Recruit Blood Donors via SMS 2'],,https://clinicaltrials.gov/show/NCT04410458,2020-05-31,0,0
751,NCT04410510,Not yet recruiting,2020-12-01,2021-06-01,No Results Posted,,,['CS002-COVID19'],,https://clinicaltrials.gov/show/NCT04410510,2020-12-01,0,0
752,NCT04410536,Not yet recruiting,2021-12-01,2022-07-01,No Results Posted,,,['MOH'],,https://clinicaltrials.gov/show/NCT04410536,2021-12-01,0,0
753,NCT04410549,Recruiting,2020-06-30,2020-06-30,No Results Posted,,,['OCT COVID'],,https://clinicaltrials.gov/show/NCT04410549,2020-06-30,0,0
754,NCT04410562,Recruiting,2021-05-13,2021-08-01,No Results Posted,,,['2020-001587-29'],,https://clinicaltrials.gov/show/NCT04410562,2021-05-13,0,0
755,NCT04410692,Completed,2020-05-16,2020-05-17,No Results Posted,,,['SG-COVID'],,https://clinicaltrials.gov/show/NCT04410692,2020-05-16,0,0
756,NCT04411433,Recruiting,2020-07-30,2020-07-30,No Results Posted,,,['COVID-19-FAV'],,https://clinicaltrials.gov/show/NCT04411433,2020-07-30,0,0
757,NCT04411602,Recruiting,2020-12-31,2020-12-31,No Results Posted,,,['1589349'],,https://clinicaltrials.gov/show/NCT04411602,2020-12-31,0,0
758,NCT04411680,Not yet recruiting,2020-10-01,2021-01-01,No Results Posted,,,['PTX-001-002'],,https://clinicaltrials.gov/show/NCT04411680,2020-10-01,0,0
759,NCT04412239,Recruiting,2020-08-20,2020-09-20,No Results Posted,,,"['NO, F6-2017/NTP-ADMIN']",,https://clinicaltrials.gov/show/NCT04412239,2020-08-20,0,0
760,NCT04412343,Recruiting,2020-09-30,2020-09-30,No Results Posted,,,['H20-01515'],,https://clinicaltrials.gov/show/NCT04412343,2020-09-30,0,0
761,NCT04412395,Not yet recruiting,2020-08-31,2020-09-30,No Results Posted,,,['COVID-19_LF'],,https://clinicaltrials.gov/show/NCT04412395,2020-08-31,0,0
762,NCT04412486,Recruiting,2022-05-31,2022-05-31,No Results Posted,,,['2020-0137'],,https://clinicaltrials.gov/show/NCT04412486,2022-05-31,0,0
763,NCT04311697,Recruiting,2020-08-01,2020-09-01,No Results Posted,,,['COVID-AIV'],,https://clinicaltrials.gov/show/NCT04311697,2020-08-01,0,0
764,NCT04315948,Recruiting,2023-03-01,2023-03-01,No Results Posted,"['Taccone FS, Gorham J, Vincent JL. Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base. Lancet Respir Med. 2020 Jun;8(6):539-541. doi: 10.1016/S2213-2600(20)30172-7. Epub 2020 Apr 15.']",,['C20-15'],,https://clinicaltrials.gov/show/NCT04315948,2023-03-01,0,1
765,NCT04326114,Not yet recruiting,2020-12-15,2020-12-20,No Results Posted,,,['Covid_ISCIII 20/265-E_BS'],,https://clinicaltrials.gov/show/NCT04326114,2020-12-15,0,0
766,NCT04327401,"Active, not recruiting",2020-08-30,2020-08-30,No Results Posted,,,['CAAE: 30227020.5.1001.0008'],,https://clinicaltrials.gov/show/NCT04327401,2020-08-30,0,0
767,NCT04327505,Recruiting,2021-12-31,2022-12-31,No Results Posted,,,"['COVID-19-HBO', '2020-001349-37 ( EudraCT Number )', 'K-1199/2020 ( Registry Identifier: Karolinska Institutet )']",,https://clinicaltrials.gov/show/NCT04327505,2021-12-31,0,0
768,NCT04332081,Terminated,2020-05-29,2020-05-29,No Results Posted,,,['s20-00399'],,https://clinicaltrials.gov/show/NCT04332081,2020-05-29,0,0
769,NCT04333654,Suspended,2020-08-01,2020-08-01,No Results Posted,,,"['EFC16855', '2020-001269-35 ( EudraCT Number )', 'U1111-1249-6168 ( Other Identifier: UTN )']",,https://clinicaltrials.gov/show/NCT04333654,2020-08-01,0,0
770,NCT04336410,Recruiting,2021-07-01,2021-07-01,No Results Posted,,,['COVID19-001'],,https://clinicaltrials.gov/show/NCT04336410,2021-07-01,0,0
771,NCT04339816,Recruiting,2021-12-31,2022-06-30,No Results Posted,,,"['AZIQUINE-ICU-25032020', '2020-001456-18 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04339816,2021-12-31,0,0
772,NCT04341142,Recruiting,2020-09-09,2020-09-09,No Results Posted,,,['69HCL20_0329'],,https://clinicaltrials.gov/show/NCT04341142,2020-09-09,0,0
773,NCT04343092,Completed,2020-05-31,2020-06-01,Results Submitted,,,['PRO20040001'],,https://clinicaltrials.gov/show/NCT04343092,2020-05-31,0,0
774,NCT04343248,Recruiting,2020-08-31,2020-08-31,No Results Posted,,,['RM08-3006'],,https://clinicaltrials.gov/show/NCT04343248,2020-08-31,0,0
775,NCT04345276,Completed,2020-04-15,2020-04-15,No Results Posted,,,['ASC-CTP-HS-01'],,https://clinicaltrials.gov/show/NCT04345276,2020-04-15,0,0
776,NCT04345692,Recruiting,2021-12-31,2021-12-31,No Results Posted,,,['RA-2020-018'],,https://clinicaltrials.gov/show/NCT04345692,2021-12-31,0,0
777,NCT04347512,Withdrawn,2020-06-02,2020-06-02,No Results Posted,,,['7783'],,https://clinicaltrials.gov/show/NCT04347512,2020-06-02,0,0
778,NCT04348500,Recruiting,2020-12-31,2021-03-31,No Results Posted,,,['00000644'],,https://clinicaltrials.gov/show/NCT04348500,2020-12-31,0,0
779,NCT04355936,Recruiting,2020-10-01,2020-10-01,No Results Posted,"['Rothlin RP, Vetulli HM, Duarte M, Pelorosso FG. Telmisartan as tentative angiotensin receptor blocker therapeutic for COVID-19. Drug Dev Res. 2020 May 1. doi: 10.1002/ddr.21679. [Epub ahead of print]']",,['2020-001'],,https://clinicaltrials.gov/show/NCT04355936,2020-10-01,0,1
780,NCT04356482,Recruiting,2020-11-01,2020-12-01,No Results Posted,,"['Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020 May;46(5):846-848. doi: 10.1007/s00134-020-05991-x. Epub 2020 Mar 3. Erratum in: Intensive Care Med. 2020 Apr 6;:.', 'Rajam G, Sampson J, Carlone GM, Ades EW. An augmented passive immune therapy to treat fulminant bacterial infections. Recent Pat Antiinfect Drug Discov. 2010 Jun;5(2):157-67. Review.', 'Keller MA, Stiehm ER. Passive immunity in prevention and treatment of infectious diseases. Clin Microbiol Rev. 2000 Oct;13(4):602-14. Review.', 'Burnouf T, Seghatchian J. Ebola virus convalescent blood products: where we are now and where we may need to go. Transfus Apher Sci. 2014 Oct;51(2):120-5. Review.', 'Jahrling PB, Frame JD, Rhoderick JB, Monson MH. Endemic Lassa fever in Liberia. IV. Selection of optimally effective plasma for treatment by passive immunization. Trans R Soc Trop Med Hyg. 1985;79(3):380-4.', 'Shen C, Wang Z, Zhao F, Yang Y, Li J, Yuan J, Wang F, Li D, Yang M, Xing L, Wei J, Xiao H, Yang Y, Qu J, Qing L, Chen L, Xu Z, Peng L, Li Y, Zheng H, Chen F, Huang K, Jiang Y, Liu D, Zhang Z, Liu Y, Liu L. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma. JAMA. 2020 Mar 27. doi: 10.1001/jama.2020.4783. [Epub ahead of print]']",['TERAPLASCOV2'],,https://clinicaltrials.gov/show/NCT04356482,2020-11-01,0,1
781,NCT04358003,Recruiting,2020-08-01,2020-12-01,No Results Posted,,,['MH-007/B'],,https://clinicaltrials.gov/show/NCT04358003,2020-08-01,0,0
782,NCT04359511,Not yet recruiting,2020-12-01,2020-12-01,No Results Posted,,,"['CORTI-COVID-19-HUGO', 'DR200136 ( Registry Identifier: Sponsor ID )']",,https://clinicaltrials.gov/show/NCT04359511,2020-12-01,0,0
783,NCT04359680,Recruiting,2020-08-31,2020-08-31,No Results Posted,,,['RM08-3007'],,https://clinicaltrials.gov/show/NCT04359680,2020-08-31,0,0
784,NCT04359901,Recruiting,2022-04-01,2023-04-01,No Results Posted,,,['IRB 3305'],,https://clinicaltrials.gov/show/NCT04359901,2022-04-01,0,0
785,NCT04361838,Recruiting,2020-08-31,2020-08-31,No Results Posted,,,['Covid Prayer Study'],,https://clinicaltrials.gov/show/NCT04361838,2020-08-31,0,0
786,NCT04371926,Withdrawn,2021-06-01,2021-07-01,No Results Posted,,,['TCAI_PREVENT'],,https://clinicaltrials.gov/show/NCT04371926,2021-06-01,0,0
787,NCT04372589,Recruiting,2021-01-01,2021-01-01,No Results Posted,"['Levi M, Thachil J, Iba T, Levy JH. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020 Jun;7(6):e438-e440. doi: 10.1016/S2352-3026(20)30145-9. Epub 2020 May 11.']",,"['ATTACC', 'OZM-113 ( Other Identifier: Ozmosis Research Inc )']",,https://clinicaltrials.gov/show/NCT04372589,2021-01-01,0,1
788,NCT04374084,Recruiting,2021-12-01,2021-12-01,No Results Posted,,,['2020YFC0845000'],,https://clinicaltrials.gov/show/NCT04374084,2021-12-01,0,0
789,NCT04374786,Enrolling by invitation,2020-09-01,2020-10-01,No Results Posted,,"['Huberty J, Green J, Glissmann C, Larkey L, Puzia M, Lee C. Efficacy of the Mindfulness Meditation Mobile App ""Calm"" to Reduce Stress Among College Students: Randomized Controlled Trial. JMIR Mhealth Uhealth. 2019 Jun 25;7(6):e14273. doi: 10.2196/14273.', 'Huberty J, Vranceanu AM, Carney C, Breus M, Gordon M, Puzia ME. Characteristics and Usage Patterns Among 12,151 Paid Subscribers of the Calm Meditation App: Cross-Sectional Survey. JMIR Mhealth Uhealth. 2019 Nov 3;7(11):e15648. doi: 10.2196/15648.', ""Huberty J, Puzia M, Eckert R, Larkey L. Cancer Patients' and Survivors' Perceptions of the Calm App: Cross-Sectional Descriptive Study. JMIR Cancer. 2020 Jan 25;6(1):e16926. doi: 10.2196/16926."", 'Wen L, Sweeney TE, Welton L, Trockel M, Katznelson L. Encouraging Mindfulness in Medical House Staff via Smartphone App: A Pilot Study. Acad Psychiatry. 2017 Oct;41(5):646-650. doi: 10.1007/s40596-017-0768-3. Epub 2017 Aug 9.']",['2003524869 [Sub-study]'],,https://clinicaltrials.gov/show/NCT04374786,2020-09-01,0,1
790,NCT04382040,Recruiting,2020-07-31,2020-07-31,No Results Posted,,,['MGC-006'],,https://clinicaltrials.gov/show/NCT04382040,2020-07-31,0,0
791,NCT04382066,Recruiting,2020-11-01,2020-11-01,No Results Posted,,,"['APL-D-002-20', '2020-001993-31 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04382066,2020-11-01,0,0
792,NCT04382950,Not yet recruiting,2020-11-01,2020-12-01,No Results Posted,,,['COV-2019 Treatment This is'],,https://clinicaltrials.gov/show/NCT04382950,2020-11-01,0,0
793,NCT04384458,Not yet recruiting,2020-10-01,2020-10-01,No Results Posted,,,['HCQZn'],,https://clinicaltrials.gov/show/NCT04384458,2020-10-01,0,0
794,NCT04385901,Recruiting,2022-04-19,2022-04-19,No Results Posted,,"['Holland AE, Hill CJ, Rochford P, Fiore J, Berlowitz DJ, McDonald CF. Telerehabilitation for people with chronic obstructive pulmonary disease: feasibility of a simple, real time model of supervised exercise training. J Telemed Telecare. 2013 Jun;19(4):222-6. doi: 10.1177/1357633X13487100. Epub 2013 May 23.', 'Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, Evaluation and Treatment Coronavirus (COVID-19). 2020 May 18. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK554776/', 'Busija L, Pausenberger E, Haines TP, Haymes S, Buchbinder R, Osborne RH. Adult measures of general health and health-related quality of life: Medical Outcomes Study Short Form 36-Item (SF-36) and Short Form 12-Item (SF-12) Health Surveys, Nottingham Health Profile (NHP), Sickness Impact Profile (SIP), Medical Outcomes Study Short Form 6D (SF-6D), Health Utilities Index Mark 3 (HUI3), Quality of Well-Being Scale (QWB), and Assessment of Quality of Life (AQoL). Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S383-412. doi: 10.1002/acr.20541. Review.']",['COVID19Recovery'],,https://clinicaltrials.gov/show/NCT04385901,2022-04-19,0,1
795,NCT04385940,Not yet recruiting,2020-08-01,2020-12-01,No Results Posted,,,['00100606'],,https://clinicaltrials.gov/show/NCT04385940,2020-08-01,0,0
796,NCT04389580,Not yet recruiting,2020-08-01,2020-09-01,No Results Posted,,,['COV-19 Treatment This is'],,https://clinicaltrials.gov/show/NCT04389580,2020-08-01,0,0
797,NCT04392414,Recruiting,2020-08-01,2020-09-15,No Results Posted,,,['CovPlas-Covid19'],,https://clinicaltrials.gov/show/NCT04392414,2020-08-01,0,0
798,NCT04393246,Not yet recruiting,2021-02-15,2021-06-15,No Results Posted,,,['TACTIC-E'],,https://clinicaltrials.gov/show/NCT04393246,2021-02-15,0,0
799,NCT04394416,Recruiting,2022-06-01,2023-06-01,No Results Posted,,,['2038GCCC'],,https://clinicaltrials.gov/show/NCT04394416,2022-06-01,0,0
800,NCT04400279,Not yet recruiting,2020-08-01,2020-10-01,No Results Posted,,,['H20-01497'],,https://clinicaltrials.gov/show/NCT04400279,2020-08-01,0,0
801,NCT04408066,Recruiting,2022-04-30,2022-04-30,No Results Posted,,,['S-CLIN-PROT-00028'],,https://clinicaltrials.gov/show/NCT04408066,2022-04-30,0,0
802,NCT04408183,Recruiting,2020-09-01,2020-11-01,No Results Posted,,,['T2R-002'],,https://clinicaltrials.gov/show/NCT04408183,2020-09-01,0,0
803,NCT04409496,Recruiting,2021-03-31,2021-06-30,No Results Posted,,,['UW 20-356'],,https://clinicaltrials.gov/show/NCT04409496,2021-03-31,0,0
804,NCT04409834,Not yet recruiting,2021-05-01,2021-05-01,No Results Posted,,,['CCCTN/TIMI COVID-PACT'],,https://clinicaltrials.gov/show/NCT04409834,2021-05-01,0,0
805,NCT04411446,Not yet recruiting,2020-12-15,2020-12-28,No Results Posted,,"['Mart√≠n Gim√©nez VM, Inserra F, Tajer CD, Mariani J, Ferder L, Reiter RJ, Manucha W. Lungs as target of COVID-19 infection: Protective common molecular mechanisms of vitamin D and melatonin as a new potential synergistic treatment. Life Sci. 2020 May 15;254:117808. doi: 10.1016/j.lfs.2020.117808. [Epub ahead of print] Review.']",['001'],,https://clinicaltrials.gov/show/NCT04411446,2020-12-15,0,1
806,NCT04411667,Recruiting,2020-11-01,2020-11-30,No Results Posted,,,"['COVID-IVIG', '2004902 ( Other Identifier: Sharp HealthCare Institutional Review Board (SHC IRB) )']",,https://clinicaltrials.gov/show/NCT04411667,2020-11-01,0,0
807,NCT04412018,Recruiting,2020-12-01,2020-12-01,No Results Posted,,,['Pro00043601'],,https://clinicaltrials.gov/show/NCT04412018,2020-12-01,0,0
808,NCT04412538,Recruiting,2020-09-01,2021-09-01,No Results Posted,,,['20200401'],,https://clinicaltrials.gov/show/NCT04412538,2020-09-01,0,0
809,NCT04412772,Recruiting,2021-12-31,2021-12-31,No Results Posted,,,['RA-2020-019'],,https://clinicaltrials.gov/show/NCT04412772,2021-12-31,0,0
810,NCT04412785,Recruiting,2020-09-01,2020-12-01,No Results Posted,,,['842998'],,https://clinicaltrials.gov/show/NCT04412785,2020-09-01,0,0
811,NCT04413006,Recruiting,2020-12-31,2021-03-31,No Results Posted,,,['sccpvgtbsas2020'],,https://clinicaltrials.gov/show/NCT04413006,2020-12-31,0,0
812,NCT04413838,Not yet recruiting,2021-06-15,2021-09-15,No Results Posted,,,['69HCL20_0478'],,https://clinicaltrials.gov/show/NCT04413838,2021-06-15,0,0
813,NCT04413864,Recruiting,2021-02-28,2021-02-28,No Results Posted,,,"['APHP200413', '2020-A00799-30 ( Other Identifier: ANSM )']",,https://clinicaltrials.gov/show/NCT04413864,2021-02-28,0,0
814,NCT04413968,Not yet recruiting,2020-09-02,2021-06-02,No Results Posted,,,"['APHP200587', '2020-A01540-39 ( Other Identifier: Registry ID : IDRCB )']",,https://clinicaltrials.gov/show/NCT04413968,2020-09-02,0,0
815,NCT04414098,Not yet recruiting,2020-08-15,2020-09-15,No Results Posted,,,['CZabala'],,https://clinicaltrials.gov/show/NCT04414098,2020-08-15,0,0
816,NCT04414124,Recruiting,2020-10-01,2020-12-01,No Results Posted,,,['K031-120'],,https://clinicaltrials.gov/show/NCT04414124,2020-10-01,0,0
817,NCT04414371,Recruiting,2020-12-31,2020-12-31,No Results Posted,,,['Pro2020000953'],,https://clinicaltrials.gov/show/NCT04414371,2020-12-31,0,0
818,NCT04414631,Not yet recruiting,2021-06-01,2021-07-01,No Results Posted,,,['2020-01252; me20Osthoff3'],,https://clinicaltrials.gov/show/NCT04414631,2021-06-01,0,0
819,NCT04415073,Recruiting,2020-11-15,2020-11-15,No Results Posted,,,['SNDX-6352-0505'],,https://clinicaltrials.gov/show/NCT04415073,2020-11-15,0,0
820,NCT04415151,Not yet recruiting,2021-03-31,2021-03-31,No Results Posted,,,['2000027848'],,https://clinicaltrials.gov/show/NCT04415151,2021-03-31,0,0
821,NCT04416048,Not yet recruiting,2021-04-30,2021-05-30,No Results Posted,,,"['COVID-PREVENT', '2020-002282-33 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04416048,2021-04-30,0,0
822,NCT04416113,Not yet recruiting,2020-12-01,2021-02-01,No Results Posted,,,['Cu-NILES/16/20'],,https://clinicaltrials.gov/show/NCT04416113,2020-12-01,0,0
823,NCT04416139,Recruiting,2021-04-30,2021-05-01,No Results Posted,,,['SCI-3354-20-21-1'],,https://clinicaltrials.gov/show/NCT04416139,2021-04-30,0,0
824,NCT04416308,Recruiting,2020-06-15,2020-11-10,No Results Posted,,,['35RC20_9716'],,https://clinicaltrials.gov/show/NCT04416308,2020-06-15,0,0
825,NCT04416360,Recruiting,2020-07-01,2021-01-01,No Results Posted,,,['RC31/20/0151'],,https://clinicaltrials.gov/show/NCT04416360,2020-07-01,0,0
826,NCT04416919,Recruiting,2025-05-01,2025-05-01,No Results Posted,,"['van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, Tamin A, Harcourt JL, Thornburg NJ, Gerber SI, Lloyd-Smith JO, de Wit E, Munster VJ. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med. 2020 Apr 16;382(16):1564-1567. doi: 10.1056/NEJMc2004973. Epub 2020 Mar 17.', 'Qian Y, Willeke K, Grinshpun SA, Donnelly J, Coffey CC. Performance of N95 respirators: filtration efficiency for airborne microbial and inert particles. Am Ind Hyg Assoc J. 1998 Feb;59(2):128-32.']",['11887'],,https://clinicaltrials.gov/show/NCT04416919,2025-05-01,0,1
827,NCT04417270,Not yet recruiting,2020-09-30,2020-10-31,No Results Posted,,,['20-0455'],,https://clinicaltrials.gov/show/NCT04417270,2020-09-30,0,0
828,NCT04417335,"Active, not recruiting",2021-05-01,2021-05-01,No Results Posted,,,"['NL73430.091.20', '2020-001591-15 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04417335,2021-05-01,0,0
829,NCT04418947,Not yet recruiting,2020-07-01,2020-07-01,No Results Posted,,,['843220'],,https://clinicaltrials.gov/show/NCT04418947,2020-07-01,0,0
830,NCT04419025,Not yet recruiting,2020-10-31,2021-03-31,No Results Posted,,,['CHA-IRB-1139/05/20'],,https://clinicaltrials.gov/show/NCT04419025,2020-10-31,0,0
831,NCT04315298,Recruiting,2021-05-20,2021-07-20,No Results Posted,,,['6R88-COV-2040'],,https://clinicaltrials.gov/show/NCT04315298,2021-05-20,0,0
832,NCT04316377,"Active, not recruiting",2020-05-25,2025-03-03,No Results Posted,"['Lyngbakken MN, Berdal JE, Eskesen A, Kvale D, Olsen IC, Rangberg A, Jonassen CM, Omland T, R√∏sj√∏ H, Dalgard O. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jun 5;21(1):485. doi: 10.1186/s13063-020-04420-0.']",,['REC 121446'],,https://clinicaltrials.gov/show/NCT04316377,2020-05-25,0,1
833,NCT04321928,Recruiting,2021-04-21,2021-08-21,No Results Posted,,,['IV/2428- 2 /2020/EKU'],,https://clinicaltrials.gov/show/NCT04321928,2021-04-21,0,0
834,NCT04335279,"Active, not recruiting",2020-06-03,2020-07-24,No Results Posted,,,['SPIN-CHAT-001'],,https://clinicaltrials.gov/show/NCT04335279,2020-06-03,0,0
835,NCT04335305,Recruiting,2020-08-30,2020-08-30,No Results Posted,,,['MedOPP376'],,https://clinicaltrials.gov/show/NCT04335305,2020-08-30,0,0
836,NCT04335851,Completed,2020-05-15,2020-06-03,No Results Posted,,,['Physical Activity Project'],,https://clinicaltrials.gov/show/NCT04335851,2020-05-15,0,0
837,NCT04339426,Recruiting,2020-10-01,2021-04-01,No Results Posted,,,['HRI-COVID-19-Anti-Malarial-001'],,https://clinicaltrials.gov/show/NCT04339426,2020-10-01,0,0
838,NCT04345653,"Active, not recruiting",2020-06-05,2021-04-08,No Results Posted,,,['Pro2020-0356'],,https://clinicaltrials.gov/show/NCT04345653,2020-06-05,0,0
839,NCT04346420,Completed,2020-05-01,2020-05-01,No Results Posted,,,['DTM-001'],,https://clinicaltrials.gov/show/NCT04346420,2020-05-01,0,0
840,NCT04346589,Recruiting,2020-08-01,2020-08-01,No Results Posted,,,['DFPP COVID 19'],,https://clinicaltrials.gov/show/NCT04346589,2020-08-01,0,0
841,NCT04347382,Recruiting,2020-08-25,2020-08-30,No Results Posted,,,"['SZMC/IRB/Internal/0026/2020', 'IRB/2020/658/SIMS ( Other Identifier: Services Institute of Medical Sciences, Services Hospital, Lahore, Pakistan )']",,https://clinicaltrials.gov/show/NCT04347382,2020-08-25,0,0
842,NCT04348656,Recruiting,2020-10-31,2020-12-31,No Results Posted,,,['CONCOR-1'],,https://clinicaltrials.gov/show/NCT04348656,2020-10-31,0,0
843,NCT04351581,Recruiting,2020-12-01,2020-12-01,No Results Posted,,,"['H-20026484', '2020-001544-26 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04351581,2020-12-01,0,0
844,NCT04357444,Not yet recruiting,2020-07-01,2020-08-01,No Results Posted,,,"['APHP200406', '2020-001571-32 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04357444,2020-07-01,0,0
845,NCT04366323,Recruiting,2021-10-01,2021-10-01,No Results Posted,,,['AdiQure/COVID-19'],,https://clinicaltrials.gov/show/NCT04366323,2021-10-01,0,0
846,NCT04367545,Recruiting,2020-07-01,2020-07-01,No Results Posted,,,['2020/0094/OB'],,https://clinicaltrials.gov/show/NCT04367545,2020-07-01,0,0
847,NCT04367662,Completed,2020-05-14,2020-05-14,No Results Posted,,,['2020/0104/OB'],,https://clinicaltrials.gov/show/NCT04367662,2020-05-14,0,0
848,NCT04368728,Recruiting,2021-06-28,2023-01-23,No Results Posted,,,"['C4591001', '2020-002641-42 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04368728,2021-06-28,0,0
849,NCT04370223,Not yet recruiting,2020-10-25,2020-12-25,No Results Posted,,,['COVID-19 Networking group'],,https://clinicaltrials.gov/show/NCT04370223,2020-10-25,0,0
850,NCT04372017,"Active, not recruiting",2020-06-04,2021-06-04,No Results Posted,,,['PEPCOH'],,https://clinicaltrials.gov/show/NCT04372017,2020-06-04,0,0
851,NCT04374565,Recruiting,2021-04-05,2021-04-05,No Results Posted,,,['200114'],,https://clinicaltrials.gov/show/NCT04374565,2021-04-05,0,0
852,NCT04381923,Not yet recruiting,2020-08-01,2020-10-01,No Results Posted,,,['843124'],,https://clinicaltrials.gov/show/NCT04381923,2020-08-01,0,0
853,NCT04381962,Recruiting,2020-09-13,2020-10-13,No Results Posted,,,"['ATOMIC2', '2020-001740-26 ( EudraCT Number )', '282892 ( Other Identifier: IRAS )', '20/HRA/2105 ( Other Identifier: London-Brent Research Ethics Committee )']",,https://clinicaltrials.gov/show/NCT04381962,2020-09-13,0,0
854,NCT04393636,Recruiting,2022-12-31,2022-12-31,No Results Posted,,"['Plomp J, Redekop WK, Dekker FW, van Geldorp TR, Haalebos MM, Jambroes G, Kingma JH, Zijlstra F, Tijssen JG. Death on the waiting list for cardiac surgery in The Netherlands in 1994 and 1995. Heart. 1999 Jun;81(6):593-7.', 'Morgan CD, Sykora K, Naylor CD. Analysis of deaths while waiting for cardiac surgery among 29,293 consecutive patients in Ontario, Canada. The Steering Committee of the Cardiac Care Network of Ontario. Heart. 1998 Apr;79(4):345-9.', 'Malaisrie SC, McDonald E, Kruse J, Li Z, McGee EC Jr, Abicht TO, Russell H, McCarthy PM, Andrei AC. Mortality while waiting for aortic valve replacement. Ann Thorac Surg. 2014 Nov;98(5):1564-70; discussion 1570-1. doi: 10.1016/j.athoracsur.2014.06.040. Epub 2014 Sep 18.', 'da Fonseca VBP, De Lorenzo A, Tura BR, Pittella FJM, da Rocha ASC. Mortality and morbidity of patients on the waiting list for coronary artery bypass graft surgery. Interact Cardiovasc Thorac Surg. 2018 Jan 1;26(1):34-40. doi: 10.1093/icvts/ivx276.', 'Turner AJ, Hiscox JA, Hooper NM. ACE2: from vasopeptidase to SARS virus receptor. Trends Pharmacol Sci. 2004 Jun;25(6):291-4. Review.', 'Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, Xing F, Liu J, Yip CC, Poon RW, Tsoi HW, Lo SK, Chan KH, Poon VK, Chan WM, Ip JD, Cai JP, Cheng VC, Chen H, Hui CK, Yuen KY. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020 Feb 15;395(10223):514-523. doi: 10.1016/S0140-6736(20)30154-9. Epub 2020 Jan 24.', 'Al-Sarraf N, Thalib L, Hughes A, Tolan M, Young V, McGovern E. Effect of smoking on short-term outcome of patients undergoing coronary artery bypass surgery. Ann Thorac Surg. 2008 Aug;86(2):517-23. doi: 10.1016/j.athoracsur.2008.03.070.', 'Grabas MP, Hansen SM, Torp-Pedersen C, B√∏ggild H, Ullits LR, Deding U, Nielsen BJ, Jensen PF, Overgaard C. Alcohol consumption and mortality in patients undergoing coronary artery bypass graft (CABG)-a register-based cohort study. BMC Cardiovasc Disord. 2016 Nov 11;16(1):219.', 'Guo P. Preoperative education interventions to reduce anxiety and improve recovery among cardiac surgery patients: a review of randomised controlled trials. J Clin Nurs. 2015 Jan;24(1-2):34-46. doi: 10.1111/jocn.12618. Epub 2014 Jun 3. Review.', 'Hulzebos EH, Helders PJ, Favi√© NJ, De Bie RA, Brutel de la Riviere A, Van Meeteren NL. Preoperative intensive inspiratory muscle training to prevent postoperative pulmonary complications in high-risk patients undergoing CABG surgery: a randomized clinical trial. JAMA. 2006 Oct 18;296(15):1851-7.', 'Mariscalco G, Wozniak MJ, Dawson AG, Serraino GF, Porter R, Nath M, Klersy C, Kumar T, Murphy GJ. Body Mass Index and Mortality Among Adults Undergoing Cardiac Surgery: A Nationwide Study With a Systematic Review and Meta-Analysis. Circulation. 2017 Feb 28;135(9):850-863. doi: 10.1161/CIRCULATIONAHA.116.022840. Epub 2016 Dec 28. Review.', 'Navaratnarajah M, Rea R, Evans R, Gibson F, Antoniades C, Keiralla A, Demosthenous M, Kassimis G, Krasopoulos G. Effect of glycaemic control on complications following cardiac surgery: literature review. J Cardiothorac Surg. 2018 Jan 17;13(1):10. doi: 10.1186/s13019-018-0700-2. Review.', 'Marmelo F, Rocha V, Moreira-Gon√ßalves D. The impact of prehabilitation on post-surgical complications in patients undergoing non-urgent cardiovascular surgical intervention: Systematic review and meta-analysis. Eur J Prev Cardiol. 2018 Mar;25(4):404-417. doi: 10.1177/2047487317752373. Epub 2018 Jan 17. Erratum in: Eur J Prev Cardiol. 2018 Jun;25(9):NP2.']",['NL72754.068.20'],,https://clinicaltrials.gov/show/NCT04393636,2022-12-31,0,1
855,NCT04395807,Recruiting,2020-12-31,2021-05-01,No Results Posted,,,['COVID HELMET'],,https://clinicaltrials.gov/show/NCT04395807,2020-12-31,0,0
856,NCT04397510,Enrolling by invitation,2020-12-31,2020-12-31,No Results Posted,,,['FHHep518'],,https://clinicaltrials.gov/show/NCT04397510,2020-12-31,0,0
857,NCT04401293,Recruiting,2020-10-22,2021-04-26,No Results Posted,,,['20-0340'],,https://clinicaltrials.gov/show/NCT04401293,2020-10-22,0,0
858,NCT04402060,Recruiting,2020-11-01,2020-11-01,No Results Posted,,,['APL9-COV-201'],,https://clinicaltrials.gov/show/NCT04402060,2020-11-01,0,0
859,NCT04403100,Recruiting,2020-09-03,2020-11-28,No Results Posted,,,['COVID19_AMB_Brasil'],,https://clinicaltrials.gov/show/NCT04403100,2020-09-03,0,0
860,NCT04412356,Recruiting,2020-12-01,2021-02-01,No Results Posted,,,['HBergquist'],,https://clinicaltrials.gov/show/NCT04412356,2020-12-01,0,0
861,NCT04413747,Not yet recruiting,2021-06-01,2021-09-30,No Results Posted,,,"['2020_COVID19_YOGA', '2020-001731-28 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04413747,2021-06-01,0,0
862,NCT04415086,Recruiting,2022-04-20,2022-05-22,No Results Posted,,,['COOP-COVID-19-MCTIC'],,https://clinicaltrials.gov/show/NCT04415086,2022-04-20,0,0
863,NCT04415879,Recruiting,2020-07-01,2020-08-01,No Results Posted,,,['20-538'],,https://clinicaltrials.gov/show/NCT04415879,2020-07-01,0,0
864,NCT04416399,Not yet recruiting,2020-11-15,2020-12-30,No Results Posted,,,['STOIC study'],,https://clinicaltrials.gov/show/NCT04416399,2020-11-15,0,0
865,NCT04418128,Not yet recruiting,2021-03-30,2021-04-30,No Results Posted,,"['Hoffmann M, Kleine-Weber H, Schroeder S, Kr√ºger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, M√ºller MA, Drosten C, P√∂hlmann S. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.', 'Hoffmann M, Schroeder S, Kleine-Weber H, M√ºller MA, Drosten C, P√∂hlmann S. Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19. Antimicrob Agents Chemother. 2020 May 21;64(6). pii: e00754-20. doi: 10.1128/AAC.00754-20. Print 2020 May 21.']",['2020-04-012'],,https://clinicaltrials.gov/show/NCT04418128,2021-03-30,0,1
866,NCT04418206,Not yet recruiting,2020-12-01,2021-06-01,No Results Posted,,,['20-PP-10'],,https://clinicaltrials.gov/show/NCT04418206,2020-12-01,0,0
867,NCT04418505,Not yet recruiting,2021-01-01,2021-01-01,No Results Posted,,,['VL-2020-02'],,https://clinicaltrials.gov/show/NCT04418505,2021-01-01,0,0
868,NCT04418518,Not yet recruiting,2021-06-01,2021-12-01,No Results Posted,,"['Wu JT, Leung K, Leung GM. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet. 2020 Feb 29;395(10225):689-697. doi: 10.1016/S0140-6736(20)30260-9. Epub 2020 Jan 31. Erratum in: Lancet. 2020 Feb 4;:.']",['20-04021981'],,https://clinicaltrials.gov/show/NCT04418518,2021-06-01,0,1
869,NCT04418531,Not yet recruiting,2020-09-01,2020-09-01,No Results Posted,,,['DFPP COVID 19 Early'],,https://clinicaltrials.gov/show/NCT04418531,2020-09-01,0,0
870,NCT04419623,Not yet recruiting,2021-07-01,2021-07-01,No Results Posted,,,['TL-895-202'],,https://clinicaltrials.gov/show/NCT04419623,2021-07-01,0,0
871,NCT04420182,Not yet recruiting,2021-06-30,2021-12-31,No Results Posted,,,['CTO 3210'],,https://clinicaltrials.gov/show/NCT04420182,2021-06-30,0,0
872,NCT04420260,Not yet recruiting,2020-09-01,2020-09-01,No Results Posted,,"['Schindewolf C, Menachery VD. Middle East Respiratory Syndrome Vaccine Candidates: Cautious Optimism. Viruses. 2019 Jan 17;11(1). pii: E74. doi: 10.3390/v11010074. Review.']",['UNIGEM PT-IC-02'],,https://clinicaltrials.gov/show/NCT04420260,2020-09-01,0,1
873,NCT04420273,Not yet recruiting,2021-03-30,2021-12-30,No Results Posted,,,['STU00212165'],,https://clinicaltrials.gov/show/NCT04420273,2021-03-30,0,0
874,NCT04420364,Not yet recruiting,2021-09-30,2021-12-31,No Results Posted,,,['2020P001516'],,https://clinicaltrials.gov/show/NCT04420364,2021-09-30,0,0
875,NCT04420390,Recruiting,2020-07-31,2020-09-08,No Results Posted,,,['LOWRAD-Cov19'],,https://clinicaltrials.gov/show/NCT04420390,2020-07-31,0,0
876,NCT04420676,Not yet recruiting,2021-12-01,2022-12-01,No Results Posted,,,['SynCov'],,https://clinicaltrials.gov/show/NCT04420676,2021-12-01,0,0
877,NCT04420806,"Active, not recruiting",2020-06-30,2020-10-01,No Results Posted,,,['ER_ACTLIFE_FU'],,https://clinicaltrials.gov/show/NCT04420806,2020-06-30,0,0
878,NCT04421391,Recruiting,2020-11-01,2020-11-08,No Results Posted,,,['QuadraMune002'],,https://clinicaltrials.gov/show/NCT04421391,2020-11-01,0,0
879,NCT04421534,Not yet recruiting,2020-09-01,2020-11-01,No Results Posted,,,['CUKA-001'],,https://clinicaltrials.gov/show/NCT04421534,2020-09-01,0,0
880,NCT04421625,Not yet recruiting,2022-06-15,2022-06-15,No Results Posted,,,['ICO-2020-16'],,https://clinicaltrials.gov/show/NCT04421625,2022-06-15,0,0
881,NCT04421664,Recruiting,2020-07-01,2020-08-26,No Results Posted,,,['2020-6549'],,https://clinicaltrials.gov/show/NCT04421664,2020-07-01,0,0
882,NCT04423042,Not yet recruiting,2021-06-01,2021-06-01,No Results Posted,,,['REB20-0713'],,https://clinicaltrials.gov/show/NCT04423042,2021-06-01,0,0
883,NCT04424134,Recruiting,2020-07-18,2020-08-23,No Results Posted,,,['MSU160520'],,https://clinicaltrials.gov/show/NCT04424134,2020-07-18,0,0
884,NCT04425616,Recruiting,2021-11-30,2022-11-30,No Results Posted,,,['RHM CRI 0403'],,https://clinicaltrials.gov/show/NCT04425616,2021-11-30,0,0
885,NCT04303507,"Active, not recruiting",2021-04-01,2021-04-01,No Results Posted,,,['VIR20001'],,https://clinicaltrials.gov/show/NCT04303507,2021-04-01,0,0
886,NCT04315987,Not yet recruiting,2020-08-01,2020-08-01,No Results Posted,,,['HOPE'],,https://clinicaltrials.gov/show/NCT04315987,2020-08-01,0,0
887,NCT04322682,Recruiting,2020-09-01,2020-09-01,No Results Posted,,,['MHIPS-2020-001'],,https://clinicaltrials.gov/show/NCT04322682,2020-09-01,0,0
888,NCT04325906,Recruiting,2020-08-31,2020-10-31,No Results Posted,,,['COVID-19-HFNC+PP'],,https://clinicaltrials.gov/show/NCT04325906,2020-08-31,0,0
889,NCT04331795,Completed,2020-06-05,2020-06-05,No Results Posted,,,['IRB20-0515'],,https://clinicaltrials.gov/show/NCT04331795,2020-06-05,0,0
890,NCT04334460,Recruiting,2020-08-01,2020-09-01,No Results Posted,,,['B-2660-204'],,https://clinicaltrials.gov/show/NCT04334460,2020-08-01,0,0
891,NCT04335786,Recruiting,2020-12-01,2021-12-01,No Results Posted,"['Gommans DHF, Nas J, Pinto-Sietsma SJ, Koop Y, Konst RE, Mensink F, Aarts GWA, Konijnenberg LSF, Cortenbach K, Verhaert DVM, Thannhauser J, Mol JQ, Rooijakkers MJP, Vos JL, van Rumund A, Vart P, Hassing RJ, Cornel JH, de Jager CPC, van den Heuvel MM, van der Hoeven HG, Verbon A, Pinto YM, van Royen N, van Kimmenade RRJ; Event committee, de Leeuw PW, van Agtmael MA, Bresser P; Data Safety Monitoring Board, van Gilst WH, Vonk-Noordergraaf A, Tijssen JGP; Steering committee, van Royen N, de Jager CPC, van den Heuvel MM, van der Hoeven HG, Verbon A, Pinto YM, van Kimmenade RRJ. Rationale and design of the PRAETORIAN-COVID trial: A double-blind, placebo-controlled randomized clinical trial with valsartan for PRevention of Acute rEspiraTORy dIstress syndrome in hospitAlized patieNts with SARS-COV-2 Infection Disease. Am Heart J. 2020 May 21;226:60-68. doi: 10.1016/j.ahj.2020.05.010. [Epub ahead of print]']",,"['NL73547.091.20', '2020-001320-34 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04335786,2020-12-01,0,1
892,NCT04337996,Not yet recruiting,2020-12-01,2020-12-01,No Results Posted,,,['RIPH_2020_6'],,https://clinicaltrials.gov/show/NCT04337996,2020-12-01,0,0
893,NCT04338074,Recruiting,2020-12-15,2020-12-31,No Results Posted,,,['TXACOVID1'],,https://clinicaltrials.gov/show/NCT04338074,2020-12-15,0,0
894,NCT04341116,Recruiting,2020-09-01,2020-09-01,No Results Posted,,,['TJ003234COV201'],,https://clinicaltrials.gov/show/NCT04341116,2020-09-01,0,0
895,NCT04341922,"Active, not recruiting",2020-09-10,2021-09-10,No Results Posted,,,['2020-01719'],,https://clinicaltrials.gov/show/NCT04341922,2020-09-10,0,0
896,NCT04343651,Recruiting,2020-12-04,2021-04-04,No Results Posted,,,['CD10_COVID-19'],,https://clinicaltrials.gov/show/NCT04343651,2020-12-04,0,0
897,NCT04344288,Recruiting,2020-11-01,2020-11-01,No Results Posted,,,"['69HCL20_0321', '2020-001553-48 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04344288,2020-11-01,0,0
898,NCT04345861,Terminated,2020-06-08,2020-06-08,No Results Posted,,,['RECHMPL20_168'],,https://clinicaltrials.gov/show/NCT04345861,2020-06-08,0,0
899,NCT04346628,Not yet recruiting,2021-07-01,2021-07-01,No Results Posted,,,['56032'],,https://clinicaltrials.gov/show/NCT04346628,2021-07-01,0,0
900,NCT04347174,Recruiting,2020-06-30,2020-07-30,No Results Posted,,,['CRSC20004'],,https://clinicaltrials.gov/show/NCT04347174,2020-06-30,0,0
901,NCT04347239,Recruiting,2020-12-31,2021-04-01,No Results Posted,,,['CD12_COVID-19'],,https://clinicaltrials.gov/show/NCT04347239,2020-12-31,0,0
902,NCT04348409,Recruiting,2020-07-31,2020-07-31,No Results Posted,,,['NITFQM0320OR'],,https://clinicaltrials.gov/show/NCT04348409,2020-07-31,0,0
903,NCT04351152,Recruiting,2020-09-01,2020-09-01,No Results Posted,,,['HGEN003-06'],,https://clinicaltrials.gov/show/NCT04351152,2020-09-01,0,0
904,NCT04353596,Recruiting,2021-05-15,2022-05-15,No Results Posted,,,['EudraCT 2020-001206-35'],,https://clinicaltrials.gov/show/NCT04353596,2021-05-15,0,0
905,NCT04355351,Recruiting,2020-10-22,2020-10-22,No Results Posted,,,['20-PP-05'],,https://clinicaltrials.gov/show/NCT04355351,2020-10-22,0,0
906,NCT04356495,Recruiting,2020-12-31,2021-01-28,No Results Posted,,,['CHUBX 2020/12'],,https://clinicaltrials.gov/show/NCT04356495,2020-12-31,0,0
907,NCT04361474,Recruiting,2020-05-18,2021-05-25,No Results Posted,,,['MDL_2020_10'],,https://clinicaltrials.gov/show/NCT04361474,2020-05-18,0,0
908,NCT04362813,Recruiting,2020-07-31,2020-11-06,No Results Posted,,,"['CACZ885D2310', '2020-001370-30 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04362813,2020-07-31,0,0
909,NCT04363606,Recruiting,2021-04-01,2021-12-01,No Results Posted,,,"['20CH085', '2020-A00982-37 ( Other Identifier: ANSM )']",,https://clinicaltrials.gov/show/NCT04363606,2021-04-01,0,0
910,NCT04366232,Not yet recruiting,2020-08-31,2020-08-31,No Results Posted,,"['Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ; HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.', 'Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 Feb 24. doi: 10.1001/jama.2020.2648. [Epub ahead of print]', 'Zalinger ZB, Elliott R, Weiss SR. Role of the inflammasome-related cytokines Il-1 and Il-18 during infection with murine coronavirus. J Neurovirol. 2017 Dec;23(6):845-854. doi: 10.1007/s13365-017-0574-4. Epub 2017 Sep 11.']","['2020-CHITS-003', '2020-001963-10 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04366232,2020-08-31,0,1
911,NCT04366245,Recruiting,2021-12-01,2021-12-01,No Results Posted,,,['PC/COVID-19'],,https://clinicaltrials.gov/show/NCT04366245,2021-12-01,0,0
912,NCT04369599,Enrolling by invitation,2021-03-01,2021-03-01,No Results Posted,,,['STUDY00000402'],,https://clinicaltrials.gov/show/NCT04369599,2021-03-01,0,0
913,NCT04375098,Recruiting,2020-12-01,2021-12-01,No Results Posted,,,['200415015'],,https://clinicaltrials.gov/show/NCT04375098,2020-12-01,0,0
914,NCT04375735,Not yet recruiting,2021-01-01,2021-07-01,No Results Posted,,,['9890'],,https://clinicaltrials.gov/show/NCT04375735,2021-01-01,0,0
915,NCT04377711,Recruiting,2020-09-01,2020-12-01,No Results Posted,,,['ALV-020-001'],,https://clinicaltrials.gov/show/NCT04377711,2020-09-01,0,0
916,NCT04379531,Completed,2020-05-22,2020-05-22,No Results Posted,,,['2020-1'],,https://clinicaltrials.gov/show/NCT04379531,2020-05-22,0,0
917,NCT04380961,Recruiting,2020-06-25,2020-09-16,No Results Posted,,,"['CR108820', 'CNTO136COV2001 ( Other Identifier: Janssen Pharmaceutica N.V., Belgium )']",,https://clinicaltrials.gov/show/NCT04380961,2020-06-25,0,0
918,NCT04381013,Not yet recruiting,2020-06-01,2020-06-01,No Results Posted,,,['55989'],,https://clinicaltrials.gov/show/NCT04381013,2020-06-01,0,0
919,NCT04382768,Recruiting,2021-01-01,2021-01-01,No Results Posted,,"['Mu√±oz AJ, Alasino RV, Garro AG, Heredia V, Garc√≠a NH, Cremonezzi DC, Beltramo DM. High Concentrations of Sodium Chloride Improve Microbicidal Activity of Ibuprofen against Common Cystic Fibrosis Pathogens. Pharmaceuticals (Basel). 2018 May 17;11(2). pii: E47. doi: 10.3390/ph11020047.', 'He L, Ding Y, Zhang Q, Che X, He Y, Shen H, Wang H, Li Z, Zhao L, Geng J, Deng Y, Yang L, Li J, Cai J, Qiu L, Wen K, Xu X, Jiang S. Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS. J Pathol. 2006 Nov;210(3):288-97.', 'Veljkovic V, Vergara-Alert J, Segal√©s J, Paessler S. Use of the informational spectrum methodology for rapid biological analysis of the novel coronavirus 2019-nCoV: prediction of potential receptor, natural reservoir, tropism and therapeutic/vaccine target. Version 3. F1000Res. 2020 Jan 27 [revised 2020 Jan 1];9:52. doi: 10.12688/f1000research.22149.3. eCollection 2020.']",['DNL000004'],,https://clinicaltrials.gov/show/NCT04382768,2021-01-01,0,1
920,NCT04386694,Recruiting,2020-07-01,2020-07-01,No Results Posted,,,['3.985.226'],,https://clinicaltrials.gov/show/NCT04386694,2020-07-01,0,0
921,NCT04386850,Recruiting,2020-11-15,2021-03-15,No Results Posted,,,"['IRCT2020-0401046909N2', 'IRCT20200401046909N1 ( Registry Identifier: IRCT )', 'IRCT2020-0401046909N2 ( Registry Identifier: IRCT )']",,https://clinicaltrials.gov/show/NCT04386850,2020-11-15,0,0
922,NCT04389450,Recruiting,2020-09-01,2021-09-01,No Results Posted,,,['PLX-COV-01'],,https://clinicaltrials.gov/show/NCT04389450,2020-09-01,0,0
923,NCT04390516,Completed,2020-05-04,2020-05-30,No Results Posted,,,['051420'],,https://clinicaltrials.gov/show/NCT04390516,2020-05-04,0,0
924,NCT04391127,Recruiting,2020-08-30,2020-09-30,No Results Posted,,,['2020-A-09'],,https://clinicaltrials.gov/show/NCT04391127,2020-08-30,0,0
925,NCT04395170,Not yet recruiting,2020-12-01,2021-06-01,No Results Posted,,"['Mair-Jenkins J, Saavedra-Campos M, Baillie JK, Cleary P, Khaw FM, Lim WS, Makki S, Rooney KD, Nguyen-Van-Tam JS, Beck CR; Convalescent Plasma Study Group. The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis. J Infect Dis. 2015 Jan 1;211(1):80-90. doi: 10.1093/infdis/jiu396. Epub 2014 Jul 16. Review.', 'Cheng Y, Wong R, Soo YO, Wong WS, Lee CK, Ng MH, Chan P, Wong KC, Leung CB, Cheng G. Use of convalescent plasma therapy in SARS patients in Hong Kong. Eur J Clin Microbiol Infect Dis. 2005 Jan;24(1):44-6.', 'Soo YO, Cheng Y, Wong R, Hui DS, Lee CK, Tsang KK, Ng MH, Chan P, Cheng G, Sung JJ. Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients. Clin Microbiol Infect. 2004 Jul;10(7):676-8.', 'Duan K, Liu B, Li C, Zhang H, Yu T, Qu J, Zhou M, Chen L, Meng S, Hu Y, Peng C, Yuan M, Huang J, Wang Z, Yu J, Gao X, Wang D, Yu X, Li L, Zhang J, Wu X, Li B, Xu Y, Chen W, Peng Y, Hu Y, Lin L, Liu X, Huang S, Zhou Z, Zhang L, Wang Y, Zhang Z, Deng K, Xia Z, Gong Q, Zhang W, Zheng X, Liu Y, Yang H, Zhou D, Yu D, Hou J, Shi Z, Chen S, Chen Z, Zhang X, Yang X. Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proc Natl Acad Sci U S A. 2020 Apr 28;117(17):9490-9496. doi: 10.1073/pnas.2004168117. Epub 2020 Apr 6.', 'Francis F, Hall M, Surg, Gaines A. Early use of convalescent serum in influenza. Mil Surg. 1920;47:177-9.', 'rice H, Genereux M, Sinclair C. Hyperimmune Immunoglobulin G. In: Production of Plasma Proteins for Therapeutic Use [Internet]. Hoboken, NJ, USA: John Wiley & Sons, Inc.; 2012.', 'Vargas M, Segura √Å, Wu YW, Herrera M, Chou ML, Villalta M, Le√≥n G, Burnouf T. Human plasma-derived immunoglobulin G fractionated by an aqueous two-phase system, caprylic acid precipitation, and membrane chromatography has a high purity level and is free of detectable in vitro thrombogenic activity. Vox Sang. 2015 Feb;108(2):169-77. doi: 10.1111/vox.12209. Epub 2014 Dec 3.', 'Redden WR. Treatment of Influenza-Pneumonia by Use of Convalescent Human Serum. Bost Med Surg J. 1919 Dec 11;181(24):688-91.', 'Wong VW, Dai D, Wu AK, Sung JJ. Treatment of severe acute respiratory syndrome with convalescent plasma. Hong Kong Med J. 2003 Jun;9(3):199-201.', 'van Griensven J, Edwards T, Baize S; Ebola-Tx Consortium. Efficacy of Convalescent Plasma in Relation to Dose of Ebola Virus Antibodies. N Engl J Med. 2016 Dec 8;375(23):2307-2309. doi: 10.1056/NEJMc1609116. Epub 2016 Nov 14.', 'Zingher A, Mortimer P. Convalescent whole blood, plasma and serum in the prophylaxis of measles: JAMA, 12 April, 1926; 1180-1187. Rev Med Virol. 2005 Nov-Dec;15(6):407-18; discussion 418-21.', 'Use of Convalescent Whole Blood or Plasma Collected from Patients Recovered from Ebola Virus Disease for Transfusion, as an Empirical Treatment during Outbreaks Interim Guidance for National Health Authorities and Blood Transfusion Services Use of Convale. 2014.', 'FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Public Health Emergency | FDA [Internet]. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/fda-guidance-conduct-clinical-trials-medical-products-during-covid-19-public-health-emergency']",['LFCOLCOVID-19-001'],,https://clinicaltrials.gov/show/NCT04395170,2020-12-01,0,1
926,NCT04399980,Recruiting,2021-05-31,2021-05-31,No Results Posted,,,"['IND 149324', 'IRB 20-523 ( Other Identifier: Cleveland Clinic IRB )']",,https://clinicaltrials.gov/show/NCT04399980,2021-05-31,0,0
927,NCT04409886,Not yet recruiting,2020-12-31,2021-03-30,No Results Posted,,,['120-20-ASF'],,https://clinicaltrials.gov/show/NCT04409886,2020-12-31,0,0
928,NCT04410016,Recruiting,2020-07-31,2020-11-30,No Results Posted,,,['COVID-WELL_May20'],,https://clinicaltrials.gov/show/NCT04410016,2020-07-31,0,0
929,NCT04412252,Not yet recruiting,2020-09-16,2020-10-18,No Results Posted,,,['A3921377'],,https://clinicaltrials.gov/show/NCT04412252,2020-09-16,0,0
930,NCT04414293,Not yet recruiting,2020-12-31,2021-03-31,No Results Posted,,,['FHPCS-20-001'],,https://clinicaltrials.gov/show/NCT04414293,2020-12-31,0,0
931,NCT04414618,Recruiting,2020-09-30,2020-12-31,No Results Posted,,,['ABC-110'],,https://clinicaltrials.gov/show/NCT04414618,2020-09-30,0,0
932,NCT04416334,Recruiting,2020-09-25,2020-12-31,No Results Posted,,,['COLCHICOVID'],,https://clinicaltrials.gov/show/NCT04416334,2020-09-25,0,0
933,NCT04420299,Recruiting,2021-03-31,2021-03-31,No Results Posted,,,"['BEMICOVID-19', '2020-001548-24 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04420299,2021-03-31,0,0
934,NCT04422353,Recruiting,2020-12-30,2024-12-30,No Results Posted,,"[""Monteiro EP, Franzoni LT, Cubillos DM, de Oliveira Fagundes A, Carvalho AR, Oliveira HB, Pantoja PD, Schuch FB, Rieder CR, Martinez FG, Peyr√©-Tartaruga LA. Effects of Nordic walking training on functional parameters in Parkinson's disease: a randomized controlled clinical trial. Scand J Med Sci Sports. 2017 Mar;27(3):351-358. doi: 10.1111/sms.12652. Epub 2016 Feb 2.""]","['PTT-Parkinson/COVID19', 'PTT-Parkinson/COVID19 ( Registry Identifier: PTT-Parkinson/COVID19 )']",,https://clinicaltrials.gov/show/NCT04422353,2020-12-30,0,1
935,NCT04422509,Not yet recruiting,2021-06-01,2021-08-01,No Results Posted,,,['UMCN-AKF20.04'],,https://clinicaltrials.gov/show/NCT04422509,2021-06-01,0,0
936,NCT04422613,Recruiting,2021-05-01,2022-05-01,No Results Posted,,,['RC31/20/0181'],,https://clinicaltrials.gov/show/NCT04422613,2021-05-01,0,0
937,NCT04422678,Not yet recruiting,2020-09-01,2020-10-01,No Results Posted,,,['Alex CCM 2020/5'],,https://clinicaltrials.gov/show/NCT04422678,2020-09-01,0,0
938,NCT04423289,Completed,2020-05-04,2020-05-18,No Results Posted,,,['PR(AG)182-2020'],,https://clinicaltrials.gov/show/NCT04423289,2020-05-04,0,0
939,NCT04423861,Not yet recruiting,2020-08-01,2020-08-01,No Results Posted,,,['NITFQM0520OR'],,https://clinicaltrials.gov/show/NCT04423861,2020-08-01,0,0
940,NCT04423991,Completed,2020-06-04,2020-06-04,No Results Posted,,,['060820'],,https://clinicaltrials.gov/show/NCT04423991,2020-06-04,0,0
941,NCT04424082,Recruiting,2020-08-07,2020-09-07,No Results Posted,,,['Karolinska'],,https://clinicaltrials.gov/show/NCT04424082,2020-08-07,0,0
942,NCT04424797,Recruiting,2020-12-01,2020-12-01,No Results Posted,,,['20-6034'],,https://clinicaltrials.gov/show/NCT04424797,2020-12-01,0,0
943,NCT04424901,Recruiting,2021-05-01,2021-05-30,No Results Posted,,,['20-192-2.F'],,https://clinicaltrials.gov/show/NCT04424901,2021-05-01,0,0
944,NCT04425005,Recruiting,2020-11-01,2021-02-01,No Results Posted,,,['21056813.3.0000.0068'],,https://clinicaltrials.gov/show/NCT04425005,2020-11-01,0,0
945,NCT04425317,Not yet recruiting,2021-06-15,2021-06-15,No Results Posted,,,['COVIDOFF001'],,https://clinicaltrials.gov/show/NCT04425317,2021-06-15,0,0
946,NCT04425460,Not yet recruiting,2020-08-01,2020-09-01,No Results Posted,,,['HS216C17(MRCT)'],,https://clinicaltrials.gov/show/NCT04425460,2020-08-01,0,0
947,NCT04425499,Not yet recruiting,2020-06-01,2020-06-01,No Results Posted,,,['CERSES 20-068-D'],,https://clinicaltrials.gov/show/NCT04425499,2020-06-01,0,0
948,NCT04425538,Recruiting,2020-09-01,2020-12-01,No Results Posted,,,['STUDY00000564'],,https://clinicaltrials.gov/show/NCT04425538,2020-09-01,0,0
949,NCT04425707,Recruiting,2020-07-01,2020-09-01,No Results Posted,,,['14-2020/3'],,https://clinicaltrials.gov/show/NCT04425707,2020-07-01,0,0
950,NCT04425733,Not yet recruiting,2020-11-10,2020-11-10,No Results Posted,,,"['5475-009', '2020-002062-14 ( EudraCT Number )', 'MK-5475-009 ( Other Identifier: Merck Protocol Number )']",,https://clinicaltrials.gov/show/NCT04425733,2020-11-10,0,0
951,NCT04425772,Not yet recruiting,2020-08-12,2020-08-12,No Results Posted,,,['FNC-Hope4'],,https://clinicaltrials.gov/show/NCT04425772,2020-08-12,0,0
952,NCT04425837,Not yet recruiting,2021-02-01,2021-02-01,No Results Posted,,,['PLASMA COVID-19'],,https://clinicaltrials.gov/show/NCT04425837,2021-02-01,0,0
953,NCT04425915,Recruiting,2021-05-30,2021-05-30,No Results Posted,,,['ILBS-COVID-04'],,https://clinicaltrials.gov/show/NCT04425915,2021-05-30,0,0
954,NCT04426006,Not yet recruiting,2020-12-01,2021-12-01,No Results Posted,,,"['IB 2020-01', '2020-A01355-34 ( Other Identifier: ANSM ID-RCB number )']",,https://clinicaltrials.gov/show/NCT04426006,2020-12-01,0,0
955,NCT04426201,Not yet recruiting,2020-11-30,2020-12-31,No Results Posted,,"['Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11. Erratum in: Lancet. 2020 Mar 28;395(10229):1038. Lancet. 2020 Mar 28;395(10229):1038.', 'Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Feb 7. doi: 10.1001/jama.2020.1585. [Epub ahead of print]', 'Francois B, Jeannet R, Daix T, Walton AH, Shotwell MS, Unsinger J, Monneret G, Rimmel√© T, Blood T, Morre M, Gregoire A, Mayo GA, Blood J, Durum SK, Sherwood ER, Hotchkiss RS. Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial. JCI Insight. 2018 Mar 8;3(5). pii: 98960. doi: 10.1172/jci.insight.98960.', 'Venet F, Foray AP, Villars-M√©chin A, Malcus C, Poitevin-Later F, Lepape A, Monneret G. IL-7 restores lymphocyte functions in septic patients. J Immunol. 2012 Nov 15;189(10):5073-81. doi: 10.4049/jimmunol.1202062. Epub 2012 Oct 10.']",['ILIAD-7 COVID US ONCO'],,https://clinicaltrials.gov/show/NCT04426201,2020-11-30,0,1
956,NCT04426292,Recruiting,2020-10-23,2021-05-12,No Results Posted,,,['COVEMUZ'],,https://clinicaltrials.gov/show/NCT04426292,2020-10-23,0,0
957,NCT04426305,Enrolling by invitation,2020-06-20,2020-10-30,No Results Posted,,,['BC-07744.'],,https://clinicaltrials.gov/show/NCT04426305,2020-06-20,0,0
958,NCT04426318,Recruiting,2021-01-30,2022-06-30,No Results Posted,,,"['2020-0533', 'A171600 ( Other Identifier: UW Madison )', 'EDUC/COUNSELING PSYCH ( Other Identifier: UW Madison )', 'Protocol Approval 6/4/2020 ( Other Identifier: UW Madison )']",,https://clinicaltrials.gov/show/NCT04426318,2021-01-30,0,0
959,NCT04426344,Not yet recruiting,2020-11-01,2020-11-01,No Results Posted,,,['202005150'],,https://clinicaltrials.gov/show/NCT04426344,2020-11-01,0,0
960,NCT04427631,Not yet recruiting,2021-01-01,2021-06-01,No Results Posted,,,['262816'],,https://clinicaltrials.gov/show/NCT04427631,2021-01-01,0,0
961,NCT04428021,Not yet recruiting,2021-06-15,2021-12-15,No Results Posted,,,['CS3/33'],,https://clinicaltrials.gov/show/NCT04428021,2021-06-15,0,0
962,NCT04428073,Not yet recruiting,2021-07-01,2021-12-01,No Results Posted,,,['GC004'],,https://clinicaltrials.gov/show/NCT04428073,2021-07-01,0,0
963,NCT04428099,Recruiting,2022-01-12,2022-07-12,No Results Posted,,,['RMD01'],,https://clinicaltrials.gov/show/NCT04428099,2022-01-12,0,0
964,NCT04428801,Not yet recruiting,2020-07-31,2021-08-10,No Results Posted,,,['CTX0020-003'],,https://clinicaltrials.gov/show/NCT04428801,2020-07-31,0,0
965,NCT04429529,Recruiting,2020-10-01,2021-01-01,No Results Posted,,,['SCT-001'],,https://clinicaltrials.gov/show/NCT04429529,2020-10-01,0,0
966,NCT04429763,Not yet recruiting,2020-09-01,2020-11-01,No Results Posted,,,['202001'],,https://clinicaltrials.gov/show/NCT04429763,2020-09-01,0,0
967,NCT04429854,Recruiting,2021-11-02,2021-11-02,No Results Posted,,,['S63992'],,https://clinicaltrials.gov/show/NCT04429854,2021-11-02,0,0
968,NCT04244591,Completed,2020-04-13,2020-04-13,No Results Posted,,,['Glucocorticoid COVID-19'],,https://clinicaltrials.gov/show/NCT04244591,2020-04-13,0,0
969,NCT04285190,Withdrawn,2020-04-15,2020-04-20,No Results Posted,,,['T89-NCP-01'],,https://clinicaltrials.gov/show/NCT04285190,2020-04-15,0,0
970,NCT04303299,Not yet recruiting,2020-12-31,2021-03-30,No Results Posted,,,['TH-DMS-COVID19 study'],,https://clinicaltrials.gov/show/NCT04303299,2020-12-31,0,0
971,NCT04311177,Recruiting,2021-04-01,2021-04-01,No Results Posted,,,['SURG-2020-28683'],,https://clinicaltrials.gov/show/NCT04311177,2021-04-01,0,0
972,NCT04312009,Recruiting,2021-04-01,2021-04-01,No Results Posted,,,"['SURG-2020-28675', 'INV-017069 ( Other Grant/Funding Number: Bill and Melinda Gates Foundation )']",,https://clinicaltrials.gov/show/NCT04312009,2021-04-01,0,0
973,NCT04312243,Recruiting,2021-04-07,2022-04-07,No Results Posted,,,['NOpreCOVID-19'],,https://clinicaltrials.gov/show/NCT04312243,2021-04-07,0,0
974,NCT04333914,Suspended,2020-06-01,2020-08-01,No Results Posted,,,"['ET20-076 - IMMUNONCOVID-20', '2020-001373-70 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04333914,2020-06-01,0,0
975,NCT04340414,Recruiting,2020-08-15,2020-10-15,No Results Posted,,,['Low flow-ECMO by CVVH in NCP'],,https://clinicaltrials.gov/show/NCT04340414,2020-08-15,0,0
976,NCT04346446,Completed,2020-05-30,2020-05-30,No Results Posted,,,['ILBS-COVID-02'],,https://clinicaltrials.gov/show/NCT04346446,2020-05-30,0,0
977,NCT04353128,Recruiting,2020-10-01,2020-12-01,No Results Posted,,,['MeCOVID'],,https://clinicaltrials.gov/show/NCT04353128,2020-10-01,0,0
978,NCT04369066,Recruiting,2020-10-28,2021-01-28,No Results Posted,,,['IC 2020-07'],,https://clinicaltrials.gov/show/NCT04369066,2020-10-28,0,0
979,NCT04370262,Recruiting,2020-09-07,2021-04-07,No Results Posted,,,['20-0268'],,https://clinicaltrials.gov/show/NCT04370262,2020-09-07,0,0
980,NCT04371029,Recruiting,2020-09-28,2020-12-28,No Results Posted,,,['CHUBX 2020/14'],,https://clinicaltrials.gov/show/NCT04371029,2020-09-28,0,0
981,NCT04376814,Completed,2020-04-05,2020-05-25,No Results Posted,,,['IR.BMSU.REC.1399.017'],,https://clinicaltrials.gov/show/NCT04376814,2020-04-05,0,0
982,NCT04382053,Recruiting,2020-11-30,2020-11-30,No Results Posted,,,"['CDFV890D12201', '2020-001870-32 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04382053,2020-11-30,0,0
983,NCT04383535,Recruiting,2020-08-15,2020-09-20,No Results Posted,,"['Luke TC, Kilbane EM, Jackson JL, Hoffman SL. Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment? Ann Intern Med. 2006 Oct 17;145(8):599-609. Epub 2006 Aug 29.']",['5565'],,https://clinicaltrials.gov/show/NCT04383535,2020-08-15,0,1
984,NCT04387409,Recruiting,2021-06-30,2021-06-30,No Results Posted,,,['VPM1002-DE-3.06CoV'],,https://clinicaltrials.gov/show/NCT04387409,2021-06-30,0,0
985,NCT04388709,Not yet recruiting,2021-05-01,2021-05-01,No Results Posted,,,['GCO 20-0820'],,https://clinicaltrials.gov/show/NCT04388709,2021-05-01,0,0
986,NCT04391140,Recruiting,2020-12-01,2021-06-01,No Results Posted,,,['PR(AG)198/2020'],,https://clinicaltrials.gov/show/NCT04391140,2020-12-01,0,0
987,NCT04394455,Not yet recruiting,2020-11-30,2020-12-30,No Results Posted,,,['1503202018052020242912'],,https://clinicaltrials.gov/show/NCT04394455,2020-11-30,0,0
988,NCT04395716,Not yet recruiting,2021-06-01,2021-11-01,No Results Posted,,,['PRG-048'],,https://clinicaltrials.gov/show/NCT04395716,2021-06-01,0,0
989,NCT04397562,"Active, not recruiting",2021-04-01,2021-04-01,No Results Posted,,,['BCD-089-4'],,https://clinicaltrials.gov/show/NCT04397562,2021-04-01,0,0
990,NCT04402944,Not yet recruiting,2021-05-31,2021-12-31,No Results Posted,,,['P00035140'],,https://clinicaltrials.gov/show/NCT04402944,2021-05-31,0,0
991,NCT04402957,Not yet recruiting,2020-12-31,2021-06-30,No Results Posted,,,['AB002'],,https://clinicaltrials.gov/show/NCT04402957,2020-12-31,0,0
992,NCT04412057,Recruiting,2020-10-01,2020-11-01,No Results Posted,,,['CERC-002-CVID-201'],,https://clinicaltrials.gov/show/NCT04412057,2020-10-01,0,0
993,NCT04421404,Recruiting,2021-04-30,2021-04-30,No Results Posted,,,['20-30794'],,https://clinicaltrials.gov/show/NCT04421404,2021-04-30,0,0
994,NCT04425252,Recruiting,2020-09-01,2020-10-01,No Results Posted,,,['CCB-CRISIS-01'],,https://clinicaltrials.gov/show/NCT04425252,2020-09-01,0,0
995,NCT04427865,Not yet recruiting,2020-09-01,2020-11-01,No Results Posted,,,['CUKA-002'],,https://clinicaltrials.gov/show/NCT04427865,2020-09-01,0,0
996,NCT04427878,Not yet recruiting,2020-07-09,2021-07-09,No Results Posted,,,['20-PP-15'],,https://clinicaltrials.gov/show/NCT04427878,2020-07-09,0,0
997,NCT04428268,Recruiting,2020-06-10,2020-08-30,No Results Posted,,,['IF20-00003'],,https://clinicaltrials.gov/show/NCT04428268,2020-06-10,0,0
998,NCT04429334,Not yet recruiting,2021-03-01,2021-03-01,No Results Posted,,,['MOT-C-204'],,https://clinicaltrials.gov/show/NCT04429334,2021-03-01,0,0
999,NCT04429555,Not yet recruiting,2021-06-30,2021-12-01,No Results Posted,,,['MN-166-COVID-19-201'],,https://clinicaltrials.gov/show/NCT04429555,2021-06-30,0,0
1000,NCT04429711,Recruiting,2020-09-30,2020-10-31,No Results Posted,,,['SHEBA-20-7156-ES-CTIL'],,https://clinicaltrials.gov/show/NCT04429711,2020-09-30,0,0
1001,NCT04429724,Not yet recruiting,2020-12-01,2020-12-01,No Results Posted,,,['RIPH_2020_8'],,https://clinicaltrials.gov/show/NCT04429724,2020-12-01,0,0
1002,NCT04429828,Not yet recruiting,2020-09-30,2020-12-30,No Results Posted,,,['PoWerS_June2020'],,https://clinicaltrials.gov/show/NCT04429828,2020-09-30,0,0
1003,NCT04429867,"Active, not recruiting",2020-12-07,2020-12-07,No Results Posted,,,['1604885'],,https://clinicaltrials.gov/show/NCT04429867,2020-12-07,0,0
1004,NCT04430608,Recruiting,2021-04-25,2021-05-25,No Results Posted,,,['H-20025305'],,https://clinicaltrials.gov/show/NCT04430608,2021-04-25,0,0
1005,NCT04431180,Enrolling by invitation,2020-06-13,2020-06-30,No Results Posted,,,['Recruit Blood Donors via SMS 3'],,https://clinicaltrials.gov/show/NCT04431180,2020-06-13,0,0
1006,NCT04431297,Not yet recruiting,2020-12-01,2021-06-01,No Results Posted,,,['GCO 20-1022'],,https://clinicaltrials.gov/show/NCT04431297,2020-12-01,0,0
1007,NCT04431453,Not yet recruiting,2020-12-01,2020-12-01,No Results Posted,,,"['GS-US-540-5823', '2020-001803-17 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04431453,2020-12-01,0,0
1008,NCT04431466,Not yet recruiting,2020-12-01,2021-07-01,No Results Posted,,,['IFORS'],,https://clinicaltrials.gov/show/NCT04431466,2020-12-01,0,0
1009,NCT04431856,Recruiting,2020-08-01,2020-08-01,No Results Posted,,,['20200484'],,https://clinicaltrials.gov/show/NCT04431856,2020-08-01,0,0
1010,NCT04432272,Not yet recruiting,2021-06-01,2021-08-01,No Results Posted,,,['2020-198'],,https://clinicaltrials.gov/show/NCT04432272,2021-06-01,0,0
1011,NCT04432324,Not yet recruiting,2020-07-01,2020-12-01,No Results Posted,,,"['GC2004', '2020-001696-32 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04432324,2020-07-01,0,0
1012,NCT04434131,Recruiting,2021-04-28,2025-04-28,No Results Posted,,,['20-227'],,https://clinicaltrials.gov/show/NCT04434131,2021-04-28,0,0
1013,NCT04269525,Recruiting,2020-12-01,2020-12-30,No Results Posted,,,['2020002'],,https://clinicaltrials.gov/show/NCT04269525,2020-12-01,0,0
1014,NCT04288102,"Active, not recruiting",2020-05-12,2020-07-10,No Results Posted,,,['2020-013-D'],,https://clinicaltrials.gov/show/NCT04288102,2020-05-12,0,0
1015,NCT04304053,Completed,2020-06-15,2020-06-15,No Results Posted,,,"['HCQ4COV19', '2020-001031-27 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04304053,2020-06-15,0,0
1016,NCT04308668,Completed,2020-05-20,2020-05-20,No Results Posted,,"['Boulware DR, Pullen MF, Bangdiwala AS, Pastick KA, Lofgren SM, Okafor EC, Skipper CP, Nascene AA, Nicol MR, Abassi M, Engen NW, Cheng MP, LaBar D, Lother SA, MacKenzie LJ, Drobot G, Marten N, Zarychanski R, Kelly LE, Schwartz IS, McDonald EG, Rajasingham R, Lee TC, Hullsiek KH. A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. N Engl J Med. 2020 Jun 3. doi: 10.1056/NEJMoa2016638. [Epub ahead of print]']",['STUDY00009267'],,https://clinicaltrials.gov/show/NCT04308668,2020-05-20,0,1
1017,NCT04312997,Recruiting,2020-09-01,2020-10-01,No Results Posted,,,['PUL-042-502'],,https://clinicaltrials.gov/show/NCT04312997,2020-09-01,0,0
1018,NCT04313023,Recruiting,2020-09-01,2020-10-01,No Results Posted,,,['PUL-042-501'],,https://clinicaltrials.gov/show/NCT04313023,2020-09-01,0,0
1019,NCT04323800,Recruiting,2022-12-31,2023-01-01,No Results Posted,,,['IRB00245634'],,https://clinicaltrials.gov/show/NCT04323800,2022-12-31,0,0
1020,NCT04324463,Recruiting,2020-12-31,2021-06-30,No Results Posted,,,['PHRI.ACT.COVID19'],,https://clinicaltrials.gov/show/NCT04324463,2020-12-31,0,0
1021,NCT04328285,"Active, not recruiting",2020-11-30,2020-11-30,No Results Posted,,,"['20PH061', '2020-001188-96 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04328285,2020-11-30,0,0
1022,NCT04329533,Recruiting,2020-06-30,2020-07-30,No Results Posted,,,['2003524869'],,https://clinicaltrials.gov/show/NCT04329533,2020-06-30,0,0
1023,NCT04329611,Suspended,2020-08-31,2020-09-30,No Results Posted,,,['ABCOV-01 version 1.5'],,https://clinicaltrials.gov/show/NCT04329611,2020-08-31,0,0
1024,NCT04331366,Recruiting,2020-08-01,2020-08-01,No Results Posted,,,['STUDY00000381'],,https://clinicaltrials.gov/show/NCT04331366,2020-08-01,0,0
1025,NCT04331899,Recruiting,2021-05-31,2022-05-31,No Results Posted,,,['55619'],,https://clinicaltrials.gov/show/NCT04331899,2021-05-31,0,0
1026,NCT04332991,"Active, not recruiting",2020-07-01,2020-07-01,No Results Posted,"['Casey JD, Johnson NJ, Semler MW, Collins SP, Aggarwal NR, Brower RG, Chang SY, Eppensteiner J, Filbin M, Gibbs KW, Ginde AA, Gong MN, Harrell F, Hayden DL, Hough CL, Khan A, Leither LM, Moss M, Oldmixon CF, Park PK, Reineck LA, Ringwood NJ, Robinson BR, Schoenfeld DA, Shapiro NI, Steingrub JS, Torr DK, Weissman A, Lindsell CJ, Rice TW, Thompson BT, Brown SM, Self WH; ORCHID Protocol Committee and the National Heart, Lung and Blood Institute Prevention and Early Treatment of Acute Lung Injury (PETAL) Network Investigators. Rationale and Design of ORCHID: A Randomized Placebo-Controlled Trial of Hydroxychloroquine for Adults Hospitalized with COVID-19. Ann Am Thorac Soc. 2020 Jun 3. doi: 10.1513/AnnalsATS.202005-478SD. [Epub ahead of print]']",,['PETAL 05 Orchid'],,https://clinicaltrials.gov/show/NCT04332991,2020-07-01,0,1
1027,NCT04335136,Recruiting,2020-09-01,2020-11-01,No Results Posted,,,['APN01-01-COVID19'],,https://clinicaltrials.gov/show/NCT04335136,2020-09-01,0,0
1028,NCT04337918,Recruiting,2020-08-31,2020-09-30,No Results Posted,,,['COVID-CTP-01'],,https://clinicaltrials.gov/show/NCT04337918,2020-08-31,0,0
1029,NCT04341285,Not yet recruiting,2022-04-01,2022-05-01,No Results Posted,,,['ECMO-VID'],,https://clinicaltrials.gov/show/NCT04341285,2022-04-01,0,0
1030,NCT04341688,Not yet recruiting,2021-01-31,2021-03-31,No Results Posted,,,['2020-Sur-ERC-4926'],,https://clinicaltrials.gov/show/NCT04341688,2021-01-31,0,0
1031,NCT04342689,Recruiting,2021-06-01,2021-06-01,No Results Posted,,,['2000027887'],,https://clinicaltrials.gov/show/NCT04342689,2021-06-01,0,0
1032,NCT04342897,Recruiting,2020-09-30,2020-09-30,No Results Posted,,,"['17824', 'I7W-MC-UDAA ( Other Identifier: Eli Lilly and Company )']",,https://clinicaltrials.gov/show/NCT04342897,2020-09-30,0,0
1033,NCT04343261,Enrolling by invitation,2020-12-01,2021-04-01,No Results Posted,,,['SFH-20-23'],,https://clinicaltrials.gov/show/NCT04343261,2020-12-01,0,0
1034,NCT04343729,"Active, not recruiting",2020-06-16,2020-09-01,No Results Posted,,,['CAEE: 30615920.2.0000.0005'],,https://clinicaltrials.gov/show/NCT04343729,2020-06-16,0,0
1035,NCT04343976,Enrolling by invitation,2021-03-01,2021-08-31,No Results Posted,,,['2020P001083'],,https://clinicaltrials.gov/show/NCT04343976,2021-03-01,0,0
1036,NCT04344561,Recruiting,2021-05-01,2021-05-01,No Results Posted,,,['IRB00246834'],,https://clinicaltrials.gov/show/NCT04344561,2021-05-01,0,0
1037,NCT04344587,Enrolling by invitation,2020-12-01,2020-12-01,No Results Posted,,,['H-40070'],,https://clinicaltrials.gov/show/NCT04344587,2020-12-01,0,0
1038,NCT04345419,Recruiting,2029-12-01,2029-12-01,No Results Posted,,,['COVID 19 treatment'],,https://clinicaltrials.gov/show/NCT04345419,2029-12-01,0,0
1039,NCT04346355,Terminated,2020-06-06,2020-06-06,No Results Posted,,,"['RCT-TCZ-COVID-19', '2020-001386-37 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04346355,2020-06-06,0,0
1040,NCT04346615,Recruiting,2020-12-01,2020-12-01,No Results Posted,,,['BHV3500-203'],,https://clinicaltrials.gov/show/NCT04346615,2020-12-01,0,0
1041,NCT04347954,Recruiting,2020-09-01,2020-10-01,No Results Posted,,,['IRB-56134'],,https://clinicaltrials.gov/show/NCT04347954,2020-09-01,0,0
1042,NCT04349241,Completed,2020-06-01,2020-06-20,No Results Posted,,,['FMASU P14 / 2020'],,https://clinicaltrials.gov/show/NCT04349241,2020-06-01,0,0
1043,NCT04350593,Recruiting,2020-10-01,2020-12-01,No Results Posted,,,"['D1690C00081', 'ESR-20-20653 ( Other Grant/Funding Number: Astra Zeneca )']",,https://clinicaltrials.gov/show/NCT04350593,2020-10-01,0,0
1044,NCT04351347,Recruiting,2030-12-01,2030-12-01,No Results Posted,,,['ivermecin covid'],,https://clinicaltrials.gov/show/NCT04351347,2030-12-01,0,0
1045,NCT04353180,Not yet recruiting,2020-08-01,2020-11-01,No Results Posted,,,['Proposed by Mahmoud Elkazzaz'],,https://clinicaltrials.gov/show/NCT04353180,2020-08-01,0,0
1046,NCT04353284,Recruiting,2021-05-31,2021-05-31,No Results Posted,,,['2000027971'],,https://clinicaltrials.gov/show/NCT04353284,2021-05-31,0,0
1047,NCT04353336,Recruiting,2030-12-01,2030-12-01,No Results Posted,,,['chloroquine covid'],,https://clinicaltrials.gov/show/NCT04353336,2030-12-01,0,0
1048,NCT04353674,Recruiting,2020-07-28,2021-01-01,No Results Posted,,"['Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 Feb 24. doi: 10.1001/jama.2020.2648. [Epub ahead of print]', 'Deng Y, Liu W, Liu K, Fang YY, Shang J, Zhou L, Wang K, Leng F, Wei S, Chen L, Liu HG. Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 in Wuhan, China: a retrospective study. Chin Med J (Engl). 2020 Jun 5;133(11):1261-1267. doi: 10.1097/CM9.0000000000000824.', 'Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, Huang H, Zhang L, Zhou X, Du C, Zhang Y, Song J, Wang S, Chao Y, Yang Z, Xu J, Zhou X, Chen D, Xiong W, Xu L, Zhou F, Jiang J, Bai C, Zheng J, Song Y. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020 Mar 13. doi: 10.1001/jamainternmed.2020.0994. [Epub ahead of print]', ""Rosenbaum L. Facing Covid-19 in Italy - Ethics, Logistics, and Therapeutics on the Epidemic's Front Line. N Engl J Med. 2020 May 14;382(20):1873-1875. doi: 10.1056/NEJMp2005492. Epub 2020 Mar 18."", 'Perlman S, Dandekar AA. Immunopathogenesis of coronavirus infections: implications for SARS. Nat Rev Immunol. 2005 Dec;5(12):917-27. Review.', 'Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ; HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.', 'Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020 May;46(5):846-848. doi: 10.1007/s00134-020-05991-x. Epub 2020 Mar 3. Erratum in: Intensive Care Med. 2020 Apr 6;:.', 'Perlman S, Netland J. Coronaviruses post-SARS: update on replication and pathogenesis. Nat Rev Microbiol. 2009 Jun;7(6):439-50. doi: 10.1038/nrmicro2147. Review.', 'Jiang Y, Xu J, Zhou C, Wu Z, Zhong S, Liu J, Luo W, Chen T, Qin Q, Deng P. Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome. Am J Respir Crit Care Med. 2005 Apr 15;171(8):850-7. Epub 2005 Jan 18.', 'Cheung CY, Poon LL, Ng IH, Luk W, Sia SF, Wu MH, Chan KH, Yuen KY, Gordon S, Guan Y, Peiris JS. Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis. J Virol. 2005 Jun;79(12):7819-26.', 'He L, Ding Y, Zhang Q, Che X, He Y, Shen H, Wang H, Li Z, Zhao L, Geng J, Deng Y, Yang L, Li J, Cai J, Qiu L, Wen K, Xu X, Jiang S. Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS. J Pathol. 2006 Nov;210(3):288-97.', 'Nicholls JM, Poon LL, Lee KC, Ng WF, Lai ST, Leung CY, Chu CM, Hui PK, Mak KL, Lim W, Yan KW, Chan KH, Tsang NC, Guan Y, Yuen KY, Peiris JS. Lung pathology of fatal severe acute respiratory syndrome. Lancet. 2003 May 24;361(9371):1773-8.', 'Alhazzani W, M√∏ller MH, Arabi YM, Loeb M, Gong MN, Fan E, Oczkowski S, Levy MM, Derde L, Dzierba A, Du B, Aboodi M, Wunsch H, Cecconi M, Koh Y, Chertow DS, Maitland K, Alshamsi F, Belley-Cote E, Greco M, Laundy M, Morgan JS, Kesecioglu J, McGeer A, Mermel L, Mammen MJ, Alexander PE, Arrington A, Centofanti JE, Citerio G, Baw B, Memish ZA, Hammond N, Hayden FG, Evans L, Rhodes A. Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19). Crit Care Med. 2020 Jun;48(6):e440-e469. doi: 10.1097/CCM.0000000000004363.', 'Ding F, Song JH, Jung JY, Lou L, Wang M, Charles L, Westover A, Smith PL, Pino CJ, Buffington DA, Humes HD. A biomimetic membrane device that modulates the excessive inflammatory response to sepsis. PLoS One. 2011 Apr 14;6(4):e18584. doi: 10.1371/journal.pone.0018584.', 'Ding F, Yevzlin AS, Xu ZY, Zhou Y, Xie QH, Liu JF, Zheng Y, DaSilva JR, Humes HD. The effects of a novel therapeutic device on acute kidney injury outcomes in the intensive care unit: a pilot study. ASAIO J. 2011 Sep-Oct;57(5):426-32. doi: 10.1097/MAT.0b013e31820a1494.', 'Humes HD, Sobota JT, Ding F, Song JH; RAD Investigator Group. A selective cytopheretic inhibitory device to treat the immunological dysregulation of acute and chronic renal failure. Blood Purif. 2010;29(2):183-90. doi: 10.1159/000245645. Epub 2010 Jan 8.', 'Tumlin JA, Galphin CM, Tolwani AJ, Chan MR, Vijayan A, Finkel K, Szamosfalvi B, Dev D, DaSilva JR, Astor BC, Yevzlin AS, Humes HD; SCD Investigator Group. A Multi-Center, Randomized, Controlled, Pivotal Study to Assess the Safety and Efficacy of a Selective Cytopheretic Device in Patients with Acute Kidney Injury. PLoS One. 2015 Aug 5;10(8):e0132482. doi: 10.1371/journal.pone.0132482. eCollection 2015.']",['115785'],,https://clinicaltrials.gov/show/NCT04353674,2020-07-28,0,1
1049,NCT04354441,Withdrawn,2020-05-01,2020-05-01,No Results Posted,,,"['1, March 30, 2020']",,https://clinicaltrials.gov/show/NCT04354441,2020-05-01,0,0
1050,NCT04354805,Not yet recruiting,2020-08-01,2020-09-01,No Results Posted,,,['Medical'],,https://clinicaltrials.gov/show/NCT04354805,2020-08-01,0,0
1051,NCT04355728,Recruiting,2021-04-30,2022-05-01,No Results Posted,,,['20200671'],,https://clinicaltrials.gov/show/NCT04355728,2021-04-30,0,0
1052,NCT04355767,Not yet recruiting,2022-12-01,2022-12-01,No Results Posted,,,['C3PO'],,https://clinicaltrials.gov/show/NCT04355767,2022-12-01,0,0
1053,NCT04356534,Recruiting,2020-06-30,2020-06-30,No Results Posted,,,['BDF/R&REC/2020-423'],,https://clinicaltrials.gov/show/NCT04356534,2020-06-30,0,0
1054,NCT04356937,Recruiting,2020-06-30,2020-08-30,No Results Posted,,,['2020P001159'],,https://clinicaltrials.gov/show/NCT04356937,2020-06-30,0,0
1055,NCT04357028,Recruiting,2020-10-01,2020-11-01,No Results Posted,,,['N-30-2020'],,https://clinicaltrials.gov/show/NCT04357028,2020-10-01,0,0
1056,NCT04357730,Recruiting,2020-09-01,2020-11-01,No Results Posted,,,['20-0880'],,https://clinicaltrials.gov/show/NCT04357730,2020-09-01,0,0
1057,NCT04358068,"Active, not recruiting",2020-07-06,2020-07-06,No Results Posted,,,"['ACTG A5395', '38720 ( Other Identifier: DAIDS-ES Registry Number )']",,https://clinicaltrials.gov/show/NCT04358068,2020-07-06,0,0
1058,NCT04358549,Recruiting,2020-08-01,2020-12-01,No Results Posted,,,['FAVI-COV-US201'],,https://clinicaltrials.gov/show/NCT04358549,2020-08-01,0,0
1059,NCT04358835,Not yet recruiting,2021-09-01,2021-12-31,No Results Posted,,,['IRB00247383'],,https://clinicaltrials.gov/show/NCT04358835,2021-09-01,0,0
1060,NCT04359277,Recruiting,2021-04-21,2021-04-21,No Results Posted,,,['s20-00479'],,https://clinicaltrials.gov/show/NCT04359277,2021-04-21,0,0
1061,NCT04360824,Recruiting,2021-04-16,2021-04-16,No Results Posted,,,['202004235'],,https://clinicaltrials.gov/show/NCT04360824,2021-04-16,0,0
1062,NCT04361396,Recruiting,2020-10-01,2020-10-01,No Results Posted,,,['CHRD 0420'],,https://clinicaltrials.gov/show/NCT04361396,2020-10-01,0,0
1063,NCT04361552,Withdrawn,2020-06-02,2020-06-02,No Results Posted,,,"['STUDY00000419', 'NCI-2020-02314 ( Registry Identifier: CTRP (Clinical Trial Reporting Program) )', 'WINSHIP4998-20 ( Other Identifier: Emory University Hospital/Winship Cancer Institute )', 'P30CA138292 ( U.S. NIH Grant/Contract )']",,https://clinicaltrials.gov/show/NCT04361552,2020-06-02,0,0
1064,NCT04362137,Recruiting,2020-10-22,2020-10-23,No Results Posted,,,"['CINC424J12301', 'INCB 18424-368 ( Other Identifier: Incyte Study Code )', '2020-001662-11 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04362137,2020-10-22,0,0
1065,NCT04362332,Terminated,2020-06-08,2020-06-08,No Results Posted,,,['NL73529.041.20 versie 3'],,https://clinicaltrials.gov/show/NCT04362332,2020-06-08,0,0
1066,NCT04363203,Suspended,2021-03-01,2021-08-01,No Results Posted,,,['20-30517'],,https://clinicaltrials.gov/show/NCT04363203,2021-03-01,0,0
1067,NCT04363385,Recruiting,2020-12-15,2020-12-15,No Results Posted,,,['COVIGENET'],,https://clinicaltrials.gov/show/NCT04363385,2020-12-15,0,0
1068,NCT04363463,Not yet recruiting,2022-05-01,2022-05-01,No Results Posted,,,['CHRO-2020-09'],,https://clinicaltrials.gov/show/NCT04363463,2022-05-01,0,0
1069,NCT04363853,Recruiting,2021-06-01,2021-08-01,No Results Posted,,,['INF-3343-20-22-1'],,https://clinicaltrials.gov/show/NCT04363853,2021-06-01,0,0
1070,NCT04364737,Recruiting,2023-01-31,2023-04-30,No Results Posted,,,['20-00541'],,https://clinicaltrials.gov/show/NCT04364737,2023-01-31,0,0
1071,NCT04364763,Not yet recruiting,2021-06-30,2021-12-31,No Results Posted,,,['REN-005'],,https://clinicaltrials.gov/show/NCT04364763,2021-06-30,0,0
1072,NCT04364893,Recruiting,2020-10-01,2020-12-01,No Results Posted,,,['PRJ_2003'],,https://clinicaltrials.gov/show/NCT04364893,2020-10-01,0,0
1073,NCT04365101,Recruiting,2020-11-30,2021-11-30,No Results Posted,,,['CYNK-001-COVID-19'],,https://clinicaltrials.gov/show/NCT04365101,2020-11-30,0,0
1074,NCT04365582,Recruiting,2020-08-07,2021-02-07,No Results Posted,,,['OUTCOV'],,https://clinicaltrials.gov/show/NCT04365582,2020-08-07,0,0
1075,NCT04366791,Recruiting,2020-10-23,2020-10-23,No Results Posted,,,"['STUDY00000476', 'NCI-2020-02676 ( Registry Identifier: CTRP (Clinical Trial Reporting Program) )', 'RAD5002-20 ( Other Identifier: Emory University Hospital/Winship Cancer Institute )', 'P30CA138292 ( U.S. NIH Grant/Contract )']",,https://clinicaltrials.gov/show/NCT04366791,2020-10-23,0,0
1076,NCT04368923,"Active, not recruiting",2020-06-21,2020-06-23,No Results Posted,,,['REC/012-2020'],,https://clinicaltrials.gov/show/NCT04368923,2020-06-21,0,0
1077,NCT04369742,Suspended,2020-06-01,2020-06-01,No Results Posted,,,['20-00463'],,https://clinicaltrials.gov/show/NCT04369742,2020-06-01,0,0
1078,NCT04370834,Recruiting,2021-11-01,2021-11-01,No Results Posted,,,"['NCI-2020-02987', 'NCI-2020-02987 ( Registry Identifier: CTRP (Clinical Trial Reporting Program) )', 'TRC-10446 ( Other Identifier: National Cancer Institute )', 'TRC-10446 ( Other Identifier: CTEP )']",,https://clinicaltrials.gov/show/NCT04370834,2021-11-01,0,0
1079,NCT04371393,Recruiting,2021-04-01,2022-04-01,No Results Posted,,,['GCO 08-1078-0014'],,https://clinicaltrials.gov/show/NCT04371393,2021-04-01,0,0
1080,NCT04371419,Completed,2020-05-24,2020-05-24,No Results Posted,,,['2003000118'],,https://clinicaltrials.gov/show/NCT04371419,2020-05-24,0,0
1081,NCT04371822,Not yet recruiting,2020-10-01,2020-11-01,No Results Posted,,,['Proposed by Mahmoud Elkazz'],,https://clinicaltrials.gov/show/NCT04371822,2020-10-01,0,0
1082,NCT04372186,Recruiting,2020-08-05,2020-10-05,No Results Posted,,,['ML42528'],,https://clinicaltrials.gov/show/NCT04372186,2020-08-05,0,0
1083,NCT04373460,Recruiting,2022-12-21,2023-01-31,No Results Posted,,,['IRB00247590'],,https://clinicaltrials.gov/show/NCT04373460,2022-12-21,0,0
1084,NCT04373707,Recruiting,2020-09-01,2020-10-01,No Results Posted,,,['2020-001709-21'],,https://clinicaltrials.gov/show/NCT04373707,2020-09-01,0,0
1085,NCT04373733,Recruiting,2021-03-31,2021-03-31,No Results Posted,,,"['CW002', '2020-001449-38 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04373733,2021-03-31,0,0
1086,NCT04375397,Recruiting,2020-08-13,2020-09-10,No Results Posted,,,['M20-310'],,https://clinicaltrials.gov/show/NCT04375397,2020-08-13,0,0
1087,NCT04376684,Recruiting,2020-12-21,2020-12-21,No Results Posted,,,['214094'],,https://clinicaltrials.gov/show/NCT04376684,2020-12-21,0,0
1088,NCT04377100,Not yet recruiting,2021-02-28,2021-02-28,No Results Posted,,,"['999920112', '20-M-N112']",,https://clinicaltrials.gov/show/NCT04377100,2021-02-28,0,0
1089,NCT04377334,Not yet recruiting,2021-04-01,2021-07-01,No Results Posted,,,['RESCOVID'],,https://clinicaltrials.gov/show/NCT04377334,2021-04-01,0,0
1090,NCT04377568,Not yet recruiting,2021-12-01,2022-05-01,No Results Posted,,,['1000070143'],,https://clinicaltrials.gov/show/NCT04377568,2021-12-01,0,0
1091,NCT04377620,Recruiting,2020-09-29,2020-09-29,No Results Posted,,,['INCB 18424-369'],,https://clinicaltrials.gov/show/NCT04377620,2020-09-29,0,0
1092,NCT04380818,Recruiting,2021-05-04,2021-07-01,No Results Posted,,,['IPACOVID'],,https://clinicaltrials.gov/show/NCT04380818,2021-05-04,0,0
1093,NCT04382586,Recruiting,2020-07-01,2020-09-01,No Results Posted,,,['BGB-3111-219'],,https://clinicaltrials.gov/show/NCT04382586,2020-07-01,0,0
1094,NCT04382651,Recruiting,2020-08-19,2020-12-01,No Results Posted,,,['CMAS825F12201'],,https://clinicaltrials.gov/show/NCT04382651,2020-08-19,0,0
1095,NCT04383613,Recruiting,2020-12-11,2020-12-11,No Results Posted,,,['2020-1'],,https://clinicaltrials.gov/show/NCT04383613,2020-12-11,0,0
1096,NCT04386252,Not yet recruiting,2020-12-01,2021-03-01,No Results Posted,,,['CL-COV-P01-US'],,https://clinicaltrials.gov/show/NCT04386252,2020-12-01,0,0
1097,NCT04386616,Recruiting,2020-09-24,2020-10-27,No Results Posted,,,['GA42469'],,https://clinicaltrials.gov/show/NCT04386616,2020-09-24,0,0
1098,NCT04387760,Not yet recruiting,2020-07-14,2020-08-14,No Results Posted,,,['40 / 07-May-2020'],,https://clinicaltrials.gov/show/NCT04387760,2020-07-14,0,0
1099,NCT04388826,Recruiting,2020-07-30,2020-08-30,No Results Posted,,,['V0211901'],,https://clinicaltrials.gov/show/NCT04388826,2020-07-30,0,0
1100,NCT04389411,Not yet recruiting,2021-02-01,2021-06-01,No Results Posted,,,['443807'],,https://clinicaltrials.gov/show/NCT04389411,2021-02-01,0,0
1101,NCT04389710,Recruiting,2021-04-14,2021-04-14,No Results Posted,,,['20D.379'],,https://clinicaltrials.gov/show/NCT04389710,2021-04-14,0,0
1102,NCT04389840,Recruiting,2021-02-01,2021-03-01,No Results Posted,,,['CMX-DS-004'],,https://clinicaltrials.gov/show/NCT04389840,2021-02-01,0,0
1103,NCT04391309,Not yet recruiting,2021-07-01,2021-09-01,No Results Posted,,,['COV04'],,https://clinicaltrials.gov/show/NCT04391309,2021-07-01,0,0
1104,NCT04392219,Recruiting,2020-08-08,2020-08-08,No Results Posted,,,"['EIDD-2801-1001', '2020-001407-17 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04392219,2020-08-08,0,0
1105,NCT04392973,Recruiting,2021-11-01,2021-11-01,No Results Posted,,,['RC20/174'],,https://clinicaltrials.gov/show/NCT04392973,2021-11-01,0,0
1106,NCT04393311,Not yet recruiting,2021-01-01,2021-01-01,No Results Posted,,,['56639'],,https://clinicaltrials.gov/show/NCT04393311,2021-01-01,0,0
1107,NCT04393948,Recruiting,2020-10-01,2020-11-01,No Results Posted,,,['2020P001494'],,https://clinicaltrials.gov/show/NCT04393948,2020-10-01,0,0
1108,NCT04394117,Recruiting,2021-01-30,2021-04-30,No Results Posted,,,['11052020'],,https://clinicaltrials.gov/show/NCT04394117,2021-01-30,0,0
1109,NCT04394377,Recruiting,2020-12-01,2020-12-01,No Results Posted,,,['002/2020'],,https://clinicaltrials.gov/show/NCT04394377,2020-12-01,0,0
1110,NCT04394793,Recruiting,2020-07-01,2020-08-01,No Results Posted,,,['COVID-AIIMS'],,https://clinicaltrials.gov/show/NCT04394793,2020-07-01,0,0
1111,NCT04397718,Not yet recruiting,2020-11-01,2020-11-01,No Results Posted,,,['COVID19-8900-15'],,https://clinicaltrials.gov/show/NCT04397718,2020-11-01,0,0
1112,NCT04399005,Completed,2020-06-05,2020-06-10,No Results Posted,,,['DACD-HuY-2005'],,https://clinicaltrials.gov/show/NCT04399005,2020-06-05,0,0
1113,NCT04399317,Recruiting,2020-07-01,2020-08-01,No Results Posted,,,['MRC-05-018'],,https://clinicaltrials.gov/show/NCT04399317,2020-07-01,0,0
1114,NCT04399889,Recruiting,2021-04-01,2021-07-31,No Results Posted,,,['Pro00105410'],,https://clinicaltrials.gov/show/NCT04399889,2021-04-01,0,0
1115,NCT04399967,Recruiting,2021-06-30,2022-06-30,No Results Posted,,,['QTW 2020'],,https://clinicaltrials.gov/show/NCT04399967,2021-06-30,0,0
1116,NCT04401579,Recruiting,2023-08-01,2023-08-01,No Results Posted,,,['20-0006 ACTT-II'],,https://clinicaltrials.gov/show/NCT04401579,2023-08-01,0,0
1117,NCT04402866,Recruiting,2020-10-01,2020-10-01,No Results Posted,,,"['0188', '2020-001807-18 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04402866,2020-10-01,0,0
1118,NCT04404361,Recruiting,2020-07-31,2021-10-31,No Results Posted,,,['PAC319'],,https://clinicaltrials.gov/show/NCT04404361,2020-07-31,0,0
1119,NCT04405076,Recruiting,2021-03-01,2021-08-01,No Results Posted,,,"['mRNA-1273-P201', '75A50120C00034 ( Other Grant/Funding Number: BARDA )']",,https://clinicaltrials.gov/show/NCT04405076,2021-03-01,0,0
1120,NCT04405570,Recruiting,2020-08-01,2020-09-01,No Results Posted,,,['EIDD-2801-2003'],,https://clinicaltrials.gov/show/NCT04405570,2020-08-01,0,0
1121,NCT04405739,Recruiting,2020-08-01,2020-09-01,No Results Posted,,,['EIDD-2801-2004'],,https://clinicaltrials.gov/show/NCT04405739,2020-08-01,0,0
1122,NCT04405908,Recruiting,2020-10-20,2021-03-30,No Results Posted,,,['CLO-SCB-2019-001'],,https://clinicaltrials.gov/show/NCT04405908,2020-10-20,0,0
1123,NCT04405921,Not yet recruiting,2020-12-01,2021-03-01,No Results Posted,,,['PACTT'],,https://clinicaltrials.gov/show/NCT04405921,2020-12-01,0,0
1124,NCT04405934,Not yet recruiting,2020-10-01,2021-04-01,No Results Posted,,,"['CTU/2020/353', '283014 ( Other Identifier: IRAS )', '20/EE/0118 ( Other Identifier: REC reference )']",,https://clinicaltrials.gov/show/NCT04405934,2020-10-01,0,0
1125,NCT04407130,Enrolling by invitation,2020-07-01,2020-07-01,No Results Posted,,,['PR-20039'],,https://clinicaltrials.gov/show/NCT04407130,2020-07-01,0,0
1126,NCT04407689,Recruiting,2020-10-30,2020-12-30,No Results Posted,,"['Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11. Erratum in: Lancet. 2020 Mar 28;395(10229):1038. Lancet. 2020 Mar 28;395(10229):1038.', 'Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Feb 7. doi: 10.1001/jama.2020.1585. [Epub ahead of print]']",['CLI107 COVID FR (ILIAD-7-FR)'],,https://clinicaltrials.gov/show/NCT04407689,2020-10-30,0,1
1127,NCT04409262,Recruiting,2020-07-31,2020-07-31,No Results Posted,,,"['WA42511', '2020-002275-34 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04409262,2020-07-31,0,0
1128,NCT04409925,Not yet recruiting,2020-08-01,2021-01-01,No Results Posted,,,['DISCONNECT-1'],,https://clinicaltrials.gov/show/NCT04409925,2020-08-01,0,0
1129,NCT04410159,Recruiting,2020-07-15,2020-08-15,No Results Posted,,"['Eggers M, Koburger-Janssen T, Eickmann M, Zorn J. In Vitro Bactericidal and Virucidal Efficacy of Povidone-Iodine Gargle/Mouthwash Against Respiratory and Oral Tract Pathogens. Infect Dis Ther. 2018 Jun;7(2):249-259. doi: 10.1007/s40121-018-0200-7. Epub 2018 Apr 9.']",['USIMalaysia'],,https://clinicaltrials.gov/show/NCT04410159,2020-07-15,0,1
1130,NCT04410354,Recruiting,2020-07-01,2020-08-01,No Results Posted,,,['VC-02-01'],,https://clinicaltrials.gov/show/NCT04410354,2020-07-01,0,0
1131,NCT04411628,Recruiting,2020-08-23,2020-08-23,No Results Posted,,,"['17823', 'J2W-MC-PYAA ( Other Identifier: Eli Lilly and Company )']",,https://clinicaltrials.gov/show/NCT04411628,2020-08-23,0,0
1132,NCT04412291,Recruiting,2020-08-01,2021-02-01,No Results Posted,,,['2020-001748-24'],,https://clinicaltrials.gov/show/NCT04412291,2020-08-01,0,0
1133,NCT04412330,Recruiting,2021-05-01,2021-05-01,No Results Posted,,,['59097'],,https://clinicaltrials.gov/show/NCT04412330,2021-05-01,0,0
1134,NCT04412668,Recruiting,2020-10-31,2020-10-31,No Results Posted,,,['ATYR1923-C-003'],,https://clinicaltrials.gov/show/NCT04412668,2020-10-31,0,0
1135,NCT04414267,Recruiting,2021-05-25,2021-05-25,No Results Posted,,,"['Activate II', '2020-002448-21 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04414267,2021-05-25,0,0
1136,NCT04415060,Not yet recruiting,2022-06-15,2022-06-15,No Results Posted,,,['2149'],,https://clinicaltrials.gov/show/NCT04415060,2022-06-15,0,0
1137,NCT04417257,Recruiting,2020-12-15,2021-01-15,No Results Posted,,,['LAU-20-01'],,https://clinicaltrials.gov/show/NCT04417257,2020-12-15,0,0
1138,NCT04419610,Not yet recruiting,2020-08-01,2021-01-01,No Results Posted,,,['283093'],,https://clinicaltrials.gov/show/NCT04419610,2020-08-01,0,0
1139,NCT04420247,Recruiting,2020-08-31,2020-08-31,No Results Posted,,,['CLOROTRIAL'],,https://clinicaltrials.gov/show/NCT04420247,2020-08-31,0,0
1140,NCT04420338,Recruiting,2020-12-15,2020-12-15,No Results Posted,,,"['2020-34', '2020-A01515-34 ( Registry Identifier: ID RCB )']",,https://clinicaltrials.gov/show/NCT04420338,2020-12-15,0,0
1141,NCT04420741,Recruiting,2021-05-31,2021-05-31,No Results Posted,,,"['COMBAT-COVID-19', '2020-001296-33 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04420741,2021-05-31,0,0
1142,NCT04421027,Recruiting,2020-09-01,2020-09-01,No Results Posted,,,"['17830', 'I4V-MC-KHAA ( Other Identifier: Eli Lilly and Company )', '2020-001517-21 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04421027,2020-09-01,0,0
1143,NCT04421508,Not yet recruiting,2021-02-01,2021-06-01,No Results Posted,,,['PULSE-CVD19-001'],,https://clinicaltrials.gov/show/NCT04421508,2021-02-01,0,0
1144,NCT04422561,Recruiting,2020-06-01,2020-07-01,No Results Posted,,,['ZU-IRB#6150/31-5-2020'],,https://clinicaltrials.gov/show/NCT04422561,2020-06-01,0,0
1145,NCT04425031,Not yet recruiting,2022-12-01,2024-03-01,No Results Posted,,,"['AAUH-ICU-03', '2017-000632-34 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04425031,2022-12-01,0,0
1146,NCT04425629,Recruiting,2020-11-21,2020-11-21,No Results Posted,,,['R10933-10987-COV-2067'],,https://clinicaltrials.gov/show/NCT04425629,2020-11-21,0,0
1147,NCT04425720,Not yet recruiting,2021-06-01,2021-06-01,No Results Posted,,,['pending'],,https://clinicaltrials.gov/show/NCT04425720,2021-06-01,0,0
1148,NCT04426695,Recruiting,2021-03-03,2021-03-03,No Results Posted,,,['R10933-10987-COV-2066'],,https://clinicaltrials.gov/show/NCT04426695,2021-03-03,0,0
1149,NCT04427098,Recruiting,2020-10-30,2020-10-30,No Results Posted,,,['2020-001308-40'],,https://clinicaltrials.gov/show/NCT04427098,2020-10-30,0,0
1150,NCT04427137,Recruiting,2022-06-01,2022-12-01,No Results Posted,,,['071-2020'],,https://clinicaltrials.gov/show/NCT04427137,2022-06-01,0,0
1151,NCT04427501,Recruiting,2020-09-15,2020-09-15,No Results Posted,,,"['17947', 'J2W-MC-PYAB ( Other Identifier: Eli Lilly and Company )']",,https://clinicaltrials.gov/show/NCT04427501,2020-09-15,0,0
1152,NCT04427566,Recruiting,2021-12-31,2021-12-31,No Results Posted,,,['VENTED'],,https://clinicaltrials.gov/show/NCT04427566,2021-12-31,0,0
1153,NCT04428008,Not yet recruiting,2021-01-01,2021-06-01,No Results Posted,,,['ACW-1221958-1'],,https://clinicaltrials.gov/show/NCT04428008,2021-01-01,0,0
1154,NCT04432051,Recruiting,2020-06-20,2020-06-26,No Results Posted,,,['Gaziosmanpasa'],,https://clinicaltrials.gov/show/NCT04432051,2020-06-20,0,0
1155,NCT04432103,Not yet recruiting,2020-07-30,2020-09-30,No Results Posted,,"['Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, Hu Y, Tao ZW, Tian JH, Pei YY, Yuan ML, Zhang YL, Dai FH, Liu Y, Wang QM, Zheng JJ, Xu L, Holmes EC, Zhang YZ. A new coronavirus associated with human respiratory disease in China. Nature. 2020 Mar;579(7798):265-269. doi: 10.1038/s41586-020-2008-3. Epub 2020 Feb 3. Erratum in: Nature. 2020 Apr;580(7803):E7.', 'van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, Tamin A, Harcourt JL, Thornburg NJ, Gerber SI, Lloyd-Smith JO, de Wit E, Munster VJ. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med. 2020 Apr 16;382(16):1564-1567. doi: 10.1056/NEJMc2004973. Epub 2020 Mar 17.', 'Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, Yu J, Kang M, Song Y, Xia J, Guo Q, Song T, He J, Yen HL, Peiris M, Wu J. SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients. N Engl J Med. 2020 Mar 19;382(12):1177-1179. doi: 10.1056/NEJMc2001737. Epub 2020 Feb 19.', 'Burke RM, Midgley CM, Dratch A, Fenstersheib M, Haupt T, Holshue M, Ghinai I, Jarashow MC, Lo J, McPherson TD, Rudman S, Scott S, Hall AJ, Fry AM, Rolfes MA. Active Monitoring of Persons Exposed to Patients with Confirmed COVID-19 - United States, January-February 2020. MMWR Morb Mortal Wkly Rep. 2020 Mar 6;69(9):245-246. doi: 10.15585/mmwr.mm6909e1.', 'Bai Y, Yao L, Wei T, Tian F, Jin DY, Chen L, Wang M. Presumed Asymptomatic Carrier Transmission of COVID-19. JAMA. 2020 Feb 21. doi: 10.1001/jama.2020.2565. [Epub ahead of print]', 'Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, Zimmer T, Thiel V, Janke C, Guggemos W, Seilmaier M, Drosten C, Vollmar P, Zwirglmaier K, Zange S, W√∂lfel R, Hoelscher M. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. N Engl J Med. 2020 Mar 5;382(10):970-971. doi: 10.1056/NEJMc2001468. Epub 2020 Jan 30.', 'Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, Chen HD, Chen J, Luo Y, Guo H, Jiang RD, Liu MQ, Chen Y, Shen XR, Wang X, Zheng XS, Zhao K, Chen QJ, Deng F, Liu LL, Yan B, Zhan FX, Wang YY, Xiao GF, Shi ZL. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020 Mar;579(7798):270-273. doi: 10.1038/s41586-020-2012-7. Epub 2020 Feb 3.', 'Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, Du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.', 'Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung KSM, Lau EHY, Wong JY, Xing X, Xiang N, Wu Y, Li C, Chen Q, Li D, Liu T, Zhao J, Liu M, Tu W, Chen C, Jin L, Yang R, Wang Q, Zhou S, Wang R, Liu H, Luo Y, Liu Y, Shao G, Li H, Tao Z, Yang Y, Deng Z, Liu B, Ma Z, Zhang Y, Shi G, Lam TTY, Wu JT, Gao GF, Cowling BJ, Yang B, Leung GM, Feng Z. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020 Mar 26;382(13):1199-1207. doi: 10.1056/NEJMoa2001316. Epub 2020 Jan 29.', 'Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, Azman AS, Reich NG, Lessler J. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Ann Intern Med. 2020 May 5;172(9):577-582. doi: 10.7326/M20-0504. Epub 2020 Mar 10.', 'Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 Feb 24. doi: 10.1001/jama.2020.2648. [Epub ahead of print]', 'Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30;:.', 'Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.', 'Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Feb 7. doi: 10.1001/jama.2020.1585. [Epub ahead of print]', 'Liu K, Fang YY, Deng Y, Liu W, Wang MF, Ma JP, Xiao W, Wang YN, Zhong MH, Li CH, Li GC, Liu HG. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J (Engl). 2020 May 5;133(9):1025-1031. doi: 10.1097/CM9.0000000000000744.', 'Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y, Zhang L, Yu Z, Fang M, Yu T, Wang Y, Pan S, Zou X, Yuan S, Shang Y. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24. Erratum in: Lancet Respir Med. 2020 Apr;8(4):e26.', 'Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, Huang H, Zhang L, Zhou X, Du C, Zhang Y, Song J, Wang S, Chao Y, Yang Z, Xu J, Zhou X, Chen D, Xiong W, Xu L, Zhou F, Jiang J, Bai C, Zheng J, Song Y. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020 Mar 13. doi: 10.1001/jamainternmed.2020.0994. [Epub ahead of print]', 'Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11. Erratum in: Lancet. 2020 Mar 28;395(10229):1038. Lancet. 2020 Mar 28;395(10229):1038.', 'Patel A, Jernigan DB; 2019-nCoV CDC Response Team. Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak - United States, December 31, 2019-February 4, 2020. MMWR Morb Mortal Wkly Rep. 2020 Feb 7;69(5):140-146. doi: 10.15585/mmwr.mm6905e1. Erratum in: MMWR Morb Mortal Wkly Rep. 2020 Feb 14;69(6):173.', 'Lu H. Drug treatment options for the 2019-new coronavirus (2019-nCoV). Biosci Trends. 2020 Mar 16;14(1):69-71. doi: 10.5582/bst.2020.01020. Epub 2020 Jan 28.', 'Kraft CS, Hewlett AL, Koepsell S, Winkler AM, Kratochvil CJ, Larson L, Varkey JB, Mehta AK, Lyon GM 3rd, Friedman-Moraco RJ, Marconi VC, Hill CE, Sullivan JN, Johnson DW, Lisco SJ, Mulligan MJ, Uyeki TM, McElroy AK, Sealy T, Campbell S, Spiropoulou C, Str√∂her U, Crozier I, Sacra R, Connor MJ Jr, Sueblinvong V, Franch HA, Smith PW, Ribner BS; Nebraska Biocontainment Unit and the Emory Serious Communicable Diseases Unit. The Use of TKM-100802 and Convalescent Plasma in 2 Patients With Ebola Virus Disease in the United States. Clin Infect Dis. 2015 Aug 15;61(4):496-502. doi: 10.1093/cid/civ334. Epub 2015 Apr 22.', 'van Griensven J, Edwards T, de Lamballerie X, Semple MG, Gallian P, Baize S, Horby PW, Raoul H, Magassouba N, Antierens A, Lomas C, Faye O, Sall AA, Fransen K, Buyze J, Ravinetto R, Tiberghien P, Claeys Y, De Crop M, Lynen L, Bah EI, Smith PG, Delamou A, De Weggheleire A, Haba N; Ebola-Tx Consortium. Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea. N Engl J Med. 2016 Jan 7;374(1):33-42. doi: 10.1056/NEJMoa1511812.', 'Florescu DF, Kalil AC, Hewlett AL, Schuh AJ, Stroher U, Uyeki TM, Smith PW. Administration of Brincidofovir and Convalescent Plasma in a Patient With Ebola Virus Disease. Clin Infect Dis. 2015 Sep 15;61(6):969-73. doi: 10.1093/cid/civ395. Epub 2015 May 19.', 'Zhou B, Zhong N, Guan Y. Treatment with convalescent plasma for influenza A (H5N1) infection. N Engl J Med. 2007 Oct 4;357(14):1450-1.', 'Hung IF, To KK, Lee CK, Lee KL, Chan K, Yan WW, Liu R, Watt CL, Chan WM, Lai KY, Koo CK, Buckley T, Chow FL, Wong KK, Chan HS, Ching CK, Tang BS, Lau CC, Li IW, Liu SH, Chan KH, Lin CK, Yuen KY. Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection. Clin Infect Dis. 2011 Feb 15;52(4):447-56. doi: 10.1093/cid/ciq106. Epub 2011 Jan 19.', 'Burnouf T, Radosevich M. Treatment of severe acute respiratory syndrome with convalescent plasma. Hong Kong Med J. 2003 Aug;9(4):309; author reply 310.', 'Cheng Y, Wong R, Soo YO, Wong WS, Lee CK, Ng MH, Chan P, Wong KC, Leung CB, Cheng G. Use of convalescent plasma therapy in SARS patients in Hong Kong. Eur J Clin Microbiol Infect Dis. 2005 Jan;24(1):44-6.', 'Mair-Jenkins J, Saavedra-Campos M, Baillie JK, Cleary P, Khaw FM, Lim WS, Makki S, Rooney KD, Nguyen-Van-Tam JS, Beck CR; Convalescent Plasma Study Group. The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis. J Infect Dis. 2015 Jan 1;211(1):80-90. doi: 10.1093/infdis/jiu396. Epub 2014 Jul 16. Review.', 'Casadevall A, Pirofski LA. The convalescent sera option for containing COVID-19. J Clin Invest. 2020 Apr 1;130(4):1545-1548. doi: 10.1172/JCI138003.', 'Shen C, Wang Z, Zhao F, Yang Y, Li J, Yuan J, Wang F, Li D, Yang M, Xing L, Wei J, Xiao H, Yang Y, Qu J, Qing L, Chen L, Xu Z, Peng L, Li Y, Zheng H, Chen F, Huang K, Jiang Y, Liu D, Zhang Z, Liu Y, Liu L. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma. JAMA. 2020 Mar 27. doi: 10.1001/jama.2020.4783. [Epub ahead of print]', 'Zhang B, Liu S, Tan T, Huang W, Dong Y, Chen L, Chen Q, Zhang L, Zhong Q, Zhang X, Zou Y, Zhang S. Treatment With Convalescent Plasma for Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Chest. 2020 Mar 31. pii: S0012-3692(20)30571-7. doi: 10.1016/j.chest.2020.03.039. [Epub ahead of print]', 'Duan K, Liu B, Li C, Zhang H, Yu T, Qu J, Zhou M, Chen L, Meng S, Hu Y, Peng C, Yuan M, Huang J, Wang Z, Yu J, Gao X, Wang D, Yu X, Li L, Zhang J, Wu X, Li B, Xu Y, Chen W, Peng Y, Hu Y, Lin L, Liu X, Huang S, Zhou Z, Zhang L, Wang Y, Zhang Z, Deng K, Xia Z, Gong Q, Zhang W, Zheng X, Liu Y, Yang H, Zhou D, Yu D, Hou J, Shi Z, Chen S, Chen Z, Zhang X, Yang X. Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proc Natl Acad Sci U S A. 2020 Apr 28;117(17):9490-9496. doi: 10.1073/pnas.2004168117. Epub 2020 Apr 6.', 'Bloch EM, Shoham S, Casadevall A, Sachais BS, Shaz B, Winters JL, van Buskirk C, Grossman BJ, Joyner M, Henderson JP, Pekosz A, Lau B, Wesolowski A, Katz L, Shan H, Auwaerter PG, Thomas D, Sullivan DJ, Paneth N, Gehrie E, Spitalnik S, Hod EA, Pollack L, Nicholson WT, Pirofski LA, Bailey JA, Tobian AA. Deployment of convalescent plasma for the prevention and treatment of COVID-19. J Clin Invest. 2020 Jun 1;130(6):2757-2765. doi: 10.1172/JCI138745. Review.', ""O'Shaughnessy DF, Atterbury C, Bolton Maggs P, Murphy M, Thomas D, Yates S, Williamson LM; British Committee for Standards in Haematology, Blood Transfusion Task Force. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol. 2004 Jul;126(1):11-28.""]",['ABC-20-14'],,https://clinicaltrials.gov/show/NCT04432103,2020-07-30,0,1
1156,NCT04432298,Recruiting,2020-12-01,2021-01-01,No Results Posted,,,['FGCL-3019-098'],,https://clinicaltrials.gov/show/NCT04432298,2020-12-01,0,0
1157,NCT04432766,Not yet recruiting,2020-10-03,2021-01-18,No Results Posted,,,['BAT2020-001-CR'],,https://clinicaltrials.gov/show/NCT04432766,2020-10-03,0,0
1158,NCT04432805,Recruiting,2021-06-15,2021-06-15,No Results Posted,,,"['2020-30', '2020-A01303-36 ( Other Identifier: ID RCB )']",,https://clinicaltrials.gov/show/NCT04432805,2021-06-15,0,0
1159,NCT04432987,Recruiting,2020-08-25,2020-09-25,No Results Posted,,,['8820'],,https://clinicaltrials.gov/show/NCT04432987,2020-08-25,0,0
1160,NCT04433013,Not yet recruiting,2020-12-01,2021-02-01,No Results Posted,,,['IRB-2020-05-029'],,https://clinicaltrials.gov/show/NCT04433013,2020-12-01,0,0
1161,NCT04433078,Recruiting,2021-01-01,2021-07-01,No Results Posted,,,['The STORM Trial'],,https://clinicaltrials.gov/show/NCT04433078,2021-01-01,0,0
1162,NCT04433546,Not yet recruiting,2020-12-18,2020-12-18,No Results Posted,,,['PB1046-PT-CL-0007'],,https://clinicaltrials.gov/show/NCT04433546,2020-12-18,0,0
1163,NCT04433910,Recruiting,2020-12-01,2021-02-01,No Results Posted,,,"['CAPSID2020-DRK-BSD', '2020-001310-38 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04433910,2020-12-01,0,0
1164,NCT04433949,Recruiting,2022-05-30,2022-05-30,No Results Posted,,,"['STUDY00000781', 'NCI-2020-04061 ( Registry Identifier: CTRP (Clinical Trial Reporting Program) )', 'RAD5049-20 ( Other Identifier: Emory University Hospital/Winship Cancer Institute )', 'P30CA138292 ( U.S. NIH Grant/Contract )']",,https://clinicaltrials.gov/show/NCT04433949,2022-05-30,0,0
1165,NCT04434248,"Active, not recruiting",2020-07-01,2020-07-01,No Results Posted,,,['COVID-FPR-01'],,https://clinicaltrials.gov/show/NCT04434248,2020-07-01,0,0
1166,NCT04435015,Not yet recruiting,2020-12-30,2021-07-30,No Results Posted,,,['2000028279'],,https://clinicaltrials.gov/show/NCT04435015,2020-12-30,0,0
1167,NCT04435184,Not yet recruiting,2020-10-01,2020-10-01,No Results Posted,,,['IRB00249874'],,https://clinicaltrials.gov/show/NCT04435184,2020-10-01,0,0
1168,NCT04435275,Not yet recruiting,2021-03-31,2021-05-01,No Results Posted,,,['20-5399'],,https://clinicaltrials.gov/show/NCT04435275,2021-03-31,0,0
1169,NCT04435314,Not yet recruiting,2020-08-01,2020-08-01,No Results Posted,,,['NITFQM0620OR'],,https://clinicaltrials.gov/show/NCT04435314,2020-08-01,0,0
1170,NCT04435353,Recruiting,2020-12-31,2021-02-01,No Results Posted,,,['AstanaMU'],,https://clinicaltrials.gov/show/NCT04435353,2020-12-31,0,0
1171,NCT04435379,Recruiting,2021-05-31,2021-05-31,No Results Posted,,,"['VPM1002-DE-3.07CoV', '2020-001675-33 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04435379,2021-05-31,0,0
1172,NCT04435587,Not yet recruiting,2021-06-01,2021-11-01,No Results Posted,,,['323/2563 (IRB3)'],,https://clinicaltrials.gov/show/NCT04435587,2021-06-01,0,0
1173,NCT04435717,Recruiting,2020-08-04,2020-08-04,No Results Posted,,,['COVITOZ-01'],,https://clinicaltrials.gov/show/NCT04435717,2020-08-04,0,0
1174,NCT04435795,Not yet recruiting,2021-02-25,2021-03-25,No Results Posted,,,['2021-6696'],,https://clinicaltrials.gov/show/NCT04435795,2021-02-25,0,0
1175,NCT04435808,Recruiting,2021-04-14,2025-04-14,No Results Posted,,,['20-206'],,https://clinicaltrials.gov/show/NCT04435808,2021-04-14,0,0
1176,NCT04436276,Not yet recruiting,2021-09-15,2023-07-08,No Results Posted,,,"['CR108828', '2020-001483-28 ( EudraCT Number )', 'VAC31518COV1001 ( Other Identifier: Janssen Vaccines & Prevention B.V. )']",,https://clinicaltrials.gov/show/NCT04436276,2021-09-15,0,0
1177,NCT04436458,Not yet recruiting,2021-01-01,2021-02-01,No Results Posted,,,['FW-COV-002'],,https://clinicaltrials.gov/show/NCT04436458,2021-01-01,0,0
1178,NCT04436471,Recruiting,2020-08-05,2020-08-15,No Results Posted,,,['02-Gam-COVID-Vac-2020'],,https://clinicaltrials.gov/show/NCT04436471,2020-08-05,0,0
1179,NCT04437693,Not yet recruiting,2021-06-30,2021-12-31,No Results Posted,,,['MRC-02-20-442'],,https://clinicaltrials.gov/show/NCT04437693,2021-06-30,0,0
1180,NCT04437719,Not yet recruiting,2021-12-31,2021-12-31,No Results Posted,,"['Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.', 'Gliklich RE, Dreyer NA, Leavy MB, Christian JB, editors. 21st Century Patient Registries: Registries for Evaluating Patient Outcomes: A User‚Äôs Guide: 3rd Edition, Addendum [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 Mar. Available from http://www.ncbi.nlm.nih.gov/books/NBK493818/']",['OBVIONCO'],,https://clinicaltrials.gov/show/NCT04437719,2021-12-31,0,1
1181,NCT04437823,Recruiting,2021-05-31,2021-06-30,No Results Posted,,,['JB&RSC-01'],,https://clinicaltrials.gov/show/NCT04437823,2021-05-31,0,0
1182,NCT04437875,Recruiting,2020-08-05,2020-08-15,No Results Posted,,,['03-Gam-COVID-Vac Lyo-2020'],,https://clinicaltrials.gov/show/NCT04437875,2020-08-05,0,0
1183,NCT04438057,Not yet recruiting,2021-07-06,2021-07-06,No Results Posted,,,['MIDC-CCP'],,https://clinicaltrials.gov/show/NCT04438057,2021-07-06,0,0
1184,NCT04438070,Recruiting,2020-06-01,2020-06-01,No Results Posted,,,['2020-10864-T'],,https://clinicaltrials.gov/show/NCT04438070,2020-06-01,0,0
1185,NCT04438694,Recruiting,2021-05-31,2021-12-31,No Results Posted,,,['N39-2020'],,https://clinicaltrials.gov/show/NCT04438694,2021-05-31,0,0
1186,NCT04438837,Not yet recruiting,2022-06-01,2022-06-01,No Results Posted,,"['Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 Feb 24. doi: 10.1001/jama.2020.2648. [Epub ahead of print]', 'Livingston E, Bucher K. Coronavirus Disease 2019 (COVID-19) in Italy. JAMA. 2020 Mar 17. doi: 10.1001/jama.2020.4344. [Epub ahead of print]', 'Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, Xing F, Liu J, Yip CC, Poon RW, Tsoi HW, Lo SK, Chan KH, Poon VK, Chan WM, Ip JD, Cai JP, Cheng VC, Chen H, Hui CK, Yuen KY. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020 Feb 15;395(10223):514-523. doi: 10.1016/S0140-6736(20)30154-9. Epub 2020 Jan 24.', 'Chang, Xu H, Rebaza A, Sharma L, Dela Cruz CS. Protecting health-care workers from subclinical coronavirus infection. Lancet Respir Med. 2020 Mar;8(3):e13. doi: 10.1016/S2213-2600(20)30066-7. Epub 2020 Feb 13.', 'Shiryaev SA, Mesci P, Pinto A, Fernandes I, Sheets N, Shresta S, Farhy C, Huang CT, Strongin AY, Muotri AR, Terskikh AV. Repurposing of the anti-malaria drug chloroquine for Zika Virus treatment and prophylaxis. Sci Rep. 2017 Nov 17;7(1):15771. doi: 10.1038/s41598-017-15467-6.', 'Devaux CA, Rolain JM, Colson P, Raoult D. New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? Int J Antimicrob Agents. 2020 May;55(5):105938. doi: 10.1016/j.ijantimicag.2020.105938. Epub 2020 Mar 12.']",['0193-20-RMB CTIL'],,https://clinicaltrials.gov/show/NCT04438837,2022-06-01,0,1
1187,NCT04438850,Not yet recruiting,2020-08-01,2020-10-01,No Results Posted,,,['cover_1'],,https://clinicaltrials.gov/show/NCT04438850,2020-08-01,0,0
1188,NCT04438980,Recruiting,2020-12-01,2021-02-01,No Results Posted,,,['CORTIVID'],,https://clinicaltrials.gov/show/NCT04438980,2020-12-01,0,0
1189,NCT04439006,Not yet recruiting,2021-12-31,2022-12-31,No Results Posted,,,"['OSU-20135', 'NCI-2020-03341 ( Registry Identifier: CTRP (Clinical Trial Reporting Program) )', 'P30CA016058 ( U.S. NIH Grant/Contract )']",,https://clinicaltrials.gov/show/NCT04439006,2021-12-31,0,0
1190,NCT04439045,Not yet recruiting,2021-04-01,2021-06-01,No Results Posted,,,['20-5413'],,https://clinicaltrials.gov/show/NCT04439045,2021-04-01,0,0
1191,NCT04439071,Not yet recruiting,2021-01-30,2021-01-30,No Results Posted,,,"['PTC299-VIR-015-COV19', '2020-001872-13 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04439071,2021-01-30,0,0
1192,NCT04440007,Not yet recruiting,2021-01-01,2021-03-01,No Results Posted,,,['STI-5656-2001'],,https://clinicaltrials.gov/show/NCT04440007,2021-01-01,0,0
1193,NCT04441385,Not yet recruiting,2020-11-30,2020-12-20,No Results Posted,,,"['MARACOVID', '2020-002011-21 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04441385,2020-11-30,0,0
1194,NCT04441398,Not yet recruiting,2020-09-01,2020-09-01,No Results Posted,,,['NITFQM0720OR'],,https://clinicaltrials.gov/show/NCT04441398,2020-09-01,0,0
1195,NCT04441424,Completed,2020-06-01,2020-06-01,No Results Posted,,,['CPT-COVID-19'],,https://clinicaltrials.gov/show/NCT04441424,2020-06-01,0,0
1196,NCT04441632,Recruiting,2020-07-26,2020-07-30,No Results Posted,,,['STUDY00000786'],,https://clinicaltrials.gov/show/NCT04441632,2020-07-26,0,0
1197,NCT04441684,Recruiting,2020-05-07,2021-08-01,No Results Posted,,,['7782'],,https://clinicaltrials.gov/show/NCT04441684,2020-05-07,0,0
1198,NCT04441918,Recruiting,2020-12-11,2020-12-11,No Results Posted,,,['JS016-001-I'],,https://clinicaltrials.gov/show/NCT04441918,2020-12-11,0,0
1199,NCT04441996,Not yet recruiting,2020-10-01,2020-10-01,No Results Posted,,,['STUDY00000949'],,https://clinicaltrials.gov/show/NCT04441996,2020-10-01,0,0
1200,NCT04442048,Not yet recruiting,2020-12-31,2021-03-31,No Results Posted,,,['IC8'],,https://clinicaltrials.gov/show/NCT04442048,2020-12-31,0,0
1201,NCT04442152,Enrolling by invitation,2020-08-01,2020-08-01,No Results Posted,,,['265A'],,https://clinicaltrials.gov/show/NCT04442152,2020-08-01,0,0
1202,NCT04442178,Not yet recruiting,2020-11-30,2020-12-31,No Results Posted,,"['Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11. Erratum in: Lancet. 2020 Mar 28;395(10229):1038. Lancet. 2020 Mar 28;395(10229):1038.', 'Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Feb 7. doi: 10.1001/jama.2020.1585. [Epub ahead of print]', 'Francois B, Jeannet R, Daix T, Walton AH, Shotwell MS, Unsinger J, Monneret G, Rimmel√© T, Blood T, Morre M, Gregoire A, Mayo GA, Blood J, Durum SK, Sherwood ER, Hotchkiss RS. Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial. JCI Insight. 2018 Mar 8;3(5). pii: 98960. doi: 10.1172/jci.insight.98960.', 'Venet F, Foray AP, Villars-M√©chin A, Malcus C, Poitevin-Later F, Lepape A, Monneret G. IL-7 restores lymphocyte functions in septic patients. J Immunol. 2012 Nov 15;189(10):5073-81. doi: 10.4049/jimmunol.1202062. Epub 2012 Oct 10.']",['ILIAD-7 COVID US INFECTIOUS'],,https://clinicaltrials.gov/show/NCT04442178,2020-11-30,0,1
1203,NCT04442191,Recruiting,2021-05-05,2021-05-05,No Results Posted,,,['2020-0441'],,https://clinicaltrials.gov/show/NCT04442191,2021-05-05,0,0
1204,NCT04442230,Not yet recruiting,2020-11-01,2020-12-01,No Results Posted,,,['ALT-601-201'],,https://clinicaltrials.gov/show/NCT04442230,2020-11-01,0,0
1205,NCT04442958,Completed,2020-06-15,2020-06-17,No Results Posted,,,['2020.05.2.14.070'],,https://clinicaltrials.gov/show/NCT04442958,2020-06-15,0,0
1206,NCT04443270,Not yet recruiting,2020-08-31,2020-11-30,No Results Posted,,,['01'],,https://clinicaltrials.gov/show/NCT04443270,2020-08-31,0,0
1207,NCT04443673,Recruiting,2021-02-28,2021-06-30,No Results Posted,,,['C40-20'],,https://clinicaltrials.gov/show/NCT04443673,2021-02-28,0,0
1208,NCT04443725,Not yet recruiting,2020-10-01,2020-12-01,No Results Posted,,,['CUKA-003'],,https://clinicaltrials.gov/show/NCT04443725,2020-10-01,0,0
1209,NCT04443868,Not yet recruiting,2021-04-01,2021-07-01,No Results Posted,,,['COVID-IND-01'],,https://clinicaltrials.gov/show/NCT04443868,2021-04-01,0,0
1210,NCT04443881,Recruiting,2020-12-01,2021-03-01,No Results Posted,,,['ANA-COVID-GEAS'],,https://clinicaltrials.gov/show/NCT04443881,2020-12-01,0,0
1211,NCT04444271,Recruiting,2020-08-30,2020-09-30,No Results Posted,,,['NIBMT-MSc-COVID-2020'],,https://clinicaltrials.gov/show/NCT04444271,2020-08-30,0,0
1212,NCT04444596,Recruiting,2021-03-31,2021-03-31,No Results Posted,,,['1104/2020'],,https://clinicaltrials.gov/show/NCT04444596,2021-03-31,0,0
1213,NCT04444674,Not yet recruiting,2020-10-01,2021-12-01,No Results Posted,,,['ChAdOx1 nCoV-19_ZA_phI/II'],,https://clinicaltrials.gov/show/NCT04444674,2020-10-01,0,0
1214,NCT04444700,Recruiting,2020-10-31,2020-12-31,No Results Posted,,,['CAAE: 33109220.7.0000.0068'],,https://clinicaltrials.gov/show/NCT04444700,2020-10-31,0,0
1215,NCT04445194,Not yet recruiting,2021-07-21,2021-09-20,No Results Posted,,,['NCV-‚Ö†-healthy'],,https://clinicaltrials.gov/show/NCT04445194,2021-07-21,0,0
1216,NCT04445220,Not yet recruiting,2021-02-01,2021-07-01,No Results Posted,,,['SBI-101-02'],,https://clinicaltrials.gov/show/NCT04445220,2021-02-01,0,0
1217,NCT04445246,Recruiting,2021-05-31,2021-05-31,No Results Posted,,,['MRC-05-026'],,https://clinicaltrials.gov/show/NCT04445246,2021-05-31,0,0
1218,NCT04445272,Recruiting,2020-08-22,2020-08-22,No Results Posted,,,['BREATH-19 (FSG011-20)'],,https://clinicaltrials.gov/show/NCT04445272,2020-08-22,0,0
1219,NCT04445285,Recruiting,2020-07-31,2020-07-31,No Results Posted,,,['USAH 1002 000'],,https://clinicaltrials.gov/show/NCT04445285,2020-07-31,0,0
1220,NCT04445311,Recruiting,2020-07-30,2020-08-15,No Results Posted,,,['ZU-IRB#6151/31-5-2020'],,https://clinicaltrials.gov/show/NCT04445311,2020-07-30,0,0
1221,NCT04445324,Not yet recruiting,2020-09-01,2020-10-01,No Results Posted,,,['2021-2281'],,https://clinicaltrials.gov/show/NCT04445324,2020-09-01,0,0
1222,NCT04445337,Not yet recruiting,2021-07-01,2021-07-01,No Results Posted,,,['603.20.FB'],,https://clinicaltrials.gov/show/NCT04445337,2021-07-01,0,0
1223,NCT04445376,Not yet recruiting,2020-07-20,2020-08-15,No Results Posted,,,['313'],,https://clinicaltrials.gov/show/NCT04445376,2020-07-20,0,0
1224,NCT04445389,Recruiting,2021-03-17,2022-06-17,No Results Posted,,,['GX-19-HV-001'],,https://clinicaltrials.gov/show/NCT04445389,2021-03-17,0,0
1225,NCT04445428,Not yet recruiting,2021-06-01,2021-06-01,No Results Posted,,,['77/CNES/INASA/2020'],,https://clinicaltrials.gov/show/NCT04445428,2021-06-01,0,0
1226,NCT04445454,Recruiting,2022-09-30,2022-09-30,No Results Posted,,,['TJT2012'],,https://clinicaltrials.gov/show/NCT04445454,2022-09-30,0,0
1227,NCT04445467,Not yet recruiting,2020-11-01,2020-11-01,No Results Posted,,,['66223'],,https://clinicaltrials.gov/show/NCT04445467,2020-11-01,0,0
1228,NCT04445597,Recruiting,2020-06-30,2020-06-30,No Results Posted,,,['S64042'],,https://clinicaltrials.gov/show/NCT04445597,2020-06-30,0,0
1229,NCT04445623,Not yet recruiting,2020-10-01,2021-01-01,No Results Posted,,,['MGI-COVID-19-prasugrel'],,https://clinicaltrials.gov/show/NCT04445623,2020-10-01,0,0
1230,NCT04445935,Recruiting,2020-09-28,2021-03-28,No Results Posted,,,['MRC-05-082'],,https://clinicaltrials.gov/show/NCT04445935,2020-09-28,0,0
1231,NCT04446065,Not yet recruiting,2020-10-30,2020-11-30,No Results Posted,,,['MEL109042020'],,https://clinicaltrials.gov/show/NCT04446065,2020-10-30,0,0
1232,NCT04446104,Recruiting,2020-07-01,2020-07-01,No Results Posted,,,['2020/00561'],,https://clinicaltrials.gov/show/NCT04446104,2020-07-01,0,0
1233,NCT04446377,Not yet recruiting,2020-12-31,2021-01-31,No Results Posted,,,['LAM-002A-CVD-CLN01'],,https://clinicaltrials.gov/show/NCT04446377,2020-12-31,0,0
1234,NCT04446429,Not yet recruiting,2020-12-31,2021-01-31,No Results Posted,,,['AB-DRUG-SARS-004'],,https://clinicaltrials.gov/show/NCT04446429,2020-12-31,0,0
1235,NCT04447235,Not yet recruiting,2020-12-01,2021-02-01,No Results Posted,,,['NP 1677/20'],,https://clinicaltrials.gov/show/NCT04447235,2020-12-01,0,0
1236,NCT04447469,Not yet recruiting,2021-02-01,2021-04-01,No Results Posted,,,['KPL-301-C203'],,https://clinicaltrials.gov/show/NCT04447469,2021-02-01,0,0
1237,NCT04447534,Recruiting,2020-08-01,2020-08-01,No Results Posted,,,['tanta zinc chloroquine'],,https://clinicaltrials.gov/show/NCT04447534,2020-08-01,0,0
1238,NCT04448119,Not yet recruiting,2021-03-01,2021-03-01,No Results Posted,,,['CONTROL-COVID-Favipiravir-1'],,https://clinicaltrials.gov/show/NCT04448119,2021-03-01,0,0
1239,NCT04448756,Not yet recruiting,2020-11-13,2020-11-13,No Results Posted,,,"['MS200569_0026', '2020-002248-22 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04448756,2020-11-13,0,0
1240,NCT04448769,Not yet recruiting,2020-07-01,2020-08-01,No Results Posted,,,['2020PI128'],,https://clinicaltrials.gov/show/NCT04448769,2020-07-01,0,0
1241,NCT04449276,Recruiting,2021-08-01,2021-08-01,No Results Posted,,,"['CV-NCOV-001', '2020-001286-36 ( EudraCT Number )']",,https://clinicaltrials.gov/show/NCT04449276,2021-08-01,0,0
1242,NCT04449380,Not yet recruiting,2021-02-01,2021-04-01,No Results Posted,,,['INTERCOP'],,https://clinicaltrials.gov/show/NCT04449380,2021-02-01,0,0
1243,NCT04324606,"Active, not recruiting",2021-05-01,2021-05-01,No Results Posted,,,['COV001'],,https://clinicaltrials.gov/show/NCT04324606,2021-05-01,0,0
1244,NCT04381936,Recruiting,2020-12-01,2021-06-01,No Results Posted,,,"['NDPHRECOVERY', '2020-001113-21 ( EudraCT Number )', 'ISRCTN50189673 ( Registry Identifier: ISRCTN )']",,https://clinicaltrials.gov/ct2/show/NCT04381936,2020-12-01,0,0
1245,NCT04348305,"Active, not recruiting",2021-03-30,2021-12-30,No Results Posted,,,"['RH-ITA-008', '2020-001395-15 ( EudraCT Number )']",,https://clinicaltrials.gov/ct2/show/NCT04348305,2021-03-30,0,0
1246,NCT04327388,Recruiting,2020-07-01,2020-08-01,No Results Posted,,,"['EFC16844', '2020-001162-12 ( EudraCT Number )']",,https://clinicaltrials.gov/ct2/show/NCT04327388,2020-07-01,0,0
1247,2020-000890-25,['Ongoing'],,,(No results available),,,{'spon_id': '202002102'},['FR'],,,0,0
1248,2020-000919-69,['Ongoing'],,,(No results available),,,{'spon_id': '73249'},['NL'],,,0,0
1249,2020-001023-14,['Ongoing'],,,(No results available),,,{'spon_id': 'SG016'},['GB'],,,0,0
1250,2020-001271-33,['Ongoing'],,,(No results available),,,{'spon_id': '49RC20_0071'},['FR'],,,0,0
1251,2020-001281-11,['Ongoing'],,,(No results available),,,{'spon_id': '20CH065'},['FR'],,,0,0
1252,2020-001236-10,['Ongoing'],,,(No results available),,,{'spon_id': 'COVID-19'},['NL'],,,0,0
1253,2020-001010-38,['Ongoing'],,,(No results available),,,{'spon_id': 'Ahus-NO-COVID-19'},['NO'],,,0,0
1254,2020-001301-23,['Ongoing'],,,(No results available),,,{'spon_id': 'APHP200387'},['FR'],,,0,0
1255,2020-001335-28,"['Ongoing', 'Ongoing']",,,(No results available),,,{'spon_id': 'IFX-1-P.2.9'},"['NL', 'DE']",,,0,0
1256,2020-001381-11,['Ongoing'],,,(No results available),,,{'spon_id': 'APHP200409'},['FR'],,,0,0
1257,2020-001457-43,['Ongoing'],,,(No results available),,,{'spon_id': 'APHP200388'},['FR'],,,0,0
1258,2020-001442-19,['Ongoing'],,,(No results available),,,{'spon_id': 'IIBSP-COV-2020-23'},['ES'],,,0,0
1259,2020-001385-11,['Ongoing'],,,(No results available),,,{'spon_id': 'PrEP_COVID_19'},['ES'],,,0,0
1260,2020-001409-21,['Ongoing'],,,(No results available),,,{'spon_id': 'IMIB-DFC-2020-02'},['ES'],,,0,0
1261,2020-001333-13,['Ongoing'],,,(No results available),,,{'spon_id': '20-37815010'},['FR'],,,0,0
1262,2020-001492-33,['Ongoing'],,,(No results available),,,{'spon_id': 'CGE_2020_9'},['FR'],,,0,0
1263,2020-001194-69,['Ongoing'],,,(No results available),,,{'spon_id': 'MEFLOCOVID-19'},['ES'],,,0,0
1264,2020-001565-37,['Ongoing'],,,(No results available),,,{'spon_id': 'PrEP_COVID'},['ES'],,,0,0
1265,2020-001421-31,['Ongoing'],,,(No results available),,,{'spon_id': 'QUINAVID-19'},['ES'],,,0,0
1266,2020-001606-33,['Ongoing'],,,(No results available),,,{'spon_id': 'HIACO-19'},['ES'],,,0,0
1267,2020-001307-16,['Ongoing'],,,(No results available),,,{'spon_id': 'SIC'},['ES'],,,0,0
1268,2020-001156-18,['Ongoing'],,,(No results available),,,{'spon_id': 'PanCOVID19'},['ES'],,,0,0
1269,2020-001160-28,['Ongoing'],,,(No results available),,,{'spon_id': 'MedOPP376'},['ES'],,,0,0
1270,2020-001262-11,['Ongoing'],,,(No results available),,,{'spon_id': 'FJD-COVID19-20-01'},['ES'],,,0,0
1271,2020-001290-74,['Ongoing'],,,(No results available),,,{'spon_id': 'SARICOVID'},['ES'],,,0,0
1272,2020-001406-27,['Ongoing'],,,(No results available),,,{'spon_id': 'RECHMPL20-168'},['FR'],,,0,0
1273,2020-001321-31,['Ongoing'],,,(No results available),,,{'spon_id': '24032020'},['ES'],,,0,0
1274,2020-001437-12,['Ongoing'],,,(No results available),,,{'spon_id': 'COVID-19_ASS'},['ES'],,,0,0
1275,2020-001530-35,['Ongoing'],,,(No results available),,,{'spon_id': 'MeCOVID'},['ES'],,,0,0
1276,2020-001587-29,['Ongoing'],,,(No results available),,,{'spon_id': '02/04/2020-001'},['ES'],,,0,0
1277,2020-001634-36,['Ongoing'],,,(No results available),,,{'spon_id': 'SARCOVID'},['ES'],,,0,0
1278,2020-001689-12,['Ongoing'],,,(No results available),,,{'spon_id': 'MHIPS-2020-001'},['ES'],,,0,0
1279,2020-001765-37,['Ongoing'],,,(No results available),,,{'spon_id': 'PROTOCOLO/ICO/COVID20'},['ES'],,,0,0
1280,2020-001466-11,['Ongoing'],,,(No results available),,,{'spon_id': 'SAVE'},['GR'],,,0,0
1281,2020-001379-34,['Ongoing'],,,(No results available),,,{'spon_id': 'SEVO-COVID19'},['ES'],,,0,0
1282,2020-001682-36,['Ongoing'],,,(No results available),,,{'spon_id': 'MSV_COVID'},['ES'],,,0,0
1283,2020-001511-25,['Ongoing'],,,(No results available),,,{'spon_id': 'IMIB-COLVID-2020-03'},['ES'],,,0,0
1284,2020-001266-11,['Ongoing'],,,(No results available),,,{'spon_id': 'BALMYS-19'},['ES'],,,0,0
1285,2020-001448-24,['Ongoing'],,,(No results available),,,{'spon_id': 'RG_20-029COVID-19'},['GB'],,,0,0
1286,2020-001254-22,['Ongoing'],,,(No results available),,,{'spon_id': 'SARPAC'},['BE'],,,0,0
1287,2020-001391-15,['Ongoing'],,,(No results available),,,{'spon_id': 'V1Mar2020'},['IE'],,,0,0
1288,2020-001329-30,['Ongoing'],,,(No results available),,,{'spon_id': '2020P000787'},['AT'],,,0,0
1289,2020-001527-14,['Ongoing'],,,(No results available),,,{'spon_id': '1'},['NL'],,,0,0
1290,2020-001255-40,['Ongoing'],,,(No results available),,,{'spon_id': 'STRIKE-SARS-CoV2'},['ES'],,,0,0
1291,2020-001659-42,['Ongoing'],,,(No results available),,,{'spon_id': 'ANTITROMBINA'},['ES'],,,0,0
1292,2020-001622-64,['Ongoing'],,,(No results available),,,{'spon_id': 'TAC-COVID19'},['ES'],,,0,0
1293,2020-001440-26,['Ongoing'],,,(No results available),,,{'spon_id': 'PrevenCOVID-19'},['ES'],,,0,0
1294,2020-001327-13,['Ongoing'],,,(No results available),,,{'spon_id': 'OnCoVID19Trial'},['AT'],,,0,0
1295,2020-001459-42,['Ongoing'],,,(No results available),,,{'spon_id': '26223678Hans'},['DK'],,,0,0
1296,2020-001417-21,['Ongoing'],,,(No results available),,,{'spon_id': 'ITM202004'},['BE'],,,0,0
1297,2020-001500-41,['Ongoing'],,,(No results available),,,{'spon_id': 'COV-AID'},['BE'],,,0,0
1298,2020-001723-13,['Ongoing'],,,(No results available),,,{'spon_id': '405'},['FR'],,,0,0
1299,2020-001198-55,['Ongoing'],,,(No results available),,,{'spon_id': 'KronLungesyg_COVID_19_protokol_2'},['DK'],,,0,0
1300,2020-001686-36,['Ongoing'],,,(No results available),,,{'spon_id': '2020-21'},['FR'],,,0,0
1301,2020-001823-15,['Ongoing'],,,(No results available),,,{'spon_id': '20CH089'},['FR'],,,0,0
1302,2020-001678-31,['Ongoing'],,,(No results available),,,{'spon_id': 'APHP200462'},['FR'],,,0,0
1303,2020-001364-29,['Ongoing'],,,(No results available),,,{'spon_id': 'AdiQure/COVID-19'},['ES'],,,0,0
1304,2020-001722-66,['Ongoing'],,,(No results available),,,{'spon_id': 'REP_COVID'},['ES'],,,0,0
1305,2020-001505-22,['Ongoing'],,,(No results available),,,{'spon_id': 'BST-COVID-01'},['ES'],,,0,0
1306,2020-001717-20,['Ongoing'],,,(No results available),,,{'spon_id': 'COVIDIOL'},['ES'],,,0,0
1307,2020-001541-39,['Ongoing'],,,(No results available),,,{'spon_id': 'BEVACOR'},['ES'],,,0,0
1308,2020-001618-39,['Ongoing'],,,(No results available),,,{'spon_id': 'CL08-ORY-2001_COVID-19'},['ES'],,,0,0
1309,2020-001408-41,['Ongoing'],,,(No results available),,,{'spon_id': 'UKF-MIT-2020-01'},['DE'],,,0,0
1310,2020-001345-38,['Ongoing'],,,(No results available),,,{'spon_id': 'UNIKINON-01/HOPE'},['GR'],,,0,0
1311,2020-001700-42,['Ongoing'],,,(No results available),,,{'spon_id': 'APHP200410'},['FR'],,,0,0
1312,2020-001635-27,['Ongoing'],,,(No results available),,,{'spon_id': 'AB20001'},['FR'],,,0,0
1313,2020-001766-11,['Ongoing'],,,(No results available),,,{'spon_id': '2020-24'},['FR'],,,0,0
1314,2020-001370-30,"['Ongoing', 'Ongoing', 'Ongoing', 'Ongoing', 'Ongoing', 'Ongoing']",,,(No results available),,,{'spon_id': 'CACZ885D2310'},"['DE', 'GB', 'FR', 'ES', 'HU', 'IT']",,,0,0
1315,2020-001370-30,"['Ongoing', 'Ongoing', 'Ongoing', 'Ongoing', 'Ongoing', 'Ongoing']",,,(No results available),,,{'spon_id': 'CACZ885D2310'},"['DE', 'GB', 'FR', 'ES', 'HU', 'IT']",,,0,0
1316,2020-001709-21,['Ongoing'],,,(No results available),,,{'spon_id': '2020PI073'},['FR'],,,0,0
1317,2020-001768-27,['Ongoing'],,,(No results available),,,{'spon_id': 'P20/07'},['FR'],,,0,0
1318,2020-001598-66,['Ongoing'],,,(No results available),,,{'spon_id': 'P20/06'},['FR'],,,0,0
1319,2020-001909-22,['Ongoing'],,,(No results available),,,{'spon_id': 'APHP200461'},['FR'],,,0,0
1320,2020-001449-38,['Ongoing'],,,(No results available),,,{'spon_id': 'CW002'},['GB'],,,0,0
1321,2020-001786-36,['Ongoing'],,,(No results available),,,{'spon_id': 'ILIAD-7-UK-Cohort'},['GB'],,,0,0
1322,2020-001632-10,['Ongoing'],,,(No results available),,,{'spon_id': 'SARS-CoV-2CP-HD-001'},['DE'],,,0,0
1323,2020-001740-26,['Ongoing'],,,(No results available),,,{'spon_id': 'ATOMIC2'},['GB'],,,0,0
1324,2020-001721-31,['Ongoing'],,,(No results available),,,{'spon_id': 'SPON-AK-0420'},['GB'],,,0,0
1325,2020-001783-28,['Ongoing'],,,(No results available),,,{'spon_id': 'BCG-COVID_HU_001'},['HU'],,,0,0
1326,2020-001882-36,['Ongoing'],,,(No results available),,,{'spon_id': 'ACHIEVE'},['GR'],,,0,0
1327,2020-001206-35,['Ongoing'],,,(No results available),,,{'spon_id': 'ACEI-COVID-19'},['AT'],,,0,0
1328,2020-000705-86,['Ongoing'],,,(No results available),,,{'spon_id': '01-2020'},['ES'],,,0,0
1329,2020-001891-14,['Ongoing'],,,(No results available),,,{'spon_id': 'Heparin-SARS-CoV2'},['ES'],,,0,0
1330,2020-001825-29,['Ongoing'],,,(No results available),,,{'spon_id': 'ANA-COVID-GEAS'},['ES'],,,0,0
1331,2020-002032-69,['Ongoing'],,,(No results available),,,{'spon_id': 'COVITOZ-01'},['ES'],,,0,0
1332,2020-001697-30,['Ongoing'],,,(No results available),,,{'spon_id': 'COVIDNA'},['ES'],,,0,0
1333,2020-001603-16,['Ongoing'],,,(No results available),,,{'spon_id': 'COLCHI-COVID'},['ES'],,,0,0
1334,2020-001375-32,['Ongoing'],,,(No results available),,,{'spon_id': 'PreToVid'},['NL'],,,0,0
1335,2020-001994-66,['Ongoing'],,,(No results available),,,{'spon_id': 'ECIT-PRO19'},['ES'],,,0,0
1336,2020-001934-37,['Ongoing'],,,(No results available),,,{'spon_id': 'GLUCOCOVID'},['ES'],,,0,0
1337,2020-002123-11,['Ongoing'],,,(No results available),,,{'spon_id': 'HUIS-04-2020'},['ES'],,,0,0
1338,2020-001474-29,['Ongoing'],,,(No results available),,,{'spon_id': 'SAINT'},['ES'],,,0,0
1339,2020-001696-32,['Ongoing'],,,(No results available),,,{'spon_id': 'GC2004'},['ES'],,,0,0
1340,2020-001953-36,['Ongoing'],,,(No results available),,,{'spon_id': 'GC2005'},['ES'],,,0,0
1341,2020-001643-13,['Ongoing'],,,(No results available),,,{'spon_id': '01.01.20'},['GB'],,,0,0
1342,2020-001805-21,['Ongoing'],,,(No results available),,,{'spon_id': 'RA486120'},['GB'],,,0,0
1343,2020-001614-38,['Ongoing'],,,(No results available),,,{'spon_id': 'S63935'},['BE'],,,0,0
1344,2020-001770-30,['Ongoing'],,,(No results available),,,{'spon_id': '2020COVID-19TCZ'},['BE'],,,0,0
1345,2020-001888-90,['Ongoing'],,,(No results available),,,{'spon_id': '20201504'},['DK'],,,0,0
1346,2020-001995-13,['Ongoing'],,,(No results available),,,{'spon_id': 'BREATH-19'},['ES'],,,0,0
1347,2020-002274-28,['Ongoing'],,,(No results available),,,{'spon_id': 'COVID-VIT-D'},['ES'],,,0,0
1348,2020-001704-42,['Ongoing'],,,(No results available),,,{'spon_id': 'SANsinCOVID'},['ES'],,,0,0
1349,2020-001807-18,['Ongoing'],,,(No results available),,,{'spon_id': '0188'},['GB'],,,0,0
1350,2020-001644-25,"['Ongoing', 'Ongoing', 'Ongoing', 'Ongoing']",,,(No results available),,,{'spon_id': 'D822FC00001/ACE-ID-201'},"['FR', 'DE', 'ES', 'SE']",,,0,0
1351,2020-001573-78,['Ongoing'],,,(No results available),,,{'spon_id': '87RI20_0012'},['FR'],,,0,0
1352,2020-001754-21,['Ongoing'],,,(No results available),,,{'spon_id': '2020-23'},['FR'],,,0,0
1353,2020-001536-98,['Prematurely Ended'],,,(No results available),,,{'spon_id': 'PREPSARS'},['ES'],,,0,0
1354,2020-001673-75,['Ongoing'],,,(No results available),,,{'spon_id': 'ABX464-401'},['FR'],,,0,0
1355,2020-001497-30,"['Ongoing', 'Ongoing', 'Ongoing']",,,(No results available),,,{'spon_id': 'ALXN1210-COV-305'},"['GB', 'FR', 'ES']",,,0,0
1356,2020-001739-28,['Ongoing'],,,(No results available),,,{'spon_id': 'S63979'},['BE'],,,0,0
1357,2020-001870-32,"['Ongoing', 'Ongoing']",,,(No results available),,,{'spon_id': 'CDFV890D12201'},"['HU', 'DK']",,,0,0
1358,2020-001623-13,['Ongoing'],,,(No results available),,,{'spon_id': 'T3inj-02/Thy-Support'},['GR'],,,0,0
1359,2020-001264-28,"['Ongoing', 'Ongoing', 'Ongoing', 'Ongoing']",,,(No results available),,,"{'nct_id': 'NCT04379271', 'spon_id': 'P2-IMU-838-COV'}","['DE', 'BG', 'GR', 'HU']",,,0,0
1360,2020-002448-21,['Ongoing'],,,(No results available),,,"{'nct_id': 'NCT04414267', 'spon_id': 'ACTIVATEII'}",['GR'],,,0,0
1361,2020-002287-31,['Ongoing'],,,(No results available),,,{'spon_id': 'PREVICHARM'},['ES'],,,0,0
1362,2020-001734-36,['Ongoing'],,,(No results available),,,{'spon_id': 'DR200111'},['FR'],,,0,0
1363,2020-002037-15,['Ongoing'],,,(No results available),,,{'spon_id': 'SARTRE'},['ES'],,,0,0
1364,2020-001960-28,['Ongoing'],,,(No results available),,,{'spon_id': 'RCTVITD/SARS-CoV-19'},['ES'],,,0,0
1365,2020-001841-38,['Ongoing'],,,(No results available),,,{'spon_id': 'Col-VID'},['ES'],,,0,0
1366,2020-001420-34,['Ongoing'],,,(No results available),,,{'spon_id': '0001'},['DK'],,,0,0
1367,2020-001684-89,['Ongoing'],,,(No results available),,,"{'isrctn': 'ISRCTN40580903', 'nct_id': 'NCT12345678', 'spon_id': 'RG_20-030'}",['GB'],,,0,0
1368,2020-001411-25,"['Ongoing', 'Ongoing', 'Ongoing', 'Ongoing']",,,(No results available),,,{'spon_id': 'XPORT-COV-1001'},"['DE', 'AT', 'GB', 'ES']",,,0,0
1369,2020-001732-10,['Ongoing'],,,(No results available),,,{'spon_id': 'KKS-278'},['DE'],,,0,0
1370,2020-001296-33,['Ongoing'],,,(No results available),,,{'spon_id': 'COMBAT-COVID-19'},['DK'],,,0,0
1371,2020-001605-23,['Ongoing'],,,(No results available),,,{'spon_id': 'HUA-COVID-19'},['ES'],,,0,0
1372,2020-002312-43,['Ongoing'],,,(No results available),,,{'spon_id': '01052020'},['ES'],,,0,0
1373,2020-001671-32,['Ongoing'],,,(No results available),,,{'spon_id': 'STS-BDB001-04'},['ES'],,,0,0
1374,2020-001759-42,"['Ongoing', 'Ongoing', 'Ongoing', 'Ongoing']",,,(No results available),,,{'spon_id': '214094'},"['GB', 'NL', 'ES', 'BE']",,,0,0
1375,2020-001597-30,['Ongoing'],,,(No results available),,,{'spon_id': 'MRx-4DP0004-II-001'},['GB'],,,0,0
1376,2020-001546-19,['Ongoing'],,,(No results available),,,{'spon_id': 'ARGX-117-2001'},['BE'],,,0,0
1377,2020-002111-22,['Ongoing'],,,(No results available),,,{'spon_id': 'BCG/COVID-19/UR/04/2020'},['PL'],,,0,0
1378,2020-001904-41,['Ongoing'],,,(No results available),,,{'spon_id': 'GETAFIX-2020'},['GB'],,,0,0
1379,2020-002091-12,['Ongoing'],,,(No results available),,,{'spon_id': 'HUVE-19-CT-001'},['BG'],,,0,0
1380,2020-001675-33,['Ongoing'],,,(No results available),,,{'spon_id': 'VPM1002-DE-3.07CoV'},['DE'],,,0,0
1381,2020-001849-39,['Ongoing'],,,(No results available),,,{'spon_id': 'NETs-C19'},['SE'],,,0,0
1382,2020-001264-28,"['Ongoing', 'Ongoing', 'Ongoing', 'Ongoing']",,,(No results available),,,"{'nct_id': 'NCT04379271', 'spon_id': 'P2-IMU-838-COV'}","['DE', 'BG', 'GR', 'HU']",,,0,0
1383,2020-001951-42,['Ongoing'],,,(No results available),,,{'spon_id': 'ReCOVery-SIRIO'},['PL'],,,0,0
1384,2020-001038-36,['Ongoing'],,,(No results available),,,{'spon_id': 'BNT162-01'},['DE'],,,0,0
1385,2020-002130-33,['Ongoing'],,,(No results available),,,{'spon_id': 'ZILU-COV'},['BE'],,,0,0
1386,2020-001310-38,['Ongoing'],,,(No results available),,,{'spon_id': 'CAPSID2020-DRK-BSD'},['DE'],,,0,0
1387,2020-001257-51,['Temporarily Halted'],,,(No results available),,,{'spon_id': '220322020'},['DK'],,,0,0
1388,2020-001363-85,['Prematurely Ended'],,,(No results available),,,{'spon_id': '60152610\u202c'},['DK'],,,0,0
1389,2020-001270-29,"['Temporarily Halted', 'Prematurely Ended', 'Temporarily Halted', 'Temporarily Halted', 'Prematurely Ended']",,,(No results available),,,{'spon_id': 'EFC16858'},"['DK', 'CZ', 'DE', 'GB', 'FR']",,,0,0
1390,2020-001376-15,['Ongoing'],,,(No results available),,,{'spon_id': 'VPM1002-DE-3.06CoV'},['DE'],,,0,0
1391,2020-001411-25,"['Ongoing', 'Ongoing', 'Ongoing', 'Ongoing']",,,(No results available),,,{'spon_id': 'XPORT-COV-1001'},"['DE', 'AT', 'GB', 'ES']",,,0,0
1392,2020-001498-63,['Ongoing'],,,(No results available),,,{'spon_id': 'BIO101-CL05'},['BE'],,,0,0
1393,2020-001264-28,"['Ongoing', 'Ongoing', 'Ongoing', 'Ongoing']",,,(No results available),,,"{'nct_id': 'NCT04379271', 'spon_id': 'P2-IMU-838-COV'}","['DE', 'BG', 'GR', 'HU']",,,0,0
1394,2020-001937-11,['Ongoing'],,,(No results available),,,{'spon_id': '132333'},['GB'],,,0,0
1395,2020-001244-26,['Ongoing'],,,(No results available),,,{'spon_id': 'COV-2-SOLNATIDE-20'},['AT'],,,0,0
1396,2020-001243-15,['Completed'],,,(No results available),,,{'spon_id': 'S63874'},['BE'],,,0,0
1397,2020-001411-25,"['Ongoing', 'Ongoing', 'Ongoing', 'Ongoing']",,,(No results available),,,{'spon_id': 'XPORT-COV-1001'},"['DE', 'AT', 'GB', 'ES']",,,0,0
1398,2020-001636-95,['Ongoing'],,,(No results available),,,{'spon_id': '282110'},['GB'],,,0,0
1399,2020-001481-11,['Ongoing'],,,(No results available),,,"{'nct_id': 'NCT04338958', 'spon_id': 'RuxCoFlam'}",['DE'],,,0,0
1400,2020-002293-28,['Ongoing'],,,(No results available),,,{'spon_id': '2020-002293-28'},['SE'],,,0,0
1401,2020-001889-10,['Ongoing'],,,(No results available),,,{'spon_id': 'STOIC'},['GB'],,,0,0
1402,2020-002120-37,['Ongoing'],,,(No results available),,,{'spon_id': 'RESP301-002'},['GB'],,,0,0
1403,2020-001644-25,"['Ongoing', 'Ongoing', 'Ongoing', 'Ongoing']",,,(No results available),,,{'spon_id': 'D822FC00001/ACE-ID-201'},"['FR', 'DE', 'ES', 'SE']",,,0,0
1404,2020-002233-15,['Ongoing'],,,(No results available),,,{'spon_id': 'NICCAM-001'},['DE'],,,0,0
1405,2020-001784-88,['Ongoing'],,,(No results available),,,{'spon_id': 'WHO-FIN-COVID-19'},['FI'],,,0,0
1406,2020-001497-30,"['Ongoing', 'Ongoing', 'Ongoing']",,,(No results available),,,{'spon_id': 'ALXN1210-COV-305'},"['GB', 'FR', 'ES']",,,0,0
1407,2020-001736-95,['Ongoing'],,,(No results available),,,"{'spon_id': 'ACCORD-2-001,Sub2,3,4,6,5,8'}",['GB'],,,0,0
1408,2020-001512-26,['Restarted'],,,(No results available),,,"{'nct_id': 'NCT04340544', 'spon_id': 'COMIHY'}",['DE'],,,0,0
1409,2020-001767-86,['Ongoing'],,,(No results available),,,{'spon_id': 'COVIRL-002'},['IE'],,,0,0
1410,2020-001777-71,['Ongoing'],,,(No results available),,,{'spon_id': 'RAVEN'},['GB'],,,0,0
1411,2020-001435-27,['Ongoing'],,,(No results available),,,"{'nct_id': 'NCT04356495', 'spon_id': 'CHUBX2020/12'}",['FR'],,,0,0
1412,2020-001513-20,['Ongoing'],,,(No results available),,,"{'nct_id': 'NCT04335201', 'spon_id': 'DEFI-VID19'}",['IT'],,,0,0
1413,2020-001745-40,['Ongoing'],,,(No results available),,,{'spon_id': 'COVID-SARI-001'},['IT'],,,0,0
1414,2020-001501-24,['Ongoing'],,,(No results available),,,{'spon_id': 'IRST100.47'},['IT'],,,0,0
1415,2020-001390-76,['Ongoing'],,,(No results available),,,{'spon_id': 'ESCAPE'},['IT'],,,0,0
1416,2020-001228-32,['Ongoing'],,,(No results available),,,{'spon_id': 'COV002'},['GB'],,,0,0
1417,2020-001528-32,['Ongoing'],,,(No results available),,,{'spon_id': 'ARCO-Homestudy'},['IT'],,,0,0
1418,2020-001987-28,['Ongoing'],,,(No results available),,,{'spon_id': 'PRECOV'},['IT'],,,0,0
1419,2020-001172-15,"['Ongoing', 'Ongoing', 'Ongoing', 'Ongoing']",,,(No results available),,,{'spon_id': 'APN01-01-COVID19'},"['DE', 'DK', 'AT', 'GB']",,,0,0
1420,2020-001921-30,['Ongoing'],,,(No results available),,,{'spon_id': 'STAUNCH-19'},['IT'],,,0,0
1421,2020-001795-15,['Ongoing'],,,(No results available),,,{'spon_id': 'COMBAT-19'},['IT'],,,0,0
1422,2020-001854-23,['Ongoing'],,,(No results available),,,{'spon_id': 'AMMURAVID'},['IT'],,,0,0
1423,2020-001558-23,['Ongoing'],,,(No results available),,,{'spon_id': 'COFID19-AIFA17/2020'},['IT'],,,0,0
1424,ISRCTN14966673,Recruiting,,2021-04-01,,,,"{'eudract_number': 'Nil known', 'ctgov_number': 'Nil known', 'other_id': 'RHM MED1696, IRAS 280621'}",,http://isrctn.com/ISRCTN14966673,2021-04-01,0,0
1425,ISRCTN14326006,Recruiting,,2022-01-30,,,,"{'eudract_number': 'Nil known', 'ctgov_number': 'Nil known', 'other_id': 'HEROs Protocol 1.1'}",,,2022-01-30,0,0
1426,ISRCTN16912075,Recruiting,,2021-05-05,,,,"{'eudract_number': 'Nil known', 'ctgov_number': 'Nil known', 'other_id': 'Sponsor: 26/19-20, IRAS 282338'}",,http://isrctn.com/ISRCTN16912075,2021-05-05,0,0
1427,ISRCTN13311119,No longer recruiting,,2020-06-26,,,,"{'eudract_number': 'Nil known', 'ctgov_number': 'Nil known', 'other_id': 'NV-05-943-2020'}",,http://isrctn.com/ISRCTN13311119,2020-06-26,0,0
1428,ISRCTN17898730,No longer recruiting,,2020-12-20,,,,"{'eudract_number': 'Nil known', 'ctgov_number': 'Nil known', 'other_id': '2020-20'}",,http://isrctn.com/ISRCTN17898730,2020-12-20,0,0
1429,ISRCTN83971151,Recruiting,,2021-03-25,,,,"{'eudract_number': 'Nil known', 'ctgov_number': 'Nil known', 'other_id': '0003361'}",,http://isrctn.com/ISRCTN83971151,2021-03-25,0,0
1430,ISRCTN40580903,Recruiting,,2021-05-01,,,,"{'eudract_number': '2020-001684-85', 'ctgov_number': 'Nil known', 'other_id': 'RG_20-030, CPMS 45648, IRAS 282431'}",,http://isrctn.com/ISRCTN40580903,2021-05-01,0,0
1431,ISRCTN85216856,Recruiting,,2020-12-31,,,,"{'eudract_number': 'Nil known', 'ctgov_number': 'Nil known', 'other_id': 'Nil known'}",,http://isrctn.com/ISRCTN85216856,2020-12-31,0,0
1432,ISRCTN44152751,Suspended,,2020-09-30,,,,"{'eudract_number': 'Nil known', 'ctgov_number': 'Nil known', 'other_id': 'Nil known'}",,http://isrctn.com/ISRCTN44152751,2020-09-30,0,0
1433,ISRCTN15254871,Recruiting,,2020-12-15,,,,"{'eudract_number': 'Nil known', 'ctgov_number': 'Nil known', 'other_id': '2020/185'}",,http://isrctn.com/ISRCTN15254871,2020-12-15,0,0
1434,ISRCTN13447477,Recruiting,,2020-07-30,,,,"{'eudract_number': 'Nil known', 'ctgov_number': 'Nil known', 'other_id': 'IRAS 283182'}",,http://isrctn.com/ISRCTN13447477,2020-07-30,0,0
1435,ISRCTN30564012,Recruiting,,2020-12-31,,,,"{'eudract_number': '2020-001643-13', 'ctgov_number': 'Nil known', 'other_id': '01.01.20, IRAS 281986, CPMS 45682'}",,http://isrctn.com/ISRCTN30564012,2020-12-31,0,0
1436,ISRCTN50212645,Recruiting,,2021-04-30,,,,"{'eudract_number': 'Nil known', 'ctgov_number': 'Nil known', 'other_id': 'CTU/2020/353, IRAS 283014'}",,http://isrctn.com/ISRCTN50212645,2021-04-30,0,0
1437,ISRCTN11188345,Recruiting,,2022-05-01,,,,"{'eudract_number': '2020-001354-22', 'ctgov_number': 'NCT04390464', 'other_id': 'CCTU0303; IRAS 282213'}",,,2022-05-01,0,0
1438,ISRCTN88057279,Recruiting,,2025-05-03,,,,"{'eudract_number': '2020-002016-48', 'ctgov_number': 'Nil known', 'other_id': 'CCTU0307, IRAS282317'}",,http://isrctn.com/ISRCTN88057279,2025-05-03,0,0
1439,ISRCTN99248812,No longer recruiting,,2020-07-10,,,,"{'eudract_number': 'Nil known', 'ctgov_number': 'Nil known', 'other_id': 'R69810/RE001'}",,http://isrctn.com/ISRCTN99248812,2020-07-10,0,0
1440,ISRCTN12107048,Recruiting,,2021-04-30,,,,"{'eudract_number': 'Nil known', 'ctgov_number': 'Nil known', 'other_id': 'Version 2.0 18.05.2020'}",,http://isrctn.com/ISRCTN12107048,2021-04-30,0,0
1441,ISRCTN11384058,No longer recruiting,,2020-06-15,,,,"{'eudract_number': 'Nil known', 'ctgov_number': 'Nil known', 'other_id': 'CoV-2-GOASUR-SWALIS2020-FP1'}",,http://isrctn.com/ISRCTN11384058,2020-06-15,0,0
1442,ISRCTN43900695,Suspended,,2022-04-06,,,,"{'eudract_number': 'Nil known', 'ctgov_number': 'Nil known', 'other_id': 'Nil known'}",,http://isrctn.com/ISRCTN43900695,2022-04-06,0,0
1443,ISRCTN59048638,Recruiting,,2020-11-30,,,,"{'eudract_number': 'Nil known', 'ctgov_number': 'Nil known', 'other_id': 'Nil known'}",,http://isrctn.com/ISRCTN59048638,2020-11-30,0,0
1444,ISRCTN89951424,Recruiting,,2021-07-31,,,,"{'eudract_number': 'Nil known', 'ctgov_number': 'Nil known', 'other_id': 'COV003'}",,http://isrctn.com/ISRCTN89951424,2021-07-31,0,0
1445,ISRCTN94091479,Recruiting,,2021-12-31,,,,"{'eudract_number': 'Nil known', 'ctgov_number': 'Nil known', 'other_id': 'CPMS 45854, IRAS 249030'}",,http://isrctn.com/ISRCTN94091479,2021-12-31,0,0
1446,ISRCTN33578935,Recruiting,,2020-12-31,,,,"{'eudract_number': '2020-002326-90', 'ctgov_number': 'Nil known', 'other_id': '89081'}",,http://isrctn.com/ISRCTN33578935,2020-12-31,0,0
1447,ISRCTN40302986,Recruiting,,2020-07-24,,,,"{'eudract_number': 'Nil known', 'ctgov_number': 'Nil known', 'other_id': 'Nil known'}",,http://isrctn.com/ISRCTN40302986,2020-07-24,0,0
1448,ISRCTN21363594,Recruiting,,2020-12-29,,2020 protocol in https://doi.org/10.1186/s13063-020-04454-4 (added 10/06/2020),,"{'eudract_number': 'Nil known', 'ctgov_number': 'Nil known', 'other_id': 'KSMC-IRB-H1R1-29-Apr20-01'}",,http://isrctn.com/ISRCTN21363594,2020-12-29,0,1
1449,ISRCTN54917435,Recruiting,,2021-06-25,,,,"{'eudract_number': 'Nil known', 'ctgov_number': 'Nil known', 'other_id': '1'}",,http://isrctn.com/ISRCTN54917435,2021-06-25,0,0
1450,ISRCTN17072692,Recruiting,,2021-07-31,,,,"{'eudract_number': '2020-001646-20', 'ctgov_number': 'Nil known', 'other_id': 'IRAS 279315'}",,http://isrctn.com/ISRCTN17072692,2021-07-31,0,0
1451,ISRCTN86534580,Recruiting,,2021-03-24,,,,"{'eudract_number': '2020-001209-22', 'ctgov_number': 'Nil known', 'other_id': 'IRAS 281958'}",,http://isrctn.com/ISRCTN86534580,2021-03-24,0,0
1452,ISRCTN37530113,Recruiting,,2021-05-31,,,,"{'eudract_number': 'Nil known', 'ctgov_number': 'Nil known', 'other_id': 'Samarbeidsorganet mellom Helse Midt-Norge RHF project nr 90023600'}",,http://isrctn.com/ISRCTN37530113,2021-05-31,0,0
1453,CTRI/2020/03/024402,Not Yet Recruiting,,,,,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID¬†</b></font></td>
<td><font color=""white""><b>Identifier¬†</b></font></td>
</tr>, <tr>
<td>NIL¬†</td>
<td>NIL¬†</td>
</tr>]",,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42638,,0,0
1454,CTRI/2020/04/024479,Not Yet Recruiting,,,,,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID¬†</b></font></td>
<td><font color=""white""><b>Identifier¬†</b></font></td>
</tr>, <tr>
<td>NIL¬†</td>
<td>NIL¬†</td>
</tr>]",,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42713,,0,0
1455,CTRI/2020/04/024659,Completed,,,,,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID¬†</b></font></td>
<td><font color=""white""><b>Identifier¬†</b></font></td>
</tr>, <tr>
<td>NIL¬†</td>
<td>NIL¬†</td>
</tr>]",,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42967,,0,0
1456,CTRI/2020/04/024731,Not Yet Recruiting,,,,,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID¬†</b></font></td>
<td><font color=""white""><b>Identifier¬†</b></font></td>
</tr>, <tr>
<td>NIL¬†</td>
<td>NIL¬†</td>
</tr>]",,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42912,,0,0
1457,CTRI/2020/04/024729,Not Yet Recruiting,,,,,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID¬†</b></font></td>
<td><font color=""white""><b>Identifier¬†</b></font></td>
</tr>, <tr>
<td>NIL¬†</td>
<td>NIL¬†</td>
</tr>]",,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42933,,0,0
1458,CTRI/2020/04/024747,Not Yet Recruiting,,,,"Mouli TC, Davuluri A, Vijaya S, Priyanka AD, Mishra SK. Effectiveness of simulation based teaching of ventilatory management among non-anaesthesiology residents to manage COVID 19 pandemic - A quasi experimental cross sectional pilot study. Indian J Anaesth 2020;64:S136-40. ",,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID¬†</b></font></td>
<td><font color=""white""><b>Identifier¬†</b></font></td>
</tr>, <tr>
<td>NIL¬†</td>
<td>NIL¬†</td>
</tr>]",,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43115,,0,1
1459,CTRI/2020/04/024775,Not Yet Recruiting,,,,,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID¬†</b></font></td>
<td><font color=""white""><b>Identifier¬†</b></font></td>
</tr>, <tr>
<td>NIL¬†</td>
<td>NIL¬†</td>
</tr>]",,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43149,,0,0
1460,CTRI/2020/04/024749,Not Yet Recruiting,,,,,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID¬†</b></font></td>
<td><font color=""white""><b>Identifier¬†</b></font></td>
</tr>, <tr>
<td>NIL¬†</td>
<td>NIL¬†</td>
</tr>]",,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42972,,0,0
1461,CTRI/2020/04/024806,Open to Recruitment,,,,,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID¬†</b></font></td>
<td><font color=""white""><b>Identifier¬†</b></font></td>
</tr>, <tr>
<td>NIL¬†</td>
<td>NIL¬†</td>
</tr>]",,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42843,,0,0
1462,CTRI/2020/04/024804,Open to Recruitment,,,,,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID¬†</b></font></td>
<td><font color=""white""><b>Identifier¬†</b></font></td>
</tr>, <tr>
<td>NIL¬†</td>
<td>NIL¬†</td>
</tr>]",,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42849,,0,0
1463,CTRI/2020/04/024776,Open to Recruitment,,,,,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID¬†</b></font></td>
<td><font color=""white""><b>Identifier¬†</b></font></td>
</tr>, <tr>
<td>NIL¬†</td>
<td>NIL¬†</td>
</tr>]",,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43160,,0,0
1464,CTRI/2020/04/024833,Not Yet Recruiting,,,,,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID¬†</b></font></td>
<td><font color=""white""><b>Identifier¬†</b></font></td>
</tr>, <tr>
<td>NIL¬†</td>
<td>NIL¬†</td>
</tr>]",,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43105,,0,0
1465,CTRI/2020/04/024846,Open to Recruitment,,,,,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID¬†</b></font></td>
<td><font color=""white""><b>Identifier¬†</b></font></td>
</tr>, <tr>
<td>NIL¬†</td>
<td>NIL¬†</td>
</tr>]",,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43004,,0,0
1466,CTRI/2020/04/024857,Not Yet Recruiting,,,,,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID¬†</b></font></td>
<td><font color=""white""><b>Identifier¬†</b></font></td>
</tr>, <tr>
<td>NIL¬†</td>
<td>NIL¬†</td>
</tr>]",,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43212,,0,0
1467,CTRI/2020/04/024858,Not Yet Recruiting,,,,,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID¬†</b></font></td>
<td><font color=""white""><b>Identifier¬†</b></font></td>
</tr>, <tr>
<td>NIL¬†</td>
<td>NIL¬†</td>
</tr>]",,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43236,,0,0
1468,CTRI/2020/04/024882,Not Yet Recruiting,,,,,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID¬†</b></font></td>
<td><font color=""white""><b>Identifier¬†</b></font></td>
</tr>, <tr>
<td>NIL¬†</td>
<td>NIL¬†</td>
</tr>]",,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42899,,0,0
1469,CTRI/2020/04/024904,Not Yet Recruiting,,,,,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID¬†</b></font></td>
<td><font color=""white""><b>Identifier¬†</b></font></td>
</tr>, <tr>
<td>NIL¬†</td>
<td>NIL¬†</td>
</tr>]",,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43130,,0,0
1470,CTRI/2020/04/024883,Open to Recruitment,,,,,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID¬†</b></font></td>
<td><font color=""white""><b>Identifier¬†</b></font></td>
</tr>, <tr>
<td>NIL¬†</td>
<td>NIL¬†</td>
</tr>]",,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43168,,0,0
1471,CTRI/2020/04/024915,Not Yet Recruiting,,,,,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID¬†</b></font></td>
<td><font color=""white""><b>Identifier¬†</b></font></td>
</tr>, <tr>
<td>NIL¬†</td>
<td>NIL¬†</td>
</tr>]",,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43332,,0,0
1472,CTRI/2020/04/024948,Not Yet Recruiting,,,,,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID¬†</b></font></td>
<td><font color=""white""><b>Identifier¬†</b></font></td>
</tr>, <tr>
<td>NIL¬†</td>
<td>NIL¬†</td>
</tr>]",,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43364,,0,0
1473,CTRI/2020/04/024949,Not Yet Recruiting,,,,,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID¬†</b></font></td>
<td><font color=""white""><b>Identifier¬†</b></font></td>
</tr>, <tr>
<td>NIL¬†</td>
<td>NIL¬†</td>
</tr>]",,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43400,,0,0
1474,CTRI/2020/04/024947,Not Yet Recruiting,,,,,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID¬†</b></font></td>
<td><font color=""white""><b>Identifier¬†</b></font></td>
</tr>, <tr>
<td>NIL¬†</td>
<td>NIL¬†</td>
</tr>]",,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43259,,0,0
1475,CTRI/2020/05/024967,Not Yet Recruiting,,,,,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID¬†</b></font></td>
<td><font color=""white""><b>Identifier¬†</b></font></td>
</tr>, <tr>
<td>NIL¬†</td>
<td>NIL¬†</td>
</tr>]",,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43338,,0,0
1476,CTRI/2020/05/024959,Open to Recruitment,,,,,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID¬†</b></font></td>
<td><font color=""white""><b>Identifier¬†</b></font></td>
</tr>, <tr>
<td>NIL¬†</td>
<td>NIL¬†</td>
</tr>]",,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42878,,0,0
1477,CTRI/2020/05/024969,Not Yet Recruiting,,,,,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID¬†</b></font></td>
<td><font color=""white""><b>Identifier¬†</b></font></td>
</tr>, <tr>
<td>NIL¬†</td>
<td>NIL¬†</td>
</tr>]",,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43393,,0,0
1478,CTRI/2020/05/024962,Not Yet Recruiting,,,,,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID¬†</b></font></td>
<td><font color=""white""><b>Identifier¬†</b></font></td>
</tr>, <tr>
<td>NIL¬†</td>
<td>NIL¬†</td>
</tr>]",,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43237,,0,0
1479,CTRI/2020/05/024981,Not Yet Recruiting,,,,,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID¬†</b></font></td>
<td><font color=""white""><b>Identifier¬†</b></font></td>
</tr>, <tr>
<td>NIL¬†</td>
<td>NIL¬†</td>
</tr>]",,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43374,,0,0
1480,CTRI/2020/05/024983,Not Yet Recruiting,,,,,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID¬†</b></font></td>
<td><font color=""white""><b>Identifier¬†</b></font></td>
</tr>, <tr>
<td>NIL¬†</td>
<td>NIL¬†</td>
</tr>]",,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43204,,0,0
1481,CTRI/2020/05/024986,Not Yet Recruiting,,,,,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID¬†</b></font></td>
<td><font color=""white""><b>Identifier¬†</b></font></td>
</tr>, <tr>
<td>NIL¬†</td>
<td>NIL¬†</td>
</tr>]",,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43455,,0,0
1482,CTRI/2020/05/025013,Not Yet Recruiting,,,,,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID¬†</b></font></td>
<td><font color=""white""><b>Identifier¬†</b></font></td>
</tr>, <tr>
<td>NIL¬†</td>
<td>NIL¬†</td>
</tr>]",,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=42858,,0,0
1483,CTRI/2020/05/025022,Not Yet Recruiting,,,,,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID¬†</b></font></td>
<td><font color=""white""><b>Identifier¬†</b></font></td>
</tr>, <tr>
<td>NIL¬†</td>
<td>NIL¬†</td>
</tr>]",,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43183,,0,0
1484,CTRI/2020/05/025067,Not Yet Recruiting,,,,,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID¬†</b></font></td>
<td><font color=""white""><b>Identifier¬†</b></font></td>
</tr>, <tr>
<td>NIL¬†</td>
<td>NIL¬†</td>
</tr>]",,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43019,,0,0
1485,CTRI/2020/05/025049,Not Yet Recruiting,,,,,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID¬†</b></font></td>
<td><font color=""white""><b>Identifier¬†</b></font></td>
</tr>, <tr>
<td>NIL¬†</td>
<td>NIL¬†</td>
</tr>]",,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43313,,0,0
1486,CTRI/2020/05/025069,Not Yet Recruiting,,,,,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID¬†</b></font></td>
<td><font color=""white""><b>Identifier¬†</b></font></td>
</tr>, <tr>
<td>NIL¬†</td>
<td>NIL¬†</td>
</tr>]",,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43522,,0,0
1487,CTRI/2020/05/025068,Not Yet Recruiting,,,,,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID¬†</b></font></td>
<td><font color=""white""><b>Identifier¬†</b></font></td>
</tr>, <tr>
<td>NIL¬†</td>
<td>NIL¬†</td>
</tr>]",,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43449,,0,0
1488,CTRI/2020/05/025071,Not Yet Recruiting,,,,,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID¬†</b></font></td>
<td><font color=""white""><b>Identifier¬†</b></font></td>
</tr>, <tr>
<td>NIL¬†</td>
<td>NIL¬†</td>
</tr>]",,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43447,,0,0
1489,CTRI/2020/05/025088,Not Yet Recruiting,,,,,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID¬†</b></font></td>
<td><font color=""white""><b>Identifier¬†</b></font></td>
</tr>, <tr>
<td>NIL¬†</td>
<td>NIL¬†</td>
</tr>]",,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43555,,0,0
1490,CTRI/2020/05/025093,Not Yet Recruiting,,,,,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID¬†</b></font></td>
<td><font color=""white""><b>Identifier¬†</b></font></td>
</tr>, <tr>
<td>NIL¬†</td>
<td>NIL¬†</td>
</tr>]",,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43539,,0,0
1491,CTRI/2020/05/025114,Open to Recruitment,,,,,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID¬†</b></font></td>
<td><font color=""white""><b>Identifier¬†</b></font></td>
</tr>, <tr>
<td>NIL¬†</td>
<td>NIL¬†</td>
</tr>]",,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43504,,0,0
1492,CTRI/2020/05/025156,Not Yet Recruiting,,,,,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID¬†</b></font></td>
<td><font color=""white""><b>Identifier¬†</b></font></td>
</tr>, <tr>
<td>NIL¬†</td>
<td>NIL¬†</td>
</tr>]",,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43590,,0,0
1493,CTRI/2020/05/025162,Not Yet Recruiting,,,,,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID¬†</b></font></td>
<td><font color=""white""><b>Identifier¬†</b></font></td>
</tr>, <tr>
<td>NIL¬†</td>
<td>NIL¬†</td>
</tr>]",,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43650,,0,0
1494,CTRI/2020/05/025161,Open to Recruitment,,,,,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID¬†</b></font></td>
<td><font color=""white""><b>Identifier¬†</b></font></td>
</tr>, <tr>
<td>NIL¬†</td>
<td>NIL¬†</td>
</tr>]",,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43442,,0,0
1495,CTRI/2020/05/025166,Not Yet Recruiting,,,,,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID¬†</b></font></td>
<td><font color=""white""><b>Identifier¬†</b></font></td>
</tr>, <tr>
<td>NIL¬†</td>
<td>NIL¬†</td>
</tr>]",,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43553,,0,0
1496,CTRI/2020/05/025178,Not Yet Recruiting,,,,,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID¬†</b></font></td>
<td><font color=""white""><b>Identifier¬†</b></font></td>
</tr>, <tr>
<td>NIL¬†</td>
<td>NIL¬†</td>
</tr>]",,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43557,,0,0
1497,CTRI/2020/05/025167,Open to Recruitment,,,,,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID¬†</b></font></td>
<td><font color=""white""><b>Identifier¬†</b></font></td>
</tr>, <tr>
<td>NIL¬†</td>
<td>NIL¬†</td>
</tr>]",,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43378,,0,0
1498,CTRI/2020/05/025171,Not Yet Recruiting,,,,,,"[<tr bgcolor=""#004080"">
<td><font color=""white""><b>Secondary ID¬†</b></font></td>
<td><font color=""white""><b>Identifier¬†</b></font></td>
</tr>, <tr>
<td>NIL¬†</td>
<td>NIL¬†</td>
</tr>]",,http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43487,,0,0
1499,DRKS00021447,Recruiting planned,,,,"[{'document_type': 'Approval of ethics comm. (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=b9e5f46a-f347-48b2-90e3-fe4b70c1b05b&LOCALE=en&FILENAME=069_20 Enghard 2.pdf'}, {'document_type': 'trial protocol (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=1d92a04f-6b19-480d-a798-3202d917284d&LOCALE=en&FILENAME=Studienprotokoll CytoResc1.pdf'}]",,"[{'id_type': 'Universal Trial Number (UTN)', 'registry': None, 'secondary_id': 'U1111-1250-8875'}]",,http://www.drks.de/DRKS00021447,,0,1
1500,DRKS00021420,Recruiting ongoing,,,,"[{'document_type': 'trial protocol (mandatory for transfer to Studybox)', 'link_to_document': 'https://www.drks.de/drks_web/AttachmentDownstreamServlet?ID=575eb75e-6a49-456f-a8cc-2db0bbc02711&LOCALE=en&FILENAME=3_Protokoll.pdf'}]",,,,http://www.drks.de/DRKS00021420,,0,1
1501,DRKS00021527,Enrolling by invitation,,,,,,,,http://www.drks.de/DRKS00021527,,0,0
1502,DRKS00021573,Recruiting ongoing,,,,,,"[{'id_type': 'EudraCT-No. (for studies acc. to Drug Law)', 'registry': None, 'secondary_id': '2020-001470-30'}]",,http://www.drks.de/DRKS00021573,,0,0
1503,DRKS00021585,Recruiting ongoing,,,,,,,,http://www.drks.de/DRKS00021585,,0,0
1504,DRKS00021588,Recruiting ongoing,,,,,,,,http://www.drks.de/DRKS00021588,,0,0
1505,DRKS00021582,Recruiting planned,,,,,,,,http://www.drks.de/DRKS00021582,,0,0
1506,DRKS00021214,Recruiting ongoing,,,,,,,,http://www.drks.de/DRKS00021214,,0,0
1507,DRKS00021153,Recruiting ongoing,,,,,,,,http://www.drks.de/DRKS00021153,,0,0
1508,DRKS00021301,Recruiting ongoing,,,,,,,,http://www.drks.de/DRKS00021301,,0,0
1509,DRKS00021300,Recruiting ongoing,,,,,,"[{'id_type': 'Primary Registry-ID', 'registry': 'clinicaltrials.gov', 'secondary_id': 'NCT04324528'}, {'id_type': 'Other Secondary-ID', 'registry': 'Hauptstudie', 'secondary_id': 'DRKS00021248'}]",,,,0,0
1510,DRKS00021273,Recruiting ongoing,,,,,,,,http://www.drks.de/DRKS00021273,,0,0
1511,DRKS00022067,Recruiting planned,,,,,,,,http://www.drks.de/DRKS00022067,,0,0
1512,DRKS00022083,Recruiting ongoing,,,,,,,,http://www.drks.de/DRKS00022083,,0,0
1513,DRKS00021732,Recruiting planned,,,,,,"[{'id_type': 'EudraCT-No. (for studies acc. to Drug Law)', 'registry': None, 'secondary_id': '2020-001431-27'}]",,http://www.drks.de/DRKS00021732,,0,0
1514,DRKS00021706,Enrolling by invitation,,,,,,,,http://www.drks.de/DRKS00021706,,0,0
1515,IRCT20200310046736N1,Not yet recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46424,,0,0
1516,IRCT20151113025025N3,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46531,,0,0
1517,IRCT20100228003449N30,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46536,,0,0
1518,IRCT20100228003449N28,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46538,,0,0
1519,IRCT20100228003449N27,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46545,,0,0
1520,IRCT20200316046792N1,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46554,,0,0
1521,IRCT20151227025726N12,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46561,,0,0
1522,IRCT20170117032004N3,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46564,,0,0
1523,IRCT20100228003449N29,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46567,,0,0
1524,IRCT20200317046797N1,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46573,,0,0
1525,IRCT20160625028622N1,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46576,,0,0
1526,IRCT20120826010664N6,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46603,,0,0
1527,IRCT20131113015393N6,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46609,,0,0
1528,IRCT20140528017891N8,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46623,,0,0
1529,IRCT20200321046828N1,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46624,,0,0
1530,IRCT20190727044343N1,Recruitment complete,,2020-04-09,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46629,2020-04-09,0,0
1531,IRCT20140617018126N2,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46637,,0,0
1532,IRCT20150914024017N1,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46665,,0,0
1533,IRCT20140911019125N6,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46668,,0,0
1534,IRCT20160316027081N1,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46678,,0,0
1535,IRCT20151227025726N13,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46681,,0,0
1536,IRCT20160310026998N11,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46690,,0,0
1537,IRCT20160310026998N10,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46693,,0,0
1538,IRCT20180610040049N3,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46697,,0,0
1539,IRCT20200324046847N1,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46720,,0,0
1540,IRCT20140907019073N4,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46736,,0,0
1541,IRCT20200324046850N5,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46751,,0,0
1542,IRCT20200325046860N1,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46759,,0,0
1543,IRCT20101219005416N2,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46775,,0,0
1544,IRCT20200317046797N2,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46786,,0,0
1545,IRCT20200325046860N2,Recruitment complete,,2020-04-29,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46789,2020-04-29,0,0
1546,IRCT20170611034452N11,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46803,,0,0
1547,IRCT20190917044805N2,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46804,,0,0
1548,IRCT20120225009124N4,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46810,,0,0
1549,IRCT20180802040678N4,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46824,,0,0
1550,IRCT20150704023055N2,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46837,,0,0
1551,IRCT20200319046819N1,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46838,,0,0
1552,IRCT20200314046764N1,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46533,,0,0
1553,IRCT20150303021315N17,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46550,,0,0
1554,IRCT20200312046749N1,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46551,,0,0
1555,IRCT20190727044343N2,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46639,,0,0
1556,IRCT20171122037571N2,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46660,,0,0
1557,IRCT20200324046850N2,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46713,,0,0
1558,IRCT20200323046841N1,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46715,,0,0
1559,IRCT20200322046833N1,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46731,,0,0
1560,IRCT20160131026298N2,Recruitment complete,,2020-03-24,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46733,2020-03-24,0,0
1561,IRCT20190804044429N1,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46741,,0,0
1562,IRCT20160313027033N2,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46762,,0,0
1563,IRCT20200204046369N1,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46776,,0,0
1564,IRCT20180712040449N2,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46782,,0,0
1565,IRCT20130812014333N145,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46790,,0,0
1566,IRCT20200325046859N1,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46811,,0,0
1567,IRCT20161204031229N3,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46814,,0,0
1568,IRCT20151228025732N51,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46828,,0,0
1569,IRCT20130917014693N10,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46849,,0,0
1570,IRCT20180610040049N4,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46850,,0,0
1571,IRCT20130812014333N147,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46853,,0,0
1572,IRCT20081019001369N2,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46868,,0,0
1573,IRCT20200402046923N1,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46879,,0,0
1574,IRCT20200328046886N1,Recruitment complete,,2020-05-04,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46885,2020-05-04,0,0
1575,IRCT20131215015805N2,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46887,,0,0
1576,IRCT20200404046933N1,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46893,,0,0
1577,IRCT20200404046937N1,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46903,,0,0
1578,IRCT20080901001157N16,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46907,,0,0
1579,IRCT20200404046934N1,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46913,,0,0
1580,IRCT20200403046926N1,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46926,,0,0
1581,IRCT20151228025732N53,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46931,,0,0
1582,IRCT20130306012728N8,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46932,,0,0
1583,IRCT20180429039463N2,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46933,,0,0
1584,IRCT20200404046935N1,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46940,,0,0
1585,IRCT20151227025726N14,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46942,,0,0
1586,IRCT20200405046958N1,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46946,,0,0
1587,IRCT20200406046965N1,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46958,,0,0
1588,IRCT20200405046960N1,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46961,,0,0
1589,IRCT20200318046812N2,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46968,,0,0
1590,IRCT20200317046797N4,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46969,,0,0
1591,IRCT20200404046948N1,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46973,,0,0
1592,IRCT20180520039738N2,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46974,,0,0
1593,IRCT20081019001369N4,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46977,,0,0
1594,IRCT20081019001369N3,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46978,,0,0
1595,IRCT20200408046992N1,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47006,,0,0
1596,IRCT20200408046987N1,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47012,,0,0
1597,IRCT20180129038542N1,Recruitment complete,,2020-04-13,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47013,2020-04-13,0,0
1598,IRCT20200317046797N3,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47014,,0,0
1599,IRCT20200317046797N5,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47015,,0,0
1600,IRCT20200404046937N2,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47016,,0,0
1601,IRCT20180923041093N5,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47018,,0,0
1602,IRCT20160131026298N3,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47019,,0,0
1603,IRCT20200406046968N1,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47021,,0,0
1604,IRCT20150808023559N20,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47022,,0,0
1605,IRCT20130616013690N7,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47034,,0,0
1606,IRCT20200410047009N1,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47052,,0,0
1607,IRCT20200409047007N1,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47058,,0,0
1608,IRCT20200408046990N1,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47061,,0,0
1609,IRCT20200217046526N2,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,,,0,0
1610,IRCT20200411047025N1,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47078,,0,0
1611,IRCT20080901001165N46,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47087,,0,0
1612,IRCT20200406046963N1,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47088,,0,0
1613,IRCT20190122042450N4,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47090,,0,0
1614,IRCT20200411047030N1,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47099,,0,0
1615,IRCT20200406046968N2,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47115,,0,0
1616,IRCT20200413047053N1,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47139,,0,0
1617,IRCT20081019001369N5,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47141,,0,0
1618,IRCT20200408046988N1,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47142,,0,0
1619,IRCT20200413047062N1,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47146,,0,0
1620,IRCT20191125045492N2,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47149,,0,0
1621,IRCT20200406046968N3,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47152,,0,0
1622,IRCT20200413047063N1,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47156,,0,0
1623,IRCT20200413047052N1,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47160,,0,0
1624,IRCT20200414047072N1,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47163,,0,0
1625,IRCT20200414047070N1,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47169,,0,0
1626,IRCT20170210032478N3,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47173,,0,0
1627,IRCT20200415047082N1,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47193,,0,0
1628,IRCT20200413047056N1,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47212,,0,0
1629,IRCT20200418047116N1,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47219,,0,0
1630,IRCT20200415047089N1,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47234,,0,0
1631,IRCT20200415047092N1,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47244,,0,0
1632,IRCT20200416047104N1,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47251,,0,0
1633,IRCT20200417047113N1,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47264,,0,0
1634,IRCT20200416047099N1,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47266,,0,0
1635,IRCT20200418047122N1,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47268,,0,0
1636,IRCT20200418047121N2,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47275,,0,0
1637,IRCT20140407017169N2,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47295,,0,0
1638,IRCT20200329046892N1,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47300,,0,0
1639,IRCT20080901001165N48,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47318,,0,0
1640,IRCT20151222025660N2,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47319,,0,0
1641,IRCT20200420047147N1,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47334,,0,0
1642,IRCT20200421047155N1,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47387,,0,0
1643,IRCT20080901001165N49,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47401,,0,0
1644,IRCT20200422047168N1,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47437,,0,0
1645,IRCT20200408046990N2,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47468,,0,0
1646,IRCT20180114038350N3,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47475,,0,0
1647,IRCT20200426047206N1,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47495,,0,0
1648,IRCT20120215009014N353,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47501,,0,0
1649,IRCT20140305016852N4,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47508,,0,0
1650,IRCT20180425039414N2,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47516,,0,0
1651,IRCT20200427047215N1,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47520,,0,0
1652,IRCT20121216011763N46,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47529,,0,0
1653,IRCT20200426047212N1,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47572,,0,0
1654,IRCT20080901001165N50,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47576,,0,0
1655,IRCT20080901001165N51,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47577,,0,0
1656,IRCT20200418047121N1,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47578,,0,0
1657,IRCT20150808023559N21,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47594,,0,0
1658,IRCT20200501047258N1,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47629,,0,0
1659,IRCT20131129015584N2,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47639,,0,0
1660,IRCT20080901001165N52,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47641,,0,0
1661,IRCT20160706028815N5,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47682,,0,0
1662,IRCT20171213037866N2,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47684,,0,0
1663,IRCT20200326046868N1,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47934,,0,0
1664,IRCT20200508047346N1,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47953,,0,0
1665,IRCT20200509047366N1,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,,,0,0
1666,IRCT20120215009014N354,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/48043,,0,0
1667,IRCT20200128046294N2,Recruitment complete,,2020-05-18,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46463,2020-05-18,0,0
1668,IRCT20200314046774N1,Recruitment complete,,2020-06-13,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46519,2020-06-13,0,0
1669,IRCT20200324046850N3,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46718,,0,0
1670,IRCT20180923041093N3,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46721,,0,0
1671,IRCT20180923041093N4,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46728,,0,0
1672,IRCT20200324046850N1,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46732,,0,0
1673,IRCT20200318046812N1,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46783,,0,0
1674,IRCT20190810044500N5,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46867,,0,0
1675,IRCT20200401046909N1,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,,,0,0
1676,IRCT20180725040596N2,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46897,,0,0
1677,IRCT20200404046947N1,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46904,,0,0
1678,IRCT20151228025732N52,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46963,,0,0
1679,IRCT20081027001411N3,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46975,,0,0
1680,IRCT20091201002804N12,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/46983,,0,0
1681,IRCT20200401046909N2,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,,,0,0
1682,IRCT20200217046526N1,Recruitment complete,,2020-04-25,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47030,2020-04-25,0,0
1683,IRCT20200411047016N1,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47044,,0,0
1684,IRCT20190727044343N3,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47062,,0,0
1685,IRCT20200223046586N2,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47091,,0,0
1686,IRCT20081019001369N6,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47188,,0,0
1687,IRCT20091012002582N21,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47197,,0,0
1688,IRCT20200325046859N2,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47200,,0,0
1689,IRCT20190418043307N1,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47209,,0,0
1690,IRCT20200411047019N1,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47279,,0,0
1691,IRCT20150303021315N19,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47335,,0,0
1692,IRCT20080901001165N59,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47477,,0,0
1693,IRCT20200209046427N1,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47504,,0,0
1694,IRCT20200428047228N1,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47559,,0,0
1695,IRCT20200501047259N1,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47609,,0,0
1696,IRCT20200115046144N2,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47645,,0,0
1697,IRCT20131129015584N3,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47665,,0,0
1698,IRCT20150107020592N25,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47666,,0,0
1699,IRCT20200502047268N1,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47692,,0,0
1700,IRCT20200503047280N1,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47704,,0,0
1701,IRCT20200418047126N1,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47707,,0,0
1702,IRCT20200405046951N1,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47722,,0,0
1703,IRCT20170211032494N3,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47735,,0,0
1704,IRCT20081011001323N25,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47935,,0,0
1705,IRCT20200421047150N1,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47964,,0,0
1706,IRCT20180923041093N6,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47974,,0,0
1707,IRCT20200509047360N1,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47979,,0,0
1708,IRCT20140428017469N1,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47989,,0,0
1709,IRCT20200506047323N2,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/47990,,0,0
1710,IRCT20200509047373N1,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/48001,,0,0
1711,IRCT20151227025726N15,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/48018,,0,0
1712,IRCT20150716023235N15,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/48019,,0,0
1713,IRCT20200510047383N1,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/48024,,0,0
1714,IRCT20120215009014N355,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/48039,,0,0
1715,IRCT20200511047396N1,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/48048,,0,0
1716,IRCT20170731035423N2,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/48049,,0,0
1717,IRCT20090609002017N35,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/48058,,0,0
1718,IRCT20080901001165N55,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/48061,,0,0
1719,IRCT20080901001165N53,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/48066,,0,0
1720,IRCT20200428047228N2,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/48096,,0,0
1721,IRCT20080901001165N60,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/48102,,0,0
1722,IRCT20200506047323N1,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/48114,,0,0
1723,IRCT20080901001165N56,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/48116,,0,0
1724,IRCT20200405046960N2,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""subsection"">
<h4 class=""subsection-label"">1</h4>
<dl class=""dl-horizontal dl-subsection"">
<dt class="""">
				Registry name			</dt>
<dd class=""field"">
</dd>
<dt class="""">
				Secondary trial Id			</dt>
<dd class=""field"">
</dd>
<dt class="""">
				Registration date			</dt>
<dd class=""field"">
<div class=""empty-field"">
		empty	</div>
</dd>
</dl>
</div>
</div>
</div>",,http://en.irct.ir/trial/48126,,0,0
1725,IRCT20200516047462N1,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/48141,,0,0
1726,IRCT20151227025726N17,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/48153,,0,0
1727,IRCT20200516047468N1,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/48176,,0,0
1728,IRCT20150107020592N23,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/48185,,0,0
1729,IRCT20160809029275N1,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/48187,,0,0
1730,IRCT20151226025699N3,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/48213,,0,0
1731,IRCT20180608040007N2,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/48218,,0,0
1732,IRCT20200517047485N1,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/48226,,0,0
1733,IRCT20150107020592N22,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/48262,,0,0
1734,IRCT20200518047497N1,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/48289,,0,0
1735,IRCT20200519047510N1,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/48292,,0,0
1736,IRCT20151227025726N18,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/48312,,0,0
1737,IRCT20161206031256N3,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/48329,,0,0
1738,IRCT20080901001165N58,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/48394,,0,0
1739,IRCT20160126026217N4,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/48403,,0,0
1740,IRCT20200422047168N2,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/48444,,0,0
1741,IRCT20200525047562N1,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/48493,,0,0
1742,IRCT20200523047550N1,Recruitment complete,,2020-05-25,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/48495,2020-05-25,0,0
1743,IRCT20150107020592N24,Recruitment complete,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/48534,,0,0
1744,IRCT20200518047497N2,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/48644,,0,0
1745,IRCT20120703010178N20,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/48702,,0,0
1746,IRCT20200412047042N1,recruiting,,,,,,"<div class=""section"">
<h3 id=""trial-secondary_id"">Secondary Ids</h3>
<div class=""section-inner"">
<div class=""empty-section"">
		empty	</div>
</div>
</div>",,http://en.irct.ir/trial/48749,,0,0
1747,NL8633,Open for patient inclusion,,2021-05-01,,,,,,https://trialregister.nl/trial/8633,2021-05-01,0,0
1748,NL8609,Planned,,2020-06-08,,,,,,https://trialregister.nl/trial/8609,2020-06-08,0,0
1749,NL8578,Planned,,2022-07-13,,,,,,https://trialregister.nl/trial/8578,2022-07-13,0,0
1750,NL8577,Planned,,2022-12-31,,,,,,https://trialregister.nl/trial/8577,2022-12-31,0,0
1751,NL8547,Open for patient inclusion,,2022-04-18,,,,,,https://trialregister.nl/trial/8547,2022-04-18,0,0
1752,NL8538,Planned,,2021-04-17,,,,,,https://trialregister.nl/trial/8538,2021-04-17,0,0
1753,NL8523,Planned,,2020-05-31,,,,,,https://trialregister.nl/trial/8523,2020-05-31,0,0
1754,NL8521,Planned,,2020-11-08,,,,,,https://trialregister.nl/trial/8521,2020-11-08,0,0
1755,NL8491,Open for patient inclusion,,2020-06-30,,,,,,https://trialregister.nl/trial/8491,2020-06-30,0,0
1756,NL8490,Open for patient inclusion,,2021-04-12,,,,,,https://trialregister.nl/trial/8490,2021-04-12,0,0
1757,NL8483,Open for patient inclusion,,2020-03-29,,,,,,https://trialregister.nl/trial/8483,2020-03-29,0,0
1758,JPRN-JapicCTI-205238,recruiting,,2020-06-30,,,,,,https://www.clinicaltrials.jp/user/showCteDetailE.jsp?japicId=JapicCTI-205238,2020-06-30,0,0
1759,JPRN-JapicCTI-205270,recruiting,,2021-03-31,,,,,,https://www.clinicaltrials.jp/user/showCteDetailE.jsp?japicId=JapicCTI-205270,2021-03-31,0,0
1760,JPRN-jRCTs031190226,Recruiting,,,,,,,,https://jrct.niph.go.jp/latest-detail/jRCTs031190226,,0,0
1761,JPRN-jRCTs031190227,Suspended,,,,,,,,https://jrct.niph.go.jp/latest-detail/jRCTs031190227,,0,0
1762,JPRN-jRCTs031190269,Recruiting,,,,,,,,https://jrct.niph.go.jp/latest-detail/jRCTs031190269,,0,0
1763,JPRN-jRCTs031200026,Recruiting,,,,,,,,https://jrct.niph.go.jp/latest-detail/jRCTs031200026,,0,0
1764,JPRN-jRCTs032200044,Recruiting,,,,,,,,https://jrct.niph.go.jp/latest-detail/jRCTs032200044,,0,0
1765,JPRN-jRCTs041190120,Not Recruiting,,,,,,,,https://jrct.niph.go.jp/latest-detail/jRCTs041190120,,0,0
1766,JPRN-jRCTs061200002,Recruiting,,,,,,,,https://jrct.niph.go.jp/latest-detail/jRCTs061200002,,0,0
1767,JPRN-UMIN000040235,Open public recruiting,,2021-04-23,,,,,,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045901,2021-04-23,0,0
1768,JPRN-UMIN000040286,Preinitiation,,2020-05-14,,,,,,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045966,2020-05-14,0,0
1769,JPRN-UMIN000040341,No longer recruiting,,2020-05-16,,,,,,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046023,2020-05-16,0,0
1770,JPRN-UMIN000040401,Enrolling by invitation,,2025-03-31,,,,,,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046104,2025-03-31,0,0
1771,JPRN-UMIN000040407,No longer recruiting,,2020-05-20,,,,,,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046108,2020-05-20,0,0
1772,JPRN-UMIN000040479,Open public recruiting,,2020-06-30,,,,,,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046202,2020-06-30,0,0
1773,JPRN-UMIN000040602,Preinitiation,,2020-12-15,,,,,,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046338,2020-12-15,0,0
1774,JPRN-UMIN000040694,Preinitiation,,2021-03-31,,,,,,https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046448,2021-03-31,0,0
1775,KCT0005003,Not yet recruiting  ,2021-03-31,2021-04-21,,,,,,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=16635,2021-03-31,0,0
1776,KCT0005105,Recruiting,2021-04-16,2021-04-16,,,,NCT04330586,,http://cris.nih.go.kr/cris/en/search/search_result_st01.jsp?seq=16795,2021-04-16,0,0
1777,PACTR202004693933092,Not yet recruiting,,2020-06-30,,,,,,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10953,2020-06-30,0,0
1778,PACTR202004761408382,Not yet recruiting,,2020-08-31,,,,,,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10957,2020-08-31,0,0
1779,PACTR202004801273802,Recruiting,,2021-01-15,,,,,,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10928,2021-01-15,0,0
1780,PACTR202004893013257,Not yet recruiting,,2021-04-25,,,,,,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10981,2021-04-25,0,0
1781,PACTR202005599385499,Not yet recruiting,,2020-05-21,,,,,,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10971,2020-05-21,0,0
1782,PACTR202005622389003,Not yet recruiting,,2020-07-15,,,,,,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11053,2020-07-15,0,0
1783,PACTR202005681895696,Not yet recruiting,,2022-05-31,,,,,,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=10988,2022-05-31,0,0
1784,PACTR202006717277937,Not yet recruiting,,2021-02-28,,,,,,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11088,2021-02-28,0,0
1785,PACTR202006899597082,Not yet recruiting,,2020-09-29,,,,,,https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11103,2020-09-29,0,0
1786,RBR-2dxyx4,Not yet recruiting,,2020-06-11,,,,U1111-1252-8144,,http://www.ensaiosclinicos.gov.br/rg/RBR-2dxyx4/,2020-06-11,0,0
1787,RBR-3k4wxb,Not yet recruiting,,2020-11-30,,,,U1111-1250-7492,,http://www.ensaiosclinicos.gov.br/rg/RBR-3k4wxb/,2020-11-30,0,0
1788,RBR-3rdhgm,Recruiting,,2021-04-30,,,,U1111-1251-0203,,http://www.ensaiosclinicos.gov.br/rg/RBR-3rdhgm/,2021-04-30,0,0
1789,RBR-4vm3yy,Recruiting,,2020-05-31,,,,U1111-1251-9286,,http://www.ensaiosclinicos.gov.br/rg/RBR-4vm3yy/,2020-05-31,0,0
1790,RBR-658khm,Recruiting,,2020-12-01,,,,,,http://www.ensaiosclinicos.gov.br/rg/RBR-658khm/,2020-12-01,0,0
1791,RBR-6m69fc,Recruiting,,2020-04-15,,,,U1111-1250-1637,,http://www.ensaiosclinicos.gov.br/rg/RBR-6m69fc/,2020-04-15,0,0
1792,RBR-6w5tbk,Not yet recruiting,,2020-07-31,,,,U1111-1251-0177,,http://www.ensaiosclinicos.gov.br/rg/RBR-6w5tbk/,2020-07-31,0,0
1793,RBR-876qb5,Recruiting,,2020-07-10,,,,,,http://www.ensaiosclinicos.gov.br/rg/RBR-876qb5/,2020-07-10,0,0
1794,RBR-8969zg,Not yet recruiting,,2020-10-14,,,,U1111-1250-3564,,http://www.ensaiosclinicos.gov.br/rg/RBR-8969zg/,2020-10-14,0,0
1795,RBR-949z6v,Recruiting,,2021-05-30,,,,,,http://www.ensaiosclinicos.gov.br/rg/RBR-949z6v/,2021-05-30,0,0
1796,RBR-9d8z6m,Recruitment completed,,2020-05-18,,,,,,http://www.ensaiosclinicos.gov.br/rg/RBR-9d8z6m/,2020-05-18,0,0
1797,RBR-9y32yy,Not yet recruiting,,2021-12-31,,,,U1111-1252-5187,,http://www.ensaiosclinicos.gov.br/rg/RBR-9y32yy/,2021-12-31,0,0
1798,RPCEC00000306,Recruiting,,2020-07-15,,,,,,https://rpcec.sld.cu/en/trials/RPCEC00000306-En,2020-07-15,0,0
1799,RPCEC00000307,Recruiting,,2020-07-30,,,,,,https://rpcec.sld.cu/en/trials/RPCEC00000307-En,2020-07-30,0,0
1800,RPCEC00000308,Pending,,2020-06-09,,,,,,https://rpcec.sld.cu/en/trials/RPCEC00000308-En,2020-06-09,0,0
1801,RPCEC00000309,Pending,,2021-01-15,,,,,,https://rpcec.sld.cu/en/trials/RPCEC00000309-En,2021-01-15,0,0
1802,RPCEC00000311,Recruiting,,2020-07-31,,,,,,https://rpcec.sld.cu/en/trials/RPCEC00000311-En,2020-07-31,0,0
1803,RPCEC00000313,Complete,,2020-04-30,,,,,,https://rpcec.sld.cu/en/trials/RPCEC00000313-En,2020-04-30,0,0
1804,RPCEC00000314,Recruiting,,2020-06-30,,,,,,https://rpcec.sld.cu/en/trials/RPCEC00000314-En,2020-06-30,0,0
1805,RPCEC00000315,Recruiting,,2020-06-30,,,,,,https://rpcec.sld.cu/en/trials/RPCEC00000315-En,2020-06-30,0,0
1806,RPCEC00000316,Pending,,2020-08-10,,,,,,https://rpcec.sld.cu/en/trials/RPCEC00000316-En,2020-08-10,0,0
1807,RPCEC00000317,Pending,,2020-06-29,,,,,,https://rpcec.sld.cu/en/trials/RPCEC00000317-En,2020-06-29,0,0
1808,RPCEC00000320,Pending,,2020-08-23,,,,,,https://rpcec.sld.cu/en/trials/RPCEC00000320-En,2020-08-23,0,0
1809,SLCTR/2020/011,Pending,,2020-05-31,,,,U1111-1251-3613,,https://slctr.lk/trials/slctr-2020-011,2020-05-31,0,0
1810,TCTR20200404004,Pending (Not yet recruiting),2020-07-31,2020-07-31,,,,,,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=5995,2020-07-31,0,0
1811,TCTR20200409006,Pending (Not yet recruiting),2021-05-01,2021-05-01,,,,,,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=6016,2021-05-01,0,0
1812,TCTR20200514001,Pending (Not yet recruiting),2021-03-31,2021-03-31,,,,,,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=6236,2021-03-31,0,0
1813,TCTR20200601002,Recruiting,2020-06-30,2020-06-30,,,,,,http://www.clinicaltrials.in.th/index.php?tp=regtrials&menu=trialsearch&smenu=fulltext&task=search&task2=view1&id=6322,2020-06-30,0,0
1814,ChiCTR2000029947,Not yet recruiting,,2020-06-01,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49599,2020-06-01,0,0
1815,ChiCTR2000029941,Not yet recruiting,,2020-06-01,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49596,2020-06-01,0,0
1816,ChiCTR2000029939,Recruiting,,2021-02-06,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49612,2021-02-06,0,0
1817,ChiCTR2000029935,Recruiting,,2021-02-06,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49607,2021-02-06,0,0
1818,ChiCTR2000029869,Not yet recruiting,,2020-06-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49486,2020-06-30,0,0
1819,ChiCTR2000029867,Recruiting,,2021-02-28,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49514,2021-02-28,0,0
1820,ChiCTR2000029855,Recruiting,,,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49543,,0,0
1821,ChiCTR2000029853,Recruiting,,2020-04-16,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49532,2020-04-16,0,0
1822,ChiCTR2000029850,Recruiting,,2022-02-15,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49533,2022-02-15,0,0
1823,ChiCTR2000029849,Recruiting,,2021-02-01,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49530,2021-02-01,0,0
1824,ChiCTR2000029822,Recruiting,,2020-04-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49502,2020-04-30,0,0
1825,ChiCTR2000029821,Not yet recruiting,,2020-06-01,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49306,2020-06-01,0,0
1826,ChiCTR2000029819,Recruiting,,2020-08-11,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49490,2020-08-11,0,0
1827,ChiCTR2000029814,Recruiting,,2020-12-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49387,2020-12-31,0,0
1828,ChiCTR2000029813,Recruiting,,2020-08-14,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49425,2020-08-14,0,0
1829,ChiCTR2000029811,Not yet recruiting,,2021-02-20,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49355,2021-02-20,0,0
1830,ChiCTR2000029806,Recruiting,,2021-01-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49161,2021-01-31,0,0
1831,ChiCTR2000029790,Recruiting,,2020-10-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49453,2020-10-31,0,0
1832,ChiCTR2000029789,Recruiting,,2021-06-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49348,2021-06-30,0,0
1833,ChiCTR2000029788,Not yet recruiting,,2020-12-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49452,2020-12-30,0,0
1834,ChiCTR2000029778,Recruiting,,2020-05-13,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49422,2020-05-13,0,0
1835,ChiCTR2000029777,Recruiting,,2020-06-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49380,2020-06-30,0,0
1836,ChiCTR2000029776,Recruiting,,2020-12-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49342,2020-12-31,0,0
1837,ChiCTR2000029769,Not yet recruiting,,2020-04-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49415,2020-04-30,0,0
1838,ChiCTR2000029768,Recruiting,,2020-05-12,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49131,2020-05-12,0,0
1839,ChiCTR2000029765,Recruiting,,2020-05-10,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49409,2020-05-10,0,0
1840,ChiCTR2000029763,Recruiting,,2020-05-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49408,2020-05-31,0,0
1841,ChiCTR2000029756,Recruiting,,2022-02-15,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49222,2022-02-15,0,0
1842,ChiCTR2000029747,Recruiting,,2021-02-10,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49287,2021-02-10,0,0
1843,ChiCTR2000029742,Recruiting,,2020-12-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49297,2020-12-31,0,0
1844,ChiCTR2000029741,Recruiting,,2020-12-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49263,2020-12-31,0,0
1845,ChiCTR2000029739,Recruiting,,2021-08-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49283,2021-08-31,0,0
1846,ChiCTR2000029656,Not yet recruiting,,2020-04-14,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49086,2020-04-14,0,0
1847,ChiCTR2000029639,Recruiting,,2020-09-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49187,2020-09-30,0,0
1848,ChiCTR2000029636,Recruiting,,2020-07-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49215,2020-07-30,0,0
1849,ChiCTR2000029621,Recruiting,,2020-12-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49165,2020-12-31,0,0
1850,ChiCTR2000029609,Not yet recruiting,,2020-12-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49145,2020-12-31,0,0
1851,ChiCTR2000029606,Recruiting,,2022-12-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49146,2022-12-31,0,0
1852,ChiCTR2000029603,Recruiting,,2020-05-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49075,2020-05-31,0,0
1853,ChiCTR2000029602,Recruiting,,2020-08-01,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=48985,2020-08-01,0,0
1854,ChiCTR2000029601,Recruiting,,2020-08-01,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=48988,2020-08-01,0,0
1855,ChiCTR2000029600,Recruiting,,2020-04-29,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49042,2020-04-29,0,0
1856,ChiCTR2000029578,Recruiting,,2020-04-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49080,2020-04-30,0,0
1857,ChiCTR2000029572,Recruiting,,2021-04-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=41760,2021-04-30,0,0
1858,ChiCTR2000029569,Not yet recruiting,,2021-04-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49062,2021-04-30,0,0
1859,ChiCTR2000029559,Recruiting,,2020-02-29,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=48880,2020-02-29,0,0
1860,ChiCTR2000029558,Recruiting,,2020-05-01,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=48792,2020-05-01,0,0
1861,ChiCTR2000029548,Not yet recruiting,,2020-06-03,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49015,2020-06-03,0,0
1862,ChiCTR2000029544,Not yet recruiting,,2020-05-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49013,2020-05-31,0,0
1863,ChiCTR2000029542,Recruiting,,2020-07-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=48968,2020-07-30,0,0
1864,ChiCTR2000029541,Not yet recruiting,,2020-12-01,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=48992,2020-12-01,0,0
1865,ChiCTR2000029539,Recruiting,,2021-02-02,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=48991,2021-02-02,0,0
1866,ChiCTR2000029518,Recruiting,,2020-04-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=48860,2020-04-30,0,0
1867,ChiCTR2000029517,Recruiting,,2020-04-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=48861,2020-04-30,0,0
1868,ChiCTR2000029495,Not yet recruiting,,2021-12-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=48971,2021-12-31,0,0
1869,ChiCTR2000029493,Not yet recruiting,,2021-12-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=48931,2021-12-31,0,0
1870,ChiCTR2000029487,Not yet recruiting,,2020-03-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=48965,2020-03-31,0,0
1871,ChiCTR2000029468,Not yet recruiting,,2020-06-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=48919,2020-06-30,0,0
1872,ChiCTR2000029461,Not yet recruiting,,2021-12-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=48927,2021-12-31,0,0
1873,ChiCTR2000029460,Not yet recruiting,,2021-12-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=48930,2021-12-31,0,0
1874,ChiCTR2000029459,Not yet recruiting,,2021-12-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=48929,2021-12-31,0,0
1875,ChiCTR2000029439,Not yet recruiting,,2021-12-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=48904,2021-12-31,0,0
1876,ChiCTR2000029438,Not yet recruiting,,2021-12-01,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=48911,2021-12-01,0,0
1877,ChiCTR2000029436,Not yet recruiting,,2020-12-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=48884,2020-12-31,0,0
1878,ChiCTR2000029435,Not yet recruiting,,2020-03-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=48827,2020-03-31,0,0
1879,ChiCTR2000029432,Not yet recruiting,,2020-04-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=48881,2020-04-30,0,0
1880,ChiCTR2000029431,Recruiting,,2021-12-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=48907,2021-12-31,0,0
1881,ChiCTR2000029418,Recruiting,,2020-08-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=48886,2020-08-31,0,0
1882,ChiCTR2000029400,Recruiting,,2020-12-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=48824,2020-12-31,0,0
1883,ChiCTR2000029381,Completed,,2020-12-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=48768,2020-12-31,0,0
1884,ChiCTR2000030188,Recruiting,,2020-03-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50025,2020-03-30,0,0
1885,ChiCTR2000030179,Recruiting,,2020-04-24,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50059,2020-04-24,0,0
1886,ChiCTR2000030173,Not yet recruiting,,2020-04-17,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49229,2020-04-17,0,0
1887,ChiCTR2000030170,Recruiting,,2020-07-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50017,2020-07-31,0,0
1888,ChiCTR2000030167,Not yet recruiting,,2020-09-01,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49567,2020-09-01,0,0
1889,ChiCTR2000030166,Not yet recruiting,,2020-05-14,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49696,2020-05-14,0,0
1890,ChiCTR2000030165,Recruiting,,2020-12-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49947,2020-12-31,0,0
1891,ChiCTR2000030138,Not yet recruiting,,2020-05-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50004,2020-05-31,0,0
1892,ChiCTR2000030136,Not yet recruiting,,2020-05-15,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50005,2020-05-15,0,0
1893,ChiCTR2000030118,Not yet recruiting,,2020-06-29,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49594,2020-06-29,0,0
1894,ChiCTR2000030117,Recruiting,,2021-12-14,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49762,2021-12-14,0,0
1895,ChiCTR2000030116,Recruiting,,2020-08-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49901,2020-08-31,0,0
1896,ChiCTR2000030113,Recruiting,,2020-05-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49988,2020-05-31,0,0
1897,ChiCTR2000030102,Recruiting,,2020-05-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49747,2020-05-31,0,0
1898,ChiCTR2000030093,Not yet recruiting,,2021-03-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49932,2021-03-31,0,0
1899,ChiCTR2000030090,Not yet recruiting,,2020-03-22,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49910,2020-03-22,0,0
1900,ChiCTR2000030089,Not yet recruiting,,2020-08-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49889,2020-08-31,0,0
1901,ChiCTR2000030088,Not yet recruiting,,2021-12-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49902,2021-12-31,0,0
1902,ChiCTR2000030084,Recruiting,,2022-02-01,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49952,2022-02-01,0,0
1903,ChiCTR2000030058,Not yet recruiting,,2020-05-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49831,2020-05-30,0,0
1904,ChiCTR2000030054,Not yet recruiting,,2020-05-21,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49869,2020-05-21,0,0
1905,ChiCTR2000030046,Recruiting,,2020-08-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49861,2020-08-31,0,0
1906,ChiCTR2000030043,Not yet recruiting,,2020-12-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49866,2020-12-31,0,0
1907,ChiCTR2000030041,Not yet recruiting,,2020-06-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49891,2020-06-30,0,0
1908,ChiCTR2000030039,Recruiting,,2020-02-01,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49544,2020-02-01,0,0
1909,ChiCTR2000030034,Recruiting,,2020-06-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49647,2020-06-30,0,0
1910,ChiCTR2000030033,Not yet recruiting,,2020-06-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49703,2020-06-30,0,0
1911,ChiCTR2000030029,Not yet recruiting,,2020-05-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49824,2020-05-30,0,0
1912,ChiCTR2000030027,Recruiting,,2021-02-18,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49852,2021-02-18,0,0
1913,ChiCTR2000030020,Recruiting,,2022-02-05,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49812,2022-02-05,0,0
1914,ChiCTR2000030016,Recruiting,,2022-12-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49799,2022-12-31,0,0
1915,ChiCTR2000030012,Not yet recruiting,,,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49718,,0,0
1916,ChiCTR2000030010,Not yet recruiting,,2020-05-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49777,2020-05-31,0,0
1917,ChiCTR2000030007,Not yet recruiting,,2020-04-10,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49619,2020-04-10,0,0
1918,ChiCTR2000030006,Recruiting,,2020-05-19,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49737,2020-05-19,0,0
1919,ChiCTR2000030003,Not yet recruiting,,2020-07-01,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49770,2020-07-01,0,0
1920,ChiCTR2000030002,Recruiting,,2020-07-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49738,2020-07-30,0,0
1921,ChiCTR2000030001,Recruiting,,2020-05-28,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49723,2020-05-28,0,0
1922,ChiCTR2000030000,Recruiting,,,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49748,,0,0
1923,ChiCTR2000029999,Not yet recruiting,,,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49717,,0,0
1924,ChiCTR2000029996,Recruiting,,2020-04-20,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49510,2020-04-20,0,0
1925,ChiCTR2000029994,Not yet recruiting,,2020-08-19,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49309,2020-08-19,0,0
1926,ChiCTR2000029992,Not yet recruiting,,2020-05-20,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49574,2020-05-20,0,0
1927,ChiCTR2000029990,Recruiting,,2020-03-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49674,2020-03-31,0,0
1928,ChiCTR2000029989,Not yet recruiting,,2020-05-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49720,2020-05-31,0,0
1929,ChiCTR2000029988,Recruiting,,2020-05-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49218,2020-05-31,0,0
1930,ChiCTR2000029978,Not yet recruiting,,2020-07-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49702,2020-07-31,0,0
1931,ChiCTR2000029974,Recruiting,,2020-08-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49321,2020-08-31,0,0
1932,ChiCTR2000029972,Recruiting,,2020-05-17,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49664,2020-05-17,0,0
1933,ChiCTR2000029960,Not yet recruiting,,2020-05-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49639,2020-05-31,0,0
1934,ChiCTR2000029956,Not yet recruiting,,2020-07-01,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49618,2020-07-01,0,0
1935,ChiCTR2000029954,Recruiting,,2020-02-10,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49402,2020-02-10,0,0
1936,ChiCTR2000029851,Recruiting,,2020-03-10,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49534,2020-03-10,0,0
1937,ChiCTR2000029803,Not yet recruiting,,2021-02-20,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49428,2021-02-20,0,0
1938,ChiCTR2000029781,Recruiting,,2020-06-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49138,2020-06-30,0,0
1939,ChiCTR2000029780,Recruiting,,2020-06-09,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49220,2020-06-09,0,0
1940,ChiCTR2000029740,Recruiting,,2020-02-29,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49317,2020-02-29,0,0
1941,ChiCTR2000030442,Not yet recruiting,,2020-05-15,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50380,2020-05-15,0,0
1942,ChiCTR2000030433,Not yet recruiting,,2020-10-01,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50273,2020-10-01,0,0
1943,ChiCTR2000030432,Not yet recruiting,,2020-08-27,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50268,2020-08-27,0,0
1944,ChiCTR2000030424,Not yet recruiting,,2022-05-02,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50174,2022-05-02,0,0
1945,ChiCTR2000030420,Not yet recruiting,,2020-08-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50286,2020-08-31,0,0
1946,ChiCTR2000030418,Recruiting,,2021-03-01,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50341,2021-03-01,0,0
1947,ChiCTR2000030398,Not yet recruiting,,,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50173,,0,0
1948,ChiCTR2000030386,Not yet recruiting,,2020-12-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50323,2020-12-31,0,0
1949,ChiCTR2000030333,Recruiting,,2020-07-07,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=48801,2020-07-07,0,0
1950,ChiCTR2000030324,Not yet recruiting,,2020-05-28,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50231,2020-05-28,0,0
1951,ChiCTR2000030317,Not yet recruiting,,2021-03-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50247,2021-03-30,0,0
1952,ChiCTR2000030314,Not yet recruiting,,2020-04-28,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50248,2020-04-28,0,0
1953,ChiCTR2000030265,Not yet recruiting,,2021-02-23,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49691,2021-02-23,0,0
1954,ChiCTR2000030261,Not yet recruiting,,2020-05-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49963,2020-05-31,0,0
1955,ChiCTR2000030260,Not yet recruiting,,2021-02-26,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50130,2021-02-26,0,0
1956,ChiCTR2000030259,Recruiting,,2020-04-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49918,2020-04-30,0,0
1957,ChiCTR2000030258,Not yet recruiting,,2020-08-20,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49887,2020-08-20,0,0
1958,ChiCTR2000030255,Not yet recruiting,,2020-07-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50089,2020-07-31,0,0
1959,ChiCTR2000030225,Not yet recruiting,,2020-12-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49945,2020-12-31,0,0
1960,ChiCTR2000030219,Recruiting,,2020-12-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50110,2020-12-31,0,0
1961,ChiCTR2000030218,Recruiting,,2020-06-25,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50115,2020-06-25,0,0
1962,ChiCTR2000030215,Not yet recruiting,,2020-12-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50107,2020-12-31,0,0
1963,ChiCTR2000030196,Not yet recruiting,,2020-05-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49883,2020-05-31,0,0
1964,ChiCTR2000030091,Not yet recruiting,,2020-03-22,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49914,2020-03-22,0,0
1965,ChiCTR2000030022,Not yet recruiting,,2020-05-22,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49797,2020-05-22,0,0
1966,ChiCTR2000030013,Not yet recruiting,,2020-06-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49796,2020-06-30,0,0
1967,ChiCTR2000029991,Recruiting,,2020-07-18,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49666,2020-07-18,0,0
1968,ChiCTR2000029975,Not yet recruiting,,2020-05-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49592,2020-05-31,0,0
1969,ChiCTR2000029899,Recruiting,,2020-04-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49536,2020-04-30,0,0
1970,ChiCTR2000029898,Recruiting,,2020-04-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49482,2020-04-30,0,0
1971,ChiCTR2000029755,Recruiting,,2020-05-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49301,2020-05-30,0,0
1972,ChiCTR2000029387,Recruiting,,2021-01-25,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=48782,2021-01-25,0,0
1973,ChiCTR2000029386,Recruiting,,2021-01-29,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=48777,2021-01-29,0,0
1974,ChiCTR2000030627,Recruiting,,2020-05-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50727,2020-05-30,0,0
1975,ChiCTR2000030578,Not yet recruiting,,2021-02-01,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50690,2021-02-01,0,0
1976,ChiCTR2000030540,Not yet recruiting,,2020-06-08,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50658,2020-06-08,0,0
1977,ChiCTR2000030535,Recruiting,,2020-03-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49790,2020-03-30,0,0
1978,ChiCTR2000030522,Recruiting,,2020-09-09,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=44213,2020-09-09,0,0
1979,ChiCTR2000030518,Recruiting,,2020-05-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50586,2020-05-31,0,0
1980,ChiCTR2000030503,Recruiting,,2022-06-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49632,2022-06-30,0,0
1981,ChiCTR2000030490,Recruiting,,2020-03-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50487,2020-03-31,0,0
1982,ChiCTR2000030487,Recruiting,,2020-05-04,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50507,2020-05-04,0,0
1983,ChiCTR2000030484,Not yet recruiting,,2021-01-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50263,2021-01-31,0,0
1984,ChiCTR2000030481,Recruiting,,2020-04-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50453,2020-04-30,0,0
1985,ChiCTR2000030480,Recruiting,,2020-07-03,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50470,2020-07-03,0,0
1986,ChiCTR2000030479,Not yet recruiting,,2021-02-25,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50450,2021-02-25,0,0
1987,ChiCTR2000030477,Not yet recruiting,,2020-06-25,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50458,2020-06-25,0,0
1988,ChiCTR2000030475,Not yet recruiting,,2020-06-25,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50452,2020-06-25,0,0
1989,ChiCTR2000030472,Recruiting,,2020-06-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49753,2020-06-30,0,0
1990,ChiCTR2000030471,Recruiting,,2020-04-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50421,2020-04-30,0,0
1991,ChiCTR2000030469,Recruiting,,2020-05-27,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50082,2020-05-27,0,0
1992,ChiCTR2000030467,Not yet recruiting,,2020-08-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50378,2020-08-31,0,0
1993,ChiCTR2000029993,Recruiting,,2020-08-20,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49435,2020-08-20,0,0
1994,ChiCTR2000029757,Recruiting,,2021-02-05,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49081,2021-02-05,0,0
1995,ChiCTR2000029580,Recruiting,,2020-12-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49088,2020-12-31,0,0
1996,ChiCTR2000029550,Recruiting,,2020-05-01,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=48775,2020-05-01,0,0
1997,ChiCTR2000029549,Recruiting,,2020-05-01,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49014,2020-05-01,0,0
1998,ChiCTR2000029308,Recruiting,,2021-01-10,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=48684,2021-01-10,0,0
1999,ChiCTR2000030897,Recruiting,,2021-05-01,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50462,2021-05-01,0,0
2000,ChiCTR2000030896,Recruiting,,2021-03-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=51028,2021-03-30,0,0
2001,ChiCTR2000030892,Recruiting,,2020-12-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=51118,2020-12-30,0,0
2002,ChiCTR2000030864,Recruiting,,2020-07-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50662,2020-07-31,0,0
2003,ChiCTR2000030855,Not yet recruiting,,2020-05-01,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=51090,2020-05-01,0,0
2004,ChiCTR2000030853,Not yet recruiting,,2020-05-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=51081,2020-05-31,0,0
2005,ChiCTR2000030849,Not yet recruiting,,2021-03-01,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=51086,2021-03-01,0,0
2006,ChiCTR2000030841,Recruiting,,2020-05-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=51072,2020-05-31,0,0
2007,ChiCTR2000030836,Not yet recruiting,,2020-06-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=51054,2020-06-30,0,0
2008,ChiCTR2000030835,Recruiting,,2021-02-14,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=51050,2021-02-14,0,0
2009,ChiCTR2000030832,Not yet recruiting,,2020-07-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=51044,2020-07-30,0,0
2010,ChiCTR2000030810,Recruiting,,2020-03-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50986,2020-03-30,0,0
2011,ChiCTR2000030804,Recruiting,,2021-03-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=51018,2021-03-31,0,0
2012,ChiCTR2000030779,Recruiting,,2020-05-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50973,2020-05-31,0,0
2013,ChiCTR2000030773,Recruiting,,2020-07-12,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50934,2020-07-12,0,0
2014,ChiCTR2000030761,Not yet recruiting,,2020-04-01,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50956,2020-04-01,0,0
2015,ChiCTR2000030759,Not yet recruiting,,2020-05-17,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49284,2020-05-17,0,0
2016,ChiCTR2000030751,Not yet recruiting,,2020-12-25,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50941,2020-12-25,0,0
2017,ChiCTR2000030744,Recruiting,,2020-08-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50910,2020-08-31,0,0
2018,ChiCTR2000030720,Recruiting,,2020-08-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50793,2020-08-31,0,0
2019,ChiCTR2000030718,Recruiting,,2020-05-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50843,2020-05-30,0,0
2020,ChiCTR2000030703,Recruiting,,2020-05-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50251,2020-05-31,0,0
2021,ChiCTR2000030702,Recruiting,,2020-08-15,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50537,2020-08-15,0,0
2022,ChiCTR2000030701,Not yet recruiting,,2020-09-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50795,2020-09-30,0,0
2023,ChiCTR2000030700,Not yet recruiting,,2020-09-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50786,2020-09-30,0,0
2024,ChiCTR2000030681,Not yet recruiting,,2021-11-16,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50763,2021-11-16,0,0
2025,ChiCTR2000030580,Recruiting,,2020-04-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50693,2020-04-30,0,0
2026,ChiCTR2000030545,Recruiting,,2020-04-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50126,2020-04-30,0,0
2027,ChiCTR2000030476,Recruiting,,2020-07-01,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50455,2020-07-01,0,0
2028,ChiCTR2000030388,Recruiting,,,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50306,,0,0
2029,ChiCTR2000030187,Recruiting,,2020-03-25,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50057,2020-03-25,0,0
2030,ChiCTR2000031139,Recruiting,,2021-03-19,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=51404,2021-03-19,0,0
2031,ChiCTR2000031138,Recruiting,,2020-12-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=51416,2020-12-31,0,0
2032,ChiCTR2000031090,Not yet recruiting,,2022-03-23,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=51148,2022-03-23,0,0
2033,ChiCTR2000031089,Not yet recruiting,,2020-04-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=51136,2020-04-30,0,0
2034,ChiCTR2000031023,Recruiting,,2020-05-16,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50984,2020-05-16,0,0
2035,ChiCTR2000030996,Recruiting,,2020-10-26,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=51349,2020-10-26,0,0
2036,ChiCTR2000030989,Not yet recruiting,,2020-08-08,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=51331,2020-08-08,0,0
2037,ChiCTR2000030946,Recruiting,,2020-04-10,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=51265,2020-04-10,0,0
2038,ChiCTR2000030944,Not yet recruiting,,2020-08-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50199,2020-08-31,0,0
2039,ChiCTR2000030939,Recruiting,,2020-10-01,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=51059,2020-10-01,0,0
2040,ChiCTR2000030933,Not yet recruiting,,2020-12-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=51184,2020-12-31,0,0
2041,ChiCTR2000030929,Not yet recruiting,,2020-06-16,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50696,2020-06-16,0,0
2042,ChiCTR2000030922,Recruiting,,2020-08-26,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=51141,2020-08-26,0,0
2043,ChiCTR2000030920,Recruiting,,2021-05-01,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50476,2021-05-01,0,0
2044,ChiCTR2000030906,Recruiting,,2020-12-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=51154,2020-12-31,0,0
2045,ChiCTR2000030539,Not yet recruiting,,2021-03-05,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50660,2021-03-05,0,0
2046,ChiCTR2000030254,Completed,,2020-03-20,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50137,2020-03-20,0,0
2047,ChiCTR2000029868,Completed,,2020-06-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49524,2020-06-30,0,0
2048,ChiCTR2000029658,Suspending,,2020-04-06,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49074,2020-04-06,0,0
2049,ChiCTR2000029573,Recruiting,,2020-06-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49065,2020-06-30,0,0
2050,ChiCTR2000029496,Recruiting,,2021-01-29,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=48809,2021-01-29,0,0
2051,ChiCTR2000031328,Recruiting,,2020-04-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=51425,2020-04-30,0,0
2052,ChiCTR2000031319,Not yet recruiting,,2020-07-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=51647,2020-07-31,0,0
2053,ChiCTR2000031272,Completed,,2020-03-02,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=51455,2020-03-02,0,0
2054,ChiCTR2000031271,Not yet recruiting,,2021-03-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=51194,2021-03-31,0,0
2055,ChiCTR2000031204,Recruiting,,2020-04-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49420,2020-04-30,0,0
2056,ChiCTR2000031203,Recruiting,,2022-02-28,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=51030,2022-02-28,0,0
2057,ChiCTR2000031196,Recruiting,,2020-12-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=51112,2020-12-31,0,0
2058,ChiCTR2000030988,Not yet recruiting,,2020-05-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=51317,2020-05-31,0,0
2059,ChiCTR2000030940,Not yet recruiting,,2020-06-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=51061,2020-06-30,0,0
2060,ChiCTR2000030937,Recruiting,,2020-08-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=51240,2020-08-30,0,0
2061,ChiCTR2000030936,Recruiting,,2020-05-10,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=51100,2020-05-10,0,0
2062,ChiCTR2000030923,Recruiting,,2020-04-16,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=51139,2020-04-16,0,0
2063,ChiCTR2000030704,Suspending,,2020-03-10,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50778,2020-03-10,0,0
2064,ChiCTR2000030288,Recruiting,,2020-12-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50202,2020-12-31,0,0
2065,ChiCTR2000030198,Not yet recruiting,,2020-08-24,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50066,2020-08-24,0,0
2066,ChiCTR2000030028,Not yet recruiting,,2020-08-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49840,2020-08-31,0,0
2067,ChiCTR2000031639,Not yet recruiting,,2021-03-27,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=51119,2021-03-27,0,0
2068,ChiCTR2000031630,Recruiting,,2020-06-17,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50474,2020-06-17,0,0
2069,ChiCTR2000031540,Recruiting,,2020-12-05,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=51684,2020-12-05,0,0
2070,ChiCTR2000031503,Not yet recruiting,,2022-10-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=51911,2022-10-31,0,0
2071,ChiCTR2000031501,Not yet recruiting,,2020-07-17,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50254,2020-07-17,0,0
2072,ChiCTR2000031494,Recruiting,,2020-12-02,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=51904,2020-12-02,0,0
2073,ChiCTR2000031454,Recruiting,,2021-07-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=51693,2021-07-31,0,0
2074,ChiCTR2000031453,Not yet recruiting,,2020-08-01,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=51859,2020-08-01,0,0
2075,ChiCTR2000031430,Recruiting,,2021-12-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49254,2021-12-31,0,0
2076,ChiCTR2000031834,Not yet recruiting,,2020-10-20,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=52216,2020-10-20,0,0
2077,ChiCTR2000031781,Not yet recruiting,,2021-01-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=52006,2021-01-31,0,0
2078,ChiCTR2000031772,Recruiting,,2020-10-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=52165,2020-10-31,0,0
2079,ChiCTR2000031735,Not yet recruiting,,2021-02-28,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50613,2021-02-28,0,0
2080,ChiCTR2000031734,Recruiting,,2020-05-29,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=52103,2020-05-29,0,0
2081,ChiCTR2000031672,Not yet recruiting,,2020-12-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=51940,2020-12-31,0,0
2082,ChiCTR2000030750,Not yet recruiting,,2021-02-28,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50928,2021-02-28,0,0
2083,ChiCTR2000032098,Recruiting,,2020-07-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=52477,2020-07-31,0,0
2084,ChiCTR2000032013,Completed,,2020-06-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=52483,2020-06-30,0,0
2085,ChiCTR2000032011,Not yet recruiting,,2020-05-17,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=52142,2020-05-17,0,0
2086,ChiCTR2000031955,Recruiting,,2020-12-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=52364,2020-12-31,0,0
2087,ChiCTR2000031944,Recruiting,,2020-12-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=52414,2020-12-31,0,0
2088,ChiCTR2000031888,Recruiting,,2020-11-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=52106,2020-11-30,0,0
2089,ChiCTR2000029976,Recruiting,,2022-02-19,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49631,2022-02-19,0,0
2090,ChiCTR2000029434,Completed,,2020-12-01,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=48889,2020-12-01,0,0
2091,ChiCTR2000029433,Completed,,2020-12-01,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=48898,2020-12-01,0,0
2092,ChiCTR2000032400,Recruiting,,2020-06-01,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=52958,2020-06-01,0,0
2093,ChiCTR2000032399,Recruiting,,2020-07-01,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=52942,2020-07-01,0,0
2094,ChiCTR2000032367,Recruiting,,2020-07-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=52972,2020-07-31,0,0
2095,ChiCTR2000032346,Recruiting,,2020-12-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=52692,2020-12-31,0,0
2096,ChiCTR2000032314,Recruiting,,2020-12-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=52867,2020-12-31,0,0
2097,ChiCTR2000032313,Not yet recruiting,,2020-12-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=52916,2020-12-31,0,0
2098,ChiCTR2000032242,Not yet recruiting,,2021-05-01,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=52824,2021-05-01,0,0
2099,ChiCTR2000032237,Recruiting,,2020-06-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=52699,2020-06-30,0,0
2100,ChiCTR2000032214,Not yet recruiting,,2020-07-10,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=52781,2020-07-10,0,0
2101,ChiCTR2000032205,Not yet recruiting,,2020-07-15,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=52662,2020-07-15,0,0
2102,ChiCTR2000032165,Not yet recruiting,,2021-03-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=52679,2021-03-31,0,0
2103,ChiCTR2000032632,Recruiting,,2020-05-22,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=53190,2020-05-22,0,0
2104,ChiCTR2000032573,Not yet recruiting,,2021-05-01,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=53225,2021-05-01,0,0
2105,ChiCTR2000032487,Not yet recruiting,,2020-09-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=52394,2020-09-30,0,0
2106,ChiCTR2000032459,Recruiting,,2021-11-28,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=53003,2021-11-28,0,0
2107,ChiCTR2000032456,Completed,,2020-05-01,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=53048,2020-05-01,0,0
2108,ChiCTR2000032455,Recruiting,,2021-12-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=53050,2021-12-31,0,0
2109,ChiCTR2000032135,Not yet recruiting,,2020-12-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=52506,2020-12-31,0,0
2110,ChiCTR2000031174,Not yet recruiting,,2020-09-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=51437,2020-09-30,0,0
2111,ChiCTR2000032769,Recruiting,,,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=53368,,0,0
2112,ChiCTR2000032737,Not yet recruiting,,2021-06-08,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=53458,2021-06-08,0,0
2113,ChiCTR2000032717,Completed,,2021-01-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=53322,2021-01-31,0,0
2114,ChiCTR2000032716,Completed,,2020-04-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=53389,2020-04-30,0,0
2115,ChiCTR2000032635,Not yet recruiting,,2021-03-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=52671,2021-03-31,0,0
2116,ChiCTR2000033003,Not yet recruiting,,2022-04-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=53790,2022-04-30,0,0
2117,ChiCTR2000032919,Recruiting,,2021-05-08,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=53274,2021-05-08,0,0
2118,ChiCTR2000032915,Recruiting,,2020-12-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=53658,2020-12-31,0,0
2119,ChiCTR2000030262,Recruiting,,2020-12-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=50136,2020-12-31,0,0
2120,ChiCTR2000029638,Recruiting,,2020-08-01,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49224,2020-08-01,0,0
2121,ChiCTR2000029605,Recruiting,,2021-02-05,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49051,2021-02-05,0,0
2122,ChiCTR2000033133,Completed,,2020-04-20,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=53925,2020-04-20,0,0
2123,ChiCTR2000033057,Recruiting,,2020-09-01,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=53529,2020-09-01,0,0
2124,ChiCTR2000033056,Completed,,2020-04-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=53859,2020-04-30,0,0
2125,ChiCTR2000033049,Recruiting,,2020-12-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=53840,2020-12-31,0,0
2126,ChiCTR2000033433,Not yet recruiting,,2022-04-01,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=54482,2022-04-01,0,0
2127,ChiCTR2000033372,Completed,,2020-05-17,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=54408,2020-05-17,0,0
2128,ChiCTR2000033323,Completed,,2020-05-19,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=54346,2020-05-19,0,0
2129,ChiCTR2000033320,Recruiting,,2020-12-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=54321,2020-12-31,0,0
2130,ChiCTR2000033318,Recruiting,,2020-12-30,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=54326,2020-12-30,0,0
2131,ChiCTR2000033286,Completed,,2020-03-09,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=54176,2020-03-09,0,0
2132,ChiCTR2000033284,Not yet recruiting,,2025-05-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49590,2025-05-31,0,0
2133,ChiCTR2000033261,Completed,,2021-02-08,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=54185,2021-02-08,0,0
2134,ChiCTR2000029479,Completed,,2020-05-01,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=48773,2020-05-01,0,0
2135,ChiCTR2000033627,Not yet recruiting,,2020-07-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=54707,2020-07-31,0,0
2136,ChiCTR2000033491,Completed,,2020-05-12,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=54278,2020-05-12,0,0
2137,ChiCTR2000033774,Not yet recruiting,,2020-12-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=55097,2020-12-31,0,0
2138,ChiCTR2000033936,Recruiting,,2021-06-15,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=55291,2021-06-15,0,0
2139,ChiCTR2000034164,Not yet recruiting,,2021-03-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=55154,2021-03-31,0,0
2140,ChiCTR2000034112,Not yet recruiting,,2021-12-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=55524,2021-12-31,0,0
2141,ChiCTR2000034076,Recruiting,,2022-04-15,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=55582,2022-04-15,0,0
2142,ChiCTR2000029589,Recruiting,,2021-12-31,,,,,,http://www.chictr.org.cn/showproj.aspx?proj=49104,2021-12-31,0,0
2143,ACTRN12620000443998,Not yet recruiting,,2020-12-31,,,,,,https://anzctr.org.au/ACTRN12620000443998.aspx,2020-12-31,0,0
2144,ACTRN12620000448943,Not yet recruiting,,2020-12-01,,,,,,https://anzctr.org.au/ACTRN12620000448943.aspx,2020-12-01,0,0
2145,ACTRN12620000447954,Recruiting,,2020-07-31,,,,,,https://anzctr.org.au/ACTRN12620000447954.aspx,2020-07-31,0,0
2146,ACTRN12620000454976,Not yet recruiting,,2021-03-09,,,,['Protocol Number DT 62996/2020'],,https://anzctr.org.au/ACTRN12620000454976.aspx,2021-03-09,0,0
2147,ACTRN12620000468921,Not yet recruiting,,2020-07-13,,,,,,https://anzctr.org.au/ACTRN12620000468921.aspx,2020-07-13,0,0
2148,ACTRN12620000477921,Not yet recruiting,,2020-04-20,,,,,,https://anzctr.org.au/ACTRN12620000477921.aspx,2020-04-20,0,0
2149,ACTRN12620000472976,Not yet recruiting,,2020-10-13,,,,,,https://anzctr.org.au/ACTRN12620000472976.aspx,2020-10-13,0,0
2150,ACTRN12620000470998,Not yet recruiting,,2020-05-01,,,,['Protocol Number FBP-004'],,https://anzctr.org.au/ACTRN12620000470998.aspx,2020-05-01,0,0
2151,ACTRN12620000473965,Not yet recruiting,,2020-07-31,,,,['BV-2020/19'],,https://anzctr.org.au/ACTRN12620000473965.aspx,2020-07-31,0,0
2152,ACTRN12620000478910,Not yet recruiting,,2020-12-31,,,,,,https://anzctr.org.au/ACTRN12620000478910.aspx,2020-12-31,0,0
2153,ACTRN12620000480987,Not yet recruiting,,2020-07-16,,,,,,https://anzctr.org.au/ACTRN12620000480987.aspx,2020-07-16,0,0
2154,ACTRN12620000417987,Recruiting,,2020-05-11,,,,,,https://anzctr.org.au/ACTRN12620000417987.aspx,2020-05-11,0,0
2155,ACTRN12620000457943,Not yet recruiting,,2021-01-01,,,,['MRINZ/20/01'],,https://anzctr.org.au/ACTRN12620000457943.aspx,2021-01-01,0,0
2156,ACTRN12620000492954,Not yet recruiting,,,,,,,,https://anzctr.org.au/ACTRN12620000492954.aspx,,0,0
2157,ACTRN12620000482965,"Active, not recruiting",,2020-03-18,,,,,,https://anzctr.org.au/ACTRN12620000482965.aspx,2020-03-18,0,0
2158,ACTRN12620000516987,Not yet recruiting,,,,,,,,https://anzctr.org.au/ACTRN12620000516987.aspx,,0,0
2159,ACTRN12620000517976,Not yet recruiting,,2021-05-26,,,,,,https://anzctr.org.au/ACTRN12620000517976.aspx,2021-05-26,0,0
2160,ACTRN12620000524998,Not yet recruiting,,2020-12-01,,,,,,https://anzctr.org.au/ACTRN12620000524998.aspx,2020-12-01,0,0
2161,ACTRN12620000555954,Not yet recruiting,,2020-06-30,,,,,,https://anzctr.org.au/ACTRN12620000555954.aspx,2020-06-30,0,0
2162,ACTRN12620000557932,Not yet recruiting,,2021-05-31,,,,,,https://anzctr.org.au/ACTRN12620000557932.aspx,2021-05-31,0,0
2163,ACTRN12620000566932,Not yet recruiting,,2022-08-03,,,,,,https://anzctr.org.au/ACTRN12620000566932.aspx,2022-08-03,0,0
2164,ACTRN12620000445976,Recruiting,,,,,,,,https://anzctr.org.au/ACTRN12620000445976.aspx,,0,0
2165,ACTRN12620000580976,Not yet recruiting,,,,,,,,https://anzctr.org.au/ACTRN12620000580976.aspx,,0,0
2166,ACTRN12620000588998,Not yet recruiting,,,,,,,,https://anzctr.org.au/ACTRN12620000588998.aspx,,0,0
2167,ACTRN12620000571976,Not yet recruiting,,2020-07-20,,,,,,https://anzctr.org.au/ACTRN12620000571976.aspx,2020-07-20,0,0
2168,ACTRN12620000579998,Not yet recruiting,,2020-06-01,,,,,,https://anzctr.org.au/ACTRN12620000579998.aspx,2020-06-01,0,0
2169,ACTRN12620000612910,Not yet recruiting,,,,,,,,https://anzctr.org.au/ACTRN12620000612910.aspx,,0,0
2170,ACTRN12620000640909,Not yet recruiting,,2020-10-19,,,,,,https://anzctr.org.au/ACTRN12620000640909.aspx,2020-10-19,0,0
2171,ACTRN12620000635965,Not yet recruiting,,2020-08-31,,,,,,https://anzctr.org.au/ACTRN12620000635965.aspx,2020-08-31,0,0
2172,ACTRN12620000636954,Not yet recruiting,,,,,,,,https://anzctr.org.au/ACTRN12620000636954.aspx,,0,0
2173,ACTRN12620000634976,Not yet recruiting,,,,,,,,https://anzctr.org.au/ACTRN12620000634976.aspx,,0,0
2174,ACTRN12620000501943,Recruiting,,2020-12-31,,,,,,https://anzctr.org.au/ACTRN12620000501943.aspx,2020-12-31,0,0
2175,ACTRN12620000500954,Not yet recruiting,,2020-06-01,,,,,,https://anzctr.org.au/ACTRN12620000500954.aspx,2020-06-01,0,0
2176,ACTRN12620000674932,Not yet recruiting,,,,,,['UQ-1-SARS-CoV-2-Sclamp'],,https://anzctr.org.au/ACTRN12620000674932.aspx,,0,0
2177,ACTRN12620000676910,Not yet recruiting,,2021-06-30,,,,,,https://anzctr.org.au/ACTRN12620000676910.aspx,2021-06-30,0,0
2178,ACTRN12620000688987,Completed,,2020-06-05,,,,,,https://anzctr.org.au/ACTRN12620000688987.aspx,2020-06-05,0,0
2179,ACTRN12620000698976,Recruiting,,2020-11-30,,,,,,https://anzctr.org.au/ACTRN12620000698976.aspx,2020-11-30,0,0
2180,ACTRN12620000707965,Not yet recruiting,,2020-09-30,,,,,,https://anzctr.org.au/ACTRN12620000707965.aspx,2020-09-30,0,0
